陈立新
2021年药物和家庭日用化学品领域的PCT专利申请状况——中国占9.6%,美国占40.7%,日本占9.1%,欧洲占17%
2022-11-28 22:09
阅读:1053

陈立新 张琳 黄颖:中美欧日韩五局专利报告3115.doc

武汉大学科教管理与评价研究中心 陈立新 张琳 黄颖

微信号:chenlixinip5

附录2  2021PCT国际专利申请统计分析报告

附录2.7 各技术领域的PCT专利申请状况

附录2.7.5 药物和家庭日用化学品领域的PCT专利申请状况

5个技术领域是药物和家庭日用化学品,主要包括医用配置品和药物制剂,以及盥洗、梳妆和化妆等家庭日用化学品。2021年,该领域的PCT专利申请总计12906项(增长率为6.1%),占总申请量的4.9%,是申请量第1多的领域。

2021年,中国局在药物和家庭日用化学品领域上申请PCT专利1236项,占该领域申请量的9.6%。美国局在该领域上申请专利5256项,份额为40.7%。日本局申请专利1180项,份额为9.1%。欧洲局申请专利2195项,份额为17%

 

附表2.7.5-1  2021年药物和家庭日用化学品领域各专利局的PCT专利申请数量


专利局

申请数量

占本局比例

占领域比例

1

中国

1236

1.8%

9.6%

2

美国

5256

9.4%

40.7%

3

日本

1180

2.5%

9.1%

4

欧洲

2195

5.9%

17.0%

5

韩国

742

4.0%

5.7%

6

国际

862

6.9%

6.7%

7

英国

271

7.9%

2.1%

8

法国

85

3.4%

0.7%

9

加拿大

113

6.1%

0.9%

10

澳大利亚

126

8.2%

1.0%

11

土耳其

152

10.6%

1.2%

12

德国

10

0.7%

0.1%

13

以色列

152

10.9%

1.2%

14

瑞典

24

1.9%

0.2%

15

其他

502

--

3.9%


小计

12906

--

100%

注:本表按照提交PCT国际专利申请的专利局进行统计。

 


附图2.7.5-1  2021年药物和家庭日用化学品领域各专利局的PCT专利申请数量对比

 

2021年,在药物和家庭日用化学品领域上PCT专利申请最多的机构是欧莱雅、加州大学、株式会社资生堂。

 

附表2.7.5-2  2021年药物和家庭日用化学品领域的PCT国际专利申请前10机构


机构名称

国家

机构英文名称

2021

1

欧莱雅

法国

L'OREAL

187

2

加州大学

美国

THE REGENTS OF THE UNIVERSITY OF   CALIFORNIA

142

3

株式会社资生堂

日本

SHISEIDO COMPANY, LTD.

91

4

联合利华知识产权控股私人有限公司

荷兰

UNILEVER IP HOLDINGS B.V.

88

5

汉高股份有限及两合公司

德国

HENKEL AG & CO., KGAA

85

6

宝洁公司

美国

THE PROCTER & GAMBLE COMPANY

72

7

法国国家健康与医学研究院

法国

INSERM (INSTITUT NATIONAL DE LA   SANTé ET DE LA RECHERCHE MéDICALE)

67

8

花王株式会社

日本

KAO CORPORATION

65

9

拜尔斯道夫公司

德国

BEIERSDORF AG

64

10

诺华公司

瑞士

NOVARTIS AG

58

注:本表数据按照第一申请人进行统计。

 


附图2.7.5-2  2021年药物和家庭日用化学品领域的PCT国际专利申请前10机构

 

 

 

 

 

 

 

致谢

感谢大连理工大学刘则渊教授、河南师范大学梁立明教授、科技部中国科学技术发展战略研究院武夷山研究员、大连理工大学丁堃教授、大连理工大学杨中楷教授对本报告的大力支持与帮助。同时,向以不同形式对本报告提出意见和建议的专家学者们表示诚挚的感谢。

如需要中美欧日韩五局及PCT专利数据、专利报告,以及咨询相关专利问题请添加微信号。

微信号:chenlixinip5

 

 

附表  2021年该领域PCT国际专利申请

 

IDTitleApplicant
WO/2021/087536DENTAL FLOSSLENZING PLASTICS GMBH & CO KG
WO/2021/159155COMPOSITIONBENTSEN, Paal
WO/2021/222964IMMUNOGENIC COMPLEXES AND METHODS OF PRODUCING AND USING THE  SAMEESS HOLDING GMBH
WO/2021/222965MANNOSE-BINDING LECTIN FOR TREATMENT OR PROPHYLAXIS OF  INFECTIOUS DISEASESESS HOLDING GMBH
WO/2021/000004METHODS OF TREATING MYOCARDITIS AND/OR CARDIOMYOPATHY AND  REAGENTS THEREFORCELLMID LIMITED
WO/2021/051149BIODEGRADABLE DRUG-POLYMER CONJUGATEPOLYACTIVA PTY LTD
WO/2021/051151ORAL HEALTH IMPROVING PRODUCTSYNDK PTY. LTD.
WO/2021/051153PROTEIN PARTICLES COMPRISING A DIPHTHERIA TOXIN CROSS REACTING  MATERIAL (CRM) AMINO ACID SEQUENCE AND USES THEREOFGRIFFITH UNIVERSITY
WO/2021/056048THERAPEUTIC FORMULATIONS AND USES THEREOFBIONOMICS LIMITED
WO/2021/016652METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND  PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLSTHE UNIVERSITY OF MELBOURNE
WO/2021/127722PHARMACEUTICAL COMPOSITIONSPROTA THERAPEUTICS PTY LTD
WO/2021/174284COMBINATION TREATMENT FOR MICROORGANISMSTHE UNIVERSITY OF ADELAIDE
WO/2021/000013COMPOSITIONS AND METHODS OF USETHE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
WO/2021/000024METHODS AND AAV VECTORS FOR <i>IN VIVO</i>  TRANSDUCTIONCHILDREN'S MEDICAL RESEARCH INSTITUTE
WO/2021/007610INJECTABLE NUTRITIONAL SUPPLEMENTCHEMVET AUSTRALIA PTY LTD
WO/2021/003531PEPTIDES AND USES THEREOFLATERAL IP PTY LTD
WO/2021/003535METHOD FOR GUT MUCOSA PREPARATION TO ENHANCE MICROBIAL  ENGRAFTMENTMILIS, Antony
WO/2021/007618IMMUNO-ONCOLOGY THERAPY USING ISOFLAVONE COMPOUNDSNOXOPHARM LIMITED
WO/2021/007623COMPOSITIONS FOR MAINTAINING OR MODULATING MIXTURES OF ETHER  LIPID MOLECULES IN A TISSUE OF A HUMAN SUBJECTBAKER HEART AND DIABETES INSTITUTE
WO/2021/016663KLF INDUCED CARDIOMYOGENESISVICTOR CHANG CARDIAC RESEARCH INSTITUTE
WO/2021/016668IMMUNOCONJUGATEDENDROCYTE BIOTECH PTY LTD
WO/2021/022336COMPOSITIONS OF PROBIOTICS AND BIOMASS AND METHODS FOR  PROMOTING HEALTH IN A SUBJECTCOMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
WO/2021/022340USES OF LONG-CHAIN POLYUNSATURATED FATTY ACIDSSWINBURNE UNIVERSITY OF TECHNOLOGY
WO/2021/030867METHOD OF MODULATING ADIPOSITYBAKER HEART AND DIABETES INSTITUTE
WO/2021/035289THERAPEUTIC METHODS AND USES THEREOFEUSTRALIS PHARMACEUTICALS LIMITED (TRADING AS PRESSURA NEURO)
WO/2021/035310TARGETED DENDRIMER CONJUGATESSTARPHARMA PTY LTD
WO/2021/042171CANCER IMMUNOTHERAPYENA THERAPEUTICS PTY LTD
WO/2021/042174CANCER TREATMENTENA THERAPEUTICS PTY LTD
WO/2021/042178TREATMENT OF OPIOID WITHDRAWALKINOXIS THERAPEUTICS PTY LTD
WO/2021/056051METHOD AND COMPOSITION FOR THE TREATMENT OF DISEASEDIMERIX BIOSCIENCE PTY LTD
WO/2021/051172LIPID PRODRUGS OF CELECOXIB AND USES THEREOFMONASH UNIVERSITY
WO/2021/056053SILICONE DROPLETSFORMULAE 8 PTY LTD
WO/2021/056056PHARMACEUTICAL COMPOUNDS AND METHODS OF USEDERMCARE-VET PTY LTD
WO/2021/056064TREATMENT OF TAUOPATHIESMACQUARIE UNIVERSITY
WO/2021/056071TREATMENT OF DEMENTIAMACQUARIE UNIVERSITY
WO/2021/056072TREATMENT OF EXCITOTOXICITY-RELATED CONDITIONSMACQUARIE UNIVERSITY
WO/2021/056077THERAPEUTIC DENDRIMERSTARPHARMA PTY LTD
WO/2021/062472MEDICINAL COGNITIVE TREATMENTSACTINOGEN MEDICAL LIMITED
WO/2021/062481COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF  TRAUMATIC BRAIN INJURYINCANNEX HEALTHCARE LIMITED
WO/2021/077162MODULATION OF CELLULAR VIABILITYMACQUARIE UNIVERSITY
WO/2021/077166CONTRAST AGENTSMONASH UNIVERSITY
WO/2021/077174METHODS OF TREATING CANCER USING ANDROGEN RECEPTOR ANTAGONISTSGARVAN INSTITUTE OF MEDICAL RESEARCH
WO/2021/081580TREATMENT OF RENAL CYSTIC DISEASEMONASH UNIVERSITY
WO/2021/081581ANTIBODIES FOR BINDING PLASMINOGENMONASH UNIVERSITY
WO/2021/097537MAGNETIC TRACER COMPOSITIONSFERRONOVA PTY LTD
WO/2021/097538BONE FORMATIONTHE UNIVERSITY OF SYDNEY
WO/2021/097540IMMUNOSTIMULATORY COMPOSITIONS COMPRISING SOLUBLE PARASITE  EXTRACTS AND USES THEREOFGRIFFITH UNIVERSITY
WO/2021/102508METHODS OF TREATING HIV-1 INFECTIONBIOTRON LIMITED
WO/2021/102510METHODS AND PRODUCTS FOR REDUCING SIDE EFFECTS ASSOCIATED WITH  USE OF IMMUNE AGONIST ANTIBODIESSOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE LIMITED
WO/2021/102513LEGIONELLA TREATMENT USING CANNABINOIDSBOTANIX PHARMACEUTICALS LIMITED
WO/2021/102514MORAXELLA TREATMENT USING CANNABINOIDSBOTANIX PHARMACEUTICALS LIMITED
WO/2021/102515ANTIBACTERIAL TREATMENT USING A CANNABINOID AND AN ACTIVE  AGENTBOTANIX PHARMACEUTICALS LIMITED
WO/2021/102516NEISSERIA TREATMENT USING CANNABINOIDSBOTANIX PHARMACEUTICALS LIMITED
WO/2021/108853POLYMER NANOPARTICLESTHE UNIVERSITY OF QUEENSLAND
WO/2021/108855NEUROLOGICALLY ACTIVE FLAVONOID COMPOSITIONS AND METHODS OF  USE THEREOFGRETALS AUSTRALIA PTY LTD
WO/2021/108861TREATMENT OF NEURODEGENERATIVE DISEASES USING ULTRASOUND AND  AMYLOID-BETA ANTIBODIESTHE UNIVERSITY OF QUEENSLAND
WO/2021/108867METHODS OF ACTIVATING CYTOTOXIC LEUKOCYTES USING PTP1B AND  PTPN2 INHIBITORSMONASH UNIVERSITY
WO/2021/108868ANTIGEN LOADINGDENDROCYTE BIOTECH PTY LTD
WO/2021/113912THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND  TREATMENT OF DIASTOLIC DYSFUNCTIONAMBETEX PTY LTD
WO/2021/113914THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND  TREATMENT OF DIASTOLIC DYSFUNCTIONAMBETEX PTY LTD
WO/2021/113917THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND  TREATMENT OF DIASTOLIC DYSFUNCTIONAMBETEX PTY LTD
WO/2021/113926BOTULINUM TOXIN FORMULATIONS AND METHODS FOR INTRANASAL  DELIVERY THEREOF FOR THE TREATMENT OF ALLERGIC RHINITISBARBAGALLO, Francesco
WO/2021/119749TREATMENT OF GASTROINTESTINAL DISEASETHE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/127736ALLERGY TREATMENTPROTA THERAPEUTICS PTY LTD
WO/2021/127749COMPOSITIONS COMPRISING TERPENES AND THEIR USE IN THE  TREATMENT OR ALLEVIATION OF PAIN OR ANXIETYCANNADOL PHARMACEUTICALS LTD
WO/2021/127752CYCLIC PEPTIDE RECEPTOR LANTHIONINE SYNTHETASE C-LIKE PROTEIN  (LANCL) AND USES THEREOFLATERAL IP PTY LTD
WO/2021/222967TREATMENT OF PROLIFERATIVE DISEASES OF THE CNSAUCENTRA THERAPEUTICS PTY LTD
WO/2021/237270METHOD OF TREATING LEUKAEMIAST VINCENT'S HOSPITAL SYDNEY LIMITED
WO/2021/138721SELF-ASSEMBLING, SELF-ADJUVANTING SYSTEM FOR DELIVERY OF  VACCINESTHE UNIVERSITY OF QUEENSLAND
WO/2021/142513COMPOSITIONS AND METHODMONASH UNIVERSITY
WO/2021/142514COMPOSITIONS AND METHODSMONASH UNIVERSITY
WO/2021/142516ORAL PEPTIDE ADMINISTRATIONTHE UNIVERSITY OF SYDNEY
WO/2021/151156DRUG DELIVERY DEVICESIDERIS, Anders William James
WO/2021/151168METHOD OF CANNABINOID THERAPYAUSCANN GROUP HOLDINGS LTD
WO/2021/151169CANNABINOID COMPOSITION AND MANUFACTURING METHODAUSCANN GROUP HOLDINGS LTD
WO/2021/155427COMPOSITION AND METHODSNORETOX PTY LTD
WO/2021/155443PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING  OR PREVENTING CORONAVIRUS INFECTIONCENTRE FOR DIGESTIVE DISEASES PTY LIMITED
WO/2021/159187METHOD OF TREATMENT USING META-ARSENITEKOMIPHARM INTERNATIONAL AUSTRALIA PTY LTD
WO/2021/168516METHODS OF TREATMENT AND RELATED COMPOSITIONSASCEND BIOPHARMACEUTICALS LTD
WO/2021/168518S1P RECEPTOR MODULATORSAKAAL PHARMA PTY LTD
WO/2021/179047TREATMENT FOR CORONAVIRUS INFECTION AND ASSOCIATED CYTOKINE  TOXICITYCULLIS-HILL, Sydney David
WO/2021/179050VIRAL INHIBITIONMONASH UNIVERSITY
WO/2021/184059TREATMENT METHODSNEWSOUTH INNOVATIONS PTY LIMITED
WO/2021/195691METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AN  INFLAMMATORY CONDITIONINCANNEX HEALTHCARE LIMITED
WO/2021/184062COMPOSITIONS FOR TREATING RESPIRATORY TRACT INFECTION AND USES  THEREOFLATERAL IP PTY LTD
WO/2021/184070ANTIVIRAL COMPOSITION FOR ORAL CAREADVANCE NANOTEK LTD.
WO/2021/189109QUERCETIN ENHANCEMENT FORMULATIONSMARTDNA PTY LTD
WO/2021/195694ATTENUATED POXVIRUS VECTOR BASED VACCINE FOR PROTECTION  AGAINST COVID-19SEMENTIS LIMITED
WO/2021/195698METHODS FOR THE TREATMENT OF INFLAMMATION ASSOCIATED WITH  INFECTIONNOXOPHARM LIMITED
WO/2021/195703COMBINATION THERAPY FOR INFLAMMATORY BOWEL DISEASESERVATUS LTD
WO/2021/195706NEW DYNAMIN INHIBITORS AND USESCHILDREN'S MEDICAL RESEARCH INSTITUTE
WO/2021/243396THERAPEUTIC METHODS OF USING CD 14 ANTAGONISTIC ANTIBODIES IN  TREATING CONDITIONS ASSOCIATED WITH A CORONAVIRUS INFECTION INCLUDING  SARS-COV-2 (COVID-19)IMPLICIT BIOSCIENCE LIMITED
WO/2021/195723METHODS FOR TREATMENT OF CORONAVIRUS INFECTIONSTHE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/203168TREATMENT FOR SEPSIS-INDUCED ORGAN DYSFUNCTIONTHE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH
WO/2021/203174TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) WITH  POLYSULFATED POLYSACCHARIDESPARADIGM BIOPHARMACEUTICALS LTD
WO/2021/207790METHOD OF PROPHYLAXIS OF CORONAVIRUS AND/OR RESPIRATORY  SYNCYTIAL VIRUS INFECTIONSTARPHARMA PTY LTD
WO/2021/207801IMMUNE CELLS WITH ENHANCED FUNCTIONTHE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/212168METHODS AND COMPOSITIONSMONASH UNIVERSITY
WO/2021/212181METHODS AND COMPOSITIONS FOR TREATING FUNGAL INFECTIONSNEOCULI PTY LTD
WO/2021/212183PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING  OR PREVENTING MICROBIAL INFECTIONSCENTRE FOR DIGESTIVE DISEASES PTY LIMITED
WO/2021/217221PREVENTING AND TREATING VIRAL INFECTIONSMUCPHARM PTY LTD
WO/2021/222971TREATMENT FOR VIRUS INDUCED ACUTE RESPIRATORY DISTRESS  SYNDROMEDIMERIX BIOSCIENCE LTD
WO/2021/222972TREATMENT FOR ACUTE RESPIRATORY DISTRESS SYNDROMEDIMERIX BIOSCIENCE LTD
WO/2021/222987COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF  FIBROTIC AND INFLAMMATORY CONDITIONSGRETALS AUSTRALIA PTY LTD
WO/2021/222988CELL ENTRY-MODULATING AGENTS AND USES THEREFORGRIFFITH UNIVERSITY
WO/2021/226662USE OF AMINOACETONITRILE COMPOUNDS FOR THE TREATMENT OF  INFECTION AND DISEASEPITNEY PHARMACEUTICALS PTY LIMITED
WO/2021/226664A HEPATITIS C NUCLEIC ACID VACCINE COMPRISING A VARIABLE  DOMAIN DELETED E2 POLYPEPTIDEMACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC  HEALTH LIMITED
WO/2021/226672METHODS AND COMPOSITIONS FOR ATI DIGESTIONGLUTAGEN PTY LTD
WO/2021/226677TREATMENT OF THROMBOSIS AND ASSOCIATED DISORDERS WITH AN  ANTI-PLATELET AGENT.THE HEART RESEARCH INSTITUTE LTD
WO/2021/237273METHODS OF TREATING PULMONARY FIBROSISAMPLIA THERAPEUTICS PTY LTD
WO/2021/232094HEDGEHOG SIGNALING -DEPENDENT CANCER TREATMENTHUDSON INSTITUTE OF MEDICAL RESEARCH
WO/2021/237291TREATMENT OF CORONAVIRUSAXELIA ONCOLOGY PTY LTD
WO/2021/237295CELL HARVEST METHODTHE UNIVERSITY OF MELBOURNE
WO/2021/237297ANTI-VIRAL EXTRACELLULAR VESICLES, THEIR METHODS OF  PREPARATION AND USESEXOPHARM LIMITED
WO/2021/237299METHODS OF ANTIPATHOGENIC TREATMENTCROFT INFRASTRUCTURE DESIGNS PTY LTD
WO/2021/243399METHODS FOR TREATING MAJOR DEPRESSIVE DISORDER AND  TREATMENT-RESISTANT DEPRESSIONIX BIOPHARMA LIMITED
WO/2021/243410ANTI-MICROBIAL AND ANTI-INFLAMMATORY COMPOSITION COMPRISING  ARTHROSPIRA EXTRACTS AND AN ORGANIC ACIDBIOVITE AUSTRALIA PTY LTD
WO/2021/243415THERAPEUTIC CONJUGATESSTARPHARMA PTY LTD
WO/2021/243417IMMUNOGENIC FORMULATIONSCENTENARY INSTITUTE OF CANCER MEDICINE AND CELL BIOLOGY
WO/2021/243424METHOD OF TREATING OR PREVENTING ACUTE RESPIRATORY DISTRESS  SYNDROMECSL INNOVATION PTY LTD
WO/2021/248189COMPOUND FOR PREVENTION OR TREATMENT OF A SKIN CANCER OR SKIN  PRECANCERUNIQUEST PTY LTD
WO/2021/248196IMPROVED VIRUCIDAL FORMULATIONSFIREBRICK PHARMA LIMITED
WO/2021/248207COMPOSITION AND METHOD FOR TREATING CHRONIC PAINZELIRA THERAPEUTICS OPERATIONS PTY LTD
WO/2021/248210TREATMENT METHODS AND FORMULATIONSCURTIN UNIVERSITY
WO/2021/253087NOVEL ANTIBACTERIAL HYDROGELSNEWSOUTH INNOVATIONS PTY LIMITED
WO/2021/253098AMIDO COMPOUNDSANAXIS PHARMA PTY LTD
WO/2021/258140CD83 BINDING PROTEIN CONJUGATES FOR TREATING LYMPHOMAKIRA BIOTECH PTY LIMITED
WO/2021/258150METHODS OF TREATING OR PREVENTING ORGANOPHOSPHORUS POISONINGLACHESIS BIOSCIENCES LIMITED
WO/2021/258159HALOALLYLAMINE DUAL AMINE OXIDASE INHIBITORSPHARMAXIS LTD.
WO/2021/258163LIQUID DISPERSIBLE CURCUMINOID COMPOSITIONS AND METHODS OF  IMPROVING COGNITIVE FUNCTIONPHARMAKO BIOTECHNOLOGIES PTY LTD
WO/2021/168522METHOD FOR OBTAINING OF AN ANTITUMOR COMPOSITION, AN ANTITUMOR  COMPOSITION AND ITS USEHADJIEVA, Nasya Spartakova
WO/2021/007626ORAL MEDICATION FOR TREATING LIPOEDEMABENITTI, Daniel Augusto
WO/2021/016679ANHYDROUS SUNSCREEN COMPOSITION COMPRISING SILICA AEROGELL'OREAL
WO/2021/016680ANHYDROUS SUNSCREEN COMPOSITION COMPRISING SILICA AEROGELL'OREAL
WO/2021/016682ANHYDROUS COSMETIC COMPOSITION WITH HIGH CONCENTRATION OF  HYDROPHOBIC FILLERS AND USE THEREOF FOR REDUCING SKIN LESIONS AND OILINESSL'OREAL
WO/2021/016683ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITION, PROCESS  FOR ITS PRODUCTION AND USE THEREOFL'OREAL
WO/2021/016684COSMETIC COMPOSITION, PROCESS FOR MANUFACTURING THE COSMETIC  COMPOSITION AND ITS USEL'OREAL
WO/2021/022344COSMETIC COMPLEX FOR MOISTURIZING SKIN, USE OF THE COSMETIC  COMPLEX, COSMETIC COMPOSITION AND SKIN MOISTURIZING METHODNATURA COSMéTICOS S.A.
WO/2021/022345TOPICAL COSMETIC COMPOSITION, USE OF THE COMPOSITION AND TONIC  FOR FACIAL APPLICATIONNATURA COSMéTICOS S.A.
WO/2021/022346TOPICAL COSMETIC COMPOSITION, USE OF THE COMPOSITION AND SERUM  FOR FACIAL APPLICATIONNATURA COSMéTICOS S.A.
WO/2021/022347TOPICAL COSMETIC COMPOSITION, USE OF THE COSMETIC COMPOSITION  AND MASK FOR FACIAL APPLICATIONNATURA COSMéTICOS S.A.
WO/2021/046622NATURAL SILICONE REPLACEMENT COMPOSITION, PRODUCTION METHOD  AND USE THEREOFMAIAN INDUSTRIA DE PRODUTOS QUIMICOS LTDA
WO/2021/056086ORAL-HEALTH COMPOSITION AND PREPARATION METHOD FOR ORAL-HEALTH  COMPOSITIONMMF&T DESENVOLVIMENTO TECNOLóGICO E INOVAÇÃO LTDA.
WO/2021/119770COSMETIC COMPOSITION FOR A KERATIN SUBSTANCE, PROCESS FOR  MANUFACTURING A COSMETIC COMPOSITION AND USE OF THE COSMETIC COMPOSITIONL'OREAL
WO/2021/119771COSMETIC COMPOSITION, PROCESS OF MANUFACTURING THE COSMETIC  COMPOSITION AND USE OF THE COSMETIC COMPOSITIONL'OREAL
WO/2021/134118COSMETIC COMPOSITION COMPRISING A FATTY AMINE, A FATTY  ALCOHOL, A VEGETABLE FAT, A CATIONIC SURFACTANT AND A SILICONE CROSS-POLYMER  FOR USE IN HAIR CAREL'OREAL
WO/2021/151174ORAL COMPOSITION WITH SYNERGISTIC ASSOCIATION OF ORGANIC AND  INORGANIC COMPONENTS FOR COMPLETE MAINTENANCE OF ORAL HEALTH, METHOD FOR  OBTAINING SAME AND USESVILHENA, Fabiano Vieira
WO/2021/151177COSMETIC COMPOSITION, USE OF A COSMETIC COMPOSITION, PROCESS  FOR THE PREPARATION OF A COSMETIC COMPOSITION AND METHOD FOR STYLING THE HAIRL'OREAL
WO/2021/203180HAIR COSMETIC COMPOSITION AND PROCESS FOR SHAPING OR ALTERING  THE SHAPE OF THE HAIRL'OREAL
WO/2021/217225HAIR CARE COSMETIC COMPOSITION, METHOD FOR TREATING AND/OR  SHAPING HAIR, AND PROCESS FOR MANUFACTURING A HAIR CARE COSMETIC COMPOSITIONL'OREAL
WO/2021/072514COMPOSITION, USE OF A COMBINATION OF SILVER NANOPARTICLES AND  OF A NITRIC OXIDE DONOR, PHARMACEUTICAL KIT FOR TREATING CANCER, AND METHOD  FOR TREATING CANCERFUNDAÇÃO UNIVERSIDADE FEDERAL DO ABC -UFABC
WO/2021/237317ANTIPERSPIRANT COMPOSITION, PROCESS FOR ITS PRODUCTION AND USE  THEREOFL'OREAL
WO/2021/237318COSMETIC COMPOSITION COMPRISING UNSATURATED DIOIC ACID AND  USES THEREOFL'OREAL
WO/2021/000037METHOD FOR OBTAINING BIOACTIVE INGREDIENTS, USE OF  SUBCRITICAL-WATER EXTRACTION PROCESS, BIOACTIVE INGREDIENT, USE OF BIOACTIVE  INGREDIENT AND COSMETIC COMPOSITIONNATURA COSMéTICOS S.A.
WO/2021/003543IMMUNOMODULATORY COMPOUNDS AND/OR THE PHARMACEUTICALLY  ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITION INCLUDING  IMMUNOMODULATORY COMPOUNDS AND USE OF IMMUNOMODULATORY COMPOUNDS IN THE  PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL  DISEASESUNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/007635PROCESS FOR OBTAINING A FREEZE-DRIED COMPOSITION OF  CHITOSAN-BASED NANOPARTICLES CONTAINING BROMELAIN, FREEZE-DRIED COMPOSITION  OF CHITOSAN-BASED NANOPARTICLES CONTAINING BROMELAIN AND USE IN THE TREATMENT  OF WOUNDSUNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/012028HAIR TREATMENT COMPOSITION, METHOD FOR OBTAINING SAME, USE OF  THE COMPOSITION AND HAIR TREATMENT METHODCHEMYUNION LTDA
WO/2021/207806LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH CONTROLLED  RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR  THE TREATMENT OF ENDOMETRIOSISLUIZ PERACCHI, Edson
WO/2021/237321LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH SUSTAINED  RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR  THE TREATMENT OF CHRONIC ADRENAL INSUFFICIENCY OR HYPOCORTISOLISMLUIZ PERACCHI, Edson
WO/2021/237322LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH SUSTAINED  RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR  THE TREATMENT OF ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIALUIZ PERACCHI, Edson
WO/2021/042193METHOD AND USE OF PNPP-19 FOR PREVENTING AND TREATING EYE  DISEASESBIOZEUS DESENVOLVIMENTO DE PRODUTOS BIOFARMACêUTICOS
WO/2021/042194COMPOUND DERIVED FROM QUINOLINE, USE OF A COMPOUND,  COMPOSITION AND METHOD FOR THE TREATMENT OR PROPHYLAXIS OF A CONDITION CAUSED  BY A BLOOD PARASITEFUNDAÇÃO OSWALDO CRUZ
WO/2021/092667PHOTOPROTECTIVE COMPOSITIONS, PHOTOPROTECTIVE FORMULATIONS  INCLUDING PHOTOPROTECTIVE COMPOSITIONS, PREPARATION METHODS AND USES THEREOFBIOART BIOCOSMéTICOS LTDA - ME
WO/2021/151178WATER-BASED PROPYLENE GLYCOL-FREE MICROEMULSION FOR DELIVERY  OF MINOXIDIL IN THE TREATMENT OF HAIR LOSS AND METHOD FOR OBTAINING SAMEGERALDI, Katia Solange Cardoso Rodrigues Dos Santos
WO/2021/077191METHOD FOR OBTAINING CB-AG-NMS AND CB-AG-<sb>  </sb><sb>  </sb><sb><i>P</i></sb><sb>  </sb><sb> </sb>ABA DEVICES, CB-AG-NMS AND CB-AG-<sb>  </sb><sb> </sb><sb><i>P</i></sb><sb>  </sb><sb> </sb>ABA DEVICES, AND USE OF CB-AG-NMS AND  CB-AG-<sb> </sb><sb>  </sb><sb><i>P</i></sb><sb>  </sb><sb> </sb>ABA DEVICESUNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/108884PROCESS FOR PRODUCING A PROPHYLACTIC AND THERAPEUTIC DNA  IMMUNOLOGICAL COMPOSITION FOR HPV AND CANCERS ASSOCIATED WITH THE VIRUS,  HYBRID PROTEIN, EXPRESSION VECTOR, IMMUNOLOGICAL COMPOSITION AND USES THEREOFINSTITUTO BUTANTAN
WO/2021/113938VITAMIN AND MINERAL FOOD SUPPLEMENTCELLAVIT REPRESENTAÇÃO DE PRODUTOS NATURAIS LTDA
WO/2021/163776SUBCUTANEOUS IMPLANTS FOR SLOW CONTROLLED RELEASE OF ACTIVE  AGENTSBITTENCOURT, Marco Antonio
WO/2021/119791OLEAGINOUS COMPLEX OBTAINED FROM ACHIOTE SEEDS AND RELATED  USESUNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/127768ANTI-PERSPIRANT COMPOSITION, COSMETIC USE AND METHOD FOR  APPLYING SAMEHART'S ALIMENTOS NATURAIS LTDA
WO/2021/127769COMPOSITION FOR TREATING CONJUNCTIVITISNARDINI, Antonio Roberto
WO/2021/151185HERBAL MEDICINE, HERBAL MEDICINAL PRODUCT AND USE THEREOFEVOLUÇÕES CIENTíFICAS E TECNOLóGICAS LTDA
WO/2021/184094ADDITIVE FOR DETOXIFICATIONSILVA, Wellington Nascimbeni
WO/2021/184095BIOACTIVE SUPPLEMENTSILVA, Wellington
WO/2021/163777COSMETIC COMPOSITION FOR KERATIN FIBERS AND APPLICATION  METHODS FOR SAID COMPOSITIONGLOSS EXPRESS DO BRASIL COMERCIO DE PRODUTOS DE BELEZA LTDA -  EPP
WO/2021/159198METHOD FOR PRODUCING DECELLULARIZED BIOMATERIAL,  DECELLULARIZED BIOMATERIAL AND USE THEREOFKHEIROS PATER INOVAÇÃO S.A
WO/2021/189121PARAMAGNETIC NANOPARTICLES, MANUFACTURING METHOD AND USE  THEREOF WITH MAGNETIC RESONANCE IMAGING CONTRASTUNIVERSIDADE DE SÃO PAULO - USP
WO/2021/195730ANTIBACTERIAL COMBINATION COMPOSITION FOR REDUCING THE  RESISTANCE OF BACTERIA TO THE MEDICINAL DRUGS IN USE AND METHOD FOR OBTAINING  SAMEWEGHER, Ermete Antonio
WO/2021/207813TERPENE-CONTAINING COMPOSITION AND ITS COSMETIC USEBERACA INGREDIENTES NATURAIS S.A.
WO/2021/232123TASTE-MASKING SYSTEMOUROFINO SAUDE ANIMAL LTDA
WO/2021/222997COMPOSITION FOR REGULATING THE NEURO-IMMUNE-ENDOCRINE SYSTEMABOU NEHMI FILHO, Victor
WO/2021/223001NIGHT-TIME ORAL GEL COMPOSITIONOLIVEIRA, Eder Gonzaga De
WO/2021/258180PROCESS FOR OBTAINING ANTIGEN-PRESENTING VESICLES (APV) THAT  ENABLES THE COUPLING OF ONE OR MORE ANTIGENSINSTITUTO BUTANTAN
WO/2021/046628STABLE MEDICINAL CANNABIDIOL COMPOSITIONSCARDIOL THERAPEUTICS INC.
WO/2021/081619HEMP PEPTIDE COMPOSITIONS FOR NUTRACEUTICAL AND PERSONAL CARE  PRODUCTSEC LABS INC.
WO/2021/243432PHARMACEUTICAL COMPOSITIONS FOR STAINING MEMBRANES AND OTHER  BIOLOGICAL STRUCTURESTANG, Connie
WO/2021/003553COMPOUNDS FOR TREATMENT OF DIARRHEA, INFLAMMATORY BOWEL  DISEASE AND METHODS THEREOFALGERNON PHARMACEUTICALS INC.
WO/2021/081624USE OF GLUTAMATE 2B RECEPTOR ANTAGONISTS AND SIGMA RECEPTOR  AGONSISTS AS ANTITUSSIVESALGERNON PHARMACEUTICALS INC.
WO/2021/000046QUORUM-SENSING INHIBITORS AND/OR POSTBIOTIC METABOLITES AND  RELATED METHODSMICROSINTESIS INC.
WO/2021/012046CANNABINOIDS COMPOSITIONS WITH POLYUNSATURATED FATTY ACID  MONOGLYCERIDES, METHODS AND USES THEREOFSCF PHARMA INC.
WO/2021/016710CONTROLLED RELEASE FORMULATIONS OF MULTIPLE ACTIVE  PHARMACEUTICAL AGENTS, AND PSILOCYBE-DERIVED AGENTS IN COMBINATION WITH  CANNABIS-DERIVED AGENTS AND METHODS FOR THEIR USETASSILI LIFE SCIENCES, CORP.
WO/2021/022377PERIVASCULAR LYSATES AND USES THEREOFTISSUE REGENERATION THERAPEUTICS INC.
WO/2021/022378ORAL FORMULATIONS OF CANNABIS EXTRACTS AND METHODS OF MAKING  SAMENEPTUNE WELLNESS SOLUTIONS INC.
WO/2021/026653CHOLINERGIC POTENTIATION OF BINOCULAR VISIONTHE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL  UNIVERSITY
WO/2021/035335COMPOSITION AND METHOD FOR FORMING A COMPOSITION FOR  INCREASING DERMAL NITRIC OXIDESPINAL RELIEF CENTRES OF CANADA INC.
WO/2021/030913CANNABINOID COMPOSITIONS, METHODS OF MAKING SAME AND USES  THEREOFHEXO OPERATIONS INC.
WO/2021/035344METHODS FOR REDUCING THC CONTENT IN COMPLEX CANNABINOID  MIXTURES IN WHICH THC IS A MINOR COMPONENTCANOPY GROWTH CORPORATION
WO/2021/046634METHODS OF TREATING CANCER BY THE USE OF PD-1 AXIS INHIBITORS  AND ANTI-PERIOSTIN ANTIBODIESBOEHRINGER INGELHEIM IO CANADA, INC.
WO/2021/046646AVOCATIN B FOR THE TREATMENT OF DISEASES AND CONDITIONSSP NUTRACEUTICALS INC.
WO/2021/046652INHIBITING ZD17-JNK INTERACTION AS A THERAPY FOR ACUTE  MYOCARDIAL INFARCTIONTHE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/051192COMPOSITION OF RADIOACTIVE AND NON-RADIOACTIVE MICROPARTICLESABK BIOMEDICAL INCORPORATED
WO/2021/056098NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLSKORANEX CAPITAL
WO/2021/056105COMPOSITIONS AND METHODS BASED ON HIV GP120 MUTANTSCENTRE HOSPITALIER DE L'UNIVERSITé DE MONTRéAL
WO/2021/056106LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTSDDS RESEARCH INC.
WO/2021/056109GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE  DELIVERY SYSTEMMEDISCA PHARMACEUTIQUE INC.
WO/2021/062546USE OF IBALIZUMAB FOR THE TREATMENT OF HIV-2 INFECTIONTAIMED BIOLOGICS INC.
WO/2021/062554ORAL CARE COMPOSITION COMPRISING CUTTLEFISH BONE POWDERVISIONATUROLAB INC.
WO/2021/062555TOPICAL FORMULATIONS AND INSTILLATES, KITS, AND METHODS FOR  TREATING INTEGUMENTARY WOUNDS, AND USES THEREOFVINSAN THERAPEUTICS INC.
WO/2021/072530CONTROLLED RELEASE FORMULATIONS OF PSILOCYBE-DERIVED AGENTS  AND METHOD FOR THEIR USE, AND METHODS AND COMPOSITIONS FOR THREATING MILD  TRAUMATIC BRAIN INJURY WITH POST TRAUMATIC STRESS DISORDER.TASSILI LIFE SCIENCES, CORP.
WO/2021/072535OIL-IN-WATER EMULSION FORMULATIONS FOR DELIVERY OF ACTIVE OR  THERAPEUTIC AGENTSIMMUNOVACCINE TECHNOLOGIES INC.
WO/2021/072538SKIN CARE FORMULATION WITH LIPOPHILIC PEPTIDESDECIEM BEAUTY GROUP INC.
WO/2021/072555COMPOSITIONS AND METHODS FOR THE TREATMENT AND/OR PROPHYLAXIS  OF DIABETES AND OTHER CONDITIONSLIFELOCK SOLUTIONS INC.
WO/2021/077211CANNABIDIOL COMPOSITIONS FOR USE IN TREATING HEART CONDITIONSCARDIOL THERAPEUTICS INC.
WO/2021/081634FORMULATION TO REDUCE OR PREVENT OXIDATIVE STRESS DAMAGEMURPHY, Kieran
WO/2021/081640FLOWABLE CANNABINOID COMPOSITIONS HAVING HIGH EFFECTIVE  CONCENTRATIONSCANOPY GROWTH CORPORATION
WO/2021/081642BIOPHOTONIC COMPOSITIONS, USES AND METHODS FOR MODULATING  MITOCHONDRIAL DYNAMICS AND FUNCTIONALITY IN SKIN AND SOFT TISSUE CONDITIONSZAGO, Michela
WO/2021/081652METHODS AND RELATED SYSTEMS FOR MAKING A RECONSTITUTED  CANNABIS MATERIAL1769474 ALBERTA LTD.
WO/2021/081654SELF-EMULSIFYING DRUG DELIVERY SYSTEM AND USES THEREOFSP NUTRACEUTICALS INC.
WO/2021/092684CHEWING GUM CONTAINING SYNERGISTIC MEDICINAL COMPOUNDSLONDON PHARMACEUTICALS AND RESEARCH CORPORATION
WO/2021/097562TOP LIQUID FILL METHOD AND APPARATUS FOR HARD CAPSULESCAO, Karl Wei
WO/2021/108911USE OF PSILOCIN, PSILOCYBIN OR ANALOGS THEREOF IN WEIGHT LOSS,  TREATMENT OF OBESITY AND COMPULSIVE EATING DISORDERNEONMIND BIOSCIENCES INC.
WO/2021/108918TREATMENT FOR ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC  SYNDROMEUNIVERSITY HEALTH NETWORK
WO/2021/108923COMBINED USE OF SODIUM  TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] AND ETOMOXIR FOR TREATING  CANCERSBOLD THERAPEUTICS INC.
WO/2021/108929SORTILIN BINDING CONJUGATE COMPOUNDS, COMPOSITIONS AND USES  THEREOF FOR TREATING CANCERTHERATECHNOLOGIES INC.
WO/2021/113982MINERAL SUPPLEMENTS FOR RUMINANT NUTRITIONALBERTA VETERINARY LABORATORIES LTD.
WO/2021/113983CHOLINE BOLUS COMPOSITIONS FOR RUMINANTSALBERTA VETERINARY LABORATORIES LTD.
WO/2021/113986COMPLEXES COMPRISING A CARBOHYDRATE POLYMER AND AN ACTIVE  INGREDIENT AND PROCESSES FOR THEIR PREPARATIONFOLIUM LABS INC.
WO/2021/119810ORAL DELIVERY SYSTEMS BASED ON IN SITU FORMING  PROTEIN/POLYSACCHARIDE COACERVATES9286-3620 QUéBEC INC.
WO/2021/119817HASHISH PRODUCT HAVING ENHANCED USER EXPERIENCE AND  MANUFACTURING PROCEDURE FOR OBTAINING SAMEHEXO OPERATIONS INC.
WO/2021/119822EMULSIONS OF BIOACTIVE LIPOPHILIC COMPOUNDS INCLUDING OILSNATIONAL RESEARCH COUNCIL OF CANADA
WO/2021/119826EXTRACTS ENRICHED WITH POLYPHENOLIC COMPOUNDS AND RELATED  METHODSROTHSTEIN, Steven
WO/2021/119827USE OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) FOR  THE TREATMENT OF ENTERIC NEUROPATHIESTRANSFERT PLUS, SOCIéTé EN COMMANDITE
WO/2021/119834MODULATORS OF CULLIN 3 ADAPTOR KBTBD4 AS ANTI-CANCER COMPOUNDSUNIVERSITE DE MONTREAL
WO/2021/119844EMULSIFYING FORMULATIONS OF CANNABINOIDS AND/OR CANNABINOID  EXTRACTSORGANIGRAM INC.
WO/2021/127786CANNABICHROMENE COMPOSITIONS AND METHODS OF SYNTHESIZING  CANNABICHROMENECANOPY GROWTH CORPORATION
WO/2021/127787CANNABICITRAN COMPOSITIONS AND METHODS OF SYNTHESIZING  CANNABICITRANCANOPY GROWTH CORPORATION
WO/2021/127788METHODS OF SYNTHESIZING HIGH-PURITY CANNABICYCLOL AND  ARTIFICIAL RESINS COMPRISING CANNABICYCLOLCANOPY GROWTH CORPORATION
WO/2021/138742COMPOSITION THAT PROMOTE PRO-RESOLVING MEDIATORSACASTI PHARMA INC.
WO/2021/146812USE OF ANTI-AGING GLYCOPEPTIDES FOR INHIBITION OF IMMUNE  REJECTION OF A GRAFTPROTOKINETIX INC.
WO/2021/151212SYSTEM AND METHOD FOR QUANTIFYING, FORMULATING AND ENHANCING  USER EXPERIENCE PROFILE OF CANNABISHEXO OPERATIONS INC.
WO/2021/159213METHOD FOR PRODUCING AN EXTRACT OF MUSHROOM AND MUSHROOM  EXTRACT MADE THEREFROMNEONMIND BIOSCIENCES INC.
WO/2021/163796METHODS AND COMPOSITIONS FOR THE INHIBITION OF HEPATITIS B AND  HEPATITIS D VIRUS INFECTIONSREPLICOR INC.
WO/2021/163802USE OF CASTALAGIN OR ANALOGS THEREOF FOR ANTI-CANCER EFFICACY  AND TO INCREASE THE RESPONSE TO IMMUNE CHECKPOINT INHIBITORSTHE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL  UNIVERSITY
WO/2021/163811POLYMERIC BINDER AND HIGH MOLECULAR WEIGHT POLYMER ANTIFOULING  COMPOSITIONSTHE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/207822DETECTION, TREATMENT, AND MONITORING OF MICROBIOME-DEPENDANT  PROTEIN FERMENTATION METABOLITESMCPHARMA BIOTECH INC.
WO/2021/168561PROCESSES FOR THE PREPARATION OF MULTICOMPONENT CRYSTALLINE  FORMS OF ACTIVE PHARMACEUTICAL INGREDIENTS USING SOLVENT VAPOURAPOTEX INC
WO/2021/168572STABLE LIQUID DISPERSINB COMPOSITIONSKANE BIOTECH INC.
WO/2021/168573NANOSTRUCTURE LIPID CARRIER DELIVERY SYSTEM, COMPOSITION, AND  METHODSCAPCIUM INC.
WO/2021/168577GENE DELIVERY SYSTEMSYMVIVO CORPORATION
WO/2021/174351COACTIVE COMBINATIONS OF ANTIMICROBIALS WITH DISPERSINBKANE BIOTECH INC.
WO/2021/179072METHODS AND APPARATUSES TO REDUCE SETTLING RATE OF A  MICRO-PARTICLE SUSPENSIONSKINLIFE TECHNOLOGIES INC.
WO/2021/179081USE OF ANTI-AGING GLYCOPEPTIDES FOR TREATMENT OF DRY EYE  DISEASE, RETINAL DEGENERATIVE DISEASES, OR OCCULAR INFLAMMATIONPROTOKINETIX INC.
WO/2021/179087TERPENE-ENHANCED COMPOSITIONS AND USES THEREOFHEXO OPERATIONS INC.
WO/2021/179088TERPENE-ENHANCED COMPOSITIONS AND USES THEREOFHEXO OPERATIONS INC.
WO/2021/179094COMPOSITION AND USE OF A CAFFEIC ACID PHENETHYL ESTER (CAPE)  COMPOUND TO TREAT CANCERUNIVERSITY OF NEW BRUNSWICK
WO/2021/184115USE OF BUCILLAMINE IN THE TREATMENT OF INFECTIOUS DISEASESREVIVE THERAPEUTICS LTD.
WO/2021/184116METHOD FOR PRODUCING ENHANCED ANTI-INFLAMMATORY/  ANTI-CATABOLIC AGENTS FROM AUTOLOGOUS PHYSIOLOGICAL FLUIDANTNOR LIMITED
WO/2021/207824USE OF PSILOCYBIN IN THE TREATMENT OF NEUROLOGICAL BRAIN  INJURY AND MIGRAINESREVIVE THERAPEUTICS LTD.
WO/2021/184123COMPOSITIONS AND METHODS FOR THE TREATMENT OF CORONAVIRUS  INFECTION AND RESPIRATORY COMPROMISESZEWCZUK, Myron R.
WO/2021/184125DISCOVERY OF FIFTEEN NEW ANTI-AGING PLANT EXTRACTS AND  IDENTIFICATION OF CELLULAR PROCESSES THEY AFFECT AS NEW CALORIC RESTRICTION  MIMETICSIDUNN TECHNOLOGIES
WO/2021/184128METHODS OF TREATING A CORONAVIRUS INFECTION USING COLCHICINEINSTITUT DE CARDIOLOGIE DE MONTREAL
WO/2021/189151ANTIMICROBIAL COMPOSITIONCOVALON TECHNOLOGIES INC.
WO/2021/189153USE OF FENRETINIDE FOR THE TREATMENT OF SARS-CORONA VIRUS  INFECTIONLAURENT PHARMACEUTICALS INC.
WO/2021/195750METHODS FOR TREATING ALZHEIMER'S DISEASEJEFFERIES, Wilfred
WO/2021/195763ANTIVIRAL RUTHENATE(III) THERAPEUTICSBOLD THERAPEUTICS INC.
WO/2021/195765DAPSONE FORMULATIONS AND METHODS OF USING SAMEPULMONEM INC.
WO/2021/212209CANNABICHROMENE FORMULATION FOR PAIN MANAGEMENTZYUS LIFE SCIENCES INC.
WO/2021/195777FUROSEMIDE COMPOSITIONS AND USES THEREOF FOR SUPPORTIVE  THERAPY IN CORONAVIRUS INFECTIONUNIVERSITY HEALTH NETWORK
WO/2021/195782METHODS OF USING MYT1 INHIBITORSREPARE THERAPEUTICS INC.
WO/2021/195785FERRITIN FOR CELLULAR TRACKING UTILIZING T1-WEIGHTED MRITHE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
WO/2021/203190COMBINATION THERAPIES FOR INHIBITION OF POLO-LIKE KINASE 4UNIVERSITY HEALTH NETWORK
WO/2021/203198COMPOSITIONS AND METHODS FOR TREATMENT OF CORONAVIRIDAE  INFECTIONSPICCHIO INTERNATIONAL INC.
WO/2021/203205PROBIOTIC COMPOSITIONS AND METHODS OF USECHANDLER BIOPHARMACEUTICAL CORPORATION
WO/2021/203206COMBINATION OF CANNABIDIOL AND A PPAR AGONISTLAVIOLETTE, Steven Robert
WO/2021/207828METHODS FOR TREATING CYTOKINE RELEASE SYNDROMEUNIVERSITY HEALTH NETWORK
WO/2021/207833METHOD OF LONG-TERM PRESERVATION OF CHEMICAL AND BIOLOGICAL  SPECIES USING SUGAR GLASSESMCMASTER UNIVERSITY
WO/2021/207850WATER SOLUBLE FORMULATIONS CONTAINING CANNABINOIDSNATIONAL RESEARCH COUNCIL OF CANADA
WO/2021/212215COMPOSITIONS AND METHODS FOR PREVENTING, CONTROLLING AND  DIAGNOSING MYCOBACTERIAL INFECTIONSUNIVERSITY OF SASKATCHEWAN
WO/2021/212222COMPOSITIONS AND METHODS FOR TREATMENT OF ACUTE RESPIRATORY  DISTRESS SYNDROMEEDESA BIOTECH RESEARCH INC.
WO/2021/212239USES OF SUPER-OXYGENATED WATER AND GELGIS GAS INFUSION SYSTEMS INC.
WO/2021/217259BIOMEDICAL IMAGING OF BACTERIA AND BACTERIOPHAGEMULTI-MAGNETICS INCORPORATED
WO/2021/217275IMMUNOMODULATORY AND ANTIVIRAL ACTION OF BOSWELLIA GUM RESIN  EXTRACTS, DERIVED FORMULATIONS, AND BOSWELLIC ACIDS AGAINST RESPIRATORY  VIRUSES AND USES THEREOFKONDOR PHARMA INC.
WO/2021/226725HASHISH HAVING SUBSTANTIALLY UNIFORM CHARACTERISTICS AND  METHOD FOR PRODUCING SAME AT AN INDUSTRIAL SCALEHEXO OPERATIONS INC.
WO/2021/232156CANNABINOID PHARMACEUTICAL COMPOSITIONAMACATHERA INC.
WO/2021/232169SYNERGISTIC ANTI-VIRAL PHARMACEUTICAL COMPOSITION CONTAINING  TARGETING NANOPARTICLESNUECOLOGY BIOMEDICAL INC.
WO/2021/237366TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASEPEMI31 THERAPEUTICS INC.
WO/2021/243460METHOD FOR WEIGHT LOSS WITH THERAPYNEONMIND BIOSCIENCES INC.
WO/2021/243461USE OF LSD, ESA, OR DMT FOR WEIGHT LOSS.NEONMIND BIOSCIENCES INC.
WO/2021/243467CANNABINOID-HYALURONIC ACID BIOCONJUGATESLONDON PHARMACEUTICALS AND RESEARCH CORPORATION
WO/2021/248251USE OF PHYTOCANNABINOIDS FOR TREATING MULTIPLE MYELOMAENTOURAGE BIOSCIENCES INC.
WO/2021/253116COMPOSITIONS COMPRISING PSYCHOACTIVE COMPOUNDS FROM  PSYCHOACTIVE ORGANISMSPSILO SCIENTIFIC LTD
WO/2021/253123EXTRACTION OF PSYCHOACTIVE COMPOUNDS FROM PSYCHEDELIC FUNGUSPSILO SCIENTIFIC LTD
WO/2021/253124METHANOL-BASED EXTRACTION OF PSYCHOACTIVE COMPOUNDS FROM  FUNGUSPSILO SCIENTIFIC LTD
WO/2021/258206WATER-SOLUBLE ARTESUNATE-BASED THERAPY FOR CORONAVIRUS  INFECTIONSOLSTAR PHARMA
WO/2021/258209COMPOSITE COATING FOR AN ACTIVE AGENT13400719 CANADA INC.
WO/2021/258218USE OF SOLUBLE NRP1 POLYPEPTIDES FOR THE TREATMENT OF  CORONAVIRUS INFECTIONSSEMATHERA INC.
WO/2021/207860COMPOSITION OF HERBS AND SPICES FOR USE IN MEDICINEMUESSLI, Daniel
WO/2021/000057FORMULATION THAT ALLOWS THE PROTECTION OF POLYPHENOLS,  PARTICULARLY THOSE OBTAINED FROM BEE POLLEN EXTRACTPONTIFICIA UNIVERSIDAD CATóLICA DE CHILE
WO/2021/022386WATER-SOLUBLE FILM WITH BIOACTIVE AGENTS OR NATURAL EXTRACTS  FOR COSMETIC USEUNIVERSIDAD DE CHILE
WO/2021/077236ONION SKIN EXTRACT WITH PROPERTIES THAT PROTECT THE  GASTROINTESTINAL MUCOSA AGAINST DAMAGE INDUCED BY NON-STEROIDAL  ANTI-INFLAMMATORY DRUGS OR BY ALCHOL, PHARMACEUTICAL COMPOSITION OR FOOD  COMPRISING IT, METHOD OF OBTAINMENT, AND USE TO PREVENT, TREAT AND/OR  MITIGATE THE ADVERSE EFFECTS OF NSAIDS OR ALCOHOLUNIVERSIDAD DE CHILE
WO/2021/097584AGAROPHYTON CHILENSIS EXTRACT, RICH IN FREE FATTY ACIDS, AS A  NUTRACEUTICAL OR NUTRITIONAL SUPPLEMENT, SUITABLE FOR MODULATING PPARϒ  ACTIVITYUNIVERSIDAD ANDRES BELLO
WO/2021/119858METHOD FOR GENERATING ALLERGEN-SPECIFIC TOLEROGENIC CELLS,  TOLEROGENIC CELLS OBTAINED, AND METHODS FOR INDUCING ALLERGEN TOLERANCE BY  MEANS OF AUTOLOGOUS IMMUNOTHERAPYPONTIFICIA UNIVERSIDAD CATóLICA DE CHILE
WO/2021/127793ANTIVIRAL COMPOSITION BASED ON EXTRACTS OF <i>DURVILLAEA  ANTARCTICA</i>, USEFUL FOR TREATING LESIONS CAUSED BY  ALPHAHERPESVIRINAE VIRUSESPONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/127794ANTIVIRAL COMPOSITION BASED ON EXTRACTS OF  <i>MACROCYSTIS PYRIFERA</i>, USEFUL FOR TREATING LESIONS CAUSED  BY ALPHAHERPESVIRINAE VIRUSESPONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/119864MULTI-POLYMER HYDROGEL AS A DEVICE FOR ADMINISTERING  PHARMACEUTICAL AND CELLULAR THERAPEUTIC COMPONENTSUNIVERSIDAD DE CONCEPCIóN
WO/2021/119866USE OF STRAINS OF <i>LACTOBACILLUS KUNKEEI</i> AND  <i>BIFIDOBACTERIUM ASTEROIDES</i> AS A PROBIOTIC BIOSTIMULANT FOR  BEESUNIVERSIDAD DE CONCEPCIóN
WO/2021/119868PROBIOTIC STRAINS OF <i>LACTOBACILLUS SP.</i> AND  OF <i>PEDIOCOCCUS SP</i>. AND USE THEREOF IN THE PREPARATION OF A  PROBIOTIC FORMULATION FOR THE PREVENTION OF DIARRHEA CAUSED BY BACTERIAL  PATHOGENS THAT AFFECT DOGS AND CATSUNIVERSIDAD DE CONCEPCIóN
WO/2021/127797NEW USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A  RESPIRATORY SYNCITIAL VIRUS PROTEIN AGAINST HMPVPONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/195797NOVEL USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A HUMAN  RESPIRATORY SYNCYTIAL VIRUS PROTEIN AGAINST HMPV IN CATTLEPONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/000062USE OF COMBINATION OF COMPOUND OF SCLEROTIORIN AND RIFAMPICIN  IN PREPARATION OF ANTI-TUBERCULOSIS DRUGSUN YAT-SEN UNIVERSITY
WO/2021/000067CELL-BINDING MOLECULE-TUBULYSIN DERIVATIVE CONJUGATE AND  PREPARATION METHOD THEREFORHANGZHOU DAC BIOTECH CO., LTD.
WO/2021/003687COMPOSITIONS AND METHODS OF USING A HUMANIZED ANTI-DKK2  ANTIBODYYALE UNIVERSITY
WO/2021/007741AQUEOUS-BASED NON-AEROSOL DRY SHAMPOO COMPOSITIONHENKEL AG & CO. KGAA
WO/2021/007800ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOFINSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/012065APPLICATION OF BEZOAR SEDATIVE PILL IN PREPARING DRUG FOR  TREATING DEPRESSIONBEIJING TONG REN TANG CHINESE MEDICINE CO., LTD.
WO/2021/012138USE OF DIAMINOGUANIDINE DERIVATIVE AND FEED COMPOSITION  THEREOF IN PREPARATION OF VETERINARY DRUGGUANGZHOU INSIGHTER BIOTECHNOLOGY CO.,LTD
WO/2021/012269ANTI-INFLAMMATORY AND ANTI-SWELLING PHARMACEUTICAL  COMPOSITION, AND USE THEREOFHU, Ping
WO/2021/016729COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUP FROM KERATIN  MATERIALSL'OREAL
WO/2021/016924CATIONIC POLYMER AND PARTICLES USABLE TO TREAT PSORIASISSUN YAT-SEN UNIVERSITY
WO/2021/016941UTILIZING STRUCTURE AND MECHANOGATING MECHANISM OF PIEZO  CHANNELS FOR PREPARATION OF MEDICAMENTS AND TECHNOLOGIESTSINGHUA UNIVERSITY
WO/2021/022466MEDICAMENT FOR TREATING STROKE CAUSED BY DEEP FUNGAL  INFECTIONSXIAO, Mingchun
WO/2021/022562PURE NATURAL COMPOUND ESSENTIAL OIL HAVING BROAD-SPECTRUM  BACTERICIDAL ACTIVITY AND PREPARATION AND APPLICATION THEREOFINSTITUTE OF MEDICINAL PLANT DEVELOPMENT, CHINESE ACADEMY OF  MEDICAL SCIENCE
WO/2021/007899INJECTABLE HYDROGEL MATERIAL AND PREPARATION METHOD THEREFOR  AND USE THEREOFZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/030932PHARMACEUTICAL COMPOSITIONS COMPRISING ONCOLYTIC HERPES  SIMPLEX VIRUS FOR SYSTEMIC ADMINISTRATIONIMMVIRA CO., LTD
WO/2021/030978USE OF NICLOSAMIDE ETHANOLAMINE SALT IN PREPARATION OF DRUGS  FOR TREATING CHEMOTHERAPY-REALATED MUSCLE INJURYSHENZHEN TRADITIONAL CHINESE MEDICINE HOSPITAL
WO/2021/031102CRYSTAL FORM OF DAPRODUSTAT, PREPARATION METHOD THEREFOR AND  USE THEREOFSHENZHEN RENTAI PHARMATECH LTD.
WO/2021/026949PHASE-INVERTED EMULSION AND PREPARATION METHODZHONGSHANSHI BOSHEN CHEMICAL CO., LTD.
WO/2021/031200CD8+T CELL AND/OR B CELL REGULATIONTONGJI HOSPITAL, TONGJI MEDICAL COLLEGE OF HUAZHONG UNIVERSITY  OF SCIENCE AND TECHNOLOGY
WO/2021/035378METHOD TO INCORPORATE OLEANOLIC ACID INTO ORAL CARE  COMPOSITIONS AND ORAL CARE COMPOSITIONS BASED THEREOFCOLGATE-PALMOLIVE COMPANY
WO/2021/035386SUNSCREEN COMPOSITION WITHOUT CYCLOMETHICONESBEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD.
WO/2021/035390MEDICINE FOR TREATING PULMONARY MYCOSISXIAO, Mingchun
WO/2021/035498ANTI-TUMOR PLATINUM-BASED DRUG MINERALIZED PROTEIN  NANOPARTICLE, PREPARATION METHOD THEREFOR AND USE THEREOFSOOCHOW UNIVERSITY
WO/2021/035655MEDICINE FOR INJECTION AND PREPARATION METHOD THEREFORSICHUAN CREDIT PHARMACEUTICAL CO., LTD
WO/2021/000417USE OF PALMITOLEIC ACID FOR PREPARING COMPOSITION FOR  PREVENTING OR TREATING INFLAMMATORY DISEASESREVAISSANT (SHENZHEN) BIOSCIENCES CO., LTD.
WO/2021/042274TRADITIONAL CHINESE AND WESTERN MEDICINE COMPOSITION FOR  TREATING OSTEOARTHRITISLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/042275TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  OSTEOARTHRITISLUNAN PHARMACEUTICALGROUP CORPORATION
WO/2021/042276COMBINATION DRUG FOR TREATING OSTEOARTHRITISLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/042278MULTI-UNIT SUSTAINED-RELEASE ACIPIMOX PELLET TABLET AND  PREPARATION METHOD THEREFORLUNAN BETTER PHARMACEUTICAL CO., LTD.
WO/2021/007933APPLICATION OF MAGGOTS IN TREATMENT OF DIABETESHUA, Xiangrong
WO/2021/007934APPLICATION OF LIQUOR PRODUCT WITH SOAKED LUCILIA SERICATA FOR  TREATING DIABETESHUA, Xiangrong
WO/2021/042325COMPOSITION OF TEMPORARY DENTAL MATERIALTAIPEI UNIVERSITY OF TECHNOLOGY
WO/2021/042369NANOPARTICLE HAVING CGAS-STING PATHWAY ACTIVATION FUNCTION,  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFNATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/046706A SUNSCREEN FORMULATIONSUN, Yimin
WO/2021/046765AN ANTICANCER COMBINATION OF CHIDAMIDE AND CELECOXIBGNT BIOTECH & MEDICALS CORPORATION
WO/2021/017115APPARATUS AND METHOD FOR PRODUCING FREEZE-DRIED FACIAL MASKBEIJING BENZHENGONGFANG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/051260TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  TRAUMATIC INJURY AND USE THEREOFLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/051261NOVEL USE OF CHINESE MEDICINE COMPOSITIONLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/051262TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREPARING DRUGS  FOR TREATING EDEMALUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/051271USE OF PICEATANNOL IN PREPARING A DRUG FOR PREVENTING AND  TREATING NEURODEGENERATIVE DISEASESSHENZHEN UNIVERSITY
WO/2021/051272USE OF BISMUTH POTASSIUM CITRATE IN PREPARING DRUG FOR  PREVENTING OR TREATING NEURODEGENERATIVE DISEASESSHENZHEN UNIVERSITY
WO/2021/031270BACTERIAL MEMBRANE VESICLES, AND SEPARATION AND PREPARATION  SYSTEM AND METHOD THEREFORSICHUAN UNIVERSITY
WO/2021/051352ISOLATED ANTIGEN-BINDING PROTEIN AND USE THEREOFSPH BIOTHERAPEUTICS (HK) LIMITED
WO/2021/056231KIT FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/056248TECHNOLOGY FOR FACIAL FAT DEGRADATION AND FIRMING AND  APPLICATION OF TECHNOLOGYSHANGHAI TONGBAI BIOTECHNOLOGY CO., LTD
WO/2021/056412TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/056431NON-DRUG HELICOBACTER PYLORI BACTERICIDAL COMPOSITIONECO-GEO BIO-TECHNOLOGY COMPANY LIMITED
WO/2021/007957MESOPOROUS SPONGE SPICULE AND PREPARATION METHOD AND USE  THEREFORXIAMEN UNIVERSITY
WO/2021/056522COSMETIC COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/062607ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND AMINO  ACIDTHE PROCTER & GAMBLE COMPANY
WO/2021/062611DENTIFRICE COMPOSITIONS COMPRISING BICARBONATE SALT AND  NEUTRAL AMINO ACIDTHE PROCTER & GAMBLE COMPANY
WO/2021/062621ORAL CARE COMPOSITIONS COMPRISING STANNOUS ION SOURCE, NEUTRAL  AMINO ACID, AND POLYPHOSPHATETHE PROCTER & GAMBLE COMPANY
WO/2021/062623DENTIFRICE COMPOSITIONS FOR TREATMENT OF DENTAL BIOFILMTHE PROCTER & GAMBLE COMPANY
WO/2021/062631DENTIFRICE COMPOSITIONS FOR TREATMENT OF DENTAL BIOFILMTHE PROCTER & GAMBLE COMPANY
WO/2021/003864USE OF GLYCINE IN PREPARATION OF DRUG DELIVERY REINFORCER AND  CELL TRANSPLANTATION REAGENTTIANJIN MEDICAL UNIVERSITY
WO/2021/056609SEQUENCE OF STRUCTURALLY SENSITIVE POLYPEPTIDE ANTIGEN OF VON  WILLEBRAND FACTORSOOCHOW UNIVERSITY
WO/2021/068188WS-635 USES THEREOF IN MEDICINEWATERSTONE PHARMACEUTICALS(WUHAN) CO., LTD.
WO/2021/068196METHODS OF USING IL-33 PROTEIN IN TREATING CANCERSGENERAL REGENERATIVES (SHANGHAI) LIMITED
WO/2021/068203USE OF CHLOROQUINE OR DERIVATIVE HYDROXYCHLOROQUINETHE FIRST AFFILIATED HOSPITAL OF SUN YAT-SEN UNIVERSITY
WO/2021/068239VAGINAL SLOW-RELEASE ADMINISTRATION SYSTEM FOR LUTEAL SUPPORT,  PREPARATION METHOD THEREFOR AND USE THEREOFNATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING
WO/2021/068242AN AGENT THAT ENABLES SIRT7 GENE EXPRESSION AND THE USE  THEREOFSHENZHEN UNIVERSITY
WO/2021/072595MEDICAL USE OF MESENCHYMAL STEM CELLS IN TREATMENT OF HEARING  IMPAIRMENTMARIA VON MED-BIOTECHNOLOGY CO., LTD.
WO/2021/072642USE OF PHENYLQUINOLINONES AND FLAVONOID DERIVATIVES FOR  TREATING NEUROPATHIC PAINHANGZHOU BIO-SINCERITY PHARMA-TECH CO., LTD.
WO/2021/072661ELECTROACTIVE AND DEGRADABLE SUPRAMOLECULAR MICROGEL AND  DRUG-LOADED SUPRAMOLECULAR MICROGEL, AND PREPARATION METHOD AND USE THEREOFNANJING FORESTRY UNIVERSITY
WO/2021/072683TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/031320NANO-PARTICLE BASED ON DNA PHOTOTHERMAL MELTING, PREPARATION  METHOD THEREFOR, AND APPLICATION THEREOFQINGDAO UNIVERSITY
WO/2021/031321MULTI-COLOR UP-CONVERSION NANOPROBE, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFQINGDAO UNIVERSITY
WO/2021/042451DUAL DRUG DELIVERY SYSTEM BASED ON TARGETING NUCLEOLIN,  PREPARATION METHOD THEREFOR AND USE THEREOFQINGDAO UNIVERSITY
WO/2021/072747COMPOSITION AND METHOD FOR TREATMENT OF DIABETESSHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/072773ORLISTAT CAPSULE AND PREPARATION METHOD THEREFORSHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/072780METHODS AND COMPOSITIONS FOR IMPROVING BONE MARROW  HEMATOPOIETIC FUNCTIONSSUN YAT-SEN UNIVERSITY
WO/2021/022678ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOFMABPLEX INTERNATIONAL CO., LTD.
WO/2021/077320COMPOSITION FOR CARING FOR THE SKINL'OREAL
WO/2021/046976APPLICATION OF CAS13A IN ANTAGONIZING VIRUSESINSTITUTE OF PATHOGEN BIOLOGY, CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/017222SUPERMOLECULAR FORMULATIONS OF RETINOL AND DERIVATIVES THEREOF  AND PREPARATION METHODS THEREFORPROYA COSMETICS CO., LTD.
WO/2021/081782SUN CARE COMPOSITIONS WITH HOLLOW MESOPOROUS SILICA  NANOSPHERESDOW GLOBAL TECHNOLOGIES LLC
WO/2021/081859SOLID ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP  KERATIN MATERIALSL'OREAL
WO/2021/081876SOLID ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP  KERATIN MATERIALSL'OREAL
WO/2021/012460MEDICINE FOR PREVENTING AND TREATING BACTERIAL ENTERITIS OF  EELS, AND PREPARATION METHOD THEREFORJIMEI UNIVERSITY
WO/2021/031371APPLICATION OF TYROSINE KINASE INHIBITOR AS THERAPEUTIC DRUG  FOR ACUTE KIDNEY INJURYSHANDONG UNIVERSITY
WO/2021/087838TUMOR-SPECIFIC POLYPEPTIDE SEQUENCE AND USE THEREOFSHENZHEN GINO BIOTECHNOLOGY CO., LTD.
WO/2021/017255PROTEIN PEPTIDE MOISTURIZING LIQUID DISSOLVED IN WEAK ALKALINE  WATER AND PREPARATION METHOD THEREFORSUZHOU LVZHONGYUAN TEXTILE TECHNOLOGY CO. LTD
WO/2021/092802A HAIR STYLING PREPARATIONBEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD.
WO/2021/092892APPLICATION OF QUINOLINE OR QUINAZOLINE COMPOUND IN  PREPARATION OF ANTITUMOR DRUGSPEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL
WO/2021/092893USE OF DIARYL ETHER COMPOUND IN PREPARATION OF ANTI-TUMOR DRUGPEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL
WO/2021/097651PHARMACEUTICAL COMPOSITION COMPRISING ORLISTAT AND  PLANT-DERIVED LIPASE INHIBITORZHONGSHAN WANHAN PHARMACEUTICAL CO., LTD
WO/2021/097652ORLISTAT NANOSPHERES AND USE THEREOF IN PREPARATION OF  MEDICINES FOR TREATMENT OF OBESITYZHONGSHAN WANHAN PHARMACEUTICAL CO., LTD
WO/2021/097684NEW ANTI-SOLUBLE CD14 SUBTYPE ANTIBODY AND USE THEREOFSHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
WO/2021/097691POROUS DISSOLVABLE SOLID STRUCTURETHE PROCTER & GAMBLE COMPANY
WO/2021/022718APPLICATION OF PYRAZOLOPYRIMIDINE COMPOUND IN PREPARATION OF  DRUGS FOR PREVENTING/TREATING TUMORSWEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/102624COVALENT PROTEIN DRUGS DEVELOPED VIA PROXIMITY-ENABLED  REACTIVE THERAPEUTICS (PERX)HANGZHOU BRANCH OF TECHNICAL INSTITUTE OF PHYSICS AND  CHEMISTRY, CHINESE ACADEMY OF SCIENCES
WO/2021/027181USE OF IRON-CONTAINING MATERIAL IN PREPARATION OF PRODUCT FOR  INHIBITING TRANSMISSION OF DENGUE VIRUSTSINGHUA UNIVERSITY
WO/2021/017335PREPARATION METHOD FOR XANTHAN GUM COPOLYMER NANOMICELLES AND  APPLICATION THEREOFJIANGNAN UNIVERSITY
WO/2021/102674APPLICATION OF COMBINATION OF AMPK-TARGETING INHIBITOR/SIRNA  AND PROTEASOME INHIBITOR IN ANTICANCERSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/017339APPLICATION OF HYDROXYSAFFLOR YELLOW A IN PREPARATION OF  MEDICATION FOR TREATMENT OR ADJUVANT TREATMENT OF OBESITY DISEASEBEIJING SHIJITAN HOSPITAL, CAPITAL MEDICAL UNIVERSITY
WO/2021/102714A CONDITIONING COMPOSITIONBEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/102715A CONDITIONING COMPOSITIONBEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD.
WO/2021/056805WILD JUJUBE SEED FLAVONE AND PHOSPHOLIPID COMPOSITE AS WELL AS  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFTAIZHOU GUOKEHUAWU BIOMEDICAL TECHNOLOGIES CO., LTD
WO/2021/036058TERIPARATIDE SUSTAINED RELEASE GEL INJECTION SOLUTION AND  PREPARATION METHOD THEREFORHYBIO PHARMACEUTICAL CO., LTD.
WO/2021/003961SKIN CARE COMPOSITION CONTAINING PLANT EXTRACT, AND  PREPARATION METHOD THEREFORZHEJIANG KANGMANJIA DAILY NECESSITIES CO., LTD.
WO/2021/003962SKINCARE COMPOSITION FOR REPAIRING SKIN, AND PREPARATION  METHOD THEREFORZHEJIANG KANGMANJIA DAILY NECESSITIES CO., LTD.
WO/2021/003963SKINCARE COMPOSITION FOR TIGHTENING SKIN, AND PREPARATION  METHOD THEREFORZHEJIANG KANGMANJIA DAILY NECESSITIES CO., LTD.
WO/2021/102873AN OIL-IN-WATER SUNSCREEN COMPOSITIONBEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/102874AN OIL-IN-WATER SUNSCREEN COMPOSITIONBEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/102886COMPOSITION FOR CARING FOR/MAKING UP KERATAIN FIBERSL'OREAL
WO/2021/102897TWO-PHASE COMPOSITION FOR TOPICAL APPLICATIONL'OREAL
WO/2021/102935FLEXIBLE, POROUS, DISSOLVABLE SOLID SHEET ARTICLES HAVING  LARGE PORES AND METHOD OF MAKING SAMETHE PROCTER & GAMBLE COMPANY
WO/2021/103018METHOD FOR PREPARING RED POMEGRANATE EXTRACT AND SKINCARE  CREAM COMPRISING SAMECHEN, Bohao
WO/2021/103019METHOD FOR PREPARING COMPOSITION COMPRISING RICE WASHING WATER  AND SHAMPOO COMPRISING COMPOSITION COMPRISING RICE WASHING WATERCHEN, Bohao
WO/2021/056815CHEMOTHERAPEUTIC IMMUNE DRUG COMPOSITION AND PREPARATION  METHOD THEREOFSUZHOU INNOVATIVE BIOMATERIALS & PHARMACEUTICS CO., LTD.
WO/2021/109132COMPOSITE MATERIAL AND PREPARATION METHOD THEREFOR AND  APPLICATION THEREOFBIOMODI BIOTECH (SUZHOU) CO., LTD
WO/2021/103119APPLICATIONS OF MACELIGNAN IN PREPARING MEDICAMENT FOR  PREVENTING AND TREATING NEURODEGENERATIVE DISEASESSHENZHEN UNIVERSITY
WO/2021/114020PHARMACEUTICAL COMPOSITION OF ALKYNYL-CONTAINING COMPOUND,  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/114024COMPOSITION FOR BRIGHTENING AND/OR WHITENING KERATIN MATERIALSL'OREAL
WO/2021/077566APPLICATION OF DIVALENT MANGANESE IN PREPARING IMMUNITY  ENHANCING DRUG OR ANTITUMOR DRUGPEKING UNIVERSITY
WO/2021/114089METHODS OF USING CROCETIN IN TREATING SOLID TUMORSHANGZHOU MENGLANRUISI BIOTECHNOLOGY CO., LTD.
WO/2021/017365CRA4S1 GENE, ENCODED CRA4S1 PROTEIN, AND APPLICATIONZHENJIANG YANGTZE GREEN BIOTECHNOLOGY CO. LTD
WO/2021/114125USE OF LEVISTOLIDE A IN PREPARATION OF DRUGS FOR TREATING OR  PREVENTING RENAL DISEASESLIAONING SHUANGSHILI PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/068401TWO-DOSAGE-FORM ESSENCE AND PREPARATION METHOD THEREFORGUANGZHOU BIOHOPE CO., LTD.
WO/2021/114159SPECIAL NON-WOVEN FABRIC FOR FACIAL MASK FOR SENSITIVE SKINJIANGSU AIKOP NEW MATERIALS CO., LTD.
WO/2021/114218MYCOSPORINE-LIKE AMINO ACIDS PORPHYRA-334 AND SHINORINE AND  METHOD FOR EXTRACTING PORPHYRA-334 AND SHINORINE FROM SEAWEEDSLE, Zhanxian
WO/2021/114256DRUG FOR TREATING PULMONARY FIBROSISTHE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY
WO/2021/114315USE OF HETEROCYCLIC DERIVATIVES WITH CARDIOMYOCYTE  PROLIFERATION ACTIVITY FOR TREATMENT OF HEART DISEASESSHANGHAI EAST HOSPITAL
WO/2021/119902USE OF NAPHTHYLUREA COMPOUNDSUZHOU RAYMON PHARMACEUTICALS COMPANY, LTD.
WO/2021/119966DRUG FOR TREATING DIGESTIVE SYSTEM MYCOSISXIAO, Mingchun
WO/2021/012589PREPARATION METHOD AND APPLICATION OF STANDARD LILY BULB AND  REHMANNIA DECOCTION HAVING ANTIDEPRESSANT EFFECTSHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
WO/2021/051685COMPOUND FORMULATION FOR REMOVING HPVJIANGXI SHANXING BIOTECHNOLOGY CO., LTD.
WO/2021/109251ESSENTIAL OIL COMPOSITION, PREPARATION METHOD THEREFOR AND USE  THEREOFGAIN SURE LIMITED
WO/2021/120084SOLID COMPOSITION IN THE FORM OF WATER-IN-OIL EMULSIONL'OREAL
WO/2021/093087TRADITIONAL CHINESE MEDICINE COMPOSITION HAVING EFFECT OF  IMPROVING COGNITION, PREPARATION METHOD THEREFOR, AND TRADITIONAL CHINESE  MEDICINE PREPARATIONCHENLAND NUTRITIONALS, INC.
WO/2021/088219APPLICATION OF TRPC1 PEPTIDE MOLECULE IN PREPARATION OF DRUG  FOR TREATING INFLAMMATION CAUSED BY VIRAL INFECTIONJIANGNAN UNIVERSITY
WO/2021/047099METHOD FOR SYNTHESIZING NOVEL FERRIHYDRITE  NANO-PHOTOSENSITIZER AND USE THEREOF IN COUNTERACTING CANCER AND BACTERIANORTHWESTERN POLYTECHNICAL UNIVERSITY
WO/2021/093090TRADITIONAL CHINESE MEDICINE EXTRACT COMPOSITION HAVING  FUNCTION OF REGULATING DEPRESSION, PREPARATION METHOD THEREFOR, AND CHINESE  MEDICINE PREPARATIONCHENLAND NUTRITIONALS, INC.
WO/2021/120213DEEP BEAUTY-TREATMENT MASSAGE CREAM AND PREPARATION METHOD AND  APPLICATION METHODTANGSHAN HARBIN SHIP TECHNOLOGY CO., LTD.
WO/2021/109276COMPLEX, TISSUE REPAIR MATERIAL, PREPARATION METHOD THEREFOR  AND USE THEREOFSHAANXI BIO REGENERATIVE MEDICINE CO., LTD
WO/2021/127814PHOTO-NANOVACCINE FOR CANCER TREATMENT, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFSHENZHEN PEOPLE'S HOSPITAL
WO/2021/103232PREPARATION METHOD FOR CORE-SHELL NANOPARTICLES BASED ON LIPID  MEMBRANE AND METAL ORGANIC FRAMEWORKSHANGHAI NATIONAL ENGINEERING RESEARCH CENTER FOR  NANOTECHNOLOGY LTD.
WO/2021/128027TACI-FC FUSION PROTEIN AND USE THEREOFREMEGEN CO., LTD.
WO/2021/008084ADRENALINE INJECTION AND PREPARATION METHOD THEREFORHYBIO PHARMACEUTICAL CO., LTD.
WO/2021/103238TRADITIONAL CHINESE MEDICINE COMPOUND PREPARATION FOR  PREVENTING AND TREATING PORCINE DIARRHEA AND PREPARATION METHOD THEREFORGUANGDONG RONGDA BIOLOGY CO., LTD.
WO/2021/103239COLISTIN SULPHATE PREMIX AND PREPARATION METHOD THEREFORGUANGDONG RONGDA BIOLOGY CO., LTD.
WO/2021/103240SOLUBLE GRANULE FOR IMPROVING PIG IMMUNITY AND METHOD FOR  PREPARATION THEREOFGUANGDONG RONGDA BIOLOGY CO., LTD.
WO/2021/128045COMPOSITION FOR CONDITIONING KERATAIN FIBERSL'OREAL
WO/2021/128054COMPOSITION FOR CONDITIONING KERATAIN FIBRESL'OREAL
WO/2021/128055COMPOSITION FOR CONDITIONING KERATAIN FIBERSL'OREAL
WO/2021/128119KIT FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/120268MUPIROCINE OINTMENT AND PREPARATION METHOD THEREFORFRONT PHARMACEUTICAL PLC.
WO/2021/128232OPHIOPOGONIS RADIX DEGRADATION EXTRACT AND USE THEREOF IN  PREPARATION OF HYPOGLYCEMIC DRUGSGUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE
WO/2021/128292COMPOSITION AND METHOD FOR TREATMENT OF MULTIPLE SCLEROSISWUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD.
WO/2021/128307FLAVOR COMPOSITION AND ELECTRONIC CIGARETTE LIQUID CONTAINING  FLAVOR COMPOSITIONSHENZHEN RELX TECHNOLOGY CO., LTD.
WO/2021/098011METHOD FOR COMPREHENSIVELY EXTRACTING AUTOLOGOUS LEUKOCYTES  AND PLATELET PLASMASICHUAN I LOVE WOLAI AUTOMOBILE CLUB CO., LTD
WO/2021/134171COMPOSITION FOR BRIGHTENING OR WHITENING KERATIN MATERIALSL'OREAL
WO/2021/134194ANHYDROUS COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/134394COMPOSITION COMPRISING PHENOLIC COMPOUNDS AND HYDROTROPESL'OREAL
WO/2021/134420COMPOSITION FOR CARING FOR KERATIN MATERIALS AND USE THEREOFL'OREAL
WO/2021/134454COMPOSITION FOR COSMETIC PRODUCTSL'OREAL
WO/2021/134458COMPOSITION FOR CONDITIONING KERATIN MATERIALSL'OREAL
WO/2021/134460COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/134463COMPOSITION FOR CONDITIONING KERATIN MATERIALSL'OREAL
WO/2021/134469COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/134482DIRECT COMPRESSED ACTIVATED CARBON TABLET FORMULATIONFRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
WO/2021/062960APPLICATION OF PEG INTERFERON AND PROTO-ONCOGENE PRODUCT  TARGETING INHIBITOR IN SYNERGISTIC TREATMENT OF RENAL CARCINOMASHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
WO/2021/062961APPLICATION OF PEG-INTERFERON AND PROTOONCOGENE PRODUCT  TARGETING INHIBITOR IN SYNERGISTIC INHIBITION OF TUMORSSHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
WO/2021/134623TERTIARY AMINE PHARMACEUTICAL COMPOSITION AND INDUSTRIAL BATCH  PREPARATION METHOD THEREFORAC PHARMACEUTICALS CO., LTD
WO/2021/134647SUSTAINED RELEASE COMPOSITION AND PREPARATION METHOD THEREFORDIQI PHARMACEUTICALS CO., LTD.
WO/2021/000558ACTIVATING AGENT FOR SIMULTANEOUSLY ACTIVATING OXIDATIVE  PHOSPHORYLATION PATHWAY AND INHIBITING GLYCOLYTIC PATHWAY AND APPLICATION  THEREOFLANZHOU UNIVERSITY
WO/2021/008100SYNERGISTIC EFFECT OF COBRA NEUROTOXIN POLYPEPTIDE ON  INHIBITING OPIOID HYPERALGESIA AND TOLERANCE AND ALLEVIATING PAIN ASSOCIATED  THEREWITHQI, Zhankai
WO/2021/042645APPLICATION OF COBRA NEUROTOXIN PEPTIDE MOLECULE IN TREATING  NEPHRITIS PROTEINURIAQI, Zhankai
WO/2021/051720CLASS OF ANTI-HUMAN EGFR ANTIBODY DRUG CONJUGATE AND  PREPARATION METHOD AND APPLICATION THEREOFINSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/068432APPLICATION OF ELAPIDAE SNAKE POSTSYNAPTIC NEUROTOXIN MONOMER  MOLECULE IN TREATMENT OF ALZHEIMER'S DISEASEQI, Zhankai
WO/2021/093134USE OF GROUP OF SNAKE NERVE GROWTH FACTORS AND SNAKE NERVE  GROWTH FACTOR PRECURSORS IN TREATMENT OF SENILE DEMENTIAQI, Zhankai
WO/2021/103288CELL CAPABLE OF BEING TRACED IN ORGANISM, PREPARATION METHOD  THEREFOR, AND USE THEREOF IN CELL PHARMACOKINETICS RESEARCHSHANGHAI HEXAELL BIOTECH CO., LTD.
WO/2021/138759PREPARATION METHOD FOR AND USE OF COMBINATION OF ANTIBODY  TARGETING TUMOR ANTIGEN AND INKT CELLSSHANGHAI SINOBAY BIOTECHNOLOGY CO., LTD.
WO/2021/138824A COSMETIC CLEANSING COMPOSITIONBEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/031519ASCIDIAN EXTRACT RICH IN VARIOUS PLASMALOGENS AND PREPARATION  AND ANALYSIS METHODS THEREFORTIAN, Bing
WO/2021/109319BATH MOISTURIZER HAVING HIGH MOISTURE RETENTION EFFECT AND  PREPARATION METHOD THEREFORJOMOO KITCHEN&BATH CO., LTD
WO/2021/142577ARYLAMIDE COMPOUND BASED ON BENZENE RING SUPRAMOLECULAR  INTERACTION, SELF-ASSEMBLY MORPHOLOGY, AND USEYI, Tianqi
WO/2021/047137MEDICINE FOR TREATING PERIODONTAL DISEASE CAUSED BY  PERIODONTAL PATHOGEN INFECTIONHOSPITAL OF STOMATOLOGY, SUNYAT-SEN UNIVERSITY
WO/2021/017434APPLICATION OF ACANTHOPANAX TRIFOLIATUS POLYSACCHARIDE ATP1-1  IN PREPARATION OF MEDICINES FOR TREATING DIABETESGUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/142733COMBINATIONAL THERAPY COMPRISING GLP-1 AND/OR GLP-1 ANALOGS,  AND INSULIN AND/OR INSULIN ANALOGSSHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/142736DOSING REGIMEN OF GLP-1SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/142737COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC  STEATOHEPATITIS (NASH)SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/134842USE OF ZC3H12B GENE OR PROTEIN AND ESTABLISHMENT METHOD FOR  LIVER DISEASE ANIMAL MODELSHANGHAI OCEAN UNIVERSITY
WO/2021/142815BERBERINE AND COPTISINE, OR ACTIVE METABOLITES THEREOF, AND  APPLICATION OF SALTS THEREOF IN MEDICATION FOR PREVENTING AND/OR TREATING  URIC ACID NEPHROPATHYINSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/017448EXTERNAL COMPOSITION FOR SKIN HAVING ITCHING RELIEVING EFFECTYANGSHENGTANG (ANJI) COSMETICS CO., LTD.
WO/2021/068439SYNERGISTIC ANTI-SKIN-AGING PREPARATION COMPRISING EXOSOME AND  SPONGE SPICULE OR ANALOGUE THEREOFSHENZHEN PEOPLE'S HOSPITAL
WO/2021/056946APPLICATION OF ANTI-LCN2 ANTIBODY IN PREPARATION OF DRUG FOR  TREATING LUPUS NEPHRITISNANJING DRUM TOWER HOSPITAL
WO/2021/151251TREATING TREATMENT-RESISTANT DIABETES WITH GLUCOKINASE  ACTIVATORHUA MEDICINE (SHANGHAI) LTD.
WO/2021/151259USE OF 3-(4-HYDROXYPHENYL)PROPIONIC ACID IN PREPARATION OF  DRUGS FOR PREVENTING AND TREATING RESPIRATORY TRACT INFECTIONSUN YAT-SEN UNIVERSITY
WO/2021/155580COMBINATION THERAPIES AND BIOMARKERS FOR TREATING CANCERCOTHERA BIOSCIENCE, INC.
WO/2021/082298COMPOSITION CAPABLE OF RELIEVING ECZEMA SKIN CONDITION, AND  PREPARATION METHOD THEREFORSHENZHEN YUANGUANGZHOUTECHNOLOGY CO., LTD.
WO/2021/120376COMPOSITE PROBIOTIC COMPOSITION HAVING ANTI-AGING EFFECT AND  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFYANG, Bo
WO/2021/159547POLYPEPTIDE DRUG FOR PREVENTING AND/OR TREATING OVARIAN CANCER  AND USE THEREOFZHUHAI TENGBAI PHARMACEUTICAL CO., LTD.
WO/2021/031536USE OF NADH AND/OR NMN IN PREPARING MEDICAMENTS AND HEALTH  CARE PRODUCTS FOR BRAIN FUNCTION RECOVERYHOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/163874RECOMBINANT VIRAL VECTOR, IMMUNOGENIC COMPOSITION COMPRISING  SAME, AND USESVACDIAGN BIOTECHNOLOGY CO., LTD.
WO/2021/163897PHARMACEUTICAL COMPOSITION CONTAINING METHYLENE BLUE DYE,  NUTRIENT OR/AND CONVENTIONAL ANTITUMOR DRUG, AND APPLICATION THEREOFCHENGDU KUACHANGAOPU MEDICAL TECHNOLOGY CO., LTD.
WO/2021/163915MILD CLEANSING COMPOSITION CONTAINING NEARLY SATURATED,  SATURATED OR SUPERSATURATED ACTIVE INGREDIENTS AND PREPARATION METHOD  THEREFORHUANG, Yaokun
WO/2021/163965FLEXIBLE, POROUS, DISSOLVABLE SOLID SHEET ARTICLES CONTAINING  CATIONIC SURFACTANTTHE PROCTER & GAMBLE COMPANY
WO/2021/163980SUBSTANCE TARGETING MASP-2 AND N PROTEIN OR BINDING THEREOF  FOR PREVENTING AND/OR TREATING CORONAVIRUS INFECTIONACADEMY OF MILITARY MEDICAL SCIENCE, ACADEMY OF MILITARY  SCIENCE, PLA.
WO/2021/164037MEDICATION FOR TREATING INFLUENZA OR INFECTIOUS DISEASEXIAO, Mingchun
WO/2021/142884USE OF ASPIRIN IN PREPARATION OF PLATELET-TARGETED DRUG  DELIVERY SYSTEMSOUTHEAST UNIVERSITY
WO/2021/138979PROBIOTIC MINERAL MATERIAL COMPOSITE PREPARATION AND  APPLICATION OF MINERAL MATERIALS IN PREPARATION OF DRUGS FOR INHIBITING  MALIGNANT TUMOR GROWTHNANJING UNIVERSITY
WO/2021/168684ORAL CARE COMPOSITIONS FOR GUM HEALTHTHE PROCTER & GAMBLE COMPANY
WO/2021/168696ORAL CARE COMPOSITIONS FOR GUM HEALTHTHE PROCTER & GAMBLE COMPANY
WO/2021/068452DNA VACCINE CAPABLE OF EFFECTIVELY TREATING AND/OR PREVENTING  TYPE 1 DIABETES AND USE THEREOFTHE FIFTH MEDICAL CENTER OF CHINESE PLA GENERAL HOSPITAL
WO/2021/174406MEDICAL USE OF ANEMOSIDE B4 IN TREATING ORAL ULCERLIU, Qi
WO/2021/174416DETECTION METHOD FOR CIRCULATING TUMOR CELLSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/168876ANTI-CORONAVIRUS APPLICATION OF ASCORBYL PALMITATESUN YAT-SEN UNIVERSITY
WO/2021/164054APPLICATION OF CANNABIDIOL IN PREPARATION OF SKINCARE PRODUCTS  HAVING SOOTHING AND ANTI-IRRITATION EFFECTSDOCTOR PLANT GUANGDONG BIOTECHNOLOGY CO., LTD.
WO/2021/051750TRADITIONAL CHINESE MEDICINE FOR TREATING DISEASES OF BODY  CAUSED BY BODY DAMPNESS, AND PREPARATION METHOD THEREFORYEUNG, Tak Wai Waisees
WO/2021/159570APPLICATION OF BAICALEIN IN PREPARING DRUG FOR PREVENTING  AND/OR TREATING NOVEL CORONOVIRUS INFECTIOUS DISEASEINSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL  SCIENCES & PEKING UNION MEDICAL COLLEGE
WO/2021/179106APPLICATION OF GP73 INHIBITOR IN PREPARATION OF DRUG FOR  TREATING DIABETESBEIJING SUNGEN BIOMEDICAL TECHNOLOGY CO. LTD.
WO/2021/134913APPLICATION OF HUMAN CRYPTOCHROME PROTEIN I (HCRY1) IN  PREPARATION OF ANTI-ULTRAVIOLET RADIATION PREPARATIONGUANGZHOU DOUBLLE BIOPRODUCT CO., LTD
WO/2021/103342POLYETHYLENE GLYCOL CONJUGATED DRUG, AND PREPARATION METHOD  THEREFOR AND USE THEREOFCHONGQING UPGRA BIOLOGICAL SCI. & TECH., LTD.
WO/2021/109351POLYETHYLENE GLYCOL CONJUGATE DRUG, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFCHONGQING UPGRA BIOLOGICAL SCI. & TECH., LTD.
WO/2021/017475OPHTHALMIC PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE,  PREPARATION METHOD AND USE THEREOFSHENYANG XINGQI PHARMACEUTICAL CO., LTD.
WO/2021/179214Methods for enhancing anti-apoptotic pathway to prevent DOX  toxicitySHENZHEN UNIVERSITY
WO/2021/012686NALOXONE HYDROCHLORIDE INJECTION AND PREPARATION METHOD  THEREFORGUANGDONG QIFANG MEDICINES CO., LTD.
WO/2021/147151USE OF FUCOSAN SULFATE IN PROMOTING FOAM CELL AUTOPHAGY TO  DECOMPOSE OX-LDLSHANDONG UNIVERSITY
WO/2021/179319COMPOSITION CONTAINING HYDROLYZED CHONDROITIN SULFATE FOR  PREVENTING AND TREATING OSTEOARTHROPATHYNANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/174581NEW USE OF INDAZOLE COMPOUNDTARAPEUTICS SCIENCE INC.
WO/2021/008149APPLICATION OF AKKERMANSIA MUCINIPHILA IN PREPARATION OF  ANTIDEPRESSANT DRUG OR HEALTH CARE PRODUCTJIANGSU PROVINCE HOSPITAL OF CHINESE MEDICINE
WO/2021/168930TABLET OF REMDESIVIR AND PREPARATION METHOD THEREFORGU, Shihai
WO/2021/036230RANOLAZINE SUSTAINED-RELEASE COMPOSITION AND PREPARATION  METHOD THEREFORHYBIO PHARMACEUTICAL CO.,LTD.
WO/2021/168931SUBMICRO EMULSION CONTAINING ACER TRUNCATUM SEED OIL AND  PREPARATION METHOD THEREFORSHENZHEN JINFENG BIOMEDICAL TECHNOLOGY CO., LTD
WO/2021/142920TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING LUNG  CANCER, AND PREPARATION AND USE THEREOFDONGGUAN HEC CORDYCEPS R&D CO., LTD.
WO/2021/147162USE OF LACTOBACILLUS REUTERI FROM BREAST MILK IN REGULATING  MATERNAL AND INFANT IMMUNE FUNCTIONFINE (HUNAN) BIOTECHNOLOGY CO., LTD.
WO/2021/012694ETHYL METHYL HYDROXYPYRIDINE MALATE OR PHARMACEUTICAL  COMPOSITION THEREOF, AND A USE IN PREVENTING AND/OR TREATING TYPE-II DIABETESKENO PHARMA LIMITED
WO/2021/073041APPLICATION OF MULTI-LINEAGE DIFFERENTIATING STRESS ENDURING  CELLS, MEDICAMENT FOR TREATING PERIPHERAL NERVE INJURY AND PREPARATION METHOD  THEREFORNANTONG UNIVERSITY
WO/2021/068459SUSPENSION CONTAINING LOW METHOXYLATION PECTIN AND  MONTMORILLONITE FOR TREATING ACUTE DIARRHEAAFFILIATED HOSPITAL OF NANTONG UNIVERSITY
WO/2021/073042USE OF MULTILINEAGE DIFFERENTIATION STRESS-ENDURING CELL, DRUG  FOR TREATING DIABETES AND PREPARATION METHOD THEREFORNANTONG UNIVERSITY
WO/2021/008161DRUG FOR ALLEVIATING PSEUDOMONAS KERATITISSHANDONG EYE INSTITUTE
WO/2021/142934APPLICATION OF JAK-1 SIGNALING PATHWAY INHIBITOR IN  PREPARATION OF MEDICAMENT FOR TREATING BRAIN INJURYSOOCHOW UNIVERSITY
WO/2021/189256USE OF MENTHOL FOR PREPARING EXTERNAL COMPOSITION FOR TREATING  NEURODEGENERATIVE DISEASE AND STROKECHINA MEDICAL UNIVERSITY
WO/2021/155631ERYTHROCYTE GEL DELIVERY SYSTEM, AND PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFSOOCHOW UNIVERSITY
WO/2021/179351IMMUNE COMBINATION FOR INDUCING BROAD-SPECTRUM NEUTRALIZING  ANTIBODY AGAINST HIV-1SHANGHAI PUBLIC HEALTH CLINICAL CENTER
WO/2021/189279METHOD FOR REDUCING BEHAVIORAL ABNORMALITIESBENED BIOMEDICAL CO., LTD.
WO/2021/184404COMPOSITION OF NOVEL IMMUNE AGONIST COMPOUND AND USE THEREOF  IN MEDICINE CAPABLE OF RESISTING MULTIPLE DISEASESHANGZHOU XINGAO BIOTECHNOLOGY CO., LTD.
WO/2021/134935USE OF CANNABIDIOL IN PREPARATION OF DRUGS FOR PROMPTING  HEALING OF ORAL MUCOSASICHUAN UNIVERSITY
WO/2021/151264USE OF ACYLATED SPIRAMYCIN IN PREPARATION OF MEDICAMENT FOR  TREATING CORONAVIRUS INFECTIOUS DISEASESHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/184405LIPOSOME COMPRISING GULURONIC ACID OLIGOSACCHARIDE,  PREPARATION METHOD, AND USE THEREOF FOR PROMOTING IMMUNE ACTIVITYSHENZHEN UNIVERSITY
WO/2021/189355AMINO ACID MEDIATED GENE DELIVERY AND ITS USESCHINESE INSTITUTE FOR BRAIN RESEARCH, BEIJING
WO/2021/031565Treatment of Neuronal DiseasesCENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE  TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/189390MEDICAMENT FOR PREVENTING/TREATING TYPE 2 DIABETES AND USESSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/189444USE OF RIFAMYCIN ANTIBIOTICS IN PREPARATION OF DRUGS AGAINST  YELLOW FEVER VIRUS INFECTIONSTHE NAVAL MEDICAL UNIVERSITY OF PLA
WO/2021/195820TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/155633USE OF ALKYL RESORCINOL COMPOUND IN PREPARATION OF DRUG FOR  PREVENTING OR TREATING ALZHEIMER'S DISEASEBEIJING TECHNOLOGY AND BUSINESS UNIVERSITY
WO/2021/195877FORMULATIONS OF HUMAN PARATHYROID HORMONE (PTH) AND METHODS  FOR PRODUCING SAMESICHUAN LUZHOU BUCHANG BIO-PHARMACEUTICAL CO., LTD.
WO/2021/195883APPLICATION OF TFF2 PROTEIN AND IFN-κ PROTEIN COMBINATION IN  TREATMENT OF A NOVEL CORONAVIRUS INFECTIONSHANDONG RUIYING PIONEER PHARMACEUTICAL CO., LTD
WO/2021/195904USE OF COMPOSITION CONTAINING ASTRAGALI RADIX, PUERARIAE  LOBATAE RADIX AND ERIGERONTIS HERBACHONGQING TAIJI INDUSTRIAL (GROUP) CO., LTD
WO/2021/195905COSMETIC COMPOSITION FOR SKIN CAREL'OREAL
WO/2021/195931COSMETIC COMPOSITION IN THE FORM OF A GELL'OREAL
WO/2021/077681HYALURONIC ACID GEL COMPOSITION FOR WATER OPTOINJECTION, AND  PREPARATION METHOD THEREFORBIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.
WO/2021/077683HYALURONIC ACID GEL FOR HYALURONIC ACID INJECTION AND USE  METHOD FOR HYALURONIC ACID GELBIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD
WO/2021/196079ENERGY-ACTIVATING, ANTI-WRINKLE, ANTI-INFLAMMATORY, AND  WHITENING ORCHID EMBRYO TISSUE EXTRACTLIANG, Chiahua
WO/2021/196086METHOD FOR INHIBITING CELL ACTIVITY BY MEANS OF INTRACELLULAR  POLYMERIZATION AND PRO-DRUG IMPLEMENTING METHODSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/189517USE OF MTHFD1 INHIBITOR IN INHIBITING AND KILLING VIRUSESTSINGHUA UNIVERSITY
WO/2021/057007RAPAMYCIN NANOSCALE SUSTAINED-RELEASE AGENT AND PREPARATION  METHOD THEREOFYAN, Pengke
WO/2021/196105ANTI-TUMOR EFFECTIVE COMPONENT OF HEDYOTIS DIFFUSA,  PREPARATION METHOD THEREFOR AND USE THEREOFGUANGDONG NEW EAR LIFE TECHNOLOGY CO., LTD.
WO/2021/164107NOVEL APPLICATION OF IL-6 RECEPTOR ANTIBODIESUNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA
WO/2021/203236BAT-DERIVED CORONAVIRUS VACCINE FOR PREVENTION OF COVID-19SICHUAN CHENGYU BIOLOGICAL PRODUCTS INC.
WO/2021/168996CATALASE NANOCAPSULES AND METHODS FOR USEVIVIBABA, INC.
WO/2021/184449PREPARATION METHOD FOR AND APPLICATION OF GENETICALLY  ENGINEERED ANTITUMOR MICROPARTICLEWUHAN SHENGRUN BIOTECHNOLOGY CO., LTD
WO/2021/031579ANTI-ACETYLCHOLINESTERASE ACTIVE COMPOSITION IN CAULIS  MAHONIAE AND SCREENING METHOD THEREFOR AND APPLICATION THEREOFSHENZHEN INSTITUTE FOR DRUG CONTROL (SHENZHEN TESTING CENTER  OF MEDICAL DEVICES)
WO/2021/203377BENDAMUSTINE COMPOSITION AND USE THEREOFBIKA BIOTECH (GUANGZHOU) CO., LTD
WO/2021/203419TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  DERMATITIS OR ECZEMALUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/203434NANO MATERIAL FOR OSTEOCLAST ACIDIC CLOSED REGION AND  PREPARATION METHOD THEREFORSIR RUN RUN SHAW HOSPITAL ZHEJIANG UNIVERSITY SCHOOL OF  MEDICINE
WO/2021/196275APPLICATION OF EMETINE IN PREPARATION OF DRUG FOR TREATING OR  PREVENTING NOVEL CORONAVIRUSES SARS-COV-2HEFEI INSTITUTES OF PHYSICAL SCIENCE, CHINESE ACADEMY OF  SCIENCES
WO/2021/179396NEW APPLICATION OF HUWE1 INHIBITOR BI8622KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/208060GAS SUPPLY DEVICE, USE THEREOF FOR LIGHTENING HAIR COLOR AND  METHODTO2M CORPORATION
WO/2021/208080USE OF OVATODIOLIDE AGAINST NOVEL CORONAVIRUSCNS BIOTEK CORP.
WO/2021/212253IBRUTINIB GLUCONOLACTONE CO-CRYSTAL AND PREPARATION METHOD  THEREFORTIANJIN CREATRON BIOTECHNOLOGY CO., LTD.
WO/2021/212267COMPOSITION FOR CARING FOR THE SKINL'OREAL
WO/2021/212269APPLICATION OF ELLAGIC ACID IN PREVENTING AND TREATING NOVEL  CORONAVIRUS INFECTIONYUNNAN AGRICULTURAL UNIVERSITY
WO/2021/212270APPLICATION OF AMARONOL A IN PREVENTION AND TREATMENT OF NOVEL  CORONAVIRUS INFECTIONYUNNAN AGRICULTURAL UNIVERSITY
WO/2021/114540PEONY FACE MASK FOR CLEANSING PORES AND PREPARATION METHOD  THEREFORSHANXI LU'AN MINING (GROUP) CO., LTD
WO/2021/068478POLYPEPTIDE AND POLYPEPTIDE COMPOSITION FOR INHIBITING  HELICOBACTER PYLORI FROM FORMING BIOLOGICAL MEMBRANE AND ELIMINATING  BIOLOGICAL MEMBRANE FORMED BY HELICOBACTER PYLORIANHUI SCIENCE AND TECHNOLOGY UNIVERSITY
WO/2021/036294VAGINAL ACID-BASE BUFFER GEL AND PREPARATION METHODNANJING TIANLANG PHARMACEUTICAL CO., LTD.
WO/2021/051807PREPARATION CONTAINING HUMAN ALBUMIN AND PREPARATION METHOD  THEREFORTONGHUA ANRATE BIOPHARMACEUTICAL CO., LTD
WO/2021/212360TREATING UNTREATED OR TREATMENT-RESISTANT DIABETES WITH  GLUCOKINASE ACTIVATOR AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORHUA MEDICINE (SHANGHAI) LTD.
WO/2021/098141AEROSOL ALCOHOL-FREE NO-WASH ANTIBACTERIAL HAND SANITIZER AND  PREPARATION METHOD THEREFORZHEJIANG LUDAO TECHNOLOGY CO., LTD.
WO/2021/212404TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAMEHENKEL AG & CO. KGAA
WO/2021/088327TOOTH MINERALIZATION SOLUTION AND MINERALIZATION METHOD  THEREOFZHEJIANG UNIVERSITY
WO/2021/057022PEARL PREPARATION AND PREPARATION METHOD THEREFOR AND  APPLICATION THEREOFOSM BIOLOGY CO., LTD.
WO/2021/208138TOAD SKIN STERENE TOTAL LACTONE EXTRACT, AND PREPARATION  METHOD THEREFOR AND USE THEREOFHEFEI HUAFANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/174656CHINESE PATENT MEDICINE FOR TREATING SUB-HEALTH CHRONIC  DISEASESWU, Guanlin
WO/2021/217388MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE AND  PREPARATION METHOD THEREFORJIANGSU TASLYDIYI PHARMACEUTICAL CO., LTD.
WO/2021/120486LITHIUM ION COMPOSITION AND APPLICATION THEREOFQINGDAO DEBAO SHANGJIA HOUSEHOLD PRODUCTS CO. , LTD
WO/2021/169026TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING  EPIDEMICS, AND PREPARATION METHOD THEREFOR AND USE THEREOFJIANGSU PROVINCE HOSPITAL OF TCM
WO/2021/196334APPLICATION OF PYR3 IN PREPARATION OF DRUG FOR PROTECTING  AGAINST LIVER DAMAGETHE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/196335USE OF PYR3THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/217560KIT FOR CARING FOR THE SKINL'OREAL
WO/2021/217568ASSEMBLED JADE-ACTIVATING MATERIAL FOR MAINTAINING BEAUTY AND  KEEPING YOUNG, AND ASSEMBLING AND SYNTHESIZING METHOD THEREFOR AND USE  THEREOFSICHUAN SANTAI PHARMACEUTICAL TECHNOLOGY CO. LTD
WO/2021/169034APPLICATIONS OF TRANSFERRIN OR OVEREXPRESSED TRANSFERRIN IN  PREPARING MEDICAMENT FOR TREATING AND/OR PREVENTING ULCERATIVE COLITISKUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/223143O/W EMULSION AND W/O EMULSION INVERTED THEREFROM, AND PERSONAL  CARE COMPOSITION CONTAINING SAMEMOMENTIVE PERFORMANCE MATERIALS INC.
WO/2021/217693USE OF SYMBIOTIC FERMENTATION PRODUCT OF HYDROLYZED CANDIDA  AND JAPANESE SAKE YEASTHANGZHOU QIANMEI COSMETIC CO., LTD
WO/2021/004145USE OF MIR-132 AND 212 IN PREPARATION OF DRUG FOR TREATING  ADDICTIONSHENZHEN KANGNING HOSPITAL (SHENZHEN MENTAL HEALTH INSTITUTE,  SHENZHEN MENTAL HEALTH CENTER)
WO/2021/226736TREATMENT OF ADVERSE EFFECTS CAUSED BY ATYPICAL ANTIPSYCHOTICSSHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/226738MOLECULAR-LEVEL PHARMACEUTICAL COMPOSITION COMPRISING  LENVATINIB AND PREPARATION METHOD THEREFOR AND USE THEREOFBEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RESEARCH CO. LTD.
WO/2021/217702MEDICINE AND FOOD FOR PREVENTING OR TREATING COVID-19, AND  APPLICATION THEREOFGUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/226762TUMOR MICROENVIRONMENT RESPONSE-TYPE NANO-COMPOSITE DRUG  LOADING SYSTEM, AND PREPARATION METHOD THEREFOR AND USE THEREOFWANG, Shubin
WO/2021/203515PREPARATION METHOD FOR MICRORNA MICRO/NANOSPHERES AND  APPLICATION THEREOF IN HEALING SPINAL CORD INJURYYAOSHUNZE BIO-MEDICAL (NANJING) CO., LTD.
WO/2021/082391COLLAGEN NANO INSTANT FACIAL MASK OF YEAST RECOMBINANT  COLLAGEN AND PREPARATION METHOD THEREFORNOX BELLCOW COSMETICS CO., LTD.
WO/2021/226849IMMUNOLOGICALLY ACTIVE PEPTIDE-BILIVERDIN CONJUGATE,  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFINSTITUTE OF PROCESS ENGINEERING, CHINESE ACADEMY OF SCIENCES
WO/2021/098164METHOD FOR EXTRACTING KELP POLYPHENOLSQINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/226883COMPOSITIONS AND METHODS FOR TREATING CANCER SUBMISSION OF  SEQUENCE LISTING ON ASCII TEXT FILEADAGENE AG
WO/2021/103434RECOMBINANT VARICELLA-ZOSTER VIRUS VACCINEBEIJING LUZHU BIOTECHNOLOGY CO., LTD.
WO/2021/008215POLYMER COMPOSITE MICROSPHERE, PREPARATION METHOD THEREFOR AND  USE THEREOFGUANGDONG INSTITUTE OF MEDICAL INSTRUMENTS
WO/2021/217740COMPOSITIONS AND METHODS FOR INHIBITING VIRUS INFECTIONSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/227077AMINO ACID COMPOSITION AND METHOD FOR CATALYTIC SYNTHESIS OF  AMINO ACID BY MEANS OF ENERGY RADIATIONBEIJING GUANGHE ORIGINAL TECHNOLOGY CO., LTD.
WO/2021/057042DRUG COMPOSITION CONTAINING ABIRATERONE ACETATE, AND  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFHUNAN HUIZE BIO-PHARMACEUTICAL CO., LTD
WO/2021/232334TRADITIONAL CHINESE MEDICINE COMPOSITION HAVING ANTI-ACNE  EFFECT, PREPARATION METHOD THEREFOR, AND USE THEREOFJOHNSON BIOTECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/237456ANTI-TUMOR PHARMACEUTICAL COMPOSITION AND USE THEREOFSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/237609NOVEL USE OF ORIDONIN OR ORIDONIN DERIVATIVETSINGHUA UNIVERSITY
WO/2021/047210IMMUNIZATION-PURPOSE SUSPENDING AGENT, VACCINE SUSPENSION  PREPARATION METHOD AND SPRAY-DROP IMMUNIZATION METHODFOSHAN STANDARD BIO-TECH CO., LTD.
WO/2021/159636USE OF COMPOUND ZZ-8 IN PREPARING DRUG FOR TREATMENT OF  OBESITYKEY LABORATORY OF SOUTH SUBTROPICAL PLANT DIVERSITY, FAIRY  LAKE BOTANICAL GARDEN, SHENZHEN & CHINESE ACADEMY OF SCIENCES
WO/2021/012789PHARMACEUTICAL COMPOSITION CONTAINING LYSOZYME AND USE THEREOFGUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/237691DEFORMABLE SOLID COMPOSITION FOR CLEANSING THE SKINL'OREAL
WO/2021/237697COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALSL'OREAL
WO/2021/042777MULTI-COMPONENT GEL SUSTAINED-RELEASE PHARMACEUTICAL  COMPOSITION FOR TREATMENT OF TUMORSSUZHOU INNOVATIVE BIOMATERIALS & PHARMACEUTICS CO., LTD.
WO/2021/042778TEMPERATURE-SENSITIVE GEL PHARMACEUTICAL COMPOSITION FOR  TREATMENT OF TUMORSSUZHOU INNOVATIVE BIOMATERIALS & PHARMACEUTICS CO., LTD.
WO/2021/155651USE OF 4-AMINOQUINOLINE COMPOUND IN TREATMENT OF CORONAVIRUS  INFECTIONACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/212617SEAWEED MASK, PREPARATION METHOD THEREFOR AND APPLICATION  THEREOFSHANDONG UNIVERSITY
WO/2021/008265ANTI-AGING SOFT CAPSULE FOR MENOPAUSAL WOMEN AND PREPARATION  METHOD THEREFORZAOZHUANG UNIVERSITY
WO/2021/068533DRUG FOR ANTAGONIZING REPLICATION OF PORCINE REPRODUCTIVE AND  RESPIRATORY SYNDROME VIRUS AND APPLICATION THEREOFNANJING AGRICULTURAL UNIVERSITY
WO/2021/135071USE OF PIPERAZINE FERULATE TABLETSSHENZHAN TRADITIONAL CHINESE MEDICINE HOSPITAL
WO/2021/227156COMPOSITIONS AND METHODS FOR TREATING CANCERADAGENE AG
WO/2021/243645GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH RENAL  IMPAIRMENTHUA MEDICINE (SHANGHAI) LTD.
WO/2021/243646GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH HEPATIC  IMPAIRMENTHUA MEDICINE (SHANGHAI) LTD.
WO/2021/243658TREATMENT OR PREVENTION OF CORONAVIRIDAE INFECTIONWATERSTONE PHARMACEUTICALS (WUHAN) CO., LTD.
WO/2021/243669USE OF A COMPOUND CONTAINING TWO OR MORE ALCOHOLIC HYDROXYL  GROUPS OR PHENOLIC HYDROXYL GROUPS AS A MICROBIOME REGULATOR ON SCALPHENKEL AG & CO. KGAA
WO/2021/093315COMPOSITION FOR PROTECTING LIVER, PREPARATION METHOD THEREFOR,  AND APPLICATION THEREOFJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/063016COMPOSITION WITH HYPOLIPIDEMIC FUNCTION, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/057089COMPOSITION WITH CHLOASMA REMOVAL FUNCTION, PREPARATION METHOD  THEREFOR AND USE THEREOFJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/022891COMPOSITION HAVING IMMUNITY-ENHANCING FUNCTION AND PREPARATION  METHOD THEREFORJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/109509COMPOSITION HAVING IMMUNITY-ENHANCING FUNCTION AND PREPARATION  METHOD THEREFORJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/109510COMPOSITION HAVING DIGESTION PROMOTING FUNCTION, PREPARATION  METHOD AND APPLICATION THEREOFJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/109511ANTI-FATIGUE COMPOSITION AND PREPARATION METHOD THEREFORJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/114586IMMUNE RESPONSE-IMPROVING COMPOSITION, PREPARATION METHOD AND  APPLICATION THEREOFJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/196402PHARMACEUTICAL COMPOSITION AND USE THEREOFDONGGUAN HEC CORDYCEPS R&D CO., LTD.
WO/2021/217788METHOD FOR PREPARING COMPOUND-TYPE TABLETS FOR PROTECTING  LIVER AND DISPELLING EFFECTS OF ALCOHOLJIANG SU ZHONGXING PHARM.CO., LTD
WO/2021/227166APPLICATION OF SUCCINYLATION MODIFICATION OF PROTEIN IN  PREPARATION OF TUMOR CELL METABOLISM REGULATORTANG, Bo
WO/2021/174714MELANIN-BASED SUNSCREEN COMPOSITION AND PREPARATION METHOD  THEREFORJIANGNAN UNIVERSITY
WO/2021/174715PERSONAL CARE SUNSCREEN COMPOSITION, PREPARATION METHOD  THEREFOR AND USE THEREOFJIANGNAN UNIVERSITY
WO/2021/073131MEDICAMENT FOR EFFICIENTLY KILLING DRUG-RESISTANT DISEASE  BACTERIA AND APPLICATION THEREOF IN INHIBITING DRUG-RESISTANT DISEASE  BACTERIAOCEAN UNIVERSITY OF CHINA
WO/2021/073132APPLICATION OF HIGH PURITY NERVONIC ACID IN WHITENING AND  PREPARATION METHOD FOR HIGH PURITY NERVONIC ACIDNANJING KANGQI BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/004229NEW APPLICATION OF CHEMOKINE RECEPTOR CCR6 INHIBITOR IN  PREVENTING RECURRENCE OF PSORIASISRUIJIN HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF  MEDICINE
WO/2021/253147METHOD FOR PREPARING CELL-MEDIATED SARS-COV-2 VACCINESYIN, Xiushan
WO/2021/114596PHENYLETHANOID GLYCOSIDE EXTRACT FROM ACANTHUS ILICIFOLIUS,  AND PREPARATION METHOD THEREOF AND APPLICATION AS DRUG FOR RESISTING LIVER  DAMAGEOCEAN UNIVERSITY OF CHINA
WO/2021/143042PHARMACEUTICAL COMPOSITION FOR TREATING SEVERE BURNS AND SKIN  GANGRENE AND APPLICATION THEREOFBEIJING GUANGJIE-YOUNG HEALTH SCIENCE AND TECHNOLOGY CO. LTD
WO/2021/189678WHOLE-CELL CONSTITUENT TRANSPORT SYSTEM AND APPLICATION  THEREOFSOOCHOW UNIVERSITY
WO/2021/217816COMPOSITION FOR PREVENTING AND TREATING PNEUMONIA, AND  PREPARATION METHOD THEREFOR AND USE THEREOF IN PREPARATION OF DRUG FOR  PREVENTING AND TREATING PNEUMONIAINSTITUTE OF SCIENCE AND TECHNOLOGY, GUANGDONG UNIVERSITY OF  CHINESE MEDICINE
WO/2021/077770MINI COMBINED ADJUVANT NANOPARTICLE, PREPARATION METHOD  THEREFOR AND APPLICATION THEREFORINSTITUTE OF BIOMEDICAL ENGINEERING, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/248532VORICONAZOLE PREPARATION FOR EXTERNAL USE AND PREPARATION  METHOD THEREFORZHEJIANG POLY PHARM CO., LTD
WO/2021/217823DIHYDROMYRICETIN HAVING FUNCTION OF DISPELLING EFFECTS OF  ALCOHOLSONG, Kunyuan
WO/2021/243756PHARMACEUTICAL USE OF MYRICETIN IN INHIBITION OF NOVEL  CORONAVIRUSSHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/243757PHARMACEUTICAL APPLICATION OF GALLIC ACIDSHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/217826PHARMACEUTICAL APPLICATION OF DIMYRICETIN-YL-DISELENIDESHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/253338USE OF ROMIDEPSIN IN PREVENTING AND TREATING  CORONAVIRUS-RELATED DISEASESSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/120562TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  EGFR-TKIS-RELATED SKIN RASH, AND USE THEREOFLIN, Lizhu
WO/2021/068550ACTIVE POLYPEPTIDE COMPOUNDSHAANXI MICOT TECHNOLOGY CO., LTD.
WO/2021/253380ORAL FORMULATIONS AND USES THEREOFINVENTISBIO CO., LTD.
WO/2021/212635APPLICATION OF BRUCEA JAVANICA FRUIT FAT-SOLUBLE EXTRACT IN  PREPARATION OF DRUG FOR PROMOTING PERIPHERAL NERVE REGENERATIONNANTONG UNIVERSITY
WO/2021/212638CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN  ANALOGSHANGZHOU DAC BIOTECH CO., LTD.
WO/2021/227200ORAL CAVITY CLEANING COMPOSITION AND APPLICATION THEREOFGUANGZHOU ZHONGYU BIOTECHNOLOGY CO., LTD.
WO/2021/147235APPLICATION OF FAVIPIRAVIR IN TREATING CORONAVIRUS INFECTIONACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/147236USE OF SUBSTITUTED AMINOPROPIONATE COMPOUND IN TREATMENT OF  SARS-COV-2 INFECTIONSACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/114605LIVER-TARGETED THERAPEUTIC DRUG BASED ON SUGAR-BASED METAL  FRAMEWORK MATERIAL AND PREPARATION METHOD THEREOFJIANGNAN UNIVERSITY
WO/2021/208237APPLICATION OF HEPTOSE CHAIN-CONTAINING OLIGOSACCHARIDE  COMPOUND IN PREPARATION OF HELICOBACTER PYLORI VACCINEJIANGNAN UNIVERSITY
WO/2021/109549JOINT APPLICATION OF QUERCETIN AND ANTIBACTERIAL MEDICAMENTCHINA AGRICULTURAL UNIVERSITY
WO/2021/000770HETEROCYCLIC COMPOUND CAPABLE OF ENHANCING IMMUNE ACTIVITY,  PREPARATION METHOD THEREFOR AND APPLICATION IN MEDICINECAMPHOR PHARMACEUTICALS LIMITED
WO/2021/169100APPLICATION OF TRISACCHARIDE REPEATING UNIT OLIGOSACCHARIDE  CHAIN IN PREPARATION OF STAPHYLOCOCCUS AUREUS VACCINESJIANGNAN UNIVERSITY
WO/2021/258326APPLICATION OF MIDAZOLAM NANOCRYSTALS IN PREPARING DRUG FOR  IMPROVING BLOOD-BRAIN BARRIER PERMEABILITYMILITARY MEDICAL INSTITUTE, ACADEMY OF MILITARY SCIENCES, PLA
WO/2021/258337HUMAN MONOCLONAL ANTIBODIES AGAINST TIGIT FOR IMMUNE RELATED  DISEASESHUAHUI HEALTH LTD.
WO/2021/258341BARNYARD GRASS EXTRACT, AND PREPARATION METHOD THEREFOR AND  APPLICATION THEREOFLEITON FUTURE RESEARCH INSTITUTION JIANGSU CO., LTD.
WO/2021/258342TRADITIONAL CHINESE MEDICINE COMPOSITION FOR DRUG WITHDRAWAL,  AND APPLICATION THEREOFLEITON FUTURE RESEARCH INSTITUTION JIANGSU CO., LTD.
WO/2021/042830RECOMBINANT HUMAN PAPILLOMA VIRUS VACCINE COMPOSITION AND USE  THEREOFIMMUNE-PATH BIOTECHNOLOGY (SUZHOU) CO., LTD.
WO/2021/063047USE OF EXTRACT OF OVERGROUND PART OF SCUTELLARIAE RADIX IN  AQUACULTURETHE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/012886ANTI-NEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND  APPLICATION THEREOFGUANGZHOU CAS LAMVAC BIOTECH CO., LTD
WO/2021/179482TRADITIONAL CHINESE MEDICINE COMPOUND COMPOSITION HAVING  EFFECT OF PROMOTING BONE HEALTH AS WELL AS PREPARATION METHOD THEREFOR AND  APPLICATION THEREOFCHENLAND NUTRITIONALS, INC.
WO/2021/227214STERILIZATION AND DISINFECTION COMPOSITIONNANJING GREEN INTERFACE NEW MATERIALS RESEARCH INSTITUTE CO.,  LTD
WO/2021/143060MAGNOLIA OFFICINALIS PLANT PRESERVATIVE AND BACTERIOSTATIC  COMPOSITION, PREPARATION PROCESS THEREFOR, AND APPLICATION THEREOFYUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO., LTD.
WO/2021/057152KIT FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/027425ANTI-INFLAMMATORY TARGETED DELIVERY SYSTEM AND PREPARATION  METHOD THEREFORSOOCHOW UNIVERSITY
WO/2021/179494DRUG FOR PREVENTING AND/OR TREATING BRAIN TUMOR AND  APPLICATION THEREOFGUANGZHOU CAS LAMVAC BIOTECH CO., LTD
WO/2021/000899A PHARMACEUTICAL COMBINATION CONTAINING mTOR INHIBITOR AND USE  THEREOFASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/000926USE OF GINSENOSIDE M1 FOR TREATING CANCERLEE, Sheau-Long
WO/2021/000950PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE AND PREPARATION  METHOD THEREFORSHENZHEN RADAK BIO CORPORATION
WO/2021/000953SUBSTANCE AND METHOD FOR TREATING TUMORJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/237879USE OF AITCTHE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/004422MICROMOLECULE PI4KIIIα INHIBITOR COMPOSITION, PREPARATION  METHOD THEREFOR AND USE THEREOFNUO-BETA PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/114647APPLICATION OF SODIUM P-HYDROXYBENZOATE IN PREPARATION OF  DRUGS FOR TREATMENT OR PREVENTION OF INFLAMMATORY BOWEL DISEASEGUILIN MEDICAL UNIVERSITY
WO/2021/082512USE OF BLUE-LIGHT ACTIVATED BLEBBISTATIN ANALOGUES IN KILLING  DRUG-RESISTANT BACTERIASHENZHEN THIRD PEOPLE'S HOSPITAL
WO/2021/243797USE OF DROSOPHILA MELANOGASTER HSP22 PROTEIN IN PREPARATION OF  ANTI-TUMOR DRUGAFFILIATED HOSPITAL OF GUILIN MEDICAL UNIVERSITY
WO/2021/174738BIONIC NANOPARTICLE COATED WITH MESENCHYMAL STEM CELL MEMBRANE  HAVING SURFACE OVEREXPRESSING PD-L1 MOLECULE, AND PREPARATION THEREFOR AND  APPLICATION THEREOFSOOCHOW UNIVERSITY
WO/2021/248601USE OF LYCHEE PEEL EXTRACT MAINLY CONTAINING MULTIMERIC  POLYPHENOL IN PREPARATION OF α-AMYLASE INHIBITORGUANGXI ZHUANG AUTONOMOUS REGION AND CHINESE ACADEMY OF  SCIENCE, GUANGXI INSTITUTE OF BOTANY
WO/2021/042865ORAL DRUG DOSAGE FORMS HAVING A DESIRED PK PROFILE AND METHODS  OF DESIGNING AND PRODUCING THEREOFTRIASTEK, INC.
WO/2021/004477MITOCHONDRIA-BASED DRUG DELIVERY SYSTEM AND USE THEREOFTANG, Lingfeng
WO/2021/243804TRADITIONAL CHINESE MEDICINE EPIDEMIC-PREVENTION BAGBEIJING GUORUN JIUHE HEALTH TECHNOLOGY CO., LTD
WO/2021/036537USE OF KOUMINE IN PREPARATION OF DRUGS FOR TREATING  INFLAMMATORY BOWEL DISEASEFUJIAN MEDICAL UNIVERSITY
WO/2021/004524PEGYLATED SYNTHETIC KL4 PEPTIDE, COMPOSITIONS AND METHODS  THEREOFTHE UNIVERSITY OF HONG KONG
WO/2021/088399MOISTURIZING AND HYDRATING FACIAL MASK COMPOSITION, FACIAL  MASK, AND PREPARATION METHOD FOR FACIAL MASK COMPOSITIONHUBEI CHUANGJIE BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/184610GALANTAMINE PAMOATE SUSTAINED-RELEASE MICROPARTICLES FOR  INJECTION, AND PREPARATION METHOD THEREFORSHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/196443LIQUID PREPARATION OF RECOMBINANT HUMANIZED ANTI-PD-1  MONOCLONAL ANTIBODYLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/184611TABLET OF STEROID CYP17 INHIBITOR SOLID DISPERSION AND  PREPARATION METHOD THEREFORSHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/217889USE OF COMBINATION OF SMALL MOLECULE COMPOUND MLN4924 AND IFNα  IN RESISTING HBVZHEJIANG UNIVERSITY
WO/2021/174741APPLICATION OF DIMETHYL BERBAMINE COMPOUND IN INHIBITION OF  SARS-COV-2ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/253545CHITOSAN OLIGOSACCHARIDE COMPOSITION, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFGUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/008501ENGINEERED VACCINIA VIRUSSHENZHEN HUA YAO KANG MING BIOPHARMACEUTICAL CO., LTD.
WO/2021/169149CATALASE NANOPARTICLES AND METHODS FOR USEVIVIBABA, INC.
WO/2021/098240USE OF RECOMBINANT SECRETED DDRGK1SHANGHAI NINTH PEOPLE'S HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY  SCHOOL OF MEDICINE
WO/2021/008520STABLE AST-3424 INJECTION PREPARATION AND PREPARATION METHODASCENTAWITS PHARMACEUTICALS, LTD.
WO/2021/179505FORSYTHIA SUSPENSA AND ASTRAGALUS MEMBRANACEUS COMPOUND  PREPARATION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOFYAOSHUNZE BIO-MEDICAL (NANJING) CO., LTD.
WO/2021/073178AVIAN EGG DROP SYNDROME VIRUS TFIBER PROTEIN FRAGMENT, VACCINE  COMPOSITION PREPARED THEREFROM, PREPARATION METHOD, AND APPLICATIONPULIKE BIOLOGICAL ENGINEERING, INC.
WO/2021/022984AZO CALIXARENE PHARMACEUTICAL ADJUVANT AND USE THEREOFTANGSHAN TIANQUAN TECHNOLOGY CO. LTD.
WO/2021/147272USE OF BENZOATE COMPOUND IN TREATMENT OF SARS-COV-2 INFECTIONSACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/208280APPLICATION OF DRIED FLY LARVA IN PREPARATION OF DRUGS FOR  PREVENTING AND TREATING BREAST HYPERPLASIAHANGZHOU YIKETANG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/155654APPLICATION OF RITONAVIR IN TREATING SARS-COV-2 INFECTIONACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/147273APPLICATION OF NITAZOXANIDE AND ACTIVE FORM THEREOF,  TIZOXANIDE, IN TREATMENT OF SARS-COV-2 INFECTIONACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/017833ANTI-AGING COSMETIC COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017834SKIN COMPOSITION FOR EXTERNAL USE HAVING ANTI-INFLAMMATORY  EFFECTZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017835ENHANCED WHITENING COSMETIC COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/008565USE OF ACETYLCHOLINE PATHWAY MODULATORS IN TREATMENT OF CANCERTSINGHUA UNIVERSITY
WO/2021/031750MIXED BIRCH SAP AND APPLICATION THEREOF IN SKIN CARE COSMETIC  COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017838TOPICAL SKIN COMPOSITION WITH ANTI-ECZEMA EFFECTZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017839EXTERNAL SKIN COMPOSITION HAVING ANTI-ACNE EFFECTZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/013028PHARMACEUTICAL COMBINATION AND USE THEREOFASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/017844EXTERNAL COMPOSITION FOR SKIN HAVING ENHANCED ANTI-ECZEMA  EFFECTZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017845ANTI-HAIR LOSS HAIR GROWTH COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017846ENHANCED ANTI-AGING COSMETIC COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017877WHITENING COSMETIC COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017878COMPOSITION WITH ACNE REMOVAL EFFECT FOR EXTERNAL APPLICATION  TO SKINZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/103581SKIN TOPICAL COMPOSITION HAVING EFFICACY OF PROMOTING WOUND  HEALING AND/OR SCAR REPAIRZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/063076APPLICATION OF ALBIZIAE CORTEX LIGNAN COMPOUND IN IMPROVING  STEATOSISJIANGNAN UNIVERSITY
WO/2021/063078LIGNAN GLYCOSIDE COMPOUND FROM BARK OF ALBIZIA JULIBRISSIN FOR  PROMOTING ENDOTHELIAL CELL PROLIFERATION AND USE THEREOFJIANGNAN UNIVERSITY
WO/2021/008600CATIONIC POLYMER NANOPARTICLE/HIL-22BP GENE COMPOUND FOR  PREVENTING AND TREATING CANCER AND PREPARATION METHOD THEREFOR AND  APPLICATION THEREOFSICHUAN UNIVERSITY
WO/2021/036572COMPOSITION FOR PREVENTING OR TREATING URIC ACID-RELATED  DISEASEGUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/017910EXTERNAL SKIN TREATMENT COMPOSITION WITH ENHANCED  ANTI-INFLAMMATORY EFFECTZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017911ENHANCED HAIR LOSS PREVENTION AND HAIR GROWTH PROMOTION  COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/008622APPLICATION OF CARBON-BASED NANOMATERIAL IN PREPARATION OF  DRUG FOR RELIEVING OR TREATING HDSOOCHOW UNIVERSITY
WO/2021/017912MOISTURIZING COSMETIC COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017913ENHANCED MOISTURE-RETAINING COSMETIC COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017925APPLICATION OF RADIX PSEUDOSTELLARIAE CYCLIC PEPTIDE B IN  IMPROVING MEMORY AND/OR PREVENTING AND TREATING ALZHEIMER’S DISEASEGUANGDONG OCEAN UNIVERSITY
WO/2021/027509PROTON-TRIGGERING-BASED NANODRUG SYSTEM HAVING  HYDROPHILIC-HYDROPHOBIC-SIZE DOUBLE CONVERSION CHARACTERISTICS AND  PREPARATION METHOD THEREFOR AND USE THEREOFCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/212678ORAL MSCS LIQUID-FILLED CAPSULE FOR TREATING INFLAMMATORY  BOWEL DISEASES AND OTHER INTESTINAL DISEASESNANJING DRUM TOWER HOSPITAL
WO/2021/208284METHOD FOR PREPARING ORAL MICROSPHERE LOADED WITH MSCS-DERIVED  EXOSOMES AND APPLICATION THEREOFNANJING DRUM TOWER HOSPITAL
WO/2021/013204METHOD FOR TREATING DISEASES BASED ON INTERFERONXIAMEN AMOYTOP BIOTECH CO., LTD.
WO/2021/013207MULTIVARIABLE DOSING METHOD FOR USE IN TREATING HIGH-EGFR  EXPRESSION CANCERSINOCELLTECH LTD
WO/2021/013214USE OF NEUTROPHILIC GRANULOCYTES IN PREPARATION OF DRUGS FOR  TREATING AND/OR PREVENTING AUTOIMMUNE HEPATITISSICHUAN UNIVERSITY
WO/2021/031791DEXIBUPROFEN FAT EMULSION INJECTION AND PREPARATION METHOD  THEREFORSOOCHOW UNIVERSITY
WO/2021/013232AIE-ACTIVE PHOTOSENSITIZER FOR SELECTIVE BACTERIAL ELIMINATION  AND CANCER CELL ABLATIONTHE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/018026LIQUID PREPARATION AND APPLICATION THEREOFZHANG, Jinyu
WO/2021/018032PHARMACEUTICAL COMPOSITION OF MDM2 INHIBITOR AND USE THEREOF  FOR PREVENTING AND/OR TREATING DISEASEASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/018046SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOFMEDSHINE DISCOVERY INC.
WO/2021/013262NANO-MICELLE PREPARATION OF ICARITIN AND PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFBEIJING SHNOGEN PHARMA GROUP LTD
WO/2021/013270PHARMACEUTICAL COMPOSITION FOR TREATING POLYPNANJING SANTONG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/143096WHITENING, ACNE-REMOVING, BLACKHEAD-REMOVING AND ANTI-AGING  COMPOSITION, AND USE AND PREPARATION THEREOFGUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/031810APPLICATION OF PTBP1 INHIBITOR IN PREVENTING AND/OR TREATING  NERVOUS SYSTEM DISEASE RELATED TO FUNCTIONAL NEURONAL DEATHCENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE  TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/023069APPLICATION OF TPK AS A TARGET IN ALZHEIMER'S DISEASESHANGHAI RIXIN BIOTECHNOLOGY CO., LTD.
WO/2021/036654GRAPHENE ALKALI TARGETING DNA MAJOR GROOVE AND INHIBITING  TOPOISOMERASE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOFSHANGHAI UNIVERSITY
WO/2021/036656ODOR-MASKING COMPOSITION, PREPARATION METHOD THEREFOR, AND USE  THEREOFLUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/208290USE OF GPHB5 GLYCOPROTEIN HORMONE IN LOWERING LIPID AND  IMPROVING INSULIN SENSITIVITYGUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/093376USE OF PHOSPHODIESTERASE 5 INHIBITOR IN PREPARATION OF  MEDICAMENT FOR RESISTING FIBROTIC DISEASESGUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/184636SHOUHUI TONGBIAN MICROCAPSULE PREPARATION AND PREPARATION  METHOD THEREFORLUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/027576COMBINATION PRODUCT COMPRISING LIMONOIDS AND SGLT-2 INHIBITORSZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/027577COMBINATION PRODUCT CONTAINING LIMONOID AND α-GLUCOSIDASE  INHIBITORZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/189743APPLICATION OF CHINESE THOROWAX ROOT-HONEYSUCKLE FLOWER  FORMULATION IN PREPARING ANTI-CORONAVIRUS DRUG AND PREPARATION METHOD FOR  CHINESE THOROWAX ROOT-HONEYSUCKLE FLOWER FORMULATIONLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/196469USE OF PREPARATION FOR REMOVING FOOD RETENTION AND RELIEVING  COUGH IN CHILDREN IN PREPARATION OF DRUG FOR TREATING FEVER SYNDROMES AND  PREPARATION METHOD THEREFORLUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/027581COMBINATION PRODUCT COMPRISING LIMONOID AND DPP-4 INHIBITORSZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/027582COMBINATION PRODUCT CONTAINING LIMONIN COMPOUND AND  THIAZOLIDINEDIONEZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/184639MICROCAPSULE PREPARATION FOR ELIMINATING FOOD STAGNATION AND  RELIEVING COUGHS IN CHILDREN AND PREPARATION METHOD THEREFORSHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/027583COMBINATION PRODUCT CONTAINING LIMONIN COMPOUND AND  SULFONYLUREA DRUGZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/018237DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE  TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASESJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/018240COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A  CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF  DISEASESASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/212686METHOD FOR RHO-ADRP BASED ON GENE EDITING, AND COMPOSITIONCHIGENOVO CO., LTD.
WO/2021/004549USE FOR DUAL TARGET VASCULAR INHIBITOR IN PREPARING DRUGS FOR  PREVENTING OR TREATING FIBROSISBINZHOU MEDICAL UNIVERSITY
WO/2021/068614APPLICATION OF HONOKIOL AND MAGNOLOL IN PREPARING MCR-1 ENZYME  INHIBITORUNIV JILIN
WO/2021/023099BRUCINE GEL FORMULATION AND PREPARATION METHOD THEREFORBEIJING INCREASEPHARM CORPORATION LIMITED
WO/2021/103632SAFE AND ENVIRONMENTALLY FRIENDLY IRIDESCENT NAIL POLISHJINHUA KVS CHEMICAL CO., LTD.
WO/2021/208294APPLICATION OF PDE4 INHIBITOR IN PREPARATION OF DRUG FOR  INHIBITING PROLIFERATION IN GLIOMAGUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/208295USE OF PDE4 INHIBITOR IN PREPARATION OF DRUG FOR TREATING  LEUKEMIAGUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/023108ANTI-PD-1 ANTIBODY AND MEDICAL USE THEREOFCTTQ-AKESO (SHANGHAI) BIOMED. TECH. CO., LTD.
WO/2021/023118USE OF 5-METHYLTETRAHYDROFOLIC ACID AND COMPOSITION OF  5-METHYLTETRAHYDROFOLIC ACIDLIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/139147BIVALENT ADENOVIRUS VACCINEGUANGZHOU N BIOMED LTD.
WO/2021/018310AMINOPYRIDINE DERIVATIVES FOR TREATMENT OF NON-SMALL CELL LUNG  CANCERCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/031839TARGETED POLYPEPTIDE-MODIFIED DRUG-LOADED LIPOPROTEIN  NANO-DRUG DELIVERY SYSTEM, AND PREPARATION AND APPLICATION THEREOFSHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/023178USE OF PYRROLO-FUSED SIX-MEMBERED HETEROCYCLIC COMPOUND IN  PREPARATION OF MEDICAMENT FOR TREATING FGFR2 GENE MUTATION TUMORJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/164210APPLICATION OF GALLIC ACID DERIVATIVE IN PREVENTION AND  TREATMENT OF ATHEROSCLEROSIS DISEASEQILU UNIVERSITY OF TECHNOLOGY
WO/2021/023231PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE  ORAL SOLID TABLET, PREPARATION METHOD THEREFOR AND USE THEREOFJIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/023237METHOD FOR TREATING ALZHEIMER'S DISEASE BY REGULATING  INTESTINAL MICROORGANISMSSHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023238METHOD FOR TREATING ALZHEIMER’S DISEASE BY INHIBITING UPTAKE  OF AMINO ACIDS BY T CELLSSHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023239USE OF MANNURONIC ACID OLIGOSACCHARIDES OR COMPOSITION  COMPRISING SAME IN TREATMENT OF TH1-DOMINANCE RELATED DISEASESSHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023240METHOD FOR IDENTIFYING CARBOHYDRATE DRUG-SENSITIVE PATIENT IN  PATIENTS HAVING ALZHEIMER'S DISEASESHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023241METHOD FOR TREATING ALZHEIMER'S DISEASE BY REGULATING AMINO  ACID LEVELSHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023263PHARMACEUTICAL COMPOSITION PRODUCING SAFE AMOUNT OF NITRIC  OXIDE IN BODY AND USE THEREOFLIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/023264PHARMACEUTICAL COMPOSITION FOR TREATING AFRICAN SWINE FEVER  AND USE THEREOFLIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/189753PHARMACEUTICAL COMPOSITION FOR STRENGTHENING BODY AND TREATING  LUNG DISEASES AND APPLICATION THEREOFGUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/023267PREPARATION COMPRISING ANTI-PD-1/HER2 BISPECIFIC ANTIBODY, AND  PREPARATION METHOD THEREFOR AND USE THEREOFINNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/023290APPLICATION OF ZINC PYRITHIONE IN TREATMENT OF LUNG CANCERXIAMEN UNIVERSITY
WO/2021/023291USE OF PROFLAVINE IN TREATMENT OF LUNG CANCERSXIAMEN UNIVERSITY
WO/2021/027704APPLICATION OF POLYPEPTIDE OR DERIVATIVE THEREOFCHENGDU HUITAI BIOMEDICINE CO., LTD.
WO/2021/036752HYPOXIC-TUMOR-TARGETING SHORT-CHAIN POLYPEPTIDE MICROMOLECULE  SELF-ASSEMBLY NANOMETER MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOFNATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/077856SIRNA AND NANO DELIVERY SYSTEM CAPABLE OF SILENCING PCSK9  PROTEIN, AND APPLICATION OF NANO DELIVERY SYSTEMGUANGZHOU MEDICAL UNIVERSITY
WO/2021/031893PROSTATITIS TREATMENTNATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
WO/2021/248674ANTIBACTERIAL NANOZYME AND PREPARATION METHOD THEREFORQINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/088446METHOD FOR STAGGERED POWERING-ON OF SERVER HARD DISKS, DEVICE,  AND MEDIUMCHENGDU QINGZHIXIN BIOTECHNOLOGY CO., LTD
WO/2021/212700PHARMACEUTICAL COMPOSITION FOR IMPROVING MOTION SICKNESS OF  PETS, PREPARATION METHOD THEREFOR AND USE METHOD THEREOFJIANGSU NANJING AGRICULTURAL UNIVERSITY ANIMAL PHARMACEUTICAL  CO., LTD
WO/2021/036793PYROPTOSIS-INDUCED IMMUNOTHERAPYNATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
WO/2021/036803USE OF LONG-ACTING PROTEIN PREPARATION FOR IMPROVING SEXUAL  DYSFUNCTIONXINTRUM PHARMACEUTICALS, LTD.
WO/2021/027912CHIDAMIDE-CONTAINING ANTI-TUMOR PHARMACEUTICAL COMPOSITION AND  USE THEREOFSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/031991COMPOSITION AND METHOD FOR TREATING HORMONE-DEPENDENT DISEASES  AND REDUCING DRUG TOLERANCE OF PATIENTS WITH HORMONE-DEPENDENT DISEASESCENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE  ACADEMY OF SCIENCES
WO/2021/169194APPLICATION OF TETRAHYDROPALMATINE IN PREPARATION OF DRUGS  AGAINST OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITYZHEJIANG UNIVERSITY
WO/2021/027971FAT EXTRACT WITHOUT ADDED INGREDIENTS, PREPARATION METHOD  THEREFOR AND USE THEREOFSHANGHAI SEME CELL TECHNOLOGY CO., LTD
WO/2021/203605COMPOUND AMINO ACID INJECTION FOR LIVESTOCK AND PREPARATION  METHOD THEREFORHEBEI KEXING PHARMACEUTICAL CO., LTD
WO/2021/032073IN-SITU GEL CONTAINING CYCLOSPORINE MICELLES AS SUSTAINED  OPHTHALMIC DRUG DELIVERY SYSTEMIVIEW THERAPEUTICS (ZHUHAI) CO., LTD.
WO/2021/032078NOVEL ANTI-SIRPA ANTIBODIESELPISCIENCE (SUZHOU) BIOPHARMA, LTD.
WO/2021/203606PREPARATION METHOD FOR COMPOUND AMINO ACID INJECTION FOR  LIVESTOCKHEBEI KEXING PHARMACEUTICAL CO., LTD
WO/2021/203607METHOD FOR PREPARING COMPOUND AMINO ACID INJECTION FOR  LIVESTOCKHEBEI KEXING PHARMACEUTICAL CO., LTD
WO/2021/248688APPLICATION OF ITPP IN PREPARATION OF DRUGS FOR PREVENTING  AND/OR TREATING HYPOXIC-ISCHEMIC INJURY AND LUNG INJURYSYMEPILIN PHARMACEUTICALS CO., LTD.
WO/2021/036884APPLICATION OF HERNANDEZINE OR PHARMACEUTICALLY ACCEPTABLE  SALT THEREOF IN DRUGS FOR DIABETES OR DIABETIC COMPLICATIONSEAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/032128APPLICATION OF FLUORO-SUBSTITUTED 2-AMINOTHIAZOLE-5-AROMATIC  CARBOXAMIDEHUNAN WARRANT PHARMACEUTICAL CO., LTD
WO/2021/073249USE OF β-NMN IN PREPARATION OF DRUG FOR TREATING AND  PREVENTING SEPSIS-INDUCED ORGAN DAMAGESOOCHOW UNIVERSITY
WO/2021/036896PLANT EXTRACTION METHODBEIJING WEHAND-BIO PHARMACEUTICAL CO., LTD
WO/2021/196505USES OF CYCLOCARYA PALIURUS LEAF FLAVONE EXTRACT IN  PREPARATION OF ANTIBACTERIAL MEDICAMENTS AND/OR ANTIBACTERIAL AGENTSWEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/032179APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN TREATING  INFECTION ASSOCIATED WITH BURN OR SCALD INJURYSICHUAN UNIVERSITY
WO/2021/036922COMPOUND INHIBITING AND INDUCING DEGRADATION OF EGFR AND ALKBEIJING TIDE PHARMACEUTICAL CO., LTD.
WO/2021/036923SILVER-/GOLD-COMPOUNDS AND METHODS THEREOFTHE UNIVERSITY OF HONG KONG
WO/2021/103679LIPODISSOLVESHANGHAI NINTH PEOPLE'S HOSPITAL, SHANGHAI JIAOTONG UNIVERSTIY  SCHOOL OF MEDICINE
WO/2021/036937APPLICATION OF PDE3 INHIBITOR AND CYTOKINE IN TREATMENT OF  TUMORSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/036975PEPTIDE AMIDE COMPOSITION AND PREPARATION METHOD THEREFORSICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/032212ANTI-AGING MEDICINE D/A TARGETING AGING CELLS IN TISSUE  MICROENVIRONMENT AND USE THEREOFSHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/032213ANTI-AGING MEDICINE D/S TARGETING AGING CELLS IN TISSUE  MICROENVIRONMENT AND USE THEREOFSHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/077889PARACETAMOL SUSTAINED-RELEASE PREPARATION AND 3D PRINTING  PREPARATION METHOD THEREFORACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/037013NOVEL APPLICATION OF PHENOTHIAZINES OR COMPOUND HAVING SIMILAR  STRUCTURE IN PHARMACEUTICSGUANGZHOU VIROTECH PHARMACEUTICAL CO., LTD.
WO/2021/037077PATENTIFLORIN A ANALOGS AS ANTIVIRAL AGENTSHONG KONG BAPTIST UNIVERSITY
WO/2021/037091CHIDAMIDE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/082683USE OF TRAMETINIB IN PREPARATION OF MEDICINE FOR PREVENTING  AND/OR TREATING NON-ALCOHOLIC HEPATITIS AND/OR NON-ALCOHOLIC FATTY LIVER  DISEASEBEIJING GIGACEUTICALS TECH. CO., LTD
WO/2021/037122STABLE GEL COMPOSITION HAVING HIGH OIL CONTENT, AND  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFSIRIO PHARMA CO., LTD.
WO/2021/037128CHIDAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION AND USE  THEREOFSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/223346APPLICATION OF YAM PROTEIN EXTRACT IN PREPARATION OF  MEDICATION FOR TREATING ERECTILE DYSFUNCTIONZHAO, Daqing
WO/2021/037188PHARMACEUTICAL USE OF PYRIMIDO[5,4-B]PYRROLIZINE COMPOUNDSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/057380COMPOSITION AND APPLICATION THEREOF IN PREPARATION OF SKIN  CARE PRODUCTS FOR REGULATING SKIN BIORHYTHMHUNAN YUJIA COSMETICS MANUFACTURING CO., LTD
WO/2021/037199TRANSDERMAL AMIDE LOCAL ANESTHETIC-CONTAINING PHARMACEUTICAL  COMPOSITION AND PREPARATION METHOD THEREFORJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/217982FOOT-AND-MOUTH DISEASE VIRUS-LIKE PARTICLE ANTIGEN AND VACCINE  COMPOSITION THEREOF, AND PREPARATION METHOD AND APPLICATION OF VACCINE  COMPOSITIONPULIKE BIOLOGICAL ENGINEERING, INC.
WO/2021/037212COMPOSITION USED FOR COMBATING METABOLIC DISEASES AND USES OF  COMPOSITIONINSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/037230USE OF ANNEXIN A5SUZHOU YABAO PHARMACEUTICAL R&D CO., LTD.
WO/2021/128919APPLICATION OF CST1 IN PREVENTION AND/OR TREATMENT OF LIVER  IMMUNE DYSREGULATION DISEASESCENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE  ACADEMY OF SCIENCES
WO/2021/037244PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOFSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/052153APPLICATION OF CYCLIC ADENOSINE MONOPHOSPHATE, DERIVATIVES  THEREOF OR PRODRUGS THEREOF IN PREPARATION OF DRUGS FOR PREVENTING AND/OR  TREATING DEPRESSIVE DISORDERCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/203614PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CORONAVIRUS  DISEASES AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOFTIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
WO/2021/057391COMPOSITION AND APPLICATION THEREOF IN PREPARATION OF SKINCARE  PRODUCTS FOR NIGHT OWLSHUNAN YUJIA COSMETICS MANUFACTURING CO., LTD.
WO/2021/037265SIRNA CAPABLE OF INHIBITING EXPRESSION OF MCM7 GENE,  COMPOSITION, AND APPLICATION THEREOFENZHI (GUANGZHOU) PHARMACEUTICALS, LTD.
WO/2021/253643APPLICATION OF SULPHATED POLYSACCHARIDES AGAINST NOVEL  CORONAVIRUSDALIAN POLYTECHNIC UNIVERSITY
WO/2021/043120COMPOUND AMINO ACID DIPEPTIDE INJECTION AND PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFZHONGSHAN HOSPITAL, FUDAN UNIVERSITY
WO/2021/232614CHITOOLIGOSACCHARIDE ORAL LIQUID AND APPLICATION THEREFOR IN  PREPARATION OF WEIGHT LOSS DRUGSGUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/043145CATIONIC NANODRUG, PREPARATION METHOD THEREFOR, AND  DRUG-LOADED IMPLANTABLE MEDICAL DEVICESHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.
WO/2021/093425ROOT OF MEMBRANOUS MILKVETCH-PAECILOMYCES CICADAE FERMENTATIVE  BACTERIUM FERMENTATION SUBSTANCE AND APPLICATION THEREOFBINZHOU MEDICAL UNIVERSITY
WO/2021/047437PHARMACEUTICAL COMPOSITION FOR TREATING VIRAL INFLUENZA AND  PREPARATION THEREOFGUANGDONG RAYNOVENT BIOTECH CO., LTD.
WO/2021/043196USE OF 5-METHYLTETRAHYDROFOLATELIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/212721TRADITIONAL CHINESE MEDICINE COMPOSITION FOR DISPELLING  DAMPNESS AND CLEARING LUNG AND APPLICATION THEREOFGUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/208334QI-TONIFYING, DAMPNESS-ELIMINATING AND SORE-THROAT-RELIEVING  DIETARY THERAPY FORMULA, AND PREDATION METHOD THEREFOR AND APPLICATION  THEREOFGUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/208335TRADITIONAL CHINESE MEDICINE COMPOSITION CAPABLE OF REMOVING  TOXINS, DISPELLING DAMPNESS, AND DISINHIBITING THROAT, AND APPLICATION  THEREOFGUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/208336TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOFGUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/043227COATED GRANULE, SOLID DISPERSION, AND PREPARATION CONTAINING  VORTIOXETINE HYDROBROMIDE FOR ORAL TASTE MASKINGSEASONS BIOTECHNOLOGY (TAIZHOU) CO., LTD.
WO/2021/043231DUAL-TARGETING MATERIAL AND USE THEREOF IN DRUG DELIVERYSHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/043234USE OF BERBAMINE OR ITS ANALOGUE FOR PREVENTING OR TREATING  RNA VIRUS INFECTIONCITY UNIVERSITY OF HONG KONG
WO/2021/253647USE OF SMALL MOLECULE INHIBITOR IN TREATMENT OF RESPIRATORY  VIRAL PNEUMONIAINSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/047451DNA NANOVACCINE, PREPARATION METHOD THEREFOR AND USE THEREOFNATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/047464USE OF 4-[9-(6-AMINOPURINYL)]-2(S)-HYDROXYMETHYL BUTYRATE FOR  PREPARING OPHTHALMIC PREPARATIONSSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/184699MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION AND  PREPARATION METHOD THEREFORSHIJIAZHUANG NO. 4 PHARMACEUTICAL CO., LTD
WO/2021/139193SUSTAINED-RELEASE LONG-LASTING ANTIBACTERIAL HAND SANITIZER  AND PREPARATION METHOD THEREFORZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/139194NANO-SCALE PLANT ANTIBACTERIAL AGENT FOR HAND SANITIZER AND  PREPARATION METHOD THEREFORZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/047573USE OF MEK INHIBITOR IN COMBINATION WITH CDK4/6 INHIBITOR IN  PREPARATION OF DRUGS FOR TREATING TUMORSJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/15970417β-ESTRADIOL AND VITAMIN C MOLECULAR COMPLEX, PREPARATION  METHOD THEREFOR AND APPLICATION THEREOFZHEJIANG MEDICINE CO., LTD.XINCHANG PHARMACEUTICAL FACTORY
WO/2021/047607APPLICATION OF NON-IGF1R-BINDING SUBSTANCE IN PREVENTION  AND/OR TREATMENT OF INFLAMMATORY DISEASESSHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/047623TREATMENT OF CANCER USING A COMBINATION COMPRISING  MULTI-TYROSINE KINASE INHIBITOR AND IMMUNE CHECKPOINT INHIBITORBEIGENE, LTD.
WO/2021/047629COMPOSITION FOR LIGHTENING SPOTS, MICRONEEDLE PATCH COMPRISING  COMPOSITION, AND PREPARATION METHOD THEREFORBEIJING CAS MICRONEEDLE TECHNOLOGY LTD.
WO/2021/052269WATER-SOLUBLE COMPOSITION, PREPARATION METHOD AND APPLICATION  THEREOFGUANGDONG HEJI BIOTECH CO., LTD
WO/2021/052274CEFUROXIME AXETIL PHARMACEUTICAL COMPOSITION AND PREPARATION  METHOD THEREFORSINOPHARM ZHIJUN (SHENZHEN) PHARMACEUTICAL CO., LTD
WO/2021/052305USE OF EIGHT-TREASURE PILL IN PREPARATION OF MEDICINE FOR  PREVENTING OR TREATING DISEASES RELATED TO IL-6 INFLAMMATORY CYTOKINE STORMXIAMEN TRADITIONAL CHINESE MEDICINE CO., LTD.
WO/2021/052386COMBINATION OF SMALL MOLECULE INHIBITOR OF THE PD-1/PD-L1  INTERACTION AND ANTI-PD-1 ANTIBODY FOR TREATING CANCERGUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
WO/2021/052398GEL COMPOSITION WITH HIGH OIL CONTENT, THE PREPARATION METHOD  AND THE USE OF THE SAMEBASF SE
WO/2021/227326COMPOSITIONS AND METHODS FOR TREATING CANCERADAGENE AG
WO/2021/057599APPLICATION OF PIRFENIDONE IN PREPARING MEDICAMENT FOR  PREVENTING AND TREATING RHEUMATOID ARTHRITISSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/052440USE OF CHIGLITAZAR AND DERIVATIVES THEREOF IN TREATING TYPE 2  DIABETES ACCOMPANIED BY ABNORMAL LIPIDS METABOLISMSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/052441USES OF COMPLEX OF ANGIOTENSIN II RECEPTOR ANTAGONIST  METABOLITE AND NEP INHIBITOR IN TREATING HEART FAILURESHENZHEN SALUBRIS PHARMACEUTICALS CO. LTD
WO/2021/218004APPLICATION OF PRUSSIAN BLUE NANOPARTICLES IN PREPARATION OF  DRUG FOR PREVENTING, DELAYING OR TREATING NERVOUS SYSTEM DEGENERATIVE DISEASETIANJIN UNIVERSITY
WO/2021/043319TRANSDERMAL PENETRATION ENHANCING COMPOSITION AND APPLICATION  THEREOF IN TIMOLOL PREPARATIONWUHAN CONFORM PHARMACEUTICAL CO., LTD.
WO/2021/052450REVERSED PHASE CHROMATOGRAPHY ISOLATION OF ACTIVE COMPONENT IN  AMNIOTIC FLUID OF NON-HUMAN ANIMALZHEJIANG HYGEIANCELLS BIOMEDICAL CO. LTD
WO/2021/258565APPLICATION OF CARNOSIC ACID IN PREPARATION OF ANTI-PHOTOAGING  PRODUCTSCENTRAL SOUTH UNIVERSITY
WO/2021/103777SPRAYING AGENT FOR PREVENTING AND TREATING ALLERGIC ASTHMA  COMBINED WITH ALLERGIC RHINITIS IN CHILDREN AND TEENAGERSLEITON FUTURE RESEARCH INSTITUTION JIANGSU CO., LTD.
WO/2021/052496IMMUNE EFFECTOR CELL IN WHICH EXPRESSION IS REGULATED BY  CYTOKINESCARSGEN THERAPEUTICS CO., LTD.
WO/2021/057661PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD SUGARSHENZHEN SALUBRIS PHARMACEUTICALS CO. LTD
WO/2021/057680APPLICATION OF 2,4-DIHYDROXYBENZOIC ACID OR ISOMER THEREOF IN  RELATED DISEASES OR CONDITIONS CAUSED BY IRON OVERLOADZHANG, Jianguo
WO/2021/057694LOW-CONTENT FLURBIPROFEN AXETIL PHARMACEUTICAL COMPOSITION,  AND APPLICATION THEREOFBEIJING PODCONLEY MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.
WO/2021/128995WHITENING AND MOISTURIZING HAND MASK AND PREPARATION METHOD  THEREFORGUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/128996NATURAL PLANT BACTERIOSTATIC OINTMENT CONTAINING ARTEMISIA  ARGYI EXTRACT AND PREPARATION METHOD THEREFORGUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/128997NATURAL PLANT EYE SPRAY AND PREPARATION METHOD THEREFORGUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/179567CHINESE MUGWORT LEAF COMPOSITE ESSENTIAL OIL FOR RELIEVING  SORE THROAT AND PREPARATION METHOD THEREFORGUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/057721SPECIFIC ANTIDOTAL DRUG FOR TREATING PARAQUAT ACUTE POISONINGENVIRONMENT AND PLANT PROTECTION INSTITUTE, CHINESE ACADEMY OF  TROPICAL AGRICULTURAL SCIENCES
WO/2021/018318PHARMACEUTICAL COMPOSITION CONTAINING CHIDAMIDE AND SURFACTANTSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/057764USE OF PD-1 ANTIBODY IN COMBINATION WITH TAXOID COMPOUND IN  PREPARATION OF DRUGS FOR TREATING TRIPLE-NEGATIVE BREAST CANCERJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/057881OSELTAMIVIR PREPARATIONSUNSHINE LAKE PHARMA CO., LTD.
WO/2021/169273USE OF ALBIFLORIN IN TREATMENT OF CORONAVIRUS PNEUMONIAZHANG, Zuoguang
WO/2021/057906IMMUNE EFFECTOR CELL EXPRESSING IL-15CARSGEN THERAPEUTICS CO., LTD.
WO/2021/057942GENE-ENGINEERED MESENCHYMAL STEM CELLS AND APPLICATIONS  THEREOFCHINA MEDICAL UNIVERSITY
WO/2021/057955METHOD FOR TREATING MOOD DISORDERSJIANGSU NUO-BETA PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/077990USE OF VITAMIN E COMPOUNDHUIYU HEALTH (HANGZHOU) PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/058005PHARMACEUTICAL COMPOSITION CONTAINING HUMANIZED ANTI-HUMAN  IL-17A MONOCLONAL ANTIBODYHUABO BIOPHARM (SHANGHAI) CO., LTD.
WO/2021/058014ORNIDAZOLE PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD  AND USE THEREOFYANGTZE RIVER PHARMACEUTICAL GROUP NANJING HAILING  PHARMACEUTICAL CO., LTD.
WO/2021/063331USE OF COMBINATION OF EZH2 INHIBITOR AND TGF-β  RECEPTOR-CONTAINING FUSION PROTEIN IN PREPARATION OF DRUGS FOR TREATING  TUMORSJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/063332USE OF EZH2 INHIBITOR COMBINED WITH CDK4/6 INHIBITOR IN  PREPARATION OF DRUG FOR TREATING TUMORJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/058021DRUG COMBINATION CONTAINING TLR7 AGONISTCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/063340USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMUNE CHECKPOINT  INHIBITOR AND TYROSINE KINASE INHIBITOR IN PREPARATION OF MEDICATION FOR  TREATING TUMORJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/253681FAVIPIRAVIR COMPOSITION AND PREPARATION METHOD THEREOFZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
WO/2021/068802APPLICATION OF NADH AND SALT AND/OR NMN THEREOF IN PREPARATION  OF DRUG OR HEALTH CARE PRODUCT FOR ENHANCING MUSCLE OR INHIBITING MUSCLE  VOLUME REDUCTIONHOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/073426APPLICATION OF NADH AND SALT THEREOF IN PREPARATION OF SKIN  PIGMENT INHIBITORHOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/078000APPLICATION OF NADH AND SALT THEREOF IN PREPARATION OF DRUGS  OR HEALTH FOOD FOR PREVENTING AND TREATING PHARYNGITISHOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/109704CHRONIC WOUND HEALING COMPOSITION AND APPLICATION THEREOFLO, Hsu En
WO/2021/063366DRUG FOR TREATING ARTERY-RELATED DISEASES, AND USE THEREOFSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/143208METHOD FOR PREPARING HAND WASH HAVING ULTRA-STRONG  DECONTAMINATION EFFECTZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/143209METHOD FOR PREPARING HAND SANITIZER SUITABLE FOR INFANT SKINZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/063376UV LIGHT-RESPONSIVE HYPERBRANCHED POLY-β-AMINO ESTER HAVING  HIGH-EFFICIENCY GENE DELIVERY ABILITY AND PREPARATION METHOD AND APPLICATION  THEREOFSOOCHOW UNIVERSITY
WO/2021/063378ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND AMINO  ACIDTHE PROCTER & GAMBLE COMPANY
WO/2021/063384DENTIFRICE COMPOSITIONS COMPRISING BICARBONATE SALT AND  NEUTRAL AMINO ACIDTHE PROCTER & GAMBLE COMPANY
WO/2021/103816USE OF UTERINE CAVITY FLUID-DERIVED EXOSOME IN PREPARATION OF  THERAPEUTIC DRUGS AND ADJUVANT THERAPEUTIC AGENTS FOR TREATING  INFERTILITY-RELATED DISEASESPHARCHOICE THERAPEUTICS INC
WO/2021/063387USE OF COMPOSITION OF IMATINIB AND DERIVATIVE THEREOF IN  PREPARATION OF DRUG FOR PREVENTING, TREATING AND CONTROLLING ADDICTION  RELAPSEWUHAN UNIVERSITY
WO/2021/063391CORNU GORAIS KERATIN, PREPARATION METHOD THEREFOR,  PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOFINSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/063408PREPARATION OF DRUG FOR TREATING ALZHEIMER'S DISEASEPLANTARX LIMITED
WO/2021/063414USE OF VALERIC ACID DERIVATIVE IN TREATMENT OF DOWN'S SYNDROMEXIAMEN UNIVERSITY
WO/2021/068868COMBINATION THERAPY FOR CANCERS WITH KRAS MUTATIONCOTHERA BIOSCIENCE, INC.
WO/2021/218039BIOMIMETIC AND CAMELLIA EXTRACT-CONTAINING SKIN BARRIER REPAIR  COMPOSITION AND APPLICATION THEREOFSHANGHAI FOREST CABIN BIOLOGICAL-TECH CO., LTD.
WO/2021/088585PARATHYROID HORMONE 1-34 NASAL SPRAY, PREPARATION METHOD AND  APPLICATION THEREOFACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/068879ANTIBODY COMPLEX MODIFIED BY TARGETED FUNCTIONAL MOLECULE,  COMPOSITION AND USE THEREOFFUDAN UNIVERSITY
WO/2021/027977USE FOR ULVA POLYSACCHARIDE IN SUPPRESSING β-AMYLOID PROTEIN  AGGREGATIONTIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/068890LYSOSOME-TARGETING ANTIBODY-DRUG CONJUGATE AND APPLICATION  THEREOFSUN YAT-SEN UNIVERSITY
WO/2021/082882METHOD FOR ANCHORING AND MODIFYING NANO-DRUG ON SURFACE OF  LIVING CELLCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/068909AMERICAN COCKROACH EXTRACT, PREPARATION THEREOF, PREPARATION  METHODS THEREFOR AND APPLICATIONS THEREOFLIANGSHAN JIANENGDA BIOMATERIALS BREEDING CO., LTD.
WO/2021/203648TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING  GINGIVAL ATROPHY AND/OR TREATING GINGIVITISSICHUAN GREEN HERB TECHNOLOGY DEVELOPMENT CO., LTD
WO/2021/068951MEDICAL USE OF BENZENESULFONAMIDE COMPOUND AND PHARMACEUTICAL  COMPOSITION THEREOFCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/068957TREATMENT AND PREVENTION OF NEPHROTOXIN-INDUCED KIDNEY  INJURIESFARSIGHT MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/082889ENVIRONMENTALLY-FRIENDLY METHOD OF PREPARING COMPOSITION  CONTAINING ANTI-INFLAMMATORY ACTIVE INGREDIENT AND APPLICATION THEREOFSHANGHAI JAKA BIOTECH CO., LTD.
WO/2021/068961INHALATION SOLUTION PHARMACEUTICAL COMPOSITION AND PREPARATION  METHOD THEREFORSICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/068971ANTI-CD20 ANTIBODY FORMULATION AND USE OF ANTI-CD20 ANTIBODY  FOR TREATMENT OF CD20 POSITIVE DISEASESBIO-THERA SOLUTIONS, LTD.
WO/2021/073518USE OF INHIBITOR OF PLASMIN INHIBITORY FACTOR FOR PREVENTING  OR TREATING PRE-ECLAMPSIA OR ECLAMPSIAINSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/073535METHOD FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH  ADMINISTRATION OF VEGFR AND/OR VEGF INHIBITORONQUALITY PHARMACEUTICALS CHINA LTD.
WO/2021/073547APPLICATION OF BORTEZOMIB IN PREPARATION OF DRUGS FOR  TREATMENT OF OSTEOSARCOMAXI'AN JIAOTONG UNIVERSITY
WO/2021/073548PHARMACEUTICAL COMPOSITIONSUNSHINE LAKE PHARMA CO., LTD.
WO/2021/073563COMPOSITION AND METHOD FOR TREATMENT OF DIABETESSHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/103833MOLECULARLY IMPRINTED POLYMERS FOR SEQUESTERING ACETATE AND  OTHER MOLECULESCLAVES LIFE SCIENCES LIMITED
WO/2021/073586DECOQUINATE LIPOSOME, PREPARATION METHOD THEREFOR AND USE  THEREOFBLUELIGHT PHARMATECH CO ., LTD
WO/2021/073610METHODS AND COMPOSITIONS FOR IMPROVING BONE MARROW  HEMATOPOIETIC FUNCTIONSSUN YAT-SEN UNIVERSITY
WO/2021/073620USE OF ACELLULAR ADIPOSE TISSUE EXTRACT IN PROMOTING HAIR  GROWTH AND RETENTIONSHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/232667STARCH-BASED COLON-TARGETING CONTROLLED-RELEASE CRYSTAL  INCLUSION COMPLEX AND PREPARATION METHOD THEREFORSOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/078087TRADITIONAL CHINESE MEDICINE PILL REALIZING TARGETED RELEASE,  AND PREPARATION METHOD THEREFORRONGCHANG PHARMACEUTICAL (ZIBO) CO., LTD.
WO/2021/073643DRUG FOR TREATING NON-ALCOHOLIC STEATOHEPATITISCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/135520SUNFLOWER SEED COMPOSITION RICH IN PLEASANT HORMONE PRECURSOR  AND ANTIDEPRESSANT USE THEREOFCHACHA FOOD CO., LTD.
WO/2021/078110DRUG COMBINATION FOR PREVENTING OR TREATING IRRITABLE BOWEL  SYNDROMEGUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/078126METHOD FOR TREATING CANCERSACURA NANOMEDICINE CORPORATION
WO/2021/174868CHLORIN NANOMETER PHOTOSENSITIZER, AND PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFSOOCHOW UNIVERSITY
WO/2021/143243USE OF IGF1 IN COMBINATION WITH IGF1EC24 IN PREPARATION OF  MEDICINE FOR PROMOTING TISSUE REPAIR AND REGENERATIONCHONGQING UNIVERSITY
WO/2021/088645CRYSTAL FORM OF APROCITENTAN, PREPARATION METHOD THEREFOR AND  USE THEREOFCRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/243925APPLICATION OF ZIF-8 NANO MATERIAL IN DEGRADATION OF  BROAD-SPECTRUM MUTANT P53 PROTEINSOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/179616NOVEL USE OF XIAOCHAIHU GRANULES IN COMBINATION WITH  CHLOROQUINE PHOSPHATEGUANGZHOU BAIYUNSHAN GUANGHUA PHARMACEUTICAL CO., LTD
WO/2021/078246PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SEPSIS,  KIT, USE THEREOF AND TREATMENT METHOD THEREOFSHENZHEN MYTANG BIOTECHNOLOGY CO., LTD.
WO/2021/093553NOVEL THERAPEUTIC DRUG FOR ISCHEMIC BRAIN DAMAGECENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE  TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/078252USE OF LIRIODENDRON CHINENSE (HEMSL.) SARG OR EXTRACT THEREOF  IN PREPARATION OF MEDICINE FOR REDUCING SERUM URIC ACID LEVEL AND PREVENTING  AND TREATING URIC ACID NEPHROPATHYSICHUAN CREATION PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/078288ACTIVATED INSULIN, COMPOUND MOMORDICA CHARANTIA PEPTIDE ORAL  MEDICINE FOR TREATMENT OF DIABETES, AND PREPARATION METHODLI, Yubao
WO/2021/078295BOTANICAL MEDICINE FOR TREATING HYPERLIPIDEMIA AND CORONARY  HEART DISEASE AND METHOD FOR PREPARATION THEREOFGUOZHONGXINGHE BIOMEDICINE TECHNOLOGY CO., LTD.
WO/2021/058038USE OF CD200 PROTEIN AND CD200 FUSION PROTEIN IN PREPARING A  DRUG FOR TREATING PSORIASISCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/088672COMPOSITION CONTAINING LEGOAMODIPINE BESYLATE HYDRATE AND  PREPARATION METHOD THEREFORSHIHUIDA PHARMACEUTICALS GROUP (JILIN) LTD.
WO/2021/078301PROTEIN DEGRADING AGENT AND USE THEREOF IN TREATMENT OF  DISEASESSHANGHAITECH UNIVERSITY
WO/2021/083089PHARMACEUTICAL COMPOSITION CONTAINING ALGINATE OLIGOSACCHARIDE  DIACIDSHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/258590APPLICATION OF β-GLUCAN AS ADHESIVE IN PREPARATION OF TABLET  OR GRANULEYICHUN WANSHEN PHARMACEUTICAL MACHINERY CO. LTD
WO/2021/114909PHOTODYNAMIC THERAPY SYSTEM, PREPARATION METHOD THEREFOR, AND  USE THEREOF IN PHOTODYNAMIC THERAPYSHENZHEN HANGUANG TECHNOLOGY CO., LTD.
WO/2021/169345METHOD AND APPLICATION FOR IMPROVING MITOCHONDRIAL FUNCTION OF  PERIPHERAL BLOOD MONONUCLEAR CELLSINSTITUTE OF ENVIRONMENTAL AND OPERATIONAL MEDICINE, ACADEMY  OF MILITARY MEDICAL SCIENCE, ACADEMY OF MILITARY SCIENCE
WO/2021/184762GOLD CLUSTERS (AuCs), COMPOSITION AND METHOD FOR TREATMENT OF  LIVER CIRRHOSISWUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD.
WO/2021/243932USE OF PHOSPHATIDYLSERINE IN PREPARATION OF DRUG FOR TREATING  INFLAMMATORY BOWEL DISEASEJIANGSU TARGET BIOMEDICAL RESEARCH INSTITUTE CO. , LTD.
WO/2021/083290RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN INHIBITOR  COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF RSV DISEASES  USING THE SAMESHANGHAI ARK BIOPHARMACEUTICAL CO. LTD.
WO/2021/083306GLP-1/GCG DUAL-ACCEPTOR AGONIST POLYPEPTIDEDONGGUAN HEC BIOPHARMACEUTICAL R&D CO., LTD.
WO/2021/083315ORALLY ADMINISTERED SOLID DOSAGE FORM DRUGASCENTAWITS PHARMACEUTICALS, LTD.
WO/2021/083336USE OF BILE ACIDS AND DERIVATIVES THEREOF IN PREPARATION OF  GPR39 AGONISTPEKING UNIVERSITY
WO/2021/083346PHARMACEUTICAL COMPOSITION COMPRISING QUINAZOLINE DERIVATIVE  OR SALT THEREOFCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/088739METHOD AND DEVICE FOR DETERMINING INTESTINAL PROBIOTIC  SUPPLEMENT FORMULA, STORAGE MEDIUM, AND PROCESSORSHENZHEN DIGITAL LIFE INSTITUTE
WO/2021/083370PREPARATION AND USE OF NANOMATERIAL SPECIFICALLY ACTIVATING  IMMUNE SYSTEMSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/083372SOLID COMPOSITION CONTAINING ANGIOTENSIN II, PREPARATION  METHOD AND USE METHOD THEREFOR AND USE THEREOFNANJING HAIWEI PHARMACEUTICAL TECHNOLOGIES CO., LTD.
WO/2021/109771METHOD FOR PREPARING MICROPOWDER MIXTURE OF ACTIVE  PHARMACEUTICAL INGREDIENTS OF GLYCOPYRRONIUM BROMIDE AND INDACATEROLCF PHARMTECH, INC.
WO/2021/129160NANOCONJUGATE OF PEGYLATED ICD INDUCER-IDO INHIBITOR,  PREPARATION METHOD THEREFOR, AND APPLICATION THEREOFSHANDONG UNIVERSITY
WO/2021/208410SKIN WHITENING, FIRMING AND MOISTURIZING FACE CREAM AND  PREPARATION METHOD THEREFORYUHUAN ZITI COSMETICS CO., LTD.
WO/2021/208411WHITENING MOISTURIZING FACE MASK IN FORM OF PASTE, AND  PREPARATION METHOD THEREFORYUHUAN ZITI COSMETICS CO., LTD.
WO/2021/093632ACTIVE ESSENCE COMPOUNDED WITH POSTBIOTICS AND PREPARATION  METHODBIO-RACE BIOTECH HANGZHOU CO., LTD.
WO/2021/129166APPLICATION OF MONASCINOL IN PREPARATION OF FAT-REDUCING  PRODUCTTIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/088846FGFR4/PD-1 COMBINATION TREATMENTSCSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/088853DRUG COMBINATION OF QUINOLINE DERIVATIVE AND PD-1 MONOCLONAL  ANTIBODYCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/174894NANOBOWL-SUPPORTED DRUG-LOADED LIPOSOME, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFSHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/088927ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 18.2LANOVA MEDICINES LIMITED COMPANY
WO/2021/088957AROMATIC HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND  APPLICATION THEREOFGUANGZHOU HENOVCOM BIOSCIENCE CO. LTD
WO/2021/109796ANTI-TUMOR DRUG SENSITIZER EMPLOYING  5-CARBOXY-8-HYDROXYQUINOLINE, AND APPLICATION THEREOFZHEJIANG UNIVERSITY
WO/2021/088975USE OF COMPOUND IN PREVENTING OR TREATING GRAFT VERSUS HOST  DISEASESHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/0889837,8-DIHYDROXYFLAVONE COMPOSITE NANO-BIOMATERIAL WITH HIGH  BIOAVAILABILITY, PREPARATION METHOD, AND APPLICATION THEREOFHANGZHOU U-MATE TECHNOLOGY CO., LTD.
WO/2021/089005USE OF FGFR INHIBITORCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/089038USE OF MULTI-TARGET PROTEIN KINASE INHIBITORCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/143313ACTIVE GENE MODIFIED PORCINE SKIN FOR COVERING AND REPAIRING  HUMAN SKIN WOUNDS AND USE THEREOFGENEO MEDICINE CO., LTD.
WO/2021/089053NANO COMPLEX FOR TARGETED REPAIRING OF NEUROVASCULAR LESION,  AND PREPARATION AND USE THEREOFSHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/227405ETAMSYLATE INJECTION AND PREPARATION METHOD THEREFORSHANDONG FANGMING PHARMACEUTICAL GROUP CO., LTD
WO/2021/135654USE OF DISULFIRAM IN PREPARATION OF MEDICAMENT FOR PREVENTION  AND TREATMENT OF DISEASES RELATED TO NLRP3 INFLAMMASOMEGUANGZHOU MEDICAL UNIVERSITY
WO/2021/098557TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  PSORIASIS, PREPARATION METHOD THEREFOR AND USE THEREOFTASLY PHARMACEUTICAL GROUP CO., LTD.
WO/2021/258614VAGINAL GEL PREPARATION AND PREPARATION METHOD THEREFORZHUHAI SHU TONG MEDICAL TECHNOLOGY CO., LTD.
WO/2021/093764PHARMACEUTICAL COMBINATION AND USE THEREOFCSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/109823CANNABINOID NANOMICELLE PREPARATION AND METHOD FOR PREPARING  SAMEHANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/135665APPLICATION OF TETRAHYDROCANNABIVARIN IN PREVENTION AND/OR  TREATMENT OF PULMONARY ARTERIAL HYPERTENSIONHANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/104034USE OF 4-HYDROXYBENZALDEHYDE IN TREATING INFLAMMATORY BOWEL  DISEASEMEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT  CENTER
WO/2021/120937APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING  DROPTONGYAN (SHANGHAI) MEDICAL DEVICE CO., LTD.
WO/2021/196628NATURAL EDIBLE SHAMPOO AND PREPARATION METHOD THEREFORNINGBO YUFANGTANG BIOLOGICAL SCIENCE AND TECHNOLOGY CO., LTD.
WO/2021/098606LIPID NANO DRUG DELIVERY SYSTEM TARGETING BRAIN LESION AND  PREPARATION METHOD AND APPLICATION THEREOFSHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/135682MICROBUBBLE DISPERSION SYSTEM USED FOR EFFICIENTLY SUPPLYING  OXYGEN TO VEINS AND STABILIZED BY POLYDOPAMINE NANOPARTICLES AND PREPARATION  METHOD FOR MICROBUBBLE DISPERSION SYSTEMZHEJIANG UNIVERSITY
WO/2021/223397TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL  CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOFBEIJING HANDIAN PHARMACEUTICAL CO., LTD.
WO/2021/093864USE OF HETEROLOGOUS TISSUE CELL COMPOSITION FOR TREATING  CANCERSCHINA MEDICAL UNIVERSITY
WO/2021/098621IMMUNOADJUVANT-ENCAPSULATED NANOPARTICLE AND USE THEREOFSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/093881COMPOSITION FOR REGULATING IMMUNE RESPONSE IN ACIDIC  ENVIRONMENT, AND PREPARATION METHOD THEREFOR AND USE THEREOFSHANGHAI SINOBAY BIOTECHNOLOGY CO., LTD.
WO/2021/104086METHOD FOR OVERCOMING TUMOR DRUG RESISTANCESHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/104088NANOPARTICLE DRUG DELIVERY SYSTEM, PREPARATION METHOD THEREFOR  AND USE THEREOFSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/203701APPLICATION OF SOFOSBUVIR IN PREPARATION OF DRUG FOR  PREVENTING AND TREATING CORONAVIRUSSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/203702USE OF PYROGLUTAMIC ACID IN PREPARATION OF DRUGS FOR  PREVENTING AND TREATING NOVEL CORONAVIRUS OF NOVEL CORONAVIRUS PNEUMONIASHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/203703USE OF CARGLUMIC ACID IN PREPARATION OF DRUGS FOR PREVENTING  AND TREATING CORONAVIRUSESSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/203704USE OF BACITRACIN A IN PREPARATION OF DRUGS FOR PREVENTING AND  TREATING CORONAVIRUSESSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/203706USE OF FOSCARNET SODIUM IN PREPARATION OF MEDICINES FOR  PREVENTING AND TREATING CORONAVIRUSESSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/098679USE OF FAK INHIBITOR IN PREPARATION OF DRUG FOR TREATING  TUMORS HAVING NRAS MUTATIONINXMED (NANJING) CO., LTD.
WO/2021/164344TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOF IN  PREVENTION AND TREATMENT OF VIRAL PNEUMONIAGUANGZHOU EIGHTH PEOPLE'S HOSPITAL
WO/2021/227417METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHYTALENGEN INTERNATIONAL LIMITED
WO/2021/098686PREPARATION METHOD FOR THERAPEUTIC DRUG DELIVERY SYSTEM  CAPABLE OF CROSSING BLOOD-BRAIN BARRIER AND SPECIFICALLY TARGETING GLIOMASHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/098688LIVING ORGANISM OXYGEN SELF-PRODUCING PHOTOSENSITIZER AND USE  THEREOFSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/104112NOVEL METHOD FOR IMPROVING TUMOR HYPOXIASHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/115070INDOCYANINE GREEN LIPOSOME FOR NEAR-INFRARED REGION II  FLUORESCENCE DETECTION, PREPARATION METHOD THEREFOR AND USE THEREOFSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/098692APPLICATION OF CHERRY PLUM PRODUCT IN INHIBITING THROMBOSISZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/104120POLYETHYLENE GLYCOL CONJUGATE MEDICAMENT, PREPARATION METHOD  THERFOR AND USE THEREOFCHONGQING UPGRA BIOLOGICAL SCI. & TECH., LTD.
WO/2021/120966SHEEP HORN KERATIN, PREPARATION METHOD THEREFOR,  PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOFINSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/098755NEW APPLICATION OF BIFIDOBACTERIUM LACTIS BL-99 IN INHIBITING  INTESTINAL INFLAMMATIONINNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD.
WO/2021/196654USE OF GLYCOSYL POLYETHER COMPOUND IN PREPARATION OF ANTI-RNA  VIRUS DRUGSWUHAN UNIVERSITY
WO/2021/184807COPPER CLUSTERS, COMPOSITION, AND METHOD FOR TREATMENT OF  LIVER CIRRHOSISWUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD.
WO/2021/098769TREATMENT OF CANCER WITH ANTI-OX40 ANTIBODIES AND MULTI-KINASE  INHIBITORSBEIGENE, LTD.
WO/2021/098771TREATMENT METHOD WITH IAP INHIBITORASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/120972TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  DEFICIENCY OF BOTH QI AND BLOOD, PREPARATION METHOD THEREFOR AND USE THEREOFSICHUAN NEO-GREEN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO.,  LTD
WO/2021/098791TRANSDERMAL PATCH CONTAINING MEMANTINECHENGDU KANGHONG PHARMACEUTICAL CO.LTD.
WO/2021/232717CONJUGATE CONTAINING MONO-PHOSPHORYLATED LIPID A AND  GLYCOANTIGEN, AND PREPARATION METHOD THEREFOR AND USE THEREOFGUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE  OF TRADITIONAL CHINESE MEDICINE)
WO/2021/232718CONJUGATE AND PREPARATION METHOD THEREFOR AND USE THEREOFGUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE  OF TRADITIONAL CHINESE MEDICINE)
WO/2021/232719CONJUGATE CONTAINING α-GALACTOSYL CERAMIDE ANALOGUE AND  CARBOHYDRATE ANTIGEN AND PREPARATION METHOD THEREFOR AND USE THEREOFGUANGZHOU UNIVERSITY OF CHINESE MEDICINE(GUANGZHOU INSTITUTE  OF TRADITIONAL CHINESE MEDICINE)
WO/2021/104155HYDROGEL TABLET FOR DISPELLING EFFECT OF ALCOHOL AND  PROTECTING LIVER, AND PREPARATION METHOD THEREFOR AND USE THEREOFGUANGDONG OCEAN UNIVERSITY
WO/2021/109879COMPOSITION HAVING WHOLESOME PERSONALIZED INTESTINAL FLORA  DIVERSITY FUNCTION AND APPLICATIONNII, Keni
WO/2021/196659GLYCOSYL POLYETHER COMPOUND LIPOSOME, PREPARATION METHOD  THEREFOR AND MEDICINE THEREOFWUHAN UNIVERSITY
WO/2021/109880PHARMACEUTICAL COMPOSITION, COMPLEMENTARY KIT AND APPLICATION  THEREOFSHANGHAI PHARMACEUTICALS HOLDING CO., LTD.
WO/2021/098826USE OF ALBIFLORIN OR PAEONIFLORIN IN THE PREVENTION AND/OR  TREATMENT OF RENAL ANEMIAZHANG, Zuoguang
WO/2021/115100NOVEL USE OF SULFORAPHANE AND PHARMACEUTICAL COMPOSITION  COMPRISING SAMEZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/098874HAIR CARE COMPOSITION AND PREPARATION METHOD THEREFORBIORIGHT WORLDWIDE COMPANY LIMITED.
WO/2021/196666USE OF HOMOHARRINGTONINE IN PREPARATION OF HUMAN BODY  BETA-CORONAVIRUS REPLICATION INHIBITORSUN YAT-SEN UNIVERSITY
WO/2021/104208ENDOGENOUS SMALL RNA MOLECULAR TARGET FOR PREVENTING SKIN  AGING AND PREMATURE AGING AND APPLICATION THEREOFSHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/104213APPLICATION OF FU TEA EXTRACT IN PREPARING ANTIFUNGAL DRUGPHARCHOICE THERAPEUTICS INC
WO/2021/104214USE OF EXOSOME DERIVED FROM CARCASS IN SKIN REGULATION PRODUCTPHARCHOICE THERAPEUTICS INC
WO/2021/218129COPPER @ RHUBARB ANTHRAQUINONE METAL ORGANIC FRAMEWORK  COMPOSITE AND USE THEREOFGUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE  OF CHINESE MEDICINE)
WO/2021/104253IBUPROFEN PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR AND USE THEREOFSHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/104276USES OF FU TEA EXTRACT IN PREPARING SKIN-CONDITIONING PRODUCTPHARCHOICE THERAPEUTICS INC
WO/2021/104319COMBINED PHARMACEUTICAL COMPOSITION OF QUINAZOLINE DERIVATIVE  OR SALT THEREOF AND USE THEREOFCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104340SUBSTITUTED CROTONAMIDE PHARMACEUTICAL COMPOSITION AND  PREPARATION METHOD THEREFORJIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104341APPLICATION OF SUBSTITUTED CROTONAMIDEJIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104363COMPOSITION CONTAINING AROMATIC HETEROCYCLIC COMPOUND IN  AMORPHOUS FORM, AND PREPARATION METHOD THEREFOR AND USE THEREOFSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/104371ANTIBODIES TO CD3 AND BCMA, AND BISPECIFIC BINDING PROTEINS  MADE THEREFROMSHANGHAI EPIMAB BIOTHERAPEUTICS CO., LTD.
WO/2021/109924USE OF MYRICETIN IN THE PREPARATION OF SALMONELLA TYPE Ⅲ  SECRETION SYSTEM INHIBITORJILIN UNIVERSITY
WO/2021/104442METHOD AND COMPOSITIONS FOR PREDICTING ANTI-CANCER EFFICACY OF  COMPOUNDS TARGETING APOPTOSIS PATHWAYASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/104454USE OF BI853520 IN CANCER TREATMENTINXMED (NANJING) CO., LTD.
WO/2021/104460PREPARATION METHOD FOR PALIPERIDONE PALMITATE SUSPENSIONNHWA PHARMA. CORPORATION
WO/2021/258642USE OF GCS INHIBITOR IN PREPARING DRUG FOR TREATING COCAINE  ADDICTIONWEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/104487COMPOSITION INCLUDING RILPIVIRINE AND USE THEREOF FOR TREATING  TUMORS OR CANCERAPTORUM THERAPEUTICS LIMITED
WO/2021/109945WEAKLY ACIDIC DERIVATIVE OF POORLY SOLUBLE DRUG, AND LIPOSOME  PREPARATION THEREOFSHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/104511APPLICATION OF CAR T-CELLS IN PREPARING DRUG FOR TREATING  CANCERSUZHOU NOVA THERAPEUTICS CO. LTD
WO/2021/109970XANTHINE DERIVATIVE PHARMACEUTICAL COMPOSITION AND PREPARATION  METHOD THEREFORCHENGDU EASTON BIOPHARMACEUTICALS CO., LTD
WO/2021/258643SOAP/AMINO ACID-TYPE FACIAL CLEANSING PRODUCT AND PREPARATION  METHOD THEREFORHUNAN YUJIA COSMETICS MANUFACTURING CO., LTD.
WO/2021/110049APPLICATION OF MANGANESE-TYPE HIGH-STABILITY SUPEROXIDE  DISMUTASE IN PREVENTION OR TREATMENT OF STROKECARRY HEALTH BIOPHARMACEUTICALS (HANGZHOU) CO., LTD.
WO/2021/121038EXOSOME FORMULATION FOR TREATING DRUG-RESISTANT BACTERIAL  INFECTIONSNANJING UNIVERSITY
WO/2021/110064NEW MULTI-FUNCTIONAL OLIGOPEPTIDESJIANGYIN USUN BIOCHEMICAL TECHNOLOGY CO., LTD.
WO/2021/110071METHODS FOR INDUCING INTERMITTENT FASTING AND MODULATING  AUTOPHAGYTHE HONG KONG POLYTECHNIC UNIVERSITY
WO/2021/110073PHARMACEUTICAL COMPOSITION CONTAINING ELEMENE, PREPARATION  METHOD THEREFOR, AND USE THEREOFCHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/135798APPLICATION OF MULBERROSIDE A AND DERIVATIVES THEREOF IN  PREPARATION OF DRUGS FOR PROTECTING INTESTINAL BARRIERNANJING UNIVERSITY
WO/2021/110097N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2  INHIBITORSASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/129340TANDOSPIRONE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR AND USE THEREOFSICHUAN CREDIT PHARMACEUTICAL CO., LTD
WO/2021/110105USE OF NEUREGULIN-1 IN PREPARATION OF PRODUCT FOR ENHANCING  TRPC6 CHANNEL ACTIVITYGUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU RESEARCH  INSTITUTE OF CHINESE MEDICINE)
WO/2021/253742APPLICATION OF WUBI CHINESE YAM PILLS IN PREPARATION OF DRUG  FOR TREATMENT OF PREMATURE OVARIAN INSUFFICIENCYHANGZHOU HUQINGYUTANG PHARMACEUTICAL CO., LTD.
WO/2021/110120ANTI-TUMOR VACCINE MOLECULE, PREPARATION METHOD THEREFOR AND  USE THEREOFCENTRAL CHINA NORMAL UNIVERSITY
WO/2021/110121HDAC6 SELECTIVE INHIBITOR AND COMBINATION THERAPY THEREOFCSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/110127METHOD OF TREATING INFLAMMATORY BOWEL DISEASECHEER GLOBAL LIMITED
WO/2021/110134THREE-LAYER HAIR CARE COMPOSITION, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFGUANGZHOU UNIASIA COSMETIC TECHNOLOGY CO., LTD.
WO/2021/110136PHARMACEUTICAL COMBINATION AND USE THEREOFASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/218154DRUG, FOOD AND APPLICATION OF ANTI-CORONAVIRUS INFECTIONGUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/110148SIRNA CONJUGATE, DOUBLE-STRANDED SIRNA CONJUGATE, SALT THEREOF  AND APPLICATION THEREOFMEDSHINE DISCOVERY INC.
WO/2021/212858APPLICATION OF HETEROCYCLIC COMPOUND CONTAINING AT LEAST TWO  SULFUR ATOMS IN PREPARING NANO-VACCINE AND PREPARED NANO-VACCINEFUZHOU UNIVERSITY
WO/2021/110164LIQUID PREPARATION CONTAINING ANTI-IL-17 ANTIBODYLIVZON MABPHARM INC.
WO/2021/143392DRUG FOR REGULATING IMMUNE FUNCTION OR TREATING IMMUNE-RELATED  DISEASESSHENZHEN YUANJIAN LIFE TECHNOLOGY CO., LTD.
WO/2021/129362USE OF AMHR2 RECOMBINANT PROTEIN OR FUSION PROTEIN IN  PREPARATION OF DRUGS FOR TREATING AMH SIGNAL AXIS ABNORMAL ACTIVATION RELATED  DISEASESPHARCHOICE THERAPEUTICS INC
WO/2021/258654SILVER ION ANTIBACTERIAL HAND SANITIZER, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFGUANGZHOU HWASUEN HEALTH INDUSTRY CO., LTD
WO/2021/110173LIPOSOME FORMULATION OF FLUTICASONE PROPIONATEANOVENT PHARMACEUTICALS CO., LTD
WO/2021/253746USE OF DALBAVANCIN IN PREPARATION OF MEDICAMENT FOR INHIBITING  BINDING OF SARS-COV-2 TO ACE2KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/115272CALCIUM-SENSING RECEPTOR AGONIST COMPOUND AND APPLICATION  THEREOFBEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD.
WO/2021/121082SCAVENGER RECEPTOR-A TARGETED DRUG CARRIER, AND PREPARATION  METHOD AND APPLICATION THEREOFSICHUAN UNIVERSITY
WO/2021/115321PHARMACEUTICAL TACI-FC FUSION PROTEIN FORMULATIONREMEGEN CO., LTD.
WO/2021/212865COMPOUND ALLICIN SOFT CAPSULE AND METHOD FOR PREPARING AND  PACKAGING SAMEGUANGZHOU HONGKANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/115389FULVESTRANT PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFSHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/169484NANOVACCINE AND PREPARATION METHOD THEREFORZHEJIANG UNIVERSITY
WO/2021/115408PHARMACEUTICAL COMPOSITION AND USE THEREOFJIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
WO/2021/115409PHARMACEUTICAL COMPOSITION AND USE THEREOFJIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
WO/2021/115410IMMUNOSTIMULATORY COMPOSITION AND USE THEREOFJIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
WO/2021/115412USE OF NITRIC OXIDE SYNTHASE PATHWAY INHIBITOR IN PREPARATION  OF MEDICINEZHUJIANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY
WO/2021/115415METHODS FOR TREATING BACTERIAL INFECTIONSMICROBIOTA I - CENTER (MAGIC) LIMITED
WO/2021/115425PHARMACEUTICAL COMPOSITION CONTAINING BPI-7711 AND PREPARATION  METHOD THEREOFBETA PHARMA (SUZHOU) , LTD.
WO/2021/115426ANTI-CLAUDIN ANTIBODY-DRUG CONJUGATE AND PHARMACEUTICAL USE  THEREOFJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/073659VACCINE VECTOR PREPARED ON BASIS OF ANIONIC POLYMERS AND  DERIVATIVES THEREOFSICHUAN UNIVERSITY
WO/2021/073660LYOPHILIZED PREPARATION OF VACCINE CONTAINING ALUMINUM  ADJUVANT AND PREPARATION METHOD AND USE THEREFORSICHUAN UNIVERSITY
WO/2021/258668METHOD FOR PREPARING P/H MICROSPHERES WITH HYDROPHOBIC SOLID  POWDER WRAPPED THEREINZHEJIANG UNIVERSITY
WO/2021/196734CONTROLLED-RELEASE BRIVARACETAM PREPARATION AND PREPARATION  METHOD THEREFORJIANGSU ALICORN PHARMATECH CO., LTD.
WO/2021/244004ZEOLITE ENERGY MASK AND PREPARATION METHOD THEREFORJIANGSU FULE BIOLOGICAL ENVIRONMENTAL PROTECTION TECHNOLOGY  CO., LTD
WO/2021/164399APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARATION OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTIONJIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/227493USE OF FGF21 IN PREPARATION OF MEDICINE FOR TREATING  COLORECTAL CANCERJIANGNAN UNIVERSITY
WO/2021/121277A METHOD AND COMPOSITION FOR TREATMENT OF A CANCERTUAN, Mei-Nan
WO/2021/164401USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION  OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTIONJIANGSU KANION PHARMACEUTICAL CO.,LTD.
WO/2021/135980SOLVENT SYSTEM CAPABLE OF EFFECTIVELY DISSOLVING ORNIDAZOLE OR  LEVORNIDAZOLE, AND APPLICATION THEREOFCHONGQING DIANSUO MEDICAL TECHNOLOGY CO., LTD
WO/2021/121366LONG-ACTING INJECTABLE FORMULATIONS OF KETAMINE PAMOATE SALTSALAR PHARMACEUTICALS INC.
WO/2021/258683APPLICATION OF BERBERINE-ORYZANOL TABLET IN TREATMENT OF  DIABETESYICHUN WANSHEN PHARMACEUTICAL MACHINERY CO., LTD
WO/2021/121387APPLICATION OF COMPOUND IN DRUG PREPARATIONMEDSHINE DISCOVERY INC.
WO/2021/121388TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  EGFR-TKIS RELATED SKIN RASH AND USE THEREOFYANGTZE RIVER PHARMACEUTICAL GROUP GUANGZHOU HAIRUI  PHARMACEUTICAL CO., LTD.
WO/2021/232777AEROSOLYUNNAN HEMPSON BIO-TECH CO., LTD.
WO/2021/129600JAK KINASE INHIBITOR PHARMACEUTICAL COMPOSITIONJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/129616PHARMACEUTICAL COMBINATION OF ANTI-PD-1 ANTIBODY AND HISTONE  DEACEYLASE INHIBITOR, USE THEREOF, AND USAGE METHOD THEREFORINNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/129635SUSTAINED-RELEASE DRUG DELIVERY SYSTEMNANJING DELOVA BIOTECH CO. LTD.
WO/2021/129649USE OF α-KETOGLUTARATE IN PREPARATION OF DRUGTONGJI UNIVERSITY
WO/2021/129658APPLICATION OF FUSION PROTEIN IN TREATING AGE-RELATED MACULAR  DEGENERATIONINNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/129673ANTI-CSF1R MOLECULES AND USE THEREOFADAGENE (SUZHOU) LIMITED
WO/2021/129678CONJUGATE WITH RADIATION-RESPONSIVE GROUP AND USE THEREOFPEKING UNIVERSITY
WO/2021/129735SOLID PREPARATION, AND PREPARATION METHOD THEREFOR AND USE  THEREOFSINOTHERAPEUTICS INC.
WO/2021/129744COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND  CANCERS BY TARGETING IGSF8SHANGHAI XBH BIOTECHNOLOGY CO., LTD.
WO/2021/129775ANTI-CTLA-4 MONOCLONAL ANTIBODY, PREPARATION METHOD THEREFOR,  AND APPLICATION THEREOFBIO-THERA SOLUTIONS, LTD.
WO/2021/129796EASILY CLEANSING MAKEUP BASE COSMETIC FOR SKINSHISEIDO COMPANY, LTD.
WO/2021/143485CURCUMIN COMPLEX, PREPARATION METHOD THEREFOR AND DETECTION  METHOD THEREFORCHENLAND NUTRITIONALS INC.
WO/2021/136089ANTI-TUMOR PHARMACEUTICAL COMPOSITION AND METHOD FOR  INCREASING SOLUBILITY OF COMPOUNDBEIJING KONRUNS PHARMACEUTICAL CO., LTD.
WO/2021/212892BROAD-SPECTRUM ANTIVIRAL DRUG AND USE THEREOFMETHYCURE BIOTECH CORP.
WO/2021/136169FILM-FORMING COMPOSITION CONTAINING GELLAN GUM AND STARCH, AND  APPLICATION IN SOFT CAPSULESIRIO PHARMA CO., LTD.
WO/2021/136226APPLICATIONS OF IMINOSTILBENE IN TERMS OF PREVENTING AND  TREATING CARDIAC CEREBRAL ISCHEMIA/REPERFUSION INJURYCHINESE ACADEMY OF MEDICAL SCIENCES INSTITUTE OF MEDICINAL  PLANT DEVELOPMENT
WO/2021/136262TWO-DIMENSIONAL NANO COMPOSITE MATERIAL, PREPARATION METHOD  THEREFOR AND USE THEREOFNINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING,  CHINESE ACADEMY OF SCIENCES
WO/2021/136274FORMULATION CONTAINING ANTI-TROP2 ANTIBODY-DRUG CONJUGATE AND  PREPARATION METHOD AND APPLICATION THEREOFBIO-THERA SOLUTIONS, LTD.
WO/2021/136275MULTI-STAGE FAT-PROTECTING SKINCARE COMPOSITION FOR PROTECTING  SKIN BARRIER OF INFANTSLUNALER HEALTH TECHNOLOGY (GUANGZHOU) CO LTD
WO/2021/136381PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE  TABLET, PREPARATION METHOD THEREFOR AND USE THEREOFJIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/184918USE OF EPHB4 AS TARGET IN SCREENING OF DRUGS OR MODELS FOR  INCREASING INSULIN SENSITIVITYINSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/136405ANTI-INFECTION USE OF CLASS OF THIAZOLE-CONTAINING COMPOUNDSINSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/136488CRYSTAL FORM OF PYRIDOPYRIMIDINE DERIVATIVE AND PREPARATION  METHOD THEREOFJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/136492GASTRIC RETENTION TABLETGUANGZHOU BOSTAL DRUG DELIVERY CO., LTD.
WO/2021/136494GASTRIC RETENTION TABLETGUANGZHOU BOSTAL DRUG DELIVERY CO., LTD.
WO/2021/136507PHARMACEUTICAL COMPOSITION OF DIPEPTIDYL PEPTIDASE-4  INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOFCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/253803PREPARATION METHOD FOR FIRE-PURGING TABLETHAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD.
WO/2021/136513METHOD FOR PREPARING PH-RESPONSIVE INTESTINE-TARGETED ACTIVE  FACTOR TRANSPORTATION SYSTEM BASED ON ANIONIC SODIUM ALGINATEDALIAN POLYTECHNIC UNIVERSITY
WO/2021/136520NEW METHOD FOR TARGETED EDITING OF RNAEDIGENE INC.
WO/2021/136523PHARMACEUTICAL COMBINATION FOR TREATING TUMORS AND APPLICATION  THEREOFFUKANG (SHANGHAI) HEALTH TECHNOLOGY CO., LTD
WO/2021/174995USE OF JQ-1 IN PREPARATION OF MEDICINE FOR TREATING PANCREATIC  CANCER AND METHOD FOR VERIFYING INHIBITION OF JQ-1 ON EXOSOME SECRETION OF  PANCREATIC CANCERAFFILIATED HOSPITAL OF NANTONG UNIVERSITY
WO/2021/196808NOVEL THERAPEUTIC VACCINE AGAINST NOVEL CORONAVIRUS,  PREPARATION METHOD THEREFOR, AND USE THEREOFHANGZHOU XINGAO BIOTECHNOLOGY CO., LTD
WO/2021/253807ANTI-NOVEL CORONAVIRUS COMPLEX AND PREPARATION METHOD THEREFORHANGZHOU XINGAO BIOTECHNOLOGY CO., LTD
WO/2021/136541APPLICATION OF A REAGENT DOWN-REGULATING CIRCULAR GENE  EXPRESSION IN PREPARATION OF A DRUG TO PREVENT AND/OR TREAT PULMONARY  FIBROSIS, AND DRUGBINZHOU MEDICAL UNIVERSITY
WO/2021/203769USE OF ANTI-PD-1 ANTIBODY IN PREPARATION OF DRUGS FOR TREATING  ACRAL LENTIGINOUS MELANOMAJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/244027APPLICATION OF COBRA POSTSYNAPTIC NEUROTOXIN IN TREATMENT OF  DISEASES RELATED TO INFLAMMATORY CYTOKINE OVEREXPRESSIONSHEN, Zhejing
WO/2021/203779COMPOUND FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION, AND  APPLICATION THEREOFEAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/136549APPLICATION OF CINEPAZIDE MALEATE IN PREPARATION OF DRUGS FOR  PREVENTION AND TREATMENT OF STROKEBEIJING SIHUAN PHARMACEUTICAL CO., LTD.
WO/2021/139642PROGRAMMED CELL DEATH RECEPTOR 1 ANTIBODY FORMULATION AND USE  THEREOFSHANGHAI HENLIUS BIOTECH, INC.
WO/2021/139661APPLICATION OF GENE EXPRESSION INHIBITOR POU2F1 IN PREPARATION  OF DRUG FOR TREATING TISSUE FIBROSIS DISEASESPEKING UNIVERSITY THIRD HOSPITAL
WO/2021/139697APPLICATION OF SUPERNATANT OF TUMOR CELLS AFTER ACTION OF  CHEMOTHERAPEUTIC DRUGZHUKANG BIOTECHNOLOGY CO. , LTD.
WO/2021/159892HEMOSTATIC AGENT FOR CENTRAL HEMANGIOMA HEMORRHAGE OF JAW,  PREPARATION METHOD THEREFOR AND USE THEREOFNANTONG UNIVERSITY
WO/2021/139739CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND  MEDICAL USE THEREOFCHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/238232PRAMIPEXOLE HYDROCHLORIDE ORAL SOLUTIONCHANGZHOU NO.4 PHARMACEUTICAL FACTORY CO. LTD
WO/2021/227541TRADITIONAL CHINESE MEDICINAL COMPOSITION FOR TREATING  DEMENTIA AND PREPARATION METHOD THEREFORWEST CHINA HOSPITAL OF SICHUAN UNIVERSITY
WO/2021/143671PHARMACEUTICAL COMPOSITION OF ANTI-PD-1 ANTIBODY AND  QUINAZOLINE DERIVATIVE, USES OF COMPOSITION, AND METHOD FOR USING SAMEINNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/147740USE OF MAPK/ERK PATHWAY INHIBITOR IN ANTAGONIZING SKIN AGING  AND RADIATION-INDUCED PREMATURE AGINGSHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/143736COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET  AGENTTHE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/143741TARGETING POLYPEPTIDE-DRUG CONJUGATE AND USE THEREOFBEIJING HOPE PHARMACEUTICAL CO. LTD.
WO/2021/143745LONG-ACTING ROPIVACAINE PHARMACEUTICAL COMPOSITION,  PREPARATION METHOD THEREFOR AND USE THEREOFSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/143746NON-AQUEOUS SUSTAINED RELEASE DRUG DELIVERY SYSTEMSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/143751INJECTABLE LONG-ACTING ANALGESIC PHARMACEUTICAL COMPOSITION,  PREPARATION METHOD THEREFOR, AND APPLICATION THEREOFSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/143754COMBINATION FOR THE TREATMENT OF CANCER AND APPLICATION  THEREOFEVERFRONT BIOTECH INC.
WO/2021/143767PREPARATION OF BISPECIFIC ANTIBODY COMBINING PD-1 AND PD-L1  AND USE THEREOFINNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/143785PHARMACEUTICAL COMPOSITION OF AEROSOL INHALANT CONTAINING  INDACATEROL AND PREPARATION METHOD THEREOFSICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/143791PHARMACEUTICAL USE OF ESRRA GENE ENCODING FOR ESTROGEN-RELATED  RECEPTOR αCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/143799USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH FRUQUINTINIB IN  PREPARATION OF MEDICAMENTS FOR TREATING CANCERGENOR BIOPHARMA CO. LTD
WO/2021/143806APPLICATION OF WIDE-SPECTRUM FLAVIVIRUS-AGAINST ACTIVITY OF  HSP70 INHIBITORACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/143826RECOMBINANT ANTI-PROGRAMMED CELL DEATH PROTEIN 1 AND  ANTI-CLUSTER OF DIFFERENTIATION ANTIGEN 137 BISPECIFIC ANTIBODY PREPARATION  AND USE THEREOFINNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/143861COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC  STEATOHEPATITIS (NASH)SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/143879COMBINATIONAL THERAPY COMPRISING GLP-1 AND/OR GLP-1 ANALOGS,  AND INSULIN AND/OR INSULIN ANALOGSSHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/143906METHOD FOR TREATMENT OF NERVE INJURY AND RELATED DISEASETALENGEN INTERNATIONAL LIMITED
WO/2021/143912THERAPEUTIC ACTION OF CELL-FREE FAT EXTRACT ON FATTY LIVER AND  COMPLICATIONS THEREOFSHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/151366HEALTH FOOD OR TRADITIONAL CHINESE MEDICINE MEDICINAL FORMULA  FOR IMPROVING MALE SEXUAL FUNCTION, AND ULTRASONIC WAVE PREPARATION METHODJIANGSU UNIVERSITY
WO/2021/143919PHARMACEUTICAL COMPOSITION AND USE THEREOFHENAN TAIFENG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/147854RECOMBINANT FULLY HUMAN ANTI-TIGIT MONOCLONAL ANTIBODY  PREPARATIONS, PREPARATION METHOD THEREFOR AND USE THEREOFINNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/143928QUINOLINE DERIVATIVE FOR TREATING RHEUMATOID ARTHRITISCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/208551APPLICATION OF THYROID HORMONE AND ANALOGUE THEREOF IN  PREPARATION OF DRUG FOR TREATING SICKLE-CELL DISEASERUIJIN HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF  MEDICINE
WO/2021/208552USE OF THYROID HORMONE AND ANALOGUE THEREOF IN PREPARATION OF  DRUGS FOR TREATING ALPHA-THALASSEMIARUIJIN HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF  MEDICINE
WO/2021/232836CANNABINOID COMPOUNDS AND APPLICATION THEREOF IN TREATMENT OF  PARKINSON'S DISEASEHANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/238242USE OF FULL-SPECTRUM HEMP OIL IN TREATMENT OF EPILEPSYHANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/169682TRADITIONAL CHINESE MEDICINE COMPOSITION, AND PREPARATION  METHOD THEREFOR AND APPLICATION THEREOFBEIJING REGEN-PHARMATECH CO., LTD.
WO/2021/147922EXTRACELLULAR VESICLE AND USE THEREOF IN SKIN PRODUCTSEV CELL BIOTECH (GUANGZHOU) CO., LTD.
WO/2021/148003DRUG CONJUGATE OF ERIBULIN DERIVATIVE, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOF IN MEDICINESHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/203798USE OF SPLICING FACTOR PRPF31 INHIBITOR IN PREPARING DRUGCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/244044EYE DROP SUITABLE FOR LIMBAL STEM CELL DEFICIENCY AND  PREPARATIONQINGDAO HAIER BIOTECH CO.LTD
WO/2021/218249SPINOSYN DERIVATIVE AS ARGININOSUCCINATE SYNTHETASE ACTIVATOR  AND APPLICATION THEREOFCENTRAL SOUTH UNIVERSITY
WO/2021/155748INHIBITORS OF MALARIAL AND PLASMODIUM FALCIPARUM HEXOSE  TRANSPORTER AND USES THEREOFTSINGHUA UNIVERSITY
WO/2021/179817PROGESTERONE EMULSION INJECTION AND PREPARATION METHOD  THEREFORJIANGSU JIAERKE PHARMACEUTICAL GROUP CO., LTD.
WO/2021/155751TRADITIONAL CHINESE MEDICINE COMPOUND WITH FUNCTIONS OF  CLEARING LUNGS AND DETOXIFICATION, AND APPLICATION THEREOFINSTITUTE OF BASIC RESEARCH IN CLINICAL MEDICINE,CHINA ACADEMY  OF CHINESE MEDICAL SCIENCES
WO/2021/179828USE OF PHARMACEUTICAL COMPOSITION IN PREPARATION OF DRUG FOR  TREATING ACUTE LUNG INJURYSHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/151387PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUNDSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/169724SUSTAINED-RELEASE DOSAGE FORM OF TOFACITINIB, PREPARATION  METHOD THEREFOR AND APPLICATION THEREOFSHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/164523AKKERMANSIA MUCINIPHILA COMPOSITIONSHANGHAI INSTITUTE OF ENDOCRINE AND METABOLIC DISEASES
WO/2021/155764COMBINATION OF BI853520 WITH CHEMOTHERAPEUTIC DRUGSINXMED (NANJING) CO., LTD.
WO/2021/129890MEDICATION FOR BLOCKING MICROBIAL INFECTION, REDUCING  CHOLESTEROL, AND PREVENTING AND TREATING ASSOCIATED TUMORS, AND USE THEREOFCENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE  ACADEMY OF SCIENCES
WO/2021/151391APPLICATION OF ISOVALERYLSPIRAMYCIN COMPOUND AND COMPOSITION  THEREOF IN PREPARATION OF ANTIVIRAL DRUGSHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/179843ANTI-TUMOR NANO ADJUVANT BASED ON VESICLE FORMED BY  CROSS-LINKED BIODEGRADABLE POLYMER, PREPARATION METHOD THEREFOR AND USE  THEREOFSOOCHOW UNIVERSITY
WO/2021/155777USE OF PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING  NOVEL CORONAVIRUS PNEUMONIASHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/184987AD7 VECTOR VACCINE FOR PREVENTING SARS-COV-2 INFECTIONGUANGZHOU N BIOMED LTD.
WO/2021/184988AD35 VECTOR VACCINE FOR PREVENTING SARS-COV-2 INFECTIONGUANGZHOU N BIOMED LTD.
WO/2021/155795PHARMACEUTICAL COMPOSITION AND USE THEREOFQIN, Caidong
WO/2021/155798USE OF IMMUNE POLYPEPTIDE IN ANTIVIRAL DRUGCHENG, Yun
WO/2021/184990SENSITIZER DRUG, DRUG COMBINATION AND USESUN YAT-SEN MEMORIAL HOSPITAL, SUN YAT-SEN UNIVERSITY
WO/2021/227572USE OF MICRO-NANO MGH<sb>2</sb> COMPOUND PARTICLES  IN INHIBITION OF LEISHMANIA INFECTION AND TREATMENT OF LEISHMANIASISSHANGHAI JIAO TONG UNIVERSITY
WO/2021/196884USE OF CATECHOL AND DERIVATIVES IN PREPARATION OF DRUGS FOR  TREATING SLEEP DISTURBANCESXI'AN LIBANG ZHAOXIN BIOTECHNOLOGY CO., LTD.
WO/2021/155825USE OF PAX6 GENE OR EXPRESSION PRODUCT THEREOF IN PREPARATION  OF DRUG FOR INHIBITING FIBROSISPEKING UNIVERSITY THIRD HOSPITAL
WO/2021/155840USE OF ANTI-PD-1 ANTIBODY IN TREATMENT OF MALIGNANT TUMORSSHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/155846PREPARATION METHOD FOR NOVEL CORONAVIRUS PNEUMONIA BIVALENT  VACCINEWENG, Binghuan
WO/2021/160049BACTERIOSTATIC COMPOSITION, PREPARATION METHOD THEREFOR AND  USE THEREOFSHENZHEN EULIKAN BIOTECHNOLOGY CO., LTD
WO/2021/203828USE OF INHIBITOR IN PREPARATION OF DRUGS FOR TREATING  SARS-COV-2 PNEUMONIA AND COMPLICATIONS THEREOFACADEMY OF MILITARY MEDICAL SCIENCES, PLA
WO/2021/223480CONTROLLED-RELEASE TICAGRELOR TABLET AND PREPARATION METHOD  THEREFORJIANGSU ALICORN PHARMATECH CO., LTD.
WO/2021/164600USE OF COMPOSITION IN TREATING ATHEROSCLEROSISINNOLIFE CO., LTD.
WO/2021/155867METHOD AND DRUG FOR PREVENTING AND TREATING MULTIPLE SCLEROSISTALENGEN INTERNATIONAL LIMITED
WO/2021/185006LENVATINIB PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFSHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/160092METHOD AND DRUG FOR TREATING VIRAL PNEUMONIATALENGEN INTERNATIONAL LIMITED
WO/2021/160104FOLIUM APOCYNI VENETI EXTRACT, AND PREPARATION METHOD THEREFOR  AND USE THEREOFXIAMEN UNIVERSITY
WO/2021/1798783CLPRO-TARGETING PHILLYRIN, DERIVATIVE THEREOF, AND USE  THEREOF AGAINST NOVEL CORONAVIRUSDALIAN FUSHENG NATURAL MEDICINE DEVELOPMENT CO., LTD.
WO/2021/160115USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME FOR TREATING BREAST  CANCERCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/160120OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTORBEIJING IMMUNOCHINA PHARMACEUTICALS CO., LTD.
WO/2021/160124OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTORBEIJING IMMUNOCHINA PHARMACEUTICALS CO., LTD.
WO/2021/160131FIBROTIC DISEASE MECHANISM AND THERAPEUTIC DRUG THEREFORGUANGZHOU WOMEN AND CHILDREN'S MEDICAL CENTER
WO/2021/179881APPLICATION OF HERBAL MEDICINE COMPOSITION IN PREPARATION OF  MEDICINE FOR PREVENTING AND TREATING CORONAVIRUS COMPLICATED WITH LUNG INJURYGUANGDONG LEIYUNSHANG PHARMACEUTICAL CO., LTD.
WO/2021/169812USE OF PAX4 INHIBITOR IN PREPARATION OF DRUG FOR INHIBITING  FIBROSISPEKING UNIVERSITY THIRD HOSPITAL
WO/2021/1601399,10-DIHYDROPHENANTHRENE COMPOUNDS AND USE THEREOF IN  TREATMENT OF LIVER INJURYSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/164672ANTI-RNA VIRUS DRUG AND APPLICATION THEREOFEAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/160144METHOD FOR PREVENTING OR TREATING THROMBOEMBOLISMS BY MEANS OF  APIXABAN INJECTIONJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/160151USE OF ANTI-PD-1 ANTIBODY IN TREATMENT OF TUMORSSHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/160152USE OF ANTI-PD-1 ANTIBODY IN TREATING NEUROENDOCRINE TUMORSSHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/232864TREATING TUMOR USING IMMUNE EFFECTOR CELLCAFA THERAPEUTICS LIMITED
WO/2021/160163METHODS FOR PREVENTION OR TREATMENT OF VIRUS-INDUCED ORGAN  INJURY OR FAILURE WITH IL-22 DIMEREVIVE BIOTECHNOLOGY (SHANGHAI) LTD
WO/2021/164685GROUP OF PEPTIDE COMPOUNDS OMICSYNIN HAVING ANTIVIRAL ACTIVITY  AND APPLICATION THEREOFINSTITUTE OF MEDICINAL BIOTECHNOLOGY CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/160170METHODS OF USE OF SOLUBLE CD24 FOR TREATING SARS-COV-2  INFECTIONONCOIMMUNE, INC.
WO/2021/160173METHODS OF USE OF SOLUBLE CD24 FOR TREATING VIRAL PNEUMONIAONCOIMMUNE, INC.
WO/2021/164689APPLICATION OF NELFINAVIR IN PREPARATION OF DRUG FOR  PREVENTING AND TREATING NOVEL CORONAVIRUS PNEUMONIASHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/160183ORAL CARE COMPOSITION AND DEVICES FORMED THEREWITHRANIR, LLC
WO/2021/164706PHARMACEUTICAL COMPOSITION CONTAINING METHYLENE BLUE DYE AND  APPLICATION THEREOFCHENGDU KUACHANGAOPU MEDICAL TECHNOLOGY CO., LTD.
WO/2021/169845METHOD FOR PREVENTING, TREATING OR DELAYING HEART FAILURE BY  USING NEUREGULIN, AND COMPOSITIONZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, CO., LTD.
WO/2021/164717ANTI-TNF-α ANTIBODY PREPARATION, PREPARATION METHOD THEREFOR  AND USE THEREOFBIO-THERA SOLUTIONS, LTD.
WO/2021/164723GINSENOSIDE M1 AS A MODULATOR OF ANGIOTENSIN REGULATING  ENZYMES AND ITS USE FOR TREATING DISEASES OR CONDITIONS INCLUDING SYMPTOMS  CAUSED BY CORONAVIRUSLEE, Sheau-Long
WO/2021/164728PHARMACEUTICAL COMPOSITION CONTAINING ANTI-IL-4R ANTIBODY AND  USE THEREOFJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/164740USE OF INTERFERON IN PREPARING DRUG FOR PREVENTING CORONAVIRUS  INFECTION OR PREVENTING DISEASE CAUSED BY CORONAVIRUS INFECTIONSHANGHAI GANYI MEDICAL BIOTECHNOLOGY INC.
WO/2021/164744METHODS FOR TREATING GRAFT VERSUS HOST DISEASEEVIVE BIOTECHNOLOGY (SHANGHAI) LTD
WO/2021/164755OLAPARIB PHARMACEUTICAL COMPOSITION, PREPARATION THEREOF,  PREPARATION METHOD THEREFOR AND USE THEREOFSINOTHERAPEUTICS INC.
WO/2021/169861USE OF NUCLEOSIDE COMPOUND IN TREATMENT OF CORONAVIRUS  INFECTIOUS DISEASESGENUINE BIOTECH CO., LTD.
WO/2021/169884USE OF RAPAMYCIN AND DERIVATIVES THEREOF IN PREPARATION OF  DRUGS FOR PREVENTING AND TREATING ADE CAUSED BY VIRUSESZHENG, Yunfeng
WO/2021/179902USE OF CORYDALIS SAXICOLA AND PREPARATION THEREOF IN  PREPARATION OF DRUG FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASESNANJING ZHONGSHAN PHARMACEUTICAL CO., LTD.
WO/2021/169957APPLICATION OF N-SUBSTITUTED PYRIDYL BENZISOSELENAZOLONE  COMPOUNDSHANGHAITECH UNIVERSITY
WO/2021/212995ANTI-AGEING COMPOSITION, DRUG AND HEALTHCARE PRODUCT  COMPRISING SAME, AND APPLICATION THEREFORBIORIGHT WORLDWIDE COMPANY LIMITED.
WO/2021/169974COMBINED PHARMACEUTICAL COMPOSITION FOR RESISTING DOUBLE-HIT  LYMPHOMAS, AND USE THEREOFTHE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY
WO/2021/169978USE OF RECOMBINANT CYTOKINE GENE DERIVED PROTEIN OR FRAGMENT  THEREOFGENOVA INC.
WO/2021/169984ANTI-CORONAVIRUS APPLICATION OF POLY ADP RIBOSE POLYMERASE  INHIBITORFUKANG (SHANGHAI) HEALTH TECHNOLOGY CO., LTD
WO/2021/227597USE FOR CORDYCEPS SINENSIS EXTRACT IN PREPARING DRUG FOR  PROMOTING ANGIOGENESIS AND/OR TREATING ISCHEMIC CARDIOVASCULAR AND  CEREBROVASCULAR DISEASESINSTITUTE OF ZOOLOGY, GUANGDONG ACADEMY OF SCIENCES
WO/2021/170045METHODS OF TREATING DLBCL USING BTK INHIBITORS AND  COMBINATIONS THEREOFBEIGENE SWITZERLAND GMBH
WO/2021/170060PURIFICATION OF BISPECIIFC ANTIBODIESWUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/170064ORAL CARE COMPOSITIONS FOR GUM HEALTHTHE PROCTER & GAMBLE COMPANY
WO/2021/170065ORAL CARE COMPOSITIONS FOR GUM HEALTHTHE PROCTER & GAMBLE COMPANY
WO/2021/170073USE OF SMALL MOLECULE COMPOUNDS IN TREATING DISEASES MEDIATED  BY LUNG EPITHELIAL CELL INJURY AND/OR VASCULAR ENDOTHELIAL CELL INJURYGUANGZHOU CELLPROTEK PHARMACEUTICAL CO., LTD.
WO/2021/170078USE OF CSF-1R KINASE INHIBITORSHANGHAI RUNSHI MEDICAL TECHNOLOGY CO., LTD
WO/2021/170093APPLICATION OF DISULFIRAM IN CORONAVIRUS RESISTANCESHANGHAITECH UNIVERSITY
WO/2021/170099METHOD AND DRUG FOR PREVENTING AND TREATING ABNORMAL BLOOD  PRESSURE CONDITIONTALENGEN INTERNATIONAL LIMITED
WO/2021/175175PHARMACEUTICAL FORMULATION COMPRISING BEVACIZUMABSHANGHAI HENLIUS BIOTECH, INC.
WO/2021/170137ANTI-TUMOR COMPOSITIONSPH SINE PHARMACEUTICAL LABORATORIES CO., LTD
WO/2021/170138ANTI-TUMOR COMPOSITIONSPH SINE PHARMACEUTICAL LABORATORIES CO., LTD
WO/2021/175186USE OF SMALL MOLECULE SHORT PEPTIDE IN PREPARATION OF PRODUCT  FOR TREATING ACNEJINAN UNIVERSITY
WO/2021/175192TREATMENT METHODS AND BIOMARKERS FOR MDM2 INHIBITORSASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/175200FERROPTOSIS INHIBITORS–DIARYLAMINE PARA-ACETAMIDESSIRONAX LTD
WO/2021/179947USE OF PHARMACEUTICAL COMPOSITION IN PREPARING ANTIBACTERIAL  DRUGSHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/179950USE OF PHARMACEUTICAL COMPOSITION IN PREPARING ANTI-VIRAL DRUGSHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/179952APPLICATION OF GW8510 IN PREPARATION OF DRUGS FOR PROLONGING  LIVES, IMPROVING COGNITIVE ABILITY, AND THE LIKE OF MAMMALS IN NATURAL AGINGPEKING UNIVERSITY
WO/2021/185071COMPOSITIONS OF ANTI-VIRAL PEPTIDES AND METHODS OF USE THEREOFTHE UNIVERSITY OF HONG KONG
WO/2021/179959PHARMACEUTICAL COMPOSITION COMPRISING JAK3/JAK1/TBK1 INHIBITOR  AND METHOTREXATE AND USE THEREOFSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/175240APPLICATION OF FULLERENE AND DERIVATIVE THEREOF IN REGULATING  INTESTINAL FLORAXIAMEN FUNANO NEW MATERIAL TECHNOLOGY CO., LTD.
WO/2021/179967APPLICATION OF IFN-γ IN PREPARING ANTI-TUMOR ADJUVANT DRUGWEST CHINA HOSPITAL OF SICHUAN UNIVERSITY
WO/2021/175250COMPOUNDS AND METHODS FOR TREATING DISEASES AND/OR CONDITIONS  CAUSED BY CORONAVIRUSAPTORUM THERAPEUTICS LIMITED
WO/2021/175274OLAPARIB DISSOLUTION ENHANCING COMPOSITIONSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/175275HYDROPHOBICALLY MODIFIED ALBUMIN, PREPARATION METHOD THEREFOR,  AND APPLICATION THEREOFKUNSHAN XINYUNDA BIOTECH CO., LTD.
WO/2021/175279APPLICATION OF PHYSICAL TRANSDERMAL TECHNOLOGY IN  SUPPLEMENTARY NUTRITION SUPPLEMENTINGSUZHOU NASHENG MICROELECTRONICS CO., LTD
WO/2021/175295APPLICATION OF MYRICETIN COMPOUND IN PREPARATION OF DRUGS FOR  PREVENTION AND TREATMENT OF NOVEL CORONAVIRUS PNEUMONIASHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/227614PHARMACEUTICAL COMPOSITION FOR CLEARING LUNG AND PULMONARY  FIBROSIS AND USE THEREOFZHANG, Yingwen
WO/2021/175311PHARMACEUTICAL COMPOSITION CONTAINING GINKGOLIDE AND  CANNABINOID COMPOUNDS AND USE THEREOF IN MEDICINECHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/175326COMBINED USE OF CTB006 AND PONATINIBBEIJING SINOTAU BIO-PHARMACEUTICALS TECHNOLOGY CO., LTD.
WO/2021/196982ANTI-ARRHYTHMIC PHARMACEUTICAL COMPOSITION AND PREPARATION  METHOD THEREFORJIANGSU KANION PHARMACEUTICAL CO.,LTD.
WO/2021/180027PHARMACEUTICAL COMBINATION OF ANTI-PD-1 ANTIBODY AND  MULTI-RECEPTOR TYROSINE KINASE INHIBITOR AND METHOD FOR USING SAMEHUTCHISON MEDIPHARMA LIMITED
WO/2021/180032Novel Therapeutic MethodsGUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
WO/2021/175333SCUTELLARIAE RADIX COMPOUNDS AND USE THEREOF FOR INHIBITING  OXIDATIVE PHOSPHORYLATION PATHWAY OF MITOCHONDRIANANJING SHIJIANG MEDICINE TECHNOLOGY CO., LTD
WO/2021/180055USE OF BRD4 INHIBITORCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/180068METHOD AND DRUG FOR TREATING DISEASES CAUSED BY 2019 NOVEL  CORONAVIRUSTALENGEN INTERNATIONAL LIMITED
WO/2021/180087MEDICAL USE OF ANYHDROICARITINLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/180110USE OF ANTI-BASIGIN HUMANIZED ANTIBODY FOR PREPARING  MEDICAMENT FOR TREATING NOVEL CORONAVIRUS PNEUMONIATHE FOURTH MILITARY MEDICAL UNIVERSITY
WO/2021/218422APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARATION OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTIONJIANGSU KANION PHARMACEUTICAL CO.,LTD.
WO/2021/213058APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARATION OF DRUGS FOR TREATING OR PREVENTING INFECTION WITH CORONAVIRUSESJIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/213059USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION  OF DRUG FOR TREATING OR PREVENTING CORONAVIRUS INFECTIONJIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/180184USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOMESCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/185154PHARMACEUTICAL COMPOSITION COMPRISING TIZOXANIDE AND  PHARMACEUTICAL USE THEREOFBEIJING JUNKE HUAYUAN MED TECH CO., LTD.
WO/2021/180196COMPOSITION OF PIPERAZINE-BASED DRUGSDONGGUAN HEC GENERIC DRUG R&D CO., LTD.
WO/2021/180205PVRIG BINDING PROTEIN AND ITS MEDICAL USESJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/223514HOUSING-LIKE DENTAL INSTRUMENT HAVING ANTICARIES FUNCTION AND  MANUFACTURING METHOD THEREFORWUXI EA BIOTECHNOLOGY LIMITED
WO/2021/180219ANTI-CORONAVIRUS EFFECT AND APPLICATION OF PI4K INHIBITORNUO-BETA PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO. LTD
WO/2021/180225NEW APPLICATION OF C60 AND METHOD FOR MEASURING ACTIVITY OF  PRODUCTS THEREOFQINGDAO AGRICULTURAL UNIVERSITY
WO/2021/203914PERAMIVIR DRY POWDER INHALANT AND PREPARATION METHOD THEREFORGUANGZHOU NUCIEN PHARMACEUTICAL CO., LTD
WO/2021/143951COLCHICINE SOLUBLE MICRONEEDLE PATCH AND PREPARATION METHOD  THEREFORNANJING UNIVERSITY
WO/2021/180237ATOMIZED INHALATION FORMULATION CONTAINING HUMAN CELL-DERIVED  EXTRACELLULAR VESICLES, PREPARATION METHOD AND USE THEREOFCELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
WO/2021/185234COMBINED PHARMACEUTICAL COMPOSITION OF COMPOUND AS C-MET  KINASE INHIBITOR AND USE THEREOFCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/213086DEXTRAN-DOCOSAHEXAENOIC ACID COUPLING POLYMER, SYNTHESIS  METHOD THEREFOR AND APPLICATION THEREOFSHANDONG UNIVERSITY
WO/2021/185265ORAL PHARMACEUTICAL COMPOSITIONSICHUAN HAISCO PHARMACEUTICAL CO LTD
WO/2021/213089A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE  NANOCARRIERS, METHODS OF MAKING AND USING THEREOFTHE UNIVERSITY OF HONG KONG
WO/2021/203933TRADITIONAL CHINESE MEDICINE FOR DISPERSING LUNG QI AND  DETOXICATIONSHANDONG BUCHANG PHARMACEUTICALS CO., LTD.
WO/2021/185292USE OF ASTRAGALUS MEDICINAL COMPOSITION FOR PREPARING DRUG FOR  ENHANCING CANCER THERAPYPHYTOHEALTH CORPORATION
WO/2021/185340USE OF MITOCHONDRIA FOR PROMOTING WOUND REPAIR AND/OR WOUND  HEALINGTAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185341USE OF MITOCHONDRIAL EXTRACT FOR TREATMENT OR/AND PREVENTION  OF KIDNEY INJURY-RELATED DISEASESTAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185342USE OF MITOCHONDRIA FOR TREATMENT AND/OR PREVENTION OF TENDON  DAMAGE OR RELATED DISEASESTAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185343GLYBURIDE LIPOSOME COMPOSITION AND PREPARATION METHOD THEREFORJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/185344METHOD FOR TREATING CHOLESTEROL-RELATED DISEASESJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/185356USE OF BUTYLPHTHALIDE AND DERIVATIVE THEREOFCSPC NBP PHARMACEUTICAL CO., LTD
WO/2021/185359Modified red blood cells and uses thereof for delivering  agentsWESTLAKE THERAPEUTICS (HANGZHOU) CO. LIMITED
WO/2021/185364CELL CULTURE COMPOSITION AND USE THEREOFTAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185373MICROPARTICLE FOR DRUG LOADING, DRUG LOADING MICROPARTICLE,  PARTICLE CONTAINING TUBE, AND IMPLANTATION SYSTEM FOR MICROPARTICLESUZHOU YIBEN LIFE TECHNOLOGY CO., LTD
WO/2021/185376COMPOSITION CONTAINING MITOCHONDRIA AND USE THEREOF FOR  REPAIRING CARTILAGE DAMAGE OR AMELIORATING DEGENERATIVE ARTHRITISTAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185377COMPOSITION FOR PROMOTING HAIR REGENERATION THAT CONTAINS  PLASMA RICH IN MITOCHONDRIA, AND MANUFACTURING METHOD THEREFOR AND USE  THEREOFTAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185382METHOD FOR IMPROVING THE STABILITY OF A PHARMACEUTICAL  COMPOSITION COMPRISING A HIGH PENETRATION DRUG, AND THE PHARMACEUTICAL  COMPOSITION OBTAINED THEREFROMYU, Chongxi
WO/2021/238367APPLICATION OF MITOXANTRONE PREPARATION IN PREPARATION OF DRUG  FOR DIAGNOSING AND TREATING DISEASE RELATED TO THYROIDECTOMYSHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL  CO., LTD
WO/2021/203959HEPARIN NANO DRUG CARRIER SYSTEM FOR LOADING AMINO ANTI-TUMOR  DRUG, AND PREPARATION METHOD THEREFORNANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO., LTD.
WO/2021/190495PEGYLATED HEPARIN NANO-MICELLE LOADED WITH CARBOXYLIC ACID  ANTI-TUMOR DRUG AND PREPARATION METHOD THEREFORKINDOS PHARMACEUTICALS CO., LTD.
WO/2021/190546PHARMACEUTICAL COMPOSITION COMPRISING PROTEIN KINASE INHIBITOR  AND CHEMOTHERAPEUTIC DRUG AND USE THEREOFSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/190553ANTI-IL-1β ANTIBODY, AND PHARMACEUTICAL COMPOSITION CONTAINING  SAME, AND USE THEREOFAKESO BIOPHARMA, INC
WO/2021/190558METHOD AND DRUG FOR TREATING ALZHEIMER DISEASETALENGEN INTERNATIONAL LIMITED
WO/2021/190561METHOD AND DRUG FOR TREATING PARKINSON'S DISEASETALENGEN INTERNATIONAL LIMITED
WO/2021/190562METHOD AND DRUG FOR PROMOTING DEGRADATION OF MISFOLDED PROTEIN  AND AGGREGATE THEREOFTALENGEN INTERNATIONAL LIMITED
WO/2021/190563METHOD AND MEDICINE FOR TREATING HUNTINGTON'S DISEASETALENGEN INTERNATIONAL LIMITED
WO/2021/190573MAGNETIC NANOCOMPOSITE MATERIAL AND PREPARATION METHOD  THEREFOR AND USE THEREOFNINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING,  CHINESE ACADEMY OF SCIENCES
WO/2021/190581PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY DRUG CONJUGATE  AND USE THEREOFJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/190582ANTI-OX40 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOFJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/218506APPLICATION OF PROGESTIN IN PREPARATION OF DRUG INHIBITING  CYTOKINE STORMSHENZHEN EVERGREEN THERAPEUTICS CO., LTD.
WO/2021/190588HERBA LYCOPI EXTRACT AND PREPARATION METHOD THEREFOR AND USE  THEREOFXIAMEN UNIVERSITY
WO/2021/190611TRADITIONAL CHINESE MEDICINE COMPOSITION FOR RECOVERY PHASE OF  EXOGENOUS FEVER, PREPARATION METHOD THEREFOR AND APPLICATION THEREOFBEIJING UNIVERSITY OF CHINESE MEDICINE THIRD AFFILIATED  HOSPITAL
WO/2021/190616METHODS FOR INHIBITING CASEIN KINASESGRITSCIENCE BIOPHARMACEUTICALS CO., LTD.
WO/2021/190624PHARMACEUTICAL COMPOSITIONS, METHOD OF MAKING AND METHOD OF  USING THEREOFGANNEX PHARMA CO., LTD.
WO/2021/190631METHOD FOR DISPLAYING BISPECIFIC ANTIBODY ON SURFACE OF  MAMMALIAN CELL AND VECTORDDBIO.CO, LTD., (SHANG HAI)
WO/2021/190637COMBINATION OF ANTI-HER2 ANTIBODY AND CDK INHIBITIOR FOR TUMOR  TREATMENTJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/190641METHODS FOR TREATING CYTOKINE STORM SYNDROME AND RELATED  DISEASESFU, Xin-Yuan
WO/2021/190647USE OF BERBERINE ANALOG AND JAK INHIBITOR IN TREATMENT OF  INFLAMMATORY DISEASES OF GASTROINTESTINAL TRACTENNOVABIO (ZHEJIANG) PHARMACEUTICALS CO., LTD.
WO/2021/197254USE OF MICROORGANISMS IN REGULATION OF BODYWEIGHT AND  CHOLESTEROL LEVELMICROBIOTA I - CENTER (MAGIC) LIMITED
WO/2021/208711APPLICATION OF TYLOPHORA ALKALOID OR SALT THEREOF IN RESISTING  CORONAVIRUSNANKAI UNIVERSITY
WO/2021/197285SEMI-DRY NASAL AND ORAL CAVITY NURSING TOWEL, NURSING MASK AND  PREPARATION METHODYANG LING ANDIYUAN BIOTECHNOLOGY CO., LTD.
WO/2021/197290NOVEL APPLICATION OF ACETYLCHOLINESTERASE ACTIVITY INHIBITORTHE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/197297PHARMACEUTICAL COMPOSITION CONTAINING GINSENOSIDES RH3, PPD,  AND RH2SHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/197333PHARMACEUTICAL COMBINATION AND USE THEREOFNATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
WO/2021/197334PHARMACEUTICAL COMBINATION AND USE THEREOFNATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
WO/2021/197335ANTIBODIES BINDING CD40 AND USES THEREOFBIOSION INC.
WO/2021/197346VACCINE ADJUVANT CONTAINING TRPV2 AGONIST AND USE THEREOFTSINGHUA UNIVERSITY
WO/2021/197372ANTI-TUMOR COMPOSITION CONTAINING RARE GINSENOSIDES RK2, CK,  AND PPTSHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/197376A FEBUXOSTAT TABLETJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/244120SARS-COV-2 VACCINECANSINO BIOLOGICS INC.
WO/2021/208749MEDICAL USE OF RIBOSOMAL PROTEIN SA ANTIBODIES IN  IMMUNOREGULATIONJILIN UNIVERSITY
WO/2021/197430COMPOSITIONS AND METHODS FOR REDUCING GRAFT REJECTION IN  ALLOGENEIC CELL THERAPYNANJING LEGEND BIOTECH CO., LTD.
WO/2021/204060COMBINATIONS OF BCL-2/BCL-XL INHIBITORS AND RELATED USESASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/197451MULTIPLE FORMULATION OF TICAGRELORJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/227700ANTI-DRY AND ANTI-SENSITIVITY COMPOSITION AND PREPARATION  METHOD THEREFORGUANGZHOU KENENG COSMETICS RESEARCH CO. LTD
WO/2021/197492BREAST MILK OLIGOSACCHARIDES FOR IMPROVING RESISTANCE OF  ORGANISM AGAINST STAPHYLOCOCCUS AUREUS INFECTIONINNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD.
WO/2021/204179NUCLEIC ACID VACCINES FOR CORONAVIRUSSUZHOU ABOGEN BIOSCIENCES CO., LTD.
WO/2021/204188UTIDELONE SEMI-HYDRATED SINGLE CRYSTAL AND PREPARATION METHOD  THEREFOR AND USE THEREOFBEIJING BIOSTAR PHARMACEUTICALS CO., LTD.
WO/2021/204192USE OF COMPOUND AS SIRT1 RECEPTOR AGONISTCATCH BIO-SCIENCE & TECHNOLOGY CO., LTD.
WO/2021/204197APPLICATION OF ACRIDINEDIONE COMPOUND IN PREPARATION OF  ANTI-DIABETIC DRUGSTHE FOURTH MILITARY MEDICAL UNIVERSITY
WO/2021/204223PHARMACEUTICAL COMPOSITION INCLUDING NICOTINAMIDEYANGTZE RIVER PHARMACEUTICAL GROUP NANJING HAILING  PHARMACEUTICAL CO., LTD.
WO/2021/218594REAGENT AND METHOD FOR REGULATING INTEGRIN β SUBUNITCENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE  ACADEMY OF SCIENCES
WO/2021/204279PROBIOTIC COMPOSITION FOR TREATING RAPID EYE MOVEMENT SLEEP  BEHAVIOR DISORDER, FORMULATION AND USEBEIJING FRIENDSHIP HOSPITAL AFFILIATED TO CAPITAL MEDICAL  UNIVERSITY
WO/2021/208842USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOMECSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/160192USE OF KAURANE COMPOUNDS IN PREPARATION OF DRUG FOR PREVENTION  AND TREATMENT OF SEPSIS AND MULTIPLE ORGAN DAMAGEKEY-PHARMA BIOMEDICAL INC.
WO/2021/208860MICROEMULSION-BASED VACCINE DELIVERY SYSTEM, PREPARATION  METHOD THEREFOR AND USE THEREOFSICHUAN UNIVERSITY
WO/2021/208910POLYMER PREPARATION FOR TREATING VIRUS INFECTION, AND  PREPARATION METHOD THEREFOR AND USE THEREOFSHANDONG HUBBLE KISEN BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/249009RSV VACCINE COMPOSITIONS, METHODS, AND USES THEREOFSICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/208947COFFEE SILVERSKIN EXTRACT, PREPARATION METHOD THEREFOR AND USE  THEREOFINGREDI BIOTECH CO., LTD.
WO/2021/208976SOLID PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR  AND USE THEREOFSHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/218638DRUG COMBINATION FOR TREATING DIABETES MELLITUS AND  COMPLICATIONS THEREOF AND PHARMACEUTICAL COMPOSITION OF DRUG COMBINATIONSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/213230APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARATION OF DRUG FOR TREATING OR PREVENTING FATTY LIVER DISEASENG, Tit
WO/2021/213232APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARING DRUG FOR TREATING OR PREVENTING HYPERLIPIDEMIANG, Tit
WO/2021/208984APPLICATION OF ABELMOSCHI COROLLA EXTRACT AS TRPC ION CHANNEL  INHIBITORJIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/208985USE OF QUERCETIN-3'-O-β-D-GLUCOSIDE AS CALCIUM CHANNEL  INHIBITORJIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/209003PREVENTION AND TREATMENT OF ORGAN INJURIESFARSIGHT MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/209007ANTIBODY-DRUG CONJUGATESHENZHEN ENDURING BIOTECH, LTD.
WO/2021/209010METHOD AND DRUG FOR TREATING HURLER SYNDROMEEDIGENE INC.
WO/2021/209017PREPARATION SPECIFICALLY BOUND WITH CD137 AND USE THEREOFDINGFU BIOTARGET, CO., LTD.
WO/2021/175339ROLE OF HUMAN SYMBIOTIC FLORA IN IMPROVING TUMOR IMMUNOTHERAPY  RESPONSESHENZHEN XBIOME BIOTECH CO., LTD.
WO/2021/209025PHARMACEUTICAL COMPOSITIONSSHENZHEN PHARMACIN CO., LTD
WO/2021/209028METHODS OF TREATING VIRAL INFECTIONS USING ARGINASEBIO-CANCER TREATMENT INTERNATIONAL LIMITED
WO/2021/213287USE OF IRAK4 INHIBITOR IN TREATMENT OF ACUTE LUNG INJURY  ALI/ARDSSHANGHAI LEADINGTAC PHARMACEUTICAL CO., LTD.
WO/2021/213327COMPOSITION CONTAINING 7-ETHYL-10-HYDROXYCAMPTOTHECIN,  PREPARATION METHOD THEREFOR AND USE THEREOFKUNSHAN XINYUNDA BIOTECH CO., LTD.
WO/2021/209070GINSENOSIDE COMPOSITION HAVING ALCOHOLIC FATTY  LIVER-PREVENTING AND -TREATING FUNCTIONSHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/218687STEM CELL DRUG FOR TREATING DIABETESSOOCHOW UNIVERSITY
WO/2021/213455DRUG COMBINATION AND USE THEREOFNATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
WO/2021/218763PERIPLOSIDE COMPOSITION, PREPARATION METHOD THEREFOR AND USE  THEREOF IN PREPARATION OF DRUG FOR TREATMENT OF AUTOIMMUNE DISEASESSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/180250PREPARATION FOR INHIBITING CANDIDA ALBICANSNORTHWEST UNIVERSITY
WO/2021/213483APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITESZHUHAI QIWEI BIO-TECHNOLOGY LTD.
WO/2021/213484APPLICATION OF RADIX GENTIANAE MACROPHYLLAE AND MONOMER  COMPOUND THEREOF IN KILLING MITESZHUHAI QIWEI BIO-TECHNOLOGY LTD.
WO/2021/213485USE OF DANDELION AND MONOMER COMPOUNDS THEREOF FOR KILLING  MITESZHUHAI QIWEI BIO-TECHNOLOGY LTD.
WO/2021/213492DRUG-CARRYING MACROMOLECULE AND PREPARATION METHOD THEREFORSHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/238529TECHNETIUM CARBON MICROSPHERE INJECTION, PREPARATION METHOD  THEREFOR AND USE THEREOFCHENGDU NEW RADIOMEDICINE TECHNOLOGY CO., LTD.
WO/2021/218802ISOLATED RECOMBINANT ONCOLYTIC POXVIRUS CAPABLE OF BEING  REGULATED AND CONTROLLED BY MICRORNA AND USE THEREOFHANGZHOU CONVERD CO., LTD.
WO/2021/213502SLEEP-IMPROVING PHARMACEUTICAL COMPOSITION CONTAINING RARE  GINSENOSIDES RG6 AND F4SHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/213504USE OF VEGF INHIBITOR IN PREPARATION OF MEDICAMENT FOR  TREATING HYPOXIA-RELATED DISEASESQILU HOSPITAL OF SHANDONG UNIVERSITY
WO/2021/213512A FORMULATION FOR TREATING OPHTHALMIC CONDITIONSGUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECHNOLOGY CO.,  LTD.
WO/2021/213520ANTI-SARS CORONAVIRUS-2 SPIKE PROTEIN ANTIBODIESSINGLE CELL TECHNOLOGY, INC.
WO/2021/213523USES OF COMBINATION OF ANTI-PD-1 ANTIBODY AND ANTI-CTLA-4  ANTIBODY IN PREVENTING OR TREATING CANCERINNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/218884USE OF ARYL GUANIDINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE  SALT THEREOFSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/227868PHARMACEUTICAL COMPOSITION PREPARATIONWANG, Zhaolin
WO/2021/218945ANTIBACTERIAL ANTIVIRAL PHARMACEUTICAL COMPOSITION AND  APPLICATION THEREOFYUNNAN BAIYAO GROUP CO., LTD
WO/2021/218964EXTRACT FROM CORIOLUS VERSICOLOR FOR TREATING VAGINAL OR  CERVICAL DISORDERS CAUSED BY INFECTIOUS AGENTSPROCARE HEALTH IBERIA, S.L.
WO/2021/218965APPLICATION OF RUBIACEAE TYPE CYCLIC PEPTIDE COMPOUNDS IN  PREPARATION OF DRUGS AS CGAS-STING SIGNAL PATHWAY ACTIVATORSCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/218974USES OF ANTRODIA CINNAMOMEA EXTRACT IN MANUFACTURING PRODUCTS  FOR REDUCING EXPRESSION AND TREATING ASSOCIATED DISEASES OF ANGIOTENSIN  CONVERTING ENZYME 2ALPS BIOTECH CO., LTD.
WO/2021/219001COMPOSITION FOR IMPROVING IMMUNITYTHE CHINESE UNIVERSITY OF HONG KONG
WO/2021/219009DIAGNOSIS AND TREATMENT OF CANCERS SHOWING HIGH EXPRESSION OF  PIWI AND/OR NMD COMPLEX PROTEINSHANGHAITECH UNIVERSITY
WO/2021/219029SARS-COV-2 VIRAL PROTEINS AND USE THEREOFVERSITECH LIMITED
WO/2021/219031TRADITIONAL CHINESE MEDICINE COMPOSITION, AND APPLICATION OF  PREPARATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARING MEDICINE  FOR PREVENTING AND/OR TREATING ‎CORONAVIRUS DISEASE 2019TASLY PHARMACEUTICAL GROUP CO., LTD.
WO/2021/219040HISTONE DEACETYLASE INHIBITORS FOR IMMUNOMODULATION IN TUMOR  MICROENVIRONMENTGNT BIOTECH & MEDICALS CORPORATION
WO/2021/219047METHOD FOR IMPROVING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGENSINOCELLTECH LIMITED
WO/2021/227887COMPOUND FOR TREATING AND/OR PREVENTING DISEASES CAUSED BY  CORONAVIRUS AND USE THEREOFSHANGHAITECH UNIVERSITY
WO/2021/223652COSMETIC PRODUCT AND MAKING-UP METHODMOMENTIVE PERFORMANCE MATERIALS INC.
WO/2021/219077PROTEOLYSIS TARGETING COMPOUND HAVING TISSUE TARGETING  CAPABILITY AND USE THEREOFTAI BI DI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO. LTD
WO/2021/258851PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES AND  PREPARATION METHOD THEREFORGUANGZHOU LIXIN PHARMACEUTICAL CO., LTD
WO/2021/223659EXTRACELLULAR VESICLES TARGETING CANCER CELLS AND USES THEREOFNANJING IASO BIOTHERAPEUTICS CO., LTD.
WO/2021/223664METHODS FOR TREATING CORONAVIRUS INFECTIONSASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/219112ISOVALERYL SPIRAMYCIN COMPOUND OR APPLICATION OF ISOVALERYL  SPIRAMYCIN COMPOSITION IN PREPARATION OF DRUG FOR TREATING SEPSIS DISEASESHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/219113USE OF ISOVALERYL SPIRAMYCIN COMPOUND OR COMPOSITION THEREOF  IN PREPARATION OF MEDICAMENT FOR TREATING IMMUNE DISORDERSSHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/219137AMINOPYRIDINE DERIVATIVE FOR TREATING DISEASES CAUSED BY MET  GENETIC ABNORMALITIESCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/219138COMBINATION DRUG FOR TREATING KIDNEY CANCERCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/223713APPLICATION OF SMS2 INHIBITOR IN PREPARATION OF DRUG FOR  TREATMENT OF HIGHLY INVASIVE BREAST CANCERSHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/227937METHOD FOR ENHANCING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGEN  BY MEANS OF FORMING FUSION PROTEIN WITH MODIFIED FC FRAGMENTSINOCELLTECH LIMITED
WO/2021/223732BLOOD PURIFICATION CONCENTRATEXIA, Yongbiao
WO/2021/180251CROSS-LINKED MEDICATION FOR TREATMENT OF CORONAVIRAL INFECTION  AND METHOD OF TREATMENT1GLOBE BIOMEDICAL CO., LTD.
WO/2021/228037COMPOSITIONS AND METHODS FOR BROAD SPECTRUM ANTI-VIRAL THERAPYVERSITECH LIMITED
WO/2021/228044DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES  THEREOFHUNILIFE BIOTECHNOLOGY, INC.
WO/2021/228069USE OF COMBINATION OF ANTI-VEGF ANTIBODY AND ANTI-PD-1  ANTIBODY FOR PREVENTING OR TREATING DISEASEINNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/244235APPLICATION OF POLYINOSINIC ACID AND SARS-COV-2 SPIKE PROTEIN  IN CONSTRUCTION OF MOUSE ARDS MODELCHINA-US (HENAN) HORMEL CANCER INSTITUTE
WO/2021/228086METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHYTALENGEN INTERNATIONAL LIMITED
WO/2021/228106ONCOLYTIC VIRUS IN COMBINATION WITH IMMUNE CHECKPOINT  INHIBITOR FOR TREATING TUMORSJOINT BIOSCIENCES (SH) LTD.
WO/2021/180252NOVEL APPLICATION AND MANUFACTURING METHOD FOR HYALURONIC ACID  FRAGMENTQINGDAO AGRICULTURAL UNIVERSITY
WO/2021/228113PREPARATION COMPRISING ANTI-IL-23P19 ANTIBODY, PREPARATION  METHOD THEREFOR AND USE THEREOFINNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/228141ANTIBODY DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND USE  THEREOFSICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/228146USE OF LSD1 INHIBITORCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/228178COMPOSITIONS AND METHODS FOR TREATING CANCERADAGENE AG
WO/2021/254054VACCINE FOR PREVENTING DISEASE CAUSED BY CORONAVIRUSACADEMAY OF MILITARY MEDICAL SCIENCES, AMS, PLA
WO/2021/228213COMBINATION COMPRISING TRICYCLE COMPOUND AND USE THEREOF IN  PREPARATION OF MEDICAMENT FOR TREATING HBVFUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
WO/2021/228222COMBINATION FOR TREATING HEPATITIS BFUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
WO/2021/238689CHINESE MEDICINE COMPOSITION FOR SOOTHING NERVES AND AIDING  SLEEP, AND CHINESE MEDICINE SACHET AND APPLICATIONCHENG, Yawei
WO/2021/238690TRADITIONAL CHINESE MEDICINE COMPOSITION AND TRADITIONAL  CHINESE MEDICINE SACHET USED FOR PREVENTING COLDS AND APPLICATION THEREOFCHENG, Yawei
WO/2021/233237TUMOR VACCINE, PREPARATION METHOD THEREFOR AND USE THEREOFNATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/233239APPLICATION OF ACTIVE INGREDIENT OF ROOT OF LIGULILOBE SAGE OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN PREPARING ANTIVIRAL DRUGSOUTHERN MEDICAL UNIVERSITY
WO/2021/238695TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING AND  TREATING COLD IN SPRING AND GRANULES AND APPLICATION THEREOFCHENG, Yawei
WO/2021/238698TRADITIONAL CHINESE MEDICINE COMPOSITION AND TRADITIONAL  CHINESE MEDICINE SACHET HELPING TO BOOST MOOD AND APPLICATION THEREOFCHENG, Yawei
WO/2021/228260PHARMACEUTICAL USE OF IRIDOID GLYCOSIDE COMPOUNDSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/233346TARGETEDLY MODIFIED EXOSOME LOADED WITH DRUG, AND PREPARATION  METHOD AND USE THEREFORBEIJING TIANTAN HOSPITAL, CAPITAL MEDICAL UNIVERSITY
WO/2021/238752PROBIOTIC PREPARATION BASED ON  W<sb>1</sb>/O/W<sb>2</sb> TYPE DUAL EMULSION  STRUCTURE, AND PREPARATION METHOD THEREFOR AND USE THEREOFHUAZHONG AGRICULTURAL UNIVERSITY
WO/2021/238761THERAPEUTIC COMPOSITION AND METHOD FOR TREATING CORONAVIRUS  INFECTIONBEIJING BJUT SCIENCE AND TECHNOLOGY PARK CO., LTD
WO/2021/233402BREXPIPRAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION AND  PREPARATION METHOD THEREFORJIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/197507RECOMBINANT NEWCASTLE DISEASE VIRUS AND PREPARATION METHOD,  RECOMBINANT PLASMID, AND USE THEREFORJIANGSU KANIONREAL BIOMEDICAL TECHNOLOGY CO., LTD
WO/2021/233432BLOOD-PURIFICATION MOLECULAR CONCENTRATE, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFXIA, Yongbiao
WO/2021/238836CANTHARIDIN ANTIVIRAL AND ANTIBACTERIAL PREPARATION,  PREPARATION METHOD THEREFOR, AND USE THEREOF FOR PREVENTING AND TREATING  NOVEL CORONAVIRUS INFECTIONGANSU YUANMEI PHARMACEUTICAL CO., LTD.
WO/2021/238957USE OF FAMITINIB IN PREPARATION OF MEDICATION FOR TREATING  TUMOR HAVING C-KIT OR PDGFRA MUTATIONJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/238978PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE PRODRUG, AND  PREPARATION METHOD AND APPLICATION THEREFORJIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/238982PHARMACEUTICAL COMPOSITION COMPRISING POLYNUCLEOTIDES AND USE  THEREOF FOR PREVENTION OR TREATMENT OF COVID-19LIAONING YISHENG BIOPHARMA CO., LTD.
WO/2021/254118APPLICATIONS OF HPK1 KINASE INHIBITOR IN PREVENTING AND/OR  TREATING ANIMAL PATHOGEN INFECTIONZHUHAI YUFAN BIOTECHNOLOGIES CO., LTD
WO/2021/244421ANTIBODIES SPECIFICALLY RECOGNIZING PSEUDOMONAS PCRV AND USES  THEREOFSTAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.
WO/2021/239106APPLICATION OF ATP POTASSIUM CHANNEL MODIFIER IN PREPARATION  OF ANTI-DIABETIC NEPHROPATHY DRUGHANGZHOU QIAN BIOTECHNOLOGY LTD
WO/2021/239130PHARMACEUTICAL PREPARATION AND PREPARATION METHOD THEREFORSICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/239134LIPOSOME CONTAINING ETHYLENEDIAMINE TETRAACETIC ACID OR SALT  THEREOF AND ERIBULIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOFJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/244460BIOMARKER RELATED TO ORAL SQUAMOUS CELL CARCINOMA AND  DIAGNOSIS AND TREATMENT METHODSQINGDAO MEDINTELL BIOMEDICAL CO., LTD
WO/2021/254132ANTI-SIGLEC15 ANTIBODY AND USE THEREOFSHENGHE (CHINA) BIOPHARMACEUTICAL CO., LTD.
WO/2021/249228CAMPTOTHECIN DRUG HAVING HIGH-STABILITY HYDROPHILIC CONNECTING  UNIT AND CONJUGATE THEREOFSICHUAN BAILI PHARM CO., LTD
WO/2021/244481COMPOSITIONS AND METHODS FOR TREATING A SARS-COV-2 INFECTIONTHE UNIVERSITY OF HONG KONG
WO/2021/239147β-CORONAVIRUS ANTIGEN, β-CORONAVIRUS BIVALENT VACCINE,  PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOFINSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/249236USE OF 12,15-DIOXO-α-SELENENE IN PHARMACEUTICALSKUNMING INSTITUTE OF BOTANY, CHINESE ACADEMY OF SCIENCES
WO/2021/249240USE OF PALOVAROTENE IN TREATMENT AGAINST HBV VIRUSYANG SHENG TANG COMPANY, LTD.
WO/2021/244515PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY SYSTEM  DAMAGE AND A USE IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR IMPROVING  RESPIRATORY SYSTEM DAMAGEBUFFALO BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/244547APPLICATION OF NATURAL COMPOUND AND DERIVATIVE THEREOF IN  TREATING ARTERIAL LESIONSSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/244551COMBINED PHARMACEUTICAL COMPOSITION OF C-MET KINASE INHIBITOR  AND ANTI-PD-L1 ANTIBODYCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/249250NOVEL IMMUNOLOGIC ADJUVANT, COMPOUND AND APPLICATION THEREOFWANG, Zhulin
WO/2021/244597METHOD FOR PREPARING FATTY ACID-BASED VC LIPOSOMEJIANGNAN UNIVERSITY
WO/2021/244606GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH HEPATIC  IMPAIRMENTHUA MEDICINE (SHANGHAI) LTD.
WO/2021/249286NEW DRUG FORMULA FOR IMMUNOTHERAPY AND TABLET STRUCTURE  THEREOFXU, Xinpeng
WO/2021/249288VORICONAZOLE EXTERNAL PREPARATION AND PREPARATION METHOD  THEREFORHAINAN POLY PHARM CO., LTD.
WO/2021/249289APPLICATION OF NORHARMANE IN IMPROVEMENT OF ANTIBIOTIC  ANTIBACTERIAL ACTIVITYZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/244627ISOLATED ANTIGEN BINDING PROTEIN AND USE THEREOFLONGBIO PHARMA (SUZHOU) CO., LTD.
WO/2021/244628PHARMACEUTICAL COMPOSITION OF ENZYMES AND VIRUSES AND  APPLICATION THEREOFSHANGHAI BAO PHARMACEUTICALS CO., LTD.
WO/2021/249352CONJUGATE OF DOUBLE-STRANDED SIRNA ANALOGUECHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/249373STABLE HIGH-CONCENTRATION ANTI-HUMAN IL-5 MONOCLONAL ANTIBODY  LIQUID PREPARATIONSUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/249376USE OF TLR4 PATHWAY INHIBITOR AND/OR ANTAGONIST IN PREPARATION  OF DRUGZHUJIANG HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY
WO/2021/249402EFFECTS OF CELL-FREE FAT LIQUID EXTRACT ON MACROPHAGE  POLARIZATION MODULATION AND DISEASE TREATMENTSHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/254221STABLE LIQUID PREPARATION OF ANTI-IL-4Rα MONOCLONAL ANTIBODIESSUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/249420USE OF KADSURA HETEROCLITA (ROXB.) CRAIB AGENT IN PREPARATION  OF MEDICAMENT FOR RESISTING RHEUMATOID ARTHRITISHUNAN UNIVERSITY OF CHINESE MEDICINE
WO/2021/249445PHARMACEUTICAL COMPOSITION OF ANTI-IL-17A ANTIBODIES AND USE  THEREOFSHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/249452RSV VACCINE COMPOSITIONS, METHODS, AND USES THEREOFSICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/249484CONJUGATE GROUP AND CONJUGATEMEDSHINE DISCOVERY INC.
WO/2021/249492METHYL-SUBSTITUTED BENZOBISOXAZOLE COMPOUND AND USE THEREOFMEDSHINE DISCOVERY INC.
WO/2021/249501ANTIVIRAL PREPARATIONSUNTRAP LIFE TECHNOLOGIES LTD.
WO/2021/254265USE OF COMPOUND IN PREVENTION AND/OR TREATMENT OF PATHOGEN  INFECTION IN ANIMALSGARGAMEL (ZHUHAI) BIOTECH LTD.
WO/2021/249548PHARMACEUTICAL COMPOSITION OF NOVEL CORONAVIRUS ANTIBODY AND  USE THEREOFSHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/254277MICROSUSPENSION OF AN MDM2 INHIBITOR AND THERAPEUTIC  APPLICATIONS THEREOFASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/249551LIQUID PREPARATION OF ANTI-PD-1 MONOCLONAL ANTIBODIESSUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/254287NOVEL CORONAVIRUS TANDEM EPITOPE POLYPEPTIDE VACCINE AND USE  THEREOFSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/249561THERAPEUTIC USE OF OF CELL-FREE FAT EXTRACT FOR PULMONARY  DISEASESSHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/254296BIOACTIVE SUBSTANCE COMPOSITION, SERUM-FREE CULTURE MEDIUM  COMPRISING THE COMPOSITION, AND USES THEREOFZHEJIANG UNIVERSITY
WO/2021/254299USE OF BACTERIA IN CHILDREN DEVELOPMENT ASSESSMENT AND  TREATMENTTHE CHINESE UNIVERSITY OF HONG KONG
WO/2021/254327ENVELOPE REPLACEMENT-TYPE VIRAL VECTOR VACCINE AND  CONSTRUCTION METHOD THEREFORFANTASIA BIOPHARMA (ZHEJIANG) CO. LTD
WO/2021/254337NEW USE OF ACTIVE INGREDIENT WGX50 IN ZANTHOXYLUM BUNGEANUM  MAXIM. EXTRACTSHANGHAI JIAO TONG UNIVERSITY
WO/2021/254360CARBOHYDRATE MOLECULAR CLUSTER AND PREPARATION METHOD THEREFOR  AND MEDICAL USE THEREOFTUOJIE BIOTECH (SHANGHAI) CO., LTD.
WO/2021/254447STABLE FORMULATION FOR RECOMBINANT ANTI-PD-1 MONOCLONAL  ANTIBODYSINOCELLTECH LIMITED
WO/2021/259143PHARMACEUTICAL USE OF (E)-3-ARYLHETEROCYCLYL PROP-2-ENOIC ACID  DERIVATIVESMEDCURIUS INC.
WO/2021/254471ORAL FORMULATIONS AND USES THEREOFINVENTISBIO CO., LTD.
WO/2021/259195COMBINED DRUG FOR TREATING CORONAVIRUS DISEASE 2019SICHUAN UNIVERSITY WEST CHINA HOSPITAL
WO/2021/259211ANTISEPTIC COMPOSITIONSRHT LIMITED
WO/2021/259215ANTISEPTIC COMPOSITIONSRHT LIMITED
WO/2021/259288AGONIST OF DEACETYLASE AND USE THEREOFGUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU RESEARCH  INSTITUTE OF CHINESE MEDICINE)
WO/2021/259334SELF-REGULATING CHIMERIC ANTIGEN RECEPTOR AND APPLICATION  THEREOF IN TUMOR IMMUNITYNANJING BOWANG PHARMACEUTICAL TECHNOLOGY CO., LTD
WO/2021/244676NOVEL COMPOSITION FOR ENAMEL REMINERALIZATIONIBRITE SUZHOU TECHNOLOGY CO., LTD.
WO/2021/254537USE OF CYCLOVIROBUXINESOUTHWEST UNIVERSITY
WO/2021/249578MEDICATION FOR THE PREVENTION AND TREATMENT OF ASTHMA, CHRONIC  OBSTRUCTIVE PULMONARY DISEASE, OR ALLERGIC DISEASESLIU, Li
WO/2021/249579MEDICATION FOR THE PREVENTION AND TREATMENT OF COLD OR VIRAL  DISEASESLIU, Li
WO/2021/043345HUMAN RECOMBINANT HYPOSIALYLATED ERYTHROPOIETIN, METHODS OF  PURIFICATION AND THERAPEUTIC USES THEREOFCENTRO DE INMUNOLOGIA MOLECULAR
WO/2021/129897PROTEIN-BASED PHARMACEUTICAL COMPOSITION WITH NEUROPROTECTIVE,  IMMUNOMODULATING, ANTI-INFLAMMATORY AND ANTIMICROBIAL ACTIVITYCENTRO NACIONAL DE BIOPREPARADOS
WO/2021/155871ORAL SUSPENSION WITH ANTI-ULCEROUS AND CHEMOPROTECTIVE EFFECT  ON COLON CANCER AND PREPARATION METHOD THEREOFCENTRO NACIONAL DE INVESTIGACIONES CIENTIFICAS
WO/2021/209080PEPTIDE FOR THE TREATMENT OF CYTOKINE STORM SYNDROMECENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
WO/2021/233484PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY  DISEASES OF VIRAL ORIGINCENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
WO/2021/239165PEPTIDE FOR TREATING CORONAVIRUS INFECTIONSCENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
WO/2021/098892DEVICE FOR THE PREPARATION OF FUNCTIONALISED SUBSTANCESGRADE MEDICAL S.R.O.
WO/2021/110185PHENOLIC DIHYDROBENZOFURANE DERIVATIVES, MEDICAL AND COSMETIC  PREPARATIONS CONTAINING THESE DERIVATIVES, AND USE THEREOFUNIVERZITA PALACKEHO V OLOMOUCI
WO/2021/233486MESYLATE SALT OF <i>PARA</i>-TOPOLIN, COMPOSITIONS  CONTAINING SAID SALT AND USE THEREOFUSTAV EXPERIMENTALNI BOTANIKY AV ČR, V. V. I.
WO/2021/047699GLYCOPOLYMER, METHOD OF PREPARATION THEREOF, USE THEREOF AS  MEDICAMENTUSTAV MAKROMOLEKULARNI CHEMIE AV CR, V. V.I.
WO/2021/073667METHOD FOR THE PREPARATION OF POLYMERIC CARRIERS FOR PH-  CONTROLLED DRUG RELEASE AND THEIR CONJUGATES WITH DRUGSUSTAV MAKROMOLEKULARNI CHEMIE AV CR, V.V.I.
WO/2021/115502N-(FURAN-2-YLMETHYL)-7H-PURIN-6-AMINE FOR TREATMENT OF  CIRCADIAN RHYTHM DISEASES, DISORDERS AND DYSFUNCTIONSUNIVERZITA PALACKEHO V OLOMOUCI
WO/2021/115503LIPOPHOSPHONOXINS, THEIR PREPARATION AND USEUSTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I.
WO/2021/121446COPOLYMER WITH HYDROLYTIC RELEASE OF CANCEROSTATIC AGENT  CYTARABINE, METHOD OF ITS PREPARATION AND USE THEREOFUSTAV MAKROMOLEKULARNI CHEMIE AV CR, V.V.I.
WO/2021/249581METHOD OF PREPARATION OF THE TRANSFER FACTOR MEDICINE,  TRANSFER FACTOR MEDICINE, METHOD OF TESTING ITS BIOLOGICAL ACTIVITY,  PHARMACEUTICAL FORM AND ITS USEAUMED, A.S.
WO/2021/148065A METHOD OF TRANSFORMATION OF GENES INTO BACTERIAL CELLSUNIVERZITA KARLOVA, LEKARSKA FAKULTA V PLZNI
WO/2021/148066DENTAL PREPARATION COMPRISING FIBERS BASED ON HYALURONIC ACID  WITH REGULATED BIODEGRADABILITYCONTIPRO A.S.
WO/2021/013283ORAL HYGIENE AGENTS CONTAINING CAFFEINE AND L-LYSIN AS BITTER  BLOCKING AGENTSDR. KASCHNY HEALTHCARE GMBH
WO/2021/027984PROTEOPHOSPHOLIPOSOMES HAVING HDL-TYPE VESICLESKORTH, Ruth-Maria
WO/2021/093912NEW FORMULATION OF LACTOBACILLUS STRAINS FOR THE TREATMENT AND  PREVENTION OF <i>HELICOBACTER PYLORI</i> COLONISATION IN THE  UPPER AIRWAYS AND THE DIGESTIVE SYSTEMBELANO MEDICAL AG
WO/2021/008652NANOSTRUCTURED IBUOPROFEN COMPOSITIONS, METHODS FOR THEIR  PREPARATION, AND PHARMACEUTICAL COMPOSITION CONTAINING THEMMYBIOTECH GMBH
WO/2021/032252ADHESIVE PLASTER CONTAINING A SPECIALLY DESIGNED RESERVOIR FOR  A PHARMACEUTICAL PREPARATIONABU-GHAZALEH, Adrian
WO/2021/143962PROVISION OF BACTERIOPHAGES IN VARIOUS DOSAGE FORMS AND  BACTERIOPHAGE APPLICATION DEVICEJUNGHANS, Simon Frank
WO/2021/209093TREATMENT OF NON-TRANSMISSIBLE INFLAMMATORY DISEASES WITH A  SUBSTANCE THAT INHIBITS TRANSCRIPTION OF THE CEBPB GENE OR THE FUNCTION OF  THE CEBPB PROTEINDERMAGNOSTIX R&D GMBH
WO/2021/213587COMBINATION WHICH CAN BE USED FOR THE TREATMENT AND  PROPHYLAXIS OF CORONAVIRUS-INDUCED PULMONARY DYSFUNCTION AND DAMAGEKIESEWETTER, Holger
WO/2021/259423USE OF COENZYME ANTAGONISTS IN ORDER TO SLOW DOWN A METABOLIC  PROCESSTAVARGENIX GMBH
WO/2021/259425BISPHOSPHONATE-MODIFIED LIPOSOMES CONTAINING NANOPARTICLESPHARMA DEVELOPMENT HOLDING GMBH
WO/2021/069036COMPRESSED NICOTINE LOZENGEFERTIN PHARMA A/S
WO/2021/001006A SKIN CARE COMPOSITIONCOLOPLAST A/S
WO/2021/023351TOPICAL FORMULATIONS COMPRISING CANNABIDIOL, METHOD OF  PREPARING THE COMPOSITION AND USE THEREOFCS GROUP APS
WO/2021/069044AN ION-EXCHANGE COMPOSITION WITH WATER-SOLUBLE MUCOADHESIVE  POLYMERSFERTIN PHARMA A/S
WO/2021/069046A VAGINAL CONTRACEPTIVE COMPOSITION FOR REINFORCEMENT OF MUCUS  BARRIER PROPERTIESCIRQLE BIOMEDICAL CONTRACEPTION ApS
WO/2021/083467ADMINISTRATION OF CD22, CD33 AND/OR TIM-3 ANTIBODIES USING  OMMAYA RESERVOIRS FOR THE TREATMENT OF CNS CANCER OR NEURODEGENERATIVE  DISEASESY-MABS THERAPEUTICS, INC.
WO/2021/151442METHOTREXATE DOSAGE FORMROS THERAPEUTICS APS
WO/2021/164832STARCH PROPIONATE USED AS A FOOD ADDITIVE AND/OR DIETARY  SUPPLEMENT FOR PREVENTION OF OVERWEIGHT AND OBESITYABILDGAARD, Ole
WO/2021/170193COMPOSITION COMPRISING EGG YOLK AND BURNT CERAL POWDER FOR  WOUND HEALINGSAHEBI, Sükrüye
WO/2021/213601B7H3 ANTIBODIES WITH CHELATORSY-MABS THERAPEUTICS, INC.
WO/2021/223824FLOWPACK FOR ORAL DELIVERY OF ACTIVE INGREDIENTSFERTIN PHARMA A/S
WO/2021/223825ORAL POWDER MIXTURE WITH SMALL SIZED PARTICLESFERTIN PHARMA A/S
WO/2021/223826MOUTHWASH FOR ORAL CARE BENEFITSFERTIN PHARMA A/S
WO/2021/244721ANTI-B7H3 ANTIBODIES FOR THE TREATMENT OF CANCERY-MABS THERAPEUTICS, INC.
WO/2021/259434METHOD FOR MANUFACTURING A MULTI-LAYERED FILM STRUCTURE AND  METHOD FOR MANUFACTURING MULTI-LAYERED MICROSTRUCURESMLMC THERAPEUTICS APS
WO/2021/078349PHARMACEUTICAL COMPOSITION BASED ON PLANT EXTRACTS FOR THE  TREATMENT OF FIBROMYALGIA, RHEUMATOID ARTHRITIS, LUPUS AND OTHER AUTOIMMUNE  DISEASESPORTILLO ROSADO, Rosa Maria
WO/2021/037322COMPOSITION FOR DELAYING AND DYEING GREY HAIRPORTILLO ROSADO, Rosa Maria
WO/2021/180293A COMPOSITION FOR NORMALIZING BLOOD LIPID LEVELDIKOVSKIY, Aleksander Vladimirovich
WO/2021/043382NOVEL BIOLOGICAL ENTERIC DIALYSIS METHOD FOR CKD AND ESRDHESEN, Sherif Salah Abdulaziz
WO/2021/028005A MEDICAMENT COMPRISING ANABASINE FOR TREATMENT OF ASTHMA,  CHEST ALLERGY AND ATOPIC DERMATITSELKAZAZ, Mohamed, Fadly, Abd el Ghany
WO/2021/151450TARGETED DRUG DELIVERY SYSTEM USING BACTERIAL GHOSTS OF  SALMONELLA TOWARD HEPATIC CANCER CELLSAHMED, Sameh Rabea Mohamed
WO/2021/254582EFFICACY OF (SOFOSBUVIR PLUS LEDIPASVIR) IN EGYPTIAN PATIENTS  WITH COVID-19COMPARED TO STANDARD OF CARE TREATMENT.ALMAZA MILITARY FEVER HOSPITAL
WO/2021/013315OINTMENT FOR DIABETIC FOOT ULCER TREATMENTMOSTAFA, Mariam Mohamed Kamel
WO/2021/259441A NEW AND SAFE PHARMACEUTICAL PREPARATION FOR PROPHYLAXIS AND  TREATMENT OF RESPIRATORY VIRAL INFECTIONS, ESPECIALLY CORONA VIRUSESKHALIL, Ibrahim Taha Ibrahim
WO/2021/063468STABLE PARENTERAL PHARMACEUTICAL COMPOSITION CONTAINING  TIGECYCLINE AND PROCESS FOR THE PREPARATION THEREOFANFARM HELLAS S.A.
WO/2021/008668PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC  ADMINISTRATION CONTAINING CYCLOSPORINEPHARMATHEN S.A.
WO/2021/001023RNA FORMULATIONS SUITABLE FOR THERAPYBIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/001029BLEND OF BEESWAX AND A LACTYLATE ESTERSYMRISE AG
WO/2021/008669PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF OPA1 FOR  USE IN THE TREATMENT OF CANCERUNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/008678USE OF N-ACYLHYDROXY AMINO ACID ESTER FOR INDUCING THE  EXPRESSION OF SUPEROXIDE-DISMUTASE AND/OR HEM OXYGENASESYMRISE AG
WO/2021/018377COSMETIC COMPOSITION WITH COMBINED FILLER AND SKIN  REGENERATIVE EFFECTGIULIANI S.P.A.
WO/2021/018387DIFFERENT FORMS OF  6-CHLORO-2-ETHYL-N-(4-(4-(4-(TRIFLUOROMETHOXY)PHENYL)PIPERIDINE-1-YL)BENZYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDEQURIENT CO., LTD.
WO/2021/028024IMPROVED DOSAGE OF BALOXAVIR MARBOXIL FOR PEDIATRIC PATIENTSF. HOFFMANN-LA ROCHE AG
WO/2021/032271INDUCTION OF FUNCTIONAL ASTROCYTES FROM PLURIPOTENT STEM CELLSLU LICENSE AB
WO/2021/037383COSMETIC USE OF β-L-ASPARTYL-L-ARGININESYMRISE AG
WO/2021/043389GINSENG COMPOSITION AND USE THEREOF AS A MEDICAMENT FOR  TREATMENT OR PREVENTION OF AN IMPAIRED COGNITIONBOTALYS SA
WO/2021/043392ANTIPERSPIRANT EMULSIONBEIERSDORF AG
WO/2021/043394ANTIPERSPIRANT ACTIVE EMULSIONBEIERSDORF AG
WO/2021/047783VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF  CANCERTHE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/052597SKIN-CARE PRODUCT CONTAINING HYALURONIC ACID (OR A SALT  THEREOF) AND A PLANT STEM CELL EXTRACTPM-INTERNATIONAL AG
WO/2021/058091TREATMENT INVOLVING THERAPEUTIC ANTIBODY AND INTERLEUKIN-2  (IL2)BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/037387PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE VIRUSELANCO US INC.
WO/2021/058117METHOD OF TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT  ASSOCIATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA)VOLUTION IMMUNO PHARMACEUTICALS SA
WO/2021/073742AGONIST OF TACR2UNIVERSITY OF COPENHAGEN
WO/2021/078359USE OF INHIBITORS OF CUBILIN FOR THE TREATMENT OF CHRONIC  KIDNEY DISEASESINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/073761COMPOSITIONS WITH ANTIMICROBIAL PROPERTIESSYMRISE AG
WO/2021/073762COMBINATION DRUG FOR MEDICAL USE FOR THE TREATMENT OF A  DISORDER CAUSED BY DAMAGE TO RENAL TUBULAR   FUNCTIONPROSALIX AG
WO/2021/104639USE OF 2-PHENYL-6-(1H-IMIDAZOL-1-YL) QUINAZOLINE FOR THE  PREVENTION OF ABUSE AND OF SIDE EFFECTS OF AT LEAST ONE OPIOIDROTTAPHARM BIOTECH S.R.L.
WO/2021/110239STAINLES STEEL CAN FOR PRESSURISED METERED DOSE INHALERSCHIESI FARMACEUTICI S.P.A.
WO/2021/013372LIQUID ANTIBODY FORMULATIONICHNOS SCIENCES SA
WO/2021/115601BIODEGRADABLE MICROCAPSULE SYSTEMSPAPIERFABRIK AUGUST KOEHLER SE
WO/2021/115610METHOD FOR PREPARING A COMPOSITION AND USE OF THE COMPOSITION  FOR TREATMENT OR PROPHYLAXIS OF DISEASEQUANTUM PHARMACEUTICALS SA
WO/2021/121566UTILIZATION OF A COMPOSITION COMPRISING ORGANIC SILICA FOR THE  IMPROVEMENT OF THE QUALITY OF CARTILAGENOUS TISSUESAA HEALTHCARE SàRL
WO/2021/063526NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/063527NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/063528NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/063529NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/063530NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/063531NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/063532NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/121627IMPROVED PERTUSSIS VACCINE COMPOSITIONUNIVERSITé D'AIX-MARSEILLE
WO/2021/151452OIL-IN-WATER-TYPE EMULSION COSMETICL V M H RECHERCHE
WO/2021/129927TREATMENT WITH IMMUNE EFFECTOR CELLS ENGINEERED TO EXPRESS AN  ANTIGEN RECEPTORBIONTECH CELL & GENE THERAPIES GMBH
WO/2021/129945<i>IN VITRO</i> AND <i>IN VIVO</i>  GENE DELIVERY TO IMMUNE EFFECTOR CELLS USING NANOPARTICLES FUNCTIONALIZED  WITH DESIGNED ANKYRIN REPEAT PROTEINS (DARPINS)BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/121645A TOPICAL ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION  COMPRISING ZILEUTONQURIENT CO., LTD.
WO/2021/013384SKINCARE COMPOSITIONSTHE BOOTS COMPANY PLC
WO/2021/018414PHARMACEUTICAL COMPOSITION COMPRISING DABIGATRAN ETEXILATEZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/037396DENTAL COMPOSITIONDENTSPLY SIRONA INC.
WO/2021/078412FRACTAL FORMULATIONSMESSADEK, Jallal
WO/2021/139872SOLUBLE MELATONIN TRIPARTATE ADDUCT FOR THE PREVENTION AND  TREATMENT OF RARE AND SEVERE EYE SIGHT-THREATENING CONDITIONS AND  NEURO-OPHTHALMIC DISORDERSWORPHMED SRL
WO/2021/139874COGNITIVE DISORDER PREVENTION AND THERAPYANIMA
WO/2021/144020ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAMEIMMATICS BIOTECHNOLOGIES GMBH
WO/2021/073775ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKINSYMRISE AG
WO/2021/013385PROCESSES FOR OBTAINING A HIGHLY CONCENTRATED ANTIBODY  SOLUTIONICHNOS SCIENCES SA
WO/2021/148124COMPOSITIONS FOR REMOVING NECROTIC OR INFECTED TISSUES FROM  BODY SURFACE LESIONSDEBX MEDICAL BV
WO/2021/155916TREATMENT INVOLVING ANTIGEN VACCINATION AND BINDING AGENTS  BINDING TO PD-L1 AND CD137BIONTECH SE
WO/2021/164848NOVEL 6-SUBSTITUTED 7-DEAZAPURINES AND CORRESPONDING  NUCLEOSIDES AS MEDICAMENTSKATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/170218STABLE, LIQUID EMULSIFIERS ON THE BASIS OF CITRATE ESTERS AND  THEIR USESYMRISE AG
WO/2021/170223ANTIPERSPIRANT ACTIVE EMULSIONBEIERSDORF AG
WO/2021/175405COMPOSITE RNA PARTICLESBIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/175432METHOD FOR ADMINISTRATION OF AN ANTI CANCER AGENTBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/175450COMPOSITION OR OAT EXTRACT COMPRISING AVENANTHRAMIDE AND  ß-GLUCANSYMRISE AG
WO/2021/175451COSMETIC OR PHARMACEUTICAL USE OF AVENANTHRAMIDE LSYMRISE AG
WO/2021/175452COMPOSITION COMPRISING AN AVENANTHRAMIDE OR AN ANALOGUE  THEREOF WITH IMPROVED SKIN PENETRATIONSYMRISE AG
WO/2021/175453COMPOSITION COMPRISING AN AVENTHRAMIDE OR AN ANALOGUE THEREOF  WITH IMPROVED STABILITYSYMRISE AG
WO/2021/175454AVENANTHRAMIDE COMPOSITIONS WITH IMPROVED SOLUBILITY  COMPRISING 4-HYDROXYPHENONESYMRISE AG
WO/2021/037400METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION  FRACTION WITH DAPAGLIFLOZINASTRAZENECA AB
WO/2021/139901PEPTIDE-CONTAINING COMPOSITION FOR USE FOR TREATING NEOPLASTIC  LESIONSCYTOVATION AS
WO/2021/047798VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF  CANCERTHE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/083555ALK INHIBITORS FOR TREATMENT OF ALK-NEGATIVE CANCER AND PLASMA  CELL-MEDIATED DISEASESUNIVERSITETET I OSLO
WO/2021/190735COSMETIC COMPOSITION FOR MAKING UP OR CARING FOR KERATIN  MATERIALS COMPRISING A FLUORESCENT COMPOUND FROM THE FAMILY OF  4-BORA-3A,4A-DIAZA-S-INDACENES, AND/OR FROM THE FAMILY OF DIFLUOROBORANE  BETA-DIKETONATESCRIME SCIENCE TECHNOLOGY
WO/2021/190770INHIBITORS OF C5A FOR THE TREATMENT OF CORONA VIRUS InfectionINFLARX GMBH
WO/2021/197589TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN  VACCINATIONBIONTECH SE
WO/2021/148143TREATMENT OF CARDIAC REMODELLINGUNIVERSITETET I OSLO
WO/2021/197639COMPOSITIONS COMPRISING 15-HEPE FOR TREATING OR PREVENTING  HEMATOLOGIC DISORDERS, AND/OR RELATED DISEASESAFIMMUNE LIMITED
WO/2021/204371ANTI-POLLUTION COMPOSITIONBEIERSDORF AG
WO/2021/073778COMPOSITIONS AND METHODS FOR VACCINATING PIGLETS AGAINST  <i>STREPTOCOCCUS</i>CEVA SANTE ANIMALE
WO/2021/209134ANTIMICROBIAL SILVER COORDINATION COMPLEXESPENTA SCIENCE INDUSTRIES HOLDING B.V.
WO/2021/136602ORAL SOLUTIONS COMPRISING LISDEXAMFETAMINE SALTSLABOSERVE PHARMACEUTICAL COMPANY S.A.
WO/2021/180338COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR  OF DNA METHYLTRANSFERASE POST STEM CELL TRANSPLANTAPREA THERAPEUTICS AB
WO/2021/219202VISUALIZATION OF HER2 EXPRESSION IN HUMAN PATIENTSHOBER BIOTECH AB
WO/2021/004673SOLID HAIR CONDITIONING COMPOSITIONSHENKEL AG & CO. KGAA
WO/2021/004674SOLID HAIR CONDITIONING COMPOSITIONSHENKEL AG & CO. KGAA
WO/2021/094000DOSING REGIMEN FOR ANTI-BCMA AGENTSAMGEN RESEARCH (MUNICH) GMBH
WO/2021/228358A SOLID MUCOADHESIVE COMPOSITIONSYMRISE AG
WO/2021/228363PREVENTION OF INFECTIOUS DISEASES BY MODULATING THE IMMUNE  SYSTEMVAKZINE PROJEKT MANAGEMENT GMBH
WO/2021/228365USES AND FORMULATIONS OF CANNABINOIDSADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228366USES AND FORMULATIONS OF CANNABINOIDSADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228414METHODS OF TREATING SMALL CELL LUNG CANCER WITH LURBINECTEDIN  FORMULATIONSPHARMA MAR, S.A.
WO/2021/098991COMPOSITIONS COMPRISING BACTERIAL STRAINS4D PHARMA RESEARCH LIMITED
WO/2021/233534USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND  MEDICAL TREATMENTS OR USES THEREOFPVAC MEDICAL TECHNOLOGIES LTD
WO/2021/233549CLEAVABLE POLYMER DRUG CONJUGATES FOR VIRAL DISEASESRS ARASTIRMA EGITIM DANISMANLIK ILAC SANAYI TICARET ANONIM  SIRKETI
WO/2021/233551OLIGONUCLEOTIDES FOR SPLICE MODULATION OF CARD9F.HOFFMANN-LA ROCHE AG
WO/2021/098992METHODS OF TREATING SMALL CELL LUNG CANCER WITH LURBINECTEDIN  FORMULATIONSPHARMA MAR, S.A.
WO/2021/001104LIPID MIXTURE CONSISTING OF LIQUID OILS, HYDROGENATED  VEGETABLE OILS, AND SHEA BUTTERBEIERSDORF AG
WO/2021/244733HYPOXIA-RESISTANT NATURAL KILLER CELLSONK THERAPEUTICS LIMITED
WO/2021/004711FATTY ACID POLYGLYCERYL ESTER-CONTAINING CLEANSING PREPARATIONBEIERSDORF AG
WO/2021/004712CLEANSING EMULSION CONTAINING FATTY ACID POLYGLYCERYL ESTERSBEIERSDORF AG
WO/2021/018443METHOD FOR TREATING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C1-C6 ALKOXY-SILANE AND AN AMINO ACID AND/OR AN AMINO ACID DERIVATIVEHENKEL AG & CO. KGAA
WO/2021/013419INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN  MATERIALHENKEL AG & CO. KGAA
WO/2021/018444METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C1-C6-ALKOXY-SILANE AND AN ALKALISING AGENTHENKEL AG & CO. KGAA
WO/2021/018445OXIDANT-FREE METHOD FOR DYEING KERATIN MATERIAL, COMPRISING  THE APPLICATION OF AN ORGANIC C1-C6-ALKOXY SILANE AND AN OXIDANT-FREE DYE  PRECURSORHENKEL AG & CO. KGAA
WO/2021/018446METHOD FOR TREATING KERATIN MATERIAL, COMPRISING THE  APPLICATION OF AN ORGANIC C1-C6-ALKOXY-SILANE AND AN AMINO ACID AND/OR AMINO  ACID DERIVATIVEHENKEL AG & CO. KGAA
WO/2021/013420INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN  MATERIALHENKEL AG & CO. KGAA
WO/2021/028093METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED USING AN ORGANOSILICON COMPOUND AND A PIGMENTHENKEL AG & CO. KGAA
WO/2021/018447METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C1-C6-ALKOXY-SILANE AND AN ALKALISING AGENTHENKEL AG & CO. KGAA
WO/2021/028094METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED USING AN ORGANOSILICON COMPOUND AND A PIGMENTHENKEL AG & CO. KGAA
WO/2021/028095METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED USING AN ORGANOSILICON COMPOUND AND A PIGMENTHENKEL AG & CO. KGAA
WO/2021/023415COMESTIC NANOEMULSIONBEIERSDORF AG
WO/2021/249641PHARMACEUTICAL COMPOSITIONS CONTAINING ENTEROKINE-RELEASING  SUBSTANCES IN MULTIPLE DOSAGE FORMS IN COMBINATION WITH GELLING AGENTSAPHAIA PHARMA IP AG
WO/2021/254588SOLID CLEANSING COMPOSITIONBEIERSDORF AG
WO/2021/004736REDUCING THE VIRAL ACTIVITY OF ELAFIBRANOR WITH RIBOFLAVIN OR  DHADSM IP ASSETS B.V.
WO/2021/254628FRAGRANCE MIXTURES CONTAINING 1-(4,4-DIMETHYLCYCLOHEXEN-1-YL)  ETHANONSYMRISE AG
WO/2021/254637ASSOCIATION OF NATURAL ACTIVES INGREDIENTS TO FIGHT SKIN AGINGTOMCAT INTERNATIONAL LIMITED
WO/2021/004770HAIR CARE COMPOSITION COMPRISING ANTIDANDRUFF AGENTUNILEVER N.V.
WO/2021/018479PROCESS AND APPARATUS FOR PRODUCTION OF A GRANULAR CANNABINOID  MATERIAL ESSENTIALLY SOLUBLE IN AQUEOUS MEDIUMADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/259454TINTED SUNSCREENBEIERSDORF AG
WO/2021/013452TSG6 POLYPEPTIDE FRAGMENT FOR DRY EYE DISEASETHE UNIVERSITY OF MANCHESTER
WO/2021/008822TOPICAL COMPOSITIONS AND METHODS OF USING SAME AGAINST  MITOCHONDRIAL FRAGMENTATIONUNILEVER PLC
WO/2021/008823STABILIZATION OF RESORCINOL COMPOUNDS IN COSMETIC COMPOSITIONSUNILEVER PLC
WO/2021/008824BIOENERGETIC COMBINATIONS AND METHODS OF USING SAMEUNILEVER PLC
WO/2021/259471DERMAL FILLER WITH HIF-1α ACTIVITY MODULATORSTHOR, Dominik
WO/2021/259472MICELLAR DOCETAXEL FOR USE IN THE TREATMENT OF CANCEROASMIA PHARMACEUTICAL AB
WO/2021/001281METHOD OF DEPOSITING A SUBSTANCE ON A SUBSTRATEDBV TECHNOLOGIES
WO/2021/001286A SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS A D1  POSITIVE ALLOSTERIC MODULATORUCB BIOPHARMA SRL
WO/2021/001288A SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS A D1  POSITIVE ALLOSTERIC MODULATORUCB BIOPHARMA SRL
WO/2021/001290COMPOSITION COMPRISING STABILIZED PHYCOCYANIN AND ITS USESCALICEA
WO/2021/001306METHYLTHIONINIUM AS ENHANCERS OF THE COGNITIVE FUNCTIONWISTA LABORATORIES LTD.
WO/2021/013476HAIR CARE COMPOSITIONUNILEVER N.V.
WO/2021/001326METHYLTHIONINIUM FOR USE IN THE TREATMENT OF SYNAPTOPATHIESWISTA LABORATORIES LTD.
WO/2021/001332METHOD FOR OBTAINING A BOTANICAL THERMAL INFUSIONLABORATOIRES LéA
WO/2021/013479MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER  DYSFUNCTIONUNIVERSITEIT ANTWERPEN
WO/2021/001349INHALABLE COMPOSITION COMPRISING CYCLODEXTRIN FOR USE IN THE  TREATMENT OF NASAL INFLAMMATIONSAQUILON PHARMACEUTICALS
WO/2021/001356CD5 SPECIFIC T CELL RECEPTOR CELL OR GENE THERAPYMAX-DELBRüCK-CENTRUM FüR MOLEKULARE MEDIZIN IN DER  HELMHOLTZ-GEMEINSCHAFT
WO/2021/001360PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES  THEREOFADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/121677RETINOL-BASED SERUML'OREAL
WO/2021/001362PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES  THEREOFADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/001365PROPHYLAXIS AND TREATMENT OF A HUMAN PAPILLOMAVIRUS (HPV)  INFECTION OF THE CERVIXEBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTÄT
WO/2021/001366METHOD FOR STABILIZING THE PH OF AN AQUEOUS COMPOSITION  COMPRISING A DRUGOCULIS SA
WO/2021/001374PHARMACEUTICAL COMPOSITIONS FOR GLUCAGON AND GLP-1 CO-AGONIST  PEPTIDESMEDIMMUNE LIMITED
WO/2021/001377cPLA2e INDUCING AGENTS AND USES THEREOFFUNDACION PARA LA INVESTIGACION MEDICA APLICADA
WO/2021/001380THERAPEUTIC INTERACTIONS OF LEUCOMETHYLTHIONINIUMWISTA LABORATORIES LTD.
WO/2021/001393COSMETIC COMPOSITION COMPRISING SILICONES BEARING A CARBOXYLIC  GROUP AND ANIONIC DIRECT DYES, AND COSMETIC TREATMENT PROCESSL'OREAL
WO/2021/008870Cosmetic composition comprising anionic and amphoteric  surfactants, cationic polysaccharides and unsaturated fatty alcohols, and  cosmetic treatment processL'OREAL
WO/2021/001405COMPOUND AND COMPOSITIONS FOR MULTITARGET TREATMENT OF TAU  PROTEIN-RELATED DISORDERSFONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
WO/2021/001417RNA FORMULATIONS SUITABLE FOR THERAPYBIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/001427METHODS FOR THE PROPHYLACTIC TREATMENT OF CANCER IN PATIENTS  SUFFERING FROM PANCREATITISINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/001431USE OF PI3KA-SELECTIVE INHIBITORS FOR TREATING METASTATIC  DISEASE IN PATIENTS SUFFERING FROM PANCREATIC CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/001457CRYSTALLINE (R)-2-AMINO-3-PHENYLPROPYLCARBAMATE ACID ADDITION  SALTSSANDOZ AG
WO/2021/001458ANTI-CD154 ANTIBODIES AND USES THEREOFTONIX PHARMA HOLDINGS LIMITED
WO/2021/001461ORAL THIN FILMLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/001462CONJUGATED DEOXYNIVALENOL TO PROTECT AGAINST MYCOTOXICOSISINTERVET INTERNATIONAL B.V.
WO/2021/001464COMBINATION THERAPY METHODS, COMPOSITIONS AND KITSBIONURE FARMA, S.L.
WO/2021/001508METHODS OF TREATING HIV IN PEDIATRIC PATIENTS WITH RILPIVIRINEJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/004910COMBINATION FOR THE TREATMENT OF INFECTIONS CAUSED BY  MYCOPLASMA GENITALIUMGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/001518PXR LIGANDS FOR THE PREVENTION OR TREATMENT OF METABOLIC  DISORDERSMEDIZINISCHE UNIVERSITÄT GRAZ
WO/2021/004913COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN  FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLESOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/004915COMPOSITIONS AND METHODS USING TRIGONELLINE AND MINERALS FOR  PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLESOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/004919COMPOSITIONS AND METHODS USING TRIGONELLINE AND VITAMINS FOR  PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLESOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/004922COMPOSITIONS AND METHODS USING TRIGONELLINE TO PRODUCE  INTRACELLULAR NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) FOR TREATING OR  PREVENTING PHYSIOLOGICAL DISORDERS OR STATESSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/001528NOVEL GALACTOSIDE INHIBITOR OF GALECTINSGALECTO BIOTECH AB
WO/2021/001538NOVEL GALACTOSIDE INHIBITOR OF GALECTINSGALECTO BIOTECH AB
WO/2021/001540DETOXIFICATION OF PROTEINSPROXI BIOTECH APS
WO/2021/004942DRY COSMETIC AND/OR SKIN CARE COMPOSITIONOMYA INTERNATIONAL AG
WO/2021/004945COMPOSITION COMPRISING A NATURAL DYE, AN ANTHRAQUINONE  CATIONIC DIRECT DYE AND AN AROMATIC COMPOUNDL'OREAL
WO/2021/004948COMPOSITION COMPRISING A NATURAL DYE, A HYDRAZONO AND/OR AZO  CATIONIC SYNTHETIC DIRECT DYE AND AN AROMATIC COMPOUNDL'OREAL
WO/2021/004950COMPOSITION COMPRISING A NATURAL DYE, A TRIARYLMETHANE DIRECT  DYE AND AN AROMATIC COMPOUNDL'OREAL
WO/2021/004958COMPOSITIONS COMPRISING BACTERIAL STRAINS4D PHARMA RESEARCH LIMITED
WO/2021/001567MODULATION OF T CELL CYTOTOXICITY AND RELATED THERAPYCANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/001568METHODS OF TREATING HIV IN PEDIATRIC PATIENTS WITH RILPIVIRINEJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/013509METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A FILM-FORMING  POLYMER IIHENKEL AG & CO. KGAA
WO/2021/013510COATED EFFECT PIGMENTS AND PRODUCTION THEREOFHENKEL AG & CO. KGAA
WO/2021/013511METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A FILM-FORMING  POLYMER IVHENKEL AG & CO. KGAA
WO/2021/013512METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A SEALING REAGENT IIIHENKEL AG & CO. KGAA
WO/2021/013513COLOURING EFFECT PIGMENTS AND PRODUCTION THEREOFHENKEL AG & CO. KGAA
WO/2021/013516METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COATED EFFECT PIGMENT AND A FILM-FORMING POLYMER  IIHENKEL AG & CO. KGAA
WO/2021/052647SKIN LIGHTENING COMPOSITIONBELLA AURORA LABS, S.A.
WO/2021/052648METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COATED EFFECT PIGMENT AND A SEALING REAGENT IHENKEL AG & CO. KGAA
WO/2021/013517METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A SEALING REAGENT IHENKEL AG & CO. KGAA
WO/2021/005011TABLETING OF SPECIFIC POLYMER STABILIZERSBASF SE
WO/2021/005059MODIFIED ESCHERICHIA COLI STRAIN NISSLE AND TREATMENT OF  GASTROINTESTINAL DISORDERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/005064A COMPOSITION, A KIT AND USE THEREOFTHERAVET SA
WO/2021/005069A METHOD FOR THE PREPARATION OF A GEL-FORMING COMPOSITIONTHERAVET SA
WO/2021/005071A COMPOSITION, A KIT AND USE THEREOFTHERAVET SA
WO/2021/098996OLIGOPEPTIDE THAT INHIBITS ANGIOGENESIS AND VASCULAR FUNCTIONUNIVERSIDAD NACIONAL AUTONOMA DE MEXICO
WO/2021/005077PHARMACEUTICAL PREPARATIONMERCK PATENT GMBH
WO/2021/013546A WATER-IN-OIL EMULSION COMPOSITION FOR ENHANCED DELIVERY OF  WATER SOLUBLE SKIN BENEFIT AGENTSUNILEVER N.V.
WO/2021/005101PHARMACEUTICAL COMPOSITION COMPRISING A  TETRAHYDROPYRAZOLOPYRIMIDINONE COMPOUNDIDORSIA PHARMACEUTICALS LTD
WO/2021/005104COSMETIC COMPOSITION OF LIQUID CRYSTAL LIPID PARTICLES FOR  HAIR CARE COMPOSITIONBASF SE
WO/2021/005117TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE  AGENT-CONTAINING LAYER COMPRISING A SILICONE-CONTAINING POLYMER AND A SKIN  CONTACT LAYER COMPRISING A SILICONE GEL ADHESIVELTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/005118TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE  AGENT-CONTAINING LAYER COMPRISING AN ACRYLIC POLYMER AND A SKIN CONTACT LAYER  COMPRISING A SILICONE GEL ADHESIVELTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/005129COMBINATION OF IBUPROFEN AND TRAMADOL FOR RELIEVING PAINFARMALíDER, S.A.
WO/2021/259506COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND  A SAPONIN OR A LIGAND-SAPONIN CONJUGATESAPREME TECHNOLOGIES B.V.
WO/2021/259507CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN  EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME,  THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITIONSAPREME TECHNOLOGIES B.V.
WO/2021/259508CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY,  PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOFSAPREME TECHNOLOGIES B.V.
WO/2021/005147COMBINATIONGENESIS PHARMA SA
WO/2021/005153SELF-ASSEMBLING PEPTIDES IN THE PREVENTION AND TREATMENT OF  CAVITATED CARIOUS LESIONSCREDENTIS AG
WO/2021/005169TREATMENT OF PATIENTS UNDER ANTIPLATELET MEDICATION  EXPERIENCING BLEEDINGFÄLKER, Knut
WO/2021/005176TREATMENT OF GLYCOGEN STORAGE DISEASE (GSD)GENETHON
WO/2021/005183INHIBITOR OF MAP KINASE INTERACTING SERINE/THREONINE KINASE 1  (MNK1) AND MAP KINASE INTERACTING SERINE/THREONINE KINASE 2 (MNK2), CANCER  THERAPY AND THERAPEUTIC COMBINATIONSFUNDACIó HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE  RECERCA
WO/2021/005189NOVEL PFAR-INHIBITING COMPOUNDSUNIVERSITE DE BRETAGNE OCCIDENTALE (UBO)
WO/2021/047804IN VITRO METHOD FOR TRANSDUCTION OF T CELLS IN THE PRESENCE OF  MALIGNANT CELLSMILTENYI BIOTEC B.V. & CO. KG
WO/2021/009020EXCIPIENT FOR BIOTHERAPEUTICSLUDWIG-MAXIMILIANS-UNIVERSITÄT MüNCHEN
WO/2021/009027HIGH CONCENTRATION INSULIN FORMULATIONNOVO NORDISK A/S
WO/2021/009029TRYPTOPHAN- AND PHENYLETHYLAMINE-DERIVED BETAXANTHINS FOR USE  IN THE TREATMENT AND/OR PREVENTION OF CANCERUNIVERSIDAD DE MURCIA
WO/2021/009040PROCESS FOR PRODUCING MICROPARTICLES LADEN WITH A VOLATILE  ORGANIC ACTIVEBASF SE
WO/2021/009050REDUCING MALARIA TRANSMISSIONGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/009083PROCESS FOR TREATING KERATIN FIBERS, COMBINING A COMPOSITION  COMPRISING A WATER-SOLUBLE SILICATE AND A COMPOSITION COMPRISING AN AMINO  ACID AND/OR AN OLIGOPEPTIDEL'OREAL
WO/2021/009091METHODS FOR PREDICTING AND TREATING CARDIAC DYSFUNCTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/058157KIT AND METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF  AMINOSILICONE AND A CHROMOPHORIC COMPOUNDHENKEL AG & CO. KGAA
WO/2021/009110COSMETIC PREPARATIONS COMPRISING NATURAL ACTIVATORSETH ZURICH
WO/2021/058158PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, A CHROMOPHORIC COMPOUND AND ETHOXYLATED FATTY ACID ESTERHENKEL AG & CO. KGAA
WO/2021/058159PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, A CHROMOPHORIC COMPOUND AND AN ORGANIC CARBONIC ACID ESTERHENKEL AG & CO. KGAA
WO/2021/009126SIRNA SEQUENCES TARGETING THE EXPRESSION OF HUMAN GENES JAK1  OR JAK3 FOR A THERAPEUTIC USECOMMISSARIAT à L'éNERGIE ATOMIQUE ET AUX éNERGIES ALTERNATIVES
WO/2021/009142COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE FOR INHIBITING  THE GROWTH OF MALASSEZIA YEASTS INVOLVED IN CRADLE CAP, IN PARTICULARLABORATOIRES EXPANSCIENCE
WO/2021/018565SKIN CARE OIL IN WATER EMULSIONBEIERSDORF AG
WO/2021/009177ACTIVE AGENT FOR USE IN HAIR GROWTH REGULATIONMONASTERIUM LABORATORY SKIN & HAIR RESEARCH SOLUTIONS GMBH
WO/2021/073788NATURAL NON-PATHOGENIC MICROORGANISMS CAPABLE OF ASSOCIATING  GLYCOLIPIDS OR LIPOPEPTIDES AND USE THEREOFACARYON GMBH
WO/2021/009197DOSE DUMPING RESISTANT PHARMACEUTICAL COMPOSITIONS COMRISING  VERINURADASTRAZENECA AB
WO/2021/009219A RECEPTOR-TARGETING CONJUGATE WITH AN EFFECTIVE  PHARMACOKINETIC PROFILEFLUOGUIDE A/S
WO/2021/009237A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDERIGSHOSPITALET
WO/2021/018596LIQUID ORAL CARE COMPOSITIONMEDA PHARMA S.P.A.
WO/2021/009266PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS ADMINISTRATIONZEALAND PHARMA A/S
WO/2021/009267ANTI-PD-L1 ANTIBODIESCAPELLA BIOSCIENCE LTD
WO/2021/013693ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORSBAYER PHARMA AKTIENGESELLSCHAFT
WO/2021/009288COMBINATION COMPRISING ALPHA-1 ANTITRYPSIN FOR USE IN TREATING  ISCHAEMIA IN A SUBJECTFUNDACIó HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE  RECERCA
WO/2021/018619STABILIZING THERAPEUTIC PROTEINS WITH PIPERAZIN- OR  MORPHOLINE-CONTAINING ZWITTERIONIC BUFFERING SUBSTANCESLUDWIG-MAXIMILIANS-UNIVERSITÄT MüNCHEN
WO/2021/009331IMPROVED TREATMENT USING EYP001ENYO PHARMA
WO/2021/009332METHOD FOR DECREASING ADVERSE-EFFECTS OF INTERFERONENYO PHARMA
WO/2021/009333SYNERGISTIC EFFECT OF EYP001 AND IFN FOR THE TREATMENT OF HBV  INFECTIONENYO PHARMA
WO/2021/009336METHODS FOR INDUCING FULL ABLATION OF HEMATOPOIESISINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/013712POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT  OF MUSCLE DISEASESANAGENESIS BIOTECHNOLOGIES S.A.S.
WO/2021/013713MESNA COMPOSITION, KIT COMPRISING MESNA AND METHOD FOR  VISUALIZATION OF A MESNA COMPOSITION APPLIED TO TISSUESAUXIN SURGERY SA
WO/2021/013714COMPOSITION AND INSTRUMENT COMPRISING MESNA FOR USE IN A  METHOD OF ROBOT-ASSISTED SURGERYAUXIN SURGERY SA
WO/2021/009355SOLID FORMULATION OF A 1,2,4-OXADIAZOLE DERIVATIVEABAXYS THERAPEUTICS
WO/2021/009358ANTIBODY COMBINATIONS FOR TREATMENT OF CANCER IN SPECIFIC  PATIENTSBIOINVENT INTERNATIONAL AB
WO/2021/009362BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE  DERIVATIVES FOR THE MODULATION OF STINGCTXT PTY LIMITED
WO/2021/009363MEDICAL USES, METHODS AND USESAOUADI, Myriam
WO/2021/009365BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE  DERIVATIVES FOR THE MODULATION OF STINGCTXT PTY LIMITED
WO/2021/009367GLYCOPEPTIDES INCREASING LIPID SYNTHESISTFCHEM
WO/2021/013764P21 EXPRESSING MONOCYTES FOR CANCER CELL THERAPYINSTITUT GUSTAVE ROUSSY
WO/2021/013771FERROPORTIN-INHIBITORS FOR THE USE IN THE TREATMENT OF  TRANSFUSION-DEPENDENT BETA-THALASSEMIA (TDT)VIFOR (INTERNATIONAL) AG
WO/2021/013772FERROPORTIN-INHIBITORS FOR THE USE IN THE PREVENTION AND  TREATMENT OF KIDNEY INJURIESVIFOR (INTERNATIONAL) AG
WO/2021/013798THERAPEUTIC VIRAL VACCINEGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/009384NOVEL PYRAZOLONE DERIVATIVES AS PD-1/PD-L1 INTERACTION  INHIBITORSCENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE
WO/2021/013815METHODS OF TREATING MULTIPLE SCLEROSISACTELION PHARMACEUTICALS LTD
WO/2021/013825SOFT CHEWABLE VETERINARY DOSAGE FORMINTERVET INTERNATIONAL B.V.
WO/2021/013861SUSTAINED RELEASE TREPROSTINIL-COMPOUND MICROPARTICLE  COMPOSITIONSNANOMI, B.V.
WO/2021/018682HYBRID MINERAL-ORGANIC COMPLEX, AND USE THEREOF FOR  MAINTAINING THE MICROBIOLOGICAL BALANCE OF THE SKIN AND/OR OF A COSMETIC  AND/OR DERMOPHARMACEUTICAL COMPOSITIONBIONUCLEI
WO/2021/023512BIFUNCTIONAL COMPOUND AND ITS USE IN IMMUNOTHERAPYCONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/013884INHIBITORS OF CHI3L1 AND THEIR USESHUMANITAS MIRASOLE S.P.A.
WO/2021/013903NEW USE OF TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVESUNIVERSITé DE LIèGE
WO/2021/013904ANTIBODY AGAINST THE OPRF PROTEIN OF <i>PSEUDOMONAS  AERUGINOSA</i>, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL  COMPOSITION CONTAINING SAMEUNIVERSITé GRENOBLE ALPES
WO/2021/028180AN ANTIPERSPIRANT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/013911INHIBITORS OF THE STING PATHWAY FOR THE TREATMENT OF  HIDRADENITIS SUPPURATIVAINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/013921THE SERPINB3 INHIBITOR PIPERIDINPROPIONIC ACID FOR TUMOR  TREATMENTUNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/013931ANTIMYCOTICKARL-FRANZENS-UNIVERSITÄT GRAZ
WO/2021/013942USE OF MYELOPEROXIDASE INHIBITORS FOR THE TREATMENT OF  CARDIOVASCULAR DISEASES IN PATIENTS SUFFERING FROM MYELOPROLIFERATIVE  NEOPLASMSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/013944FAECALIBACTERIUM PRAUSNITZII AND CHRISTENSENELLA BACTERIAL  STRAINS FOR THE TREATMENT AND PREVENTION OF BOWEL INFLAMMATIONINSTITUT NATIONAL DE RECHERCHE POUR L’AGRICULTURE,  L’ALIMENTATION ET L’ENVIRONNEMENT
WO/2021/013950IMMUNE CELLS DEFECTIVE FOR SUV39H1MNEMO THERAPEUTICS
WO/2021/013951VETERINARY COMPOSITIONS COMPRISING MELATONIN AND THEIR USES  FOR RUMINANTSCEVA SANTE ANIMALE
WO/2021/018747HAIR TREATMENT COMPOSITIONUNILEVER GLOBAL IP LIMITED
WO/2021/018750OPHTHALMIC COMPOSITIONS COMPRISING VISCOSIFYING POLYMERS AND  NUCLEIC ACIDSPROQR THERAPEUTICS II B.V.
WO/2021/018754AN ANTIDANDRUFF COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/018755AN ANTIDANDRUFF COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/013973COSMETIC COMPOSITIONS COMPRISING PLANT EXTRACTS AND USES  THEREOFALUMIER EUROPE LIMITED
WO/2021/013981CRYSTALLINE FORM OF TELMAPITANT OR  (5R,8S)-8-[[(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]METHYL]-8-PHENYL-1,3,7-TRIAZASPIRO[4.5]DECANE-2,4-DIONEINTERVET INTERNATIONAL B.V.
WO/2021/013999RECEPTOR-TARGETING PEPTIDE-DRUG CONJUGATESONTOCHEM GMBH
WO/2021/018786USE OF FFAR2 AGONISTS FOR THE TREATMENT OF BACTERIAL  SUPERINFECTIONS POST-VIRAL INFECTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/018792OSTEOCRIN, LEBETIN OR ANP FOR DESTROYING BACTERIAL BIOFILMSUNIVERSITé DE ROUEN-NORMANDIE
WO/2021/014014TREATMENT AND/OR PREVENTION OF LESIONS IN THE CENTRAL AUDITORY  NERVOUS SYSTEMSENSORION
WO/2021/018798COMPOSITION COMPRISING STEROL DERIVATIVES FOR USE IN THE  TREATMENT OF A NEURONAL PATHOLOGY RELATED TO HYPOXIA, HYPOGLYCEMIA AND/OR  HYPERGLYCEMIADENDROGENIX
WO/2021/014019SAPONIN DERIVATIVES WITH IMPROVED THERAPEUTIC WINDOWSAPREME TECHNOLOGIES B.V.
WO/2021/018806IGG-DEPLETED PORCINE SERUM AND THE USES THEREOFCEVA SANTE ANIMALE
WO/2021/018816ALGINATE-BASED FACIAL MASKBEIERSDORF AG
WO/2021/018824USE OF  (R)-9-(2,5-DIFLUOROPHENETHYL)-4-ETHYL-2-METHYL-1-OXA-4,9-DIAZASPIRO[5.5]UNDECAN-3-ONE  FOR THE TREATMENT OF NOCICEPTIVE PAIN, NEUROPATHIC PAIN, OSTEOARTHRITIS PAIN  AND CANCER PAIN, WHILE HAVING REDUCED SIDE EFFECTS COMPARED TO OPIOIDSESTEVE PHARMACEUTICALS, S.A.
WO/2021/037455ACRYLATE AND SILICON-FREE COSMETIC O/W EMULSIONBEIERSDORF AG
WO/2021/037456ACRYLATE AND SILICON-FREE COSMETIC O/W EMULSIONBEIERSDORF AG
WO/2021/023547PREPARATION AND FULLY COMPOUNDED STOCK FOR USE IN MEDICAL OR  DENTAL APPLICATIONS, MEDICAL OR DENTAL PRODUCT AND USE AND PREPARATION  THEREOFGEBR. BRASSELER GMBH & CO. KG
WO/2021/018839ISOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF  PARASITIC INFECTIONSBAYER ANIMAL HEALTH GMBH
WO/2021/014026BIOACTIVE SAPONIN LINKED TO A FUNCTIONAL MOIETYSAPREME TECHNOLOGIES B.V.
WO/2021/014027PHOSPHOLIPASE-A2 INHIBITORS FOR THE PREVENTION OF CANCER  METASTASISCOEGIN PHARMA AS
WO/2021/018859ANTIBODIES BINDING TO GPRC5DF. HOFFMANN-LA ROCHE AG
WO/2021/018862SS-31 FOR THE PREVENTION AND/OR TREATMENT OF ANEURYSMFUNDACIó INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I  SANT PAU
WO/2021/018866MEK INHIBITOR FOR TREATMENT OF STROKEEDVINCE AB
WO/2021/018879PEPTIDES FOR USE AS SENOTHERAPEUTIC AGENTSFUNDACIóN PROFESOR NOVOA SANTOS
WO/2021/018898METHODS FOR TREATING TUMORSNH THERAGUIX
WO/2021/018899USE OF GDF15 AS A MARKER FOR EXERCISE MANAGEMENTINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/018917PROCESS FOR PREPARING ADHESIVE COMPOUNDS FOR USE IN A  TRANSDERMAL THERAPEUTIC SYSTEMLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/018923PEPTIDES AS INHIBITORS OF FIBROTIC MATRIX ACCUMULATIONMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/018928NEW PHARMACEUTICAL FORMULATIONF. HOFFMANN-LA ROCHE AG
WO/2021/018931COMPOSITIONS FOR THE TREATMENT OF ATOPIC DERMATITISDERMOPHISIOLOGIQUE S.R.L. SOCIETà BENEFIT
WO/2021/018934TREATMENT OF SEBACEOUS GLAND DISORDERSECHO PHARMACEUTICALS B.V.
WO/2021/018935TREATMENT OF AGING OR UV-DAMAGED SKINECHO PHARMACEUTICALS B.V.
WO/2021/018936TREATMENT OF INFLAMMATORY SKIN CONDITIONSECHO PHARMACEUTICALS B.V.
WO/2021/018950COSMETIC COMPOSITION WITH COMBINED FILLER AND SKIN  REGENERATIVE EFFECTGIULIANI S.P.A.
WO/2021/018965ACTIVATORS OF SIRTUINS AND USES THEREOFEPI-C S.R.L.
WO/2021/018967SEROTONERGIC AGENT AND 5-HT1A-RECEPTOR ANTAGONISTATLAS PHARMACEUTICALS BV
WO/2021/023600COMBINATION PRODUCT FOR HELPING MAINTAIN THE NATURAL DEFENSES  OF THE ORGANISM AND AIDING WITH RECOVERYURGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/018990PREVENTION AND REDUCTION OF CORNIFICATION DISORDERS AND  RELATED COSMETIC AGENTSMERCK PATENT GMBH
WO/2021/023609COMBINATION OF A TYPE I PROTEIN ARGININE METHYLTRANSFERASE  (TYPE I PRMT) INHIBITOR AND A METHIONINE ADENOSYLTRANSFERASE II ALPHA (MAT2A)  INHIBITORGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/023616ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS FOR USE  IN EPILEPSY OR SEIZURESH. LUNDBECK A/S
WO/2021/023617ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERSH. LUNDBECK A/S
WO/2021/019023COMPOUNDS FOR USE IN A METHOD OF TREATING OR PREVENTING  NEUROLOGICAL AND/OR PSYCHIATRIC DISORDERSTHE BECKLEY FOUNDATION
WO/2021/019033DOSAGE AND ADMINISTRATION REGIMEN FOR THE TREATMENT OR  PREVENTION OF C5-RELATED DISEASES BY THE USE OF THE ANTI-C5 ANTIBODY  CROVALIMABF. HOFFMANN-LA ROCHE AG
WO/2021/019036DOSAGE AND ADMINISTRATION REGIMEN FOR THE TREATMENT OR  PREVENTION OF C5-RELATED DISEASES BY THE USE OF THE ANTI-C5 ANTIBODY  CROVALIMABF. HOFFMANN-LA ROCHE AG
WO/2021/023631NOVEL FORM OF A DEPILATORY COMPOSITION , AND PREPARATION  METHOD THEREFORL.C.M. LABORATOIRE DE COSMéTOLOGIE MODERNE
WO/2021/023644NEUTRALIZING GRANZYME B FOR PROVIDING CARDIOPROTECTION IN A  SUBJECT WHO EXPERIENCED A MYOCARDIAL INFARCTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/023646MELANOCYTE-REGULATING PEPTIDESIDP DISCOVERY PHARMA, S.L.
WO/2021/019067VETERINARY COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF  CRYPTOSPORIDIOSISCEVA SANTE ANIMALE
WO/2021/023649BI-FUNCTIONALIZED NANOPARTICLES, PROCESS FOR ITS PREPARATION  AND USES THEREOFFUNDACIó HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE  RECERCA
WO/2021/023662PYRAZOLO[4,3-C]PYRIDINE COMPOUNDS FOR USE IN THE TREATMENT OF  HBV INFECTIONJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/019078LIPOSOMES AND USES THEREOFUNIVERSITà DEGLI STUDI DI MILANO - BICOCCA
WO/2021/019081C3/C5 CONVERTASE ASSAYSUNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF
WO/2021/019092TOPICAL COMPOSITIONSBAUSCH HEALTH IRELAND LIMITED
WO/2021/023673PROCESS FOR PREVENTING AND/OR TREATING TRANSPIRATION AND  ASSOCIATED COMPOSITIONL'OREAL
WO/2021/023675LACOSAMIDE FOR THE TREATMENT OF ADD/ADHDSANCHEZ, Hector Mario
WO/2021/019097MEMBRANE FILTRATION OF PLANT EXTRACTS BY MEANS OF CYCLODEXTRINBIONORICA SE
WO/2021/023691IMMUNOGENIC COMPOSITIONGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/023692PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D  POLYPEPTIDEGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/023695COMBINATIONS OF OLIGOSACCHARIDES AND XYLITOL FOR  DERMATOLOGICAL TREATMENTMEDA PHARMA S.P.A.
WO/2021/023698ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS FOR USE IN THE  TREATMENT OF CANCERLANTHIOPEP B.V
WO/2021/019102A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A  POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A  POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS  COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMESACM BIOLABS PTE LTD
WO/2021/069126CLEANSING PREPARATION CONTAINING CAESALPINIA SPINOSA GUMBEIERSDORF AG
WO/2021/023733TARGETED NANOPARTICLES OF WELL-DEFINED AND REPRODUCIBLE SIZESSTAMS DIAGNOSTICS GMBH
WO/2021/023796COMPOSITIONS FOR TRANSFECTING A NUCLEIC ACID MOLECULE INTO A  CELL COMPRISING HETEROCYCLIC COMPOUNDS GRAFTED TO A CATIONIC POLYMER, AND  THEIR APPLICATIONSPOLYPLUS TRANSFECTION
WO/2021/023798COMPOSITIONS FOR TRANSFECTING A NUCLEIC ACID MOLECULE INTO A  CELL COMPRISING TRIAZOLE COMPOUNDS GRAFTED TO A CATIONIC POLYMER, AND THEIR  APPLICATIONSPOLYPLUS TRANSFECTION
WO/2021/037511SUNSCREEN COMPOSITION WITHOUT CYCLOMETHICONESBEIERSDORF AG
WO/2021/028299VIRAL PARTICLES FOR USE IN TREATING SYNUCLEINOPATHIES SUCH AS  PARKINSON'S DISEASES BY GENE THERAPYFUNDACION PARA LA INVESTIGACION MEDICA APLICADA
WO/2021/023805COMPOUND FOR COMBINATION TREATMENTINITIATOR PHARMA A/S
WO/2021/023809ETIFOXINE FOR USE IN THE TREATMENT OF DISEASES RELATED TO  ACTIVATED MAST CELLSMC SCIENCES UG
WO/2021/023811SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2  INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACIDNOVO NORDISK A/S
WO/2021/023817SOLID COMPOSITION COMPRISING A PYY COMPOUND AND A SALT OF  N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACIDNOVO NORDISK A/S
WO/2021/023820EXTRACT OF SILYBUM MARIANUM (L.) GAERTN. AKENES FOR PROMOTING  HAIR GROWTHPIERRE FABRE DERMO-COSMETIQUE
WO/2021/023837INHIBITION OF METASTASIS DEVELOPMENT BY NANGPTL-4DEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/028328TOPICAL COMPOSITION COMPRISING A PROSTAGLANDIN ANALOGUENOVALIQ GMBH
WO/2021/023848METHOD OF PREPARING A SOLID DOSAGE FORM AND A LUBRICANTEVONIK OPERATIONS GMBH
WO/2021/023849DOWN STREAMING PROCESS FOR THE PRODUCTION OF POLYUNSATURATED  FATTY ACID SALTSEVONIK OPERATIONS GMBH
WO/2021/023850METHOD OF PREPARING A SOLID DOSAGE FORM AND A BINDEREVONIK OPERATIONS GMBH
WO/2021/023855SOLID COMPOSITIONS COMPRISING AN EGF(A) DERIVATIVE AND A SALT  OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACIDNOVO NORDISK A/S
WO/2021/023857SOLUBILITY ENHANCEMENT OF POORLY SOLUBLE ACTIVESEVONIK OPERATIONS GMBH
WO/2021/028336(HETERO)ARYL-METHYL-THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVESIDORSIA PHARMACEUTICALS LTD
WO/2021/028337PEPTIDE ANTIGENS AND USES THEREOFHUMANITAS MIRASOLE S.P.A.
WO/2021/028347HLA-DR/CII PEPTIDE COMPLEXES FOR TREATING ARTHRITISFRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E.V.
WO/2021/028350PRODUCTION OF MHC II/CII COMPLEXESFRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E.V.
WO/2021/023876GNRH ANTAGONISTS FOR THE TREATMENT OF ESTROGEN-DEPENDENT  DISORDERSOBSEVA S.A.
WO/2021/023877COMPOSITIONS AND METHODS FOR THE TREATMENT OF  ESTROGEN-DEPENDENT DISORDERSOBSEVA S.A.
WO/2021/023885LIQUID DRESSING COMPOSITIONS AND THEIR USESCAMBRIDGE ENTERPRISE LIMITED
WO/2021/023886LIQUID DRESSING COMPOSITIONS AND THEIR VETERINARY USESCAMBRIDGE ENTERPRISE LIMITED
WO/2021/037532METHOD FOR TRAINING PATIENTS WITH THERAPEUTIC GAS MIXTURESEGOROV, Egor
WO/2021/028382[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINESBAYER AKTIENGESELLSCHAFT
WO/2021/028402IMMUNOGENIC COMPOSITIONGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/028406CHIKUNGUNYA VACCINE FORMULATIONSVALNEVA SE
WO/2021/028407SINGLE SHOT CHIKUNGUNYA VIRUS VACCINEVALNEVA SE
WO/2021/028415PERSONAL HYGIENE PRODUCTCRODA INTERNATIONAL PLC
WO/2021/028438TARGETING WNK1 IN BLOOD CANCERSKØBENHAVNS UNIVERSITET
WO/2021/028456HOLLOW THREE-DIMENSIONAL UNIT MADE FROM RETINAL TISSUE AND USE  THEREOF IN THE TREATMENT OF RETINOPATHIESTREEFROG THERAPEUTICS
WO/2021/028469COMPOSITIONS AND METHODS FOR TREATING CYTOKINE RELEASE  SYNDROME AND NEUROTOXICITYSITOKINE LIMITED
WO/2021/028479COMPOSITIONS COMPRISING TIGOLANER FOR CONTROLLING PARASITESVETOQUINOL S.A.
WO/2021/028502IMPLANTABLE CAPSULEMAXIVAX SA
WO/2021/028512ARYLSULFONAMIDE DERIVATIVES AS MGLUR4 NEGATIVE ALLOSTERIC  MODULATORSF. HOFFMANN-LA ROCHE AG
WO/2021/032582PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES AND PHARMACEUTICAL  COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERSGALAPAGOS NV
WO/2021/028529NON-OXIDATIVE HAIR DYE COMPOSITION AND METHODKAO CORPORATION
WO/2021/028530DYEING COMPOSITION, METHOD, USE, AND KIT-OF-PARTS THEREOFKAO CORPORATION
WO/2021/028532KIT-OF-PARTS AND COMPOSITION FOR DYEING OF KERATIN FIBERS,  METHOD, AND USE THEREOFKAO CORPORATION
WO/2021/028538MIRABEGRON COMPOSITION AND USES THEREOFBIOHORM S.L.
WO/2021/063581AN ORAL CARE SPRAY COMPOSITION COMPRISING HEXAMETAPHOSPHATEUNILEVER GLOBAL IP LIMITED
WO/2021/028559METHOD FOR OBTAINING EFFICIENT COMPOSITIONS COMPRISING VIRAL  VECTORS FOR VACCINATION OR GENE THERAPYLEUKOCARE AG
WO/2021/032611HETEROAROMATIC COMPOUNDS USEFUL IN THERAPYCUROVIR AB
WO/2021/028578FILM FORMULATION COMPRISING CARRIERSKLARIA PHARMA HOLDING AB
WO/2021/032643COMPOUNDS SUITABLE FOR THE TREATMENT AND PROPHYLAXIS OF MUSCLE  WASTING AND OTHER CONDITIONSADAMS, Volker
WO/2021/032646STABILIZING BUFFER FOR FACTOR VIII AND VWFOCTAPHARMA AG
WO/2021/028585BACTERIUM COMPRISING MYO-INOSITOL TO PROPIONATE PATHWAYWAGENINGEN UNIVERSITEIT
WO/2021/028587PHARMACEUTICAL COMPOSITIONS COMPRISING BISPECIFIC ANTIBODIES  DIRECTED AGAINST CD3 AND CD20 AND THEIR USESGENMAB A/S
WO/2021/032648COMPOUNDS FOR USE IN THE TREATMENT OF LIVER DISEASETHE PROVOST, FELLOWS, FOUNDATION SCHOLARS, & THE OTHER  MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIV. TRINITY OF QUEEN
WO/2021/032650PEPTIDES FOR TREATING MUSCLE ATROPHYNURITAS LIMITED
WO/2021/032657COSMETIC O/W EMULSION CONTAINING SUCCINOGLUCAN AND LIPOPHILIC  UV FILTER SUBSTANCESBEIERSDORF AG
WO/2021/037597ISAVUCONAZONIUM SALTS AND PROCESS FOR PREPARING THEREOFSYNTHON B.V.
WO/2021/032687ANTIMALARIAL HEXAHYDROPYRIMIDINE ANALOGUESUCB BIOPHARMA SRL
WO/2021/028598REDUCTION OF BONE RESORPTION, ESPECIALLY IN CHRONIC JOINT  DISEASESTECHNISCHE UNIVERSITÄT DARMSTADT
WO/2021/032700COSMETIC O/W EMULSION CONTAINING SUCCINOGLUCANBEIERSDORF AG
WO/2021/032777OLIGONUCLEOTIDE CONJUGATE COMPOSITIONS AND METHODS OF USEMINA THERAPEUTICS LIMITED
WO/2021/037629COMPOSITION, PROCESS AND KIT FOR SEMI-PERMANENT STRAIGHTENING  AND CURLING OF KERATIN FIBERSKAO CORPORATION
WO/2021/032784PLATINUM ISOTOPE COMBINED WITH BONE-TARGETING AGENTS FOR USE  IN ANTICANCER DRUGSNUCLEAR RESEARCH AND CONSULTANCY GROUP
WO/2021/032807COMBINATION OF A CHEMOTHERAPEUTIC AGENT AND  ALPHA-LACTOGLUBULIN-OLEIC ACID COMPLEX FOR CANCER THERAPYHAMLET PHARMA AB
WO/2021/037656SOLUBILIZED FOLIC ACIDAQUANOVA AG
WO/2021/032844FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIESMüHLBAUER TECHNOLOGY GMBH
WO/2021/037676HAIR TREATMENT COMPOSITION IN FOAM FORMATUNILEVER GLOBAL IP LIMITED
WO/2021/037679USE OF HAIR TREATMENT COMPOSITION IN FOAM FORMATUNILEVER GLOBAL IP LIMITED
WO/2021/058206KIT AND METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF  AMINOSILICONE AND A CHROMOPHORIC COMPOUNDHENKEL AG & CO. KGAA
WO/2021/032861COMBINATION OF AN UROLITHIN WITH AN IMMUNOTHERAPY TREATMENTAMAZENTIS SA
WO/2021/037702PHARMACEUTICAL COMBINATION OF A SPECIFIC THIENOPYRIDONE  DERIVATIVE WITH AN FXR AGONIST FOR THE TREATMENT OF LIVER DISEASESPOXEL
WO/2021/032873COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE OF FORMULA  (I), AT LEAST ONE ALKOXYSILANE OF FORMULA (II), AT LEAST ONE NONAMINO  SILICONE, AND OPTIONALLY PIGMENTS AND/OR DIRECT DYESL'OREAL
WO/2021/037713OIL SUBSTITUTE FOR COSMETIC PREPARATIONSBEIERSDORF AG
WO/2021/037714PARTICULARLY NATURAL OIL SUBSTITUTE FOR COSMETIC PREPARATIONSBEIERSDORF AG
WO/2021/037716PARTICULARLY NATURAL OIL SUBSTITUTE FOR COSMETIC PREPARATIONSBEIERSDORF AG
WO/2021/037717ETHYL-CELLULOSE-CONTAINING SUNSCREEN SPRAYBEIERSDORF AG
WO/2021/037719HYDROXYPROPYLCELLULOSE-CONTAINING SUNSCREEN SPRAYBEIERSDORF AG
WO/2021/037733TROPOELASTIN FOR USE IN TREATMENT OF ACNE SCARRINGALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/037750NOVEL COMPOUNDS FOR SKIN LIGHTENINGUNILEVER GLOBAL IP LIMITED
WO/2021/032883COMBINATION THERAPY OF A PATIENT SUBGROUPBERGENBIO ASA
WO/2021/032891BINDING MOLECULES TO ARGINASE II (ARG2)CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/180342COMPOSITION FOR THE TREATMENT OF LESIONS OF THE RESPIRATORY  SYSTEMORGANES TISSUS REGENERATION REPARATION REMPLACEMENT
WO/2021/032894NANOPARTICLE COMPOSITION COMPRISING CHITOSAN AND CLATHRINBIOCYTO LIMITED
WO/2021/052720METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, AN EFFECT PIGMENT AND A FILM-FORMING POLYMERHENKEL AG & CO. KGAA
WO/2021/052721METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, AN EFFECT PIGMENT AND A POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/052722METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND AN  ACIDIFIERHENKEL AG & CO. KGAA
WO/2021/047900ORAL CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/037871SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B6DSM IP ASSETS B.V.
WO/2021/037873SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B1DSM IP ASSETS B.V.
WO/2021/037874SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B12DSM IP ASSETS B.V.
WO/2021/037933COMBINATION OF AZD2811 NANOPARTICLES, 5-AZACITIDINE AND  VENETOCLAX FOR USE IN THE TREATMENT OF CANCERASTRAZENECA AB
WO/2021/043656COMPOSITIONS CONTAINING DI-SUBSTITUTED TEREPHTHALATES AND  LIGHT PROTECTION FILTER SUBSTANCES, DEODORANTS AND/OR ANTIPERSPIRANTSEVONIK OPERATIONS GMBH
WO/2021/037956COMBINATIONS OF MEK INHIBITORS WITH CAP-DEPENDENT ENDONUCLEASE  INHIBITORSATRIVA THERAPEUTICS GMBH
WO/2021/037960PHARMACEUTICAL FORMULATIONKLARIA PHARMA HOLDING AB
WO/2021/038014CONTROLLED RELEASE TOFACITINIB COMPOSITIONSSYNTHON B.V.
WO/2021/043673P-GP INDUCERS AS PROTECTORS AGAINST CHEMOTHERAPY-INDUCED SIDE  EFFECTS, SUCH AS PERIPHERAL NEUROPATHY (CIPN) AND HAIR LOSSSYDDANSK UNIVERSITET
WO/2021/038022NEW USE OF CYCLIC DINUCLEOTIDESHELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/038029LOADED GRANULES, THEIR PROCESS OF PRODUCTION AND THEIR USESSAKSO
WO/2021/038035SCYLLO-INOSITOL AND B-CELL MEDIATED DISORDERSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/038036B CELL TARGETED PARALLEL CAR (pCAR) THERAPEUTIC AGENTSKING'S COLLEGE LONDON
WO/2021/038043TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND  HEPATOCELLULAR CARCINOMA (HCC) WITH COMPOUNDS BINDING THE ECTODOMAIN OF  PLATELET GLYCOPROTEIN IB (GPIB) ALPHADEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN  RECHTS
WO/2021/038062T CELL EPITOPES OF HCMV AND USES OF THEREOFEBERHARD KARLS UNIVERSITÄT TüBINGEN, MEDIZINISCHE FAKULTÄT
WO/2021/038076USE OF BETA-L-ASPARTYL-L-ARGININE ON SENESCENT SKINSYMRISE AG
WO/2021/038078THERAPY GUIDANCE AND/OR THERAPY MONITORING FOR TREATMENT OF  SHOCK4TEEN4 PHARMACEUTICALS GMBH
WO/2021/038080TREATMENTPNEUMAGEN LTD
WO/2021/038084BIOADHESIVE PARTICLES COMPRISING ACTIVE AGENTS, AND USES  THEREOFSKINOSIVE
WO/2021/038097METHOD FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME USING AN  INHIBITORY OR CYTOTOXIC AGENT AGAINST PLASMA CELLSVESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/058230METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF A PREMIX OF  AMINOSILICONE AND A CHROMOPHORIC COMPOUNDHENKEL AG & CO. KGAA
WO/2021/043718ANTIVIRAL PHARMACEUTICAL COMPOSITION CONTAINING  6-AMINONICOTINAMIDEUNIVERSITE DE PICARDIE JULES VERNE
WO/2021/043719ANTIVIRAL PHARMACEUTICAL COMPOSITION CONTAINING  THIONICOTINAMIDEUNIVERSITE DE PICARDIE JULES VERNE
WO/2021/043721USE OF COSMETIC PREPARATIONS FOR IMPROVING THE VISIBILITY OF  SUBEPIDERMAL PIGMENTSBEIERSDORF AG
WO/2021/043723METHODS AND COMPOSITIONS FOR TREATING PAX6- DEFICIENCY RELATED  DISEASEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/043724USE OF PYRVINIUM FOR THE TREATMENT OF A RAS PATHWAY MUTATED  ACUTE MYELOID LEUKEMIAINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/043726OXYTOCIN ANTAGONIST DOSING REGIMENS FOR PROMOTING EMBRYO  IMPLANTATION AND PREVENTING MISCARRIAGEOBSEVA S.A.
WO/2021/063609BISMUTH OXYCHLORIDE-CONTAINING SUNSCREEN FOR PROTECTION FROM  BLUE LIGHTBEIERSDORF AG
WO/2021/063610NOVEL SUN PROTECTIVE AGENT CONTAINING BISMUTH OXYCHLORIDE FOR  PROTECTION AGAINST BLUE LIGHTBEIERSDORF AG
WO/2021/043757FACTOR VIII PROTEIN WITH INCREASED HALF-LIFEBIOTEST AG
WO/2021/058240PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, A CHROMOPHORIC COMPOUND AND ESTER OILHENKEL AG & CO. KGAA
WO/2021/058241KIT AND METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF  AMINOSILICONE AND A CHROMOPHORIC COMPOUNDHENKEL AG & CO. KGAA
WO/2021/043771FORMULATIONS AND TREATMENT METHODSCAMURUS AB
WO/2021/052753RECOMBINANT ONCOLYTIC NEWCASTLE DISEASE VIRUSES WITH INCREASED  ACTIVITYTHALLER, Arno
WO/2021/047971METHOD FOR REMINERALIZING AND/OR REDUCING SENSITIVITY OF TEETHUNILEVER IP HOLDINGS B.V.
WO/2021/043799COSMETIC COMPOSITION FOR COATING KERATINIC FIBERS COMPRISING A  L-BETA LAMMELLAR PHASE, A CYCLIC CARBONATE AND AN ACID DYEL'OREAL
WO/2021/043803PROCESS FOR PRODUCING A TABLET COMPRISING GLP-1 PEPTIDESNOVO NORDISK A/S
WO/2021/043804IMMUNOTHERAPY TARGETING TUMOR NEOANTIGENIC PEPTIDESINSTITUT CURIE
WO/2021/043813PHENAZINE DERIVATIVE AND USE THEREOF FOR THE TREATMENT OF  CANCERCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/043835REBAMIPIDE FOR USE IN PROPHYLAXIS AND TREATMENT OF CELIAC  DISEASESQUARE POWER LTD
WO/2021/043840REBAMIPIDE FOR USE IN PROPHYLAXIS AND TREATMENT OF CANCERSQUARE POWER LTD
WO/2021/043846REBAMIPIDE FOR USE IN PREVENTION AND TREATMENT OF CROHN'S  DISEASESQUARE POWER LTD
WO/2021/043862THIORIDAZINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF  CANCERUNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/043864COSMETIC COMPOSITION FOR COATING KERATINIC FIBERS COMPRISING A  L-BETA LAMMELLAR PHASE, A CYCLIC CARBONATE AND AN ACID DYEL'OREAL
WO/2021/043869INFLUENZA VIRUS VACCINES AND USES THEREOFJANSSEN VACCINES & PREVENTION B.V.
WO/2021/249661ECOBIOLOGICAL LIPO-ALCOHOLIC COMPOSITIONNAOS INSTITUTE OF LIFE SCIENCE
WO/2021/043905VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERSORYZON GENOMICS, S.A.
WO/2021/047997ORAL CARE WATER-IN-OIL EMULSIONSUNILEVER IP HOLDINGS B.V.
WO/2021/043926MANGANESE CHELATE ISOMERSGE HEALTHCARE LIMITED
WO/2021/043927GINSENG COMPOSITION AND USE THEREOF AS A MEDICAMENTBOTALYS SA
WO/2021/043949LURBINECTEDIN IN THE TREATMENT OF MALIGNANT MESOTHELIOMAPHARMA MAR S.A.
WO/2021/043951DRUG ANTIBODY CONJUGATESPHARMA MAR, S.A.
WO/2021/048003CHIMERIC FILOVIRUS VACCINESKATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/043955COMPOSITIONS AND METHODS FOR TREATING EXTENSIVE STAGE SMALL  CELL LUNG CANCER (ES-SCLC)ASTRAZENECA AB
WO/2021/043961DOSING REGIMEN FOR THE TREATMENT OF CANCER WITH AN ANTI ICOS  AGONISTIC ANTIBODY AND CHEMOTHERAPYGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/052779ELECTROSTATICALLY SPRAYABLE COSMETIC FORMULATIONIONIQ SKINCARE GMBH & CO. KG
WO/2021/044009HERV INHIBITORS FOR USE IN TREATING TAUOPATHIESDEUTSCHES ZENTRUM FüR NEURODEGENERATIVE ERKRANKUNGEN E.V.  (DZNE)
WO/2021/044013USE OF A COMPOSITION CONTAINING AN EXTRACT OF TULIPA  GESNERIANAFRANCE COSMEPHYL-LAB
WO/2021/044045OPHTHALMIC COMPOSITION FOR THE TREATMENT OF UVEITISNOVALIQ GMBH
WO/2021/069158SUNSCREEN CONTAINING A NATURAL, FILM-FORMING POLYMERBEIERSDORF AG
WO/2021/048034GLUCOCEREBROSIDASE MUTANTSF. HOFFMANN-LA ROCHE AG
WO/2021/048041ORAL CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/044058FAST CONSOLIDATING COMPOUNDSUNIVERSITÄT INNSBRUCK
WO/2021/044061TREATMENT OF TUMORS BY A COMBINATION OF AN ONCOLYTIC  ADENOVIRUS, A CDK4/6 INHIBITOR AND A FURTHER THERAPEUTICALLY ACTIVE AGENTKLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITÄT MüNCHEN
WO/2021/048081IMMUNOTHERAPEUTIC COMPOSITIONSGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/052811NEW ONCOLYTIC NEWCASTLE DISEASE VIRUSES AND RECOMBINANT NDV  STRAINSTHALLER, Arno
WO/2021/048129USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF PAIN, AND  CORRESPONDING COMPOSITIONSNUVAMID SA
WO/2021/048135PHARMACEUTICAL COMBINATIONS COMPRISING A  FURAZANOBENZIMIDAZOLES AND A CD40 AGONIST FOR USE IN THE TREATMENT OF  NEOPLASTIC DISEASESBASILEA PHARMACEUTICA INTERNATIONAL AG
WO/2021/048162COMPOUND FOR INHIBITING CELL DEATHCHRISTIAN-ALBRECHTS-UNIVERSITÄT ZU KIEL
WO/2021/048171METHOD TO IMPROVE PHAGOCYTOSISINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/048172DELIVERY VEHICLE FOR IN SITU DELIVERING OF PHARMACEUTICAL  AGENTSRIVER STONE BIOTECH APS
WO/2021/048200NOVEL QUINOLINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE  DISEASEF. HOFFMANN-LA ROCHE AG
WO/2021/048235TREATMENT OF HR DEFICIENT CANCERTHE FRANCIS CRICK INSTITUTE LIMITED
WO/2021/048266TREATMENT OF TYPE 2 DIABETES MELLITUSSANOFI
WO/2021/048268USE OF HDL IN THE PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASEETABLISSEMENT FRANÇAIS DU SANG
WO/2021/052855STABLE PERFUMING COMPOSITIONS HAVING GOOD SPRAY PROPERTIESSOCIéTé D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/052856STABILIZER CONCENTRATES FOR WAX DISPERSIONSBASF SE
WO/2021/048283METHOD FOR PROMOTING WEIGHT LOSS BY ADMINISTERING A DIET RICH  IN ARABINOXYLAN OLIGOSACCHARIDESUNIVERSITY OF COPENHAGEN
WO/2021/048313DENTAL COMPOSITIONDENTSPLY SIRONA INC.
WO/2021/048314REBAMIPIDE FOR USE IN PREVENTION AND/OR TREATMENT OF ARTERIAL  STIFFNESSSQUARE POWER LTD
WO/2021/048315USE OF DUOX1 INHIBITORS FOR TREATING CANCERINSTITUT GUSTAVE ROUSSY
WO/2021/048322GOLF BALL-LIKE MICROPARTICLES FOR USE IN THE TREATMENT AND  PREVENTION OF PULMONARY DISEASESAQUILON PHARMACEUTICALS
WO/2021/048324NOVEL MOLECULES FOR DIAGNOSISAC IMMUNE SA
WO/2021/223894PEPTIDE FOR PREVENTION OR TREATMENT OF COVID-19APEPTICO FORSCHUNG UND ENTWICKLUNG GMBH
WO/2021/052877PREMIX AND COMPOSITION AND METHODS OF PREPARING THE SAMEUNILEVER IP HOLDINGS B.V.
WO/2021/048338COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATIONINTERVET INTERNATIONAL B.V.
WO/2021/048339VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF  CANCERTHE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/048359METHODS OF TREATING NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)  USING IL-17RA ANTIBODYBAUSCH HEALTH IRELAND LIMITED
WO/2021/048402LASSAVIRUS VACCINESKATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/048412COMBINATION THERAPIES COMPRISING PANOBINOSTAT FOR THE  TREATMENT OF CHOLANGIOCARCINOMASEALD AS
WO/2021/048417COMBINATION THERAPIES COMPRISING DASATINIB FOR THE TREATMENT  OF CHOLANGIOCARCINOMASEALD AS
WO/2021/048418COMBINATION THERAPIES COMPRISING BORTEZOMIB FOR THE TREATMENT  OF CHOLANGIOCARCINOMASEALD AS
WO/2021/048419COMBINATION THERAPIES COMPRISING TRAMETINIB FOR THE TREATMENT  OF CHOLANGIOCARCINOMASEALD AS
WO/2021/048430COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASESAMABIOTICS
WO/2021/048431COMPOUNDS FOR TREATING ATAXIAAMABIOTICS
WO/2021/104700METHOD FOR IMPROVING COLOUR RETENTION OF DYED KERATINOUS  MATERIAL, ESPECIALLY HUMAN HAIRHENKEL AG & CO. KGAA
WO/2021/104701IMPROVING THE PERFORMANCE OF PIGMENT-BASED DYES BY USING A  PRETREAMENT AGENTHENKEL AG & CO. KGAA
WO/2021/104702METHOD FOR IMPROVING THE TACTILE SENSATION OF DYED KERATINOUS  MATERIAL, ESPECIALLY HUMAN HAIRHENKEL AG & CO. KGAA
WO/2021/104703AGENT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, A CHROMOPHORIC COMPOUND AND PHOSPHOROUS-CONTAINING SURFACTANTHENKEL AG & CO. KGAA
WO/2021/048436POLYETHYLENE GLYCOL FOR USE IN THE TREATMENT AND PREVENTION OF  ABDOMINAL INFLAMMATORY DISEASES AND/OR ASSOCIATED DISEASESCONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/104704PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, PIGMENT, POLYSACCHARIDE AND A FATTY CONSTITUENTHENKEL AG & CO. KGAA
WO/2021/104705METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED USING A PIGMENTHENKEL AG & CO. KGAA
WO/2021/048438INHIBITOR OF METADHERIN EXPRESSIONSECARNA PHARMACEUTICALS GMBH & CO. KG
WO/2021/048441METHOD AND APPARATUS FOR CELL ISOLATION AND ISOLATED CELLS FOR  WOUND HEALINGVERITACELL
WO/2021/052923ACTIVE SUBSTANCE DELIVERY SYSTEM WITH DELAYED DELIVERYCAPNOMED GMBH
WO/2021/052926AGENT FOR USE IN TREATMENT OR PREVENTION OF OPHTHALMIC  DISORDERSCHIESI FARMACEUTICI S.P.A.
WO/2021/052952METHODS OF TREATMENT AND/OR PREVENTION OF DISORDERS AND  SYMPTOMS RELATED TO BKCA AND/OR SK CHANNELOPHATHIESUNIVERSITE DE BORDEAUX
WO/2021/052960STABLE, CONCENTRATED RADIOPHARMACEUTICAL COMPOSITIONADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/052962TREATMENT OF SPINAL CORD INJURYINSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES
WO/2021/053001CAMPHORSULFONIC ACID AND COMBINATIONS THEREOF WITH CATIONIC  EXCIPIENTS AS VISCOSITY REDUCING AGENTS IN HIGH CONCENTRATED PROTEIN  FORMULATIONSMERCK PATENT GMBH
WO/2021/053018TARGETING MISSPLICED TRANSCRIPTS IN GENETIC DISORDERSUNIQURE IP B.V.
WO/2021/104706AGENT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, PIGMENT AND POLYSACCHARIDEHENKEL AG & CO. KGAA
WO/2021/063686AN ORAL CARE COMPOSITION COMPRISING HEXAMETAPHOSPHATE AND A  PIGMENTUNILEVER IP HOLDINGS B.V.
WO/2021/053040METHODS FOR RADIOLABELLING GRPR ANTAGONISTS AND THEIR KITSADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/053047BIOACTIVE IMPLANTS FOR DRUG DELIVERYTHE QUEEN'S UNIVERSITY OF BELFAST
WO/2021/053058ALVELESTAT FOR USE IN THE TREATMENT OF GRAFT REJECTION,  BRONCHIOLITIS OBLITERANS SYNDROME AND GRAFT VERSUS HOST DISEASEMEREO BIOPHARMA 4 LIMITED
WO/2021/115648DOSAGE FORM COMPRISING AN ALKALINE AGENT AND AN ENTERIC  COATING LAYEREVONIK OPERATIONS GMBH
WO/2021/115649DOSAGE FORM FOR USE IN TREATING OR PREVENTING OF A DISEASEEVONIK OPERATIONS GMBH
WO/2021/115650DOSAGE FORM FOR USE IN TREATING OR PREVENTING OF A DISEASEEVONIK OPERATIONS GMBH
WO/2021/053076COMBINATION THERAPY WITH VILDAGLIPTIN AND METFORMINNOVARTIS AG
WO/2021/053078NICOTINE POUCHENORAMA PHARMA AB
WO/2021/053093ANTIPERSPIRANT COMPOSITIONSUNILEVER IP HOLDINGS B.V.
WO/2021/053126METHOD OF TREATING HBV INFECTION USING A CORE PROTEIN  ALLOSTERIC MODULATORF. HOFFMANN-LA ROCHE AG
WO/2021/053155COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR  OF AN ANTIAPOPTOTIC BCL-2 FAMILY PROTEINAPREA THERAPEUTICS AB
WO/2021/053163IMMUNE STIMULATING MICELLE COMPOSITIONDANMARKS TEKNISKE UNIVERSITET
WO/2021/053167EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASEAMW GMBH
WO/2021/053171EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASEAMW GMBH
WO/2021/053173METHODS FOR TRIGGERING M1 MACROPHAGE POLARIZATIONNH THERAGUIX
WO/2021/053178PREPARATION FOR REMOVAL AND/OR PREVENTION OF AN INFECTION  ASSOCIATED WITH STAPHYLOCOCCUS EPIDERMIDISRLS GLOBAL AB
WO/2021/053185MELFLUFEN FORMULATIONS AND THEIR USE IN THE TREATMENT OR  PROPHYLAXIS OF OSTEOSARCOMAONCOPEPTIDES AB
WO/2021/053194KV1.3 BLOCKERSZEALAND PHARMA A/S
WO/2021/053198POLYMER OR POLYCONDENSATE BASED ON PEPTIDE, LINKER AND  OPTIONALLY OTHER MONOMERS AND METHOD FOR PREPARING THE SAMEECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/058416HETEROCYCLIC COMPOUNDSF. HOFFMANN-LA ROCHE AG
WO/2021/058423COMPOSITION WITH DRUG MICRO-NANO PARTICLES OF AN ANTI-CANCER  AGENTCAPNOMED GMBH
WO/2021/058428COMPOSITIONS FOR USE IN REDUCING INFLAMMATIONEVONIK OPERATIONS GMBH
WO/2021/053234COMPOUNDS AND COMPOSITIONS FOR TREATING KIDNEY DISEASEJOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/053240A NOVEL HUMAN RESPIRATORY SYNCYTIAL VIRUS STRAIN AND ITS USEUNIVERSITEIT ANTWERPEN
WO/2021/063727A POUCH PRODUCT SUITABLE FOR APPLICATION IN AN ORAL CAVITYSCHJÖLIN, Evaggelos
WO/2021/053246ORAL DELIVERY SYSTEMUNIVERSITY COLLEGE DUBLIN
WO/2021/063734CDK4/6 INHIBITORS FOR THE TREATMENT OF PSORIASISEBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/063737AGENT FOR THE TREATMENT OF PSORIASISEBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/058454NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR  INHALATIONCHIESI FARMACEUTICI S.P.A.
WO/2021/058463A LIPOSOME SYSTEM COMPRISING A LIPID, AN ACTIVE COMPOUND AND A  VECTOR PEPTIDEWESTFÄLISCHE WILHELMS-UNIVERSITÄT MüNSTER
WO/2021/058469ANHYDROUS COMPOSITIONSDSM IP ASSETS B.V.
WO/2021/058472TREATMENT INVOLVING THERAPEUTIC ANTIBODY AND INTERLEUKIN-2  (IL2)BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/058492NANOPARTICLE COMPOSITIONS FOR GENE THERAPYUNIVERSITY COLLEGE DUBLIN
WO/2021/104709METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED BY APPLYING A PIGMENTHENKEL AG & CO. KGAA
WO/2021/104710METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED USING AN AMINO SILICONE AND A PIGMENTHENKEL AG & CO. KGAA
WO/2021/058514COMPOSITIONS AND METHODS USING ADENOSYLCOBALAMINSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/058521A TOPICAL PLANT EXTRACT FORMULATION COMPRISING URTICA DIOICA  AND VITAMIN ATHE CEUTICS COMPANY GESMBH
WO/2021/058548ANTIBODIES FOR THE DIAGNOSIS AND/OR TREATMENT OF  ATHEROSCLEROSISCENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III  (F.S.P.)
WO/2021/058549RADIOLABELLED GRPR-ANTAGONIST FOR USE AS THERAGNOSTICADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/058604HYPOCHLORITE COMPOSITION AND SYSTEM AND METHOD FOR PREPARING A  HYPOCHLORITE COMPOSITION AND USE OF THE SAMEKONINKLIJKE PHILIPS N.V.
WO/2021/058611KIT, SYSTEM AND METHOD FOR PREPARING AND USE OF A  PEROXIDE-CONTAINING COMPOSITIONKONINKLIJKE PHILIPS N.V.
WO/2021/058628SCYLLO-INOSITOL AND ITS USE AS INSULIN SENSITIZERSOCIéTé DES PRODUITS NESTLé SA
WO/2021/058636ANTI-NRP1A ANTIBODIES AND THEIR USES FOR TREATING EYE OR  OCULAR DISEASESBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/058651HYDROGEL COMPOSITIONS FOR THE CONTROLLED AND CONSTANT RELEASE  OF ACTIVE AGENTSTECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/058656RIFAXIMIN LIQUID FORMULATIONSBAUSCH HEALTH IRELAND LIMITED
WO/2021/058670PHARMACEUTICAL DELIVERY DEVICE AND METHOD OF MANUFACTUREUNIVERSITY OF ULSTER
WO/2021/058679POWDER AND PROCESS FOR CLEANING TEETH BY USE OF SUCH POWDERFERTON HOLDING S.A.
WO/2021/058684MODIFIED VESICULAR STOMATITIS VIRUS GLYCOPROTEIN AND USES  THEREOF FOR THE TREATMENT OF BRAIN TUMORSUNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/058715HYDROGEL BASED ON ZINC GLUCONATE AND HYALURONIC ACID ESTERSBMG PHARMA S.P.A.
WO/2021/063813PROCESS FOR PREPARING NANOPARTICLES IN THE FORM OF A POWDER  COMPRISING A BIO-RESORBABLE POLYESTEREVONIK OPERATIONS GMBH
WO/2021/058735CANCER TREATMENT WITH ANTI-MET ANTIBODY COMPOSITIONSSYMPHOGEN A/S
WO/2021/058744USE OF MüLLERIAN INHIBITING SUBSTANCE INHIBITORS FOR TREATING  CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/058748FORMULATION FOR TOPICAL APPLICATION TO THE SKIN OR MUCOUS  MEMBRANESSEBBAN, Sandrine
WO/2021/058754PHARMACEUTICAL COMPOUNDSSENTINEL ONCOLOGY LIMITED
WO/2021/058758CELL COMPOSITION COMPRISING RADIOLABLED MESENCHYMAL STEM  CELLS, USE THEREOF AND METHOD FOR PREPARING RADIOLABELED MESENCHYMAL STEM  CELLSGLOBAL STEM CELL TECHNOLOGY NV
WO/2021/058794DOSING REGIMENS FOR TREATMENT OF PATIENTS WITH LOCALLY  ADVANCED SQUAMOUS CELL CARCINOMADEBIOPHARM INTERNATIONAL S.A.
WO/2021/058798USE OF FGFR INHIBITORS IN FGFR-GENETICALLY ALTERED CANCERS TO  ENHANCE PATIENT RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN SEQUENTIAL  TREATMENT SETTINGSJANSSEN PHARMACEUTICA NV
WO/2021/058804BINDING MODULES COMPRISING MODIFIED EHD2 DOMAINSUNIVERSITÄT STUTTGART
WO/2021/058807TRIVALENT BINDING MOLECULESUNIVERSITÄT STUTTGART
WO/2021/058810PEDIATRIC TRAZODONE COMPOSITIONS AND METHOD OF TREATMENT  THEREOFANGELINI S.P.A.
WO/2021/058811SHORT-CHAIN FATTY ACID PENTANOATE AS ENHANCER FOR CELLULAR  THERAPY AND ANTI-TUMOR THERAPYPHILIPPS-UNIVERSITÄT MARBURG
WO/2021/058818NOVEL MEDICAL USES OF THIOL-FUNCTIONALIZED POLYGLYCEROL  DERIVATIVESFREIE UNIVERSITÄT BERLIN
WO/2021/083593LAG TIME REDUCTION/ICE SPRAYLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/058831THERAPEUTIC EFFICACY BY PULMONARY DELIVERY OF LIVE ATTENUATED  MYCOBACTERIAUNIVERSIDAD DE ZARAGOZA
WO/2021/058835CONTROL OF TUMOUR GROWTH AND GUT BLEEDING BY BIOSURFACTANTSUNIVERSITY OF ULSTER
WO/2021/063917VACCINE AGAINST CHLAMYDIA IN SWINEUNIVERSITEIT GENT
WO/2021/069256SILICA FOR ORAL CARE COMPOSITIONSRHODIA OPERATIONS
WO/2021/063945COMBINED THERAPY COMPRISING AN INHIBITOR OF INTERLEUKIN-17  ACTIVITY AND A VITAMIN D RECEPTOR AGONISTSERVEI DE SALUT DE LES ILLES BALEARS – IBSALUT
WO/2021/063967NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS,  PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOFSANOFI
WO/2021/064009PROTEIN BINDERS TO IRHOM2 EPITOPESSCIRHOM GMBH
WO/2021/064034A PUNICA GRANATUM EXTRACT AND ITS COSMETIC USESL'OREAL
WO/2021/064050IMMUNOGENIC COMPOSITIONSGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/064069METHODS FOR THE TREATMENT OF ADULT T-CELL LEUKEMIA/LYMPHOMAINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/064072USE OF RETINOIC ACID RECEPTOR (RAR) AGONISTS FOR REVERSING,  PREVENTING, OR DELAYING CALCIFICATION OF AORTIC VALVEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/064076LIPOSOMES COMPRISING ANTI-LOX ANTIBODYISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI  TUMORI (I.R.S.T.) S.R.L.
WO/2021/064088BETA-GLUCANS HAVING SUPERIOR IMMUNO-STIMULATING PROPERTIESUNIVERSITEIT GENT
WO/2021/064105EXTRACT OF ORGANIC HUMIFIED MATERIALSFELLNER, Stefan Johannes
WO/2021/064116COMPOSITIONS WITH POLYMERIC OR OLIGOMERIC HYDROXY PHENYL  TRIAZINE UV FILTERBASF SE
WO/2021/064123PHARMACEUTICAL COMPOSITION COMPRISING ENZALUTAMIDESYNTHON B.V.
WO/2021/064132TREATMENT OF MENOPAUSAL SYNDROME AND/OR SYMPTOMS ASSOCIATED  WITH MENOPAUSEBESINS HEALTHCARE IRELAND LIMITED
WO/2021/064142HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND  THEIR USE IN THE TREATMENT OR AMELIORATION OF CANCERTOLREMO THERAPEUTICS AG
WO/2021/064151COMBINATION OF THE ETHYL ESTERS OF DOCOSAHEXAENOIC AND  EICOSAPENTAENOIC ACID PLUS VITAMIN D3 FOR PREVENTION OF AGE-RELATED DISEASESUNIVERSITÄT ZüRICH
WO/2021/064152HYBRID ANTIBODYEPSILOGEN LTD
WO/2021/064153HYBRID ANTIBODYEPSILOGEN LTD
WO/2021/064159RETINOID DERIVATIVES FOR USE IN THE TREATMENT OF DISEASES  ASSOCIATED WITH SULFATASE DEFICIENCIESGEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN  RECHTS, UNIVERSITÄTSMEDIZIN
WO/2021/064167COMBINATION PRODUCT FOR RELIEVING THE BRONCHIURGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/064169COMBINATION PRODUCT FOR RELIEVING THE BRONCHI AND FACILITATING  FALLING ASLEEPURGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/064173USE OF LEONTODIUM ALPINUM PLANT CELLS FOR AN ANTI-GLYCATION  ANTI-AGEING SKIN TREATMENTSEDERMA
WO/2021/064180METHODS AND COMPOSITIONS FOR MODULATING MACROPHAGES  POLARIZATIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/064184METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF  OVARIAN CANCER, BREAST CANCER OR PANCREATIC CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/064186NOVEL PYRIDIN-2(1<i>H</i>)ONE DERIVATIVES, THEIR  PREPARATION AND THEIR USE FOR THE TREATMENT OF PAININSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE  (INSERM)
WO/2021/064188COMBINATION COMPRISING HDAC INHIBITOR, CTLA-4 INHIBITOR AND A  PD-1 INHIBITOR OR PD-L1 INHIBITOR FOR CANCER TREATMENT4SC AG
WO/2021/064197ISOLATED POLYPEPTIDE AND POLYPEPTIDE COMPLEXES FOR PREVENTION,  ALLEVIATION AND/OR TREATMENT OF HCV INFECTIONSKØBENHAVNS UNIVERSITET
WO/2021/064217METHOD FOR TREATING AND/OR PREVENTING A PARASITIC INFECTION IN  A TELEOSTPREVIWO AS
WO/2021/064227SINGLE DOMAIN ANTIBODIES SPECIFICALLY BINDING GLOBO - SERIES  GLYCANSMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/069339HOMOPIPERAZINYL AND HOMOPIPERIDINYL QUINAZOLIN-4(3H)-ONE  DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAINESTEVE PHARMACEUTICALS, S.A.
WO/2021/069344PROCESS FOR THE PREPARATION OF A NANOPARTICULATE ACTIVE  INGREDIENTBAYER AKTIENGESELLSCHAFT
WO/2021/069345PROCESS FOR PRODUCING NANOPARTICULATE RIVAROXABANBAYER AKTIENGESELLSCHAFT
WO/2021/069349PROCESS FOR PRODUCING A PHARMACEUTICAL FORMULATION COMPRISING  CRYSTALLINE AND AMORPHOUS FRACTIONS OF AN ACTIVE SUBSTANCEBAYER AKTIENGESELLSCHAFT
WO/2021/069350PROCESS FOR PRODUCING A PHARMACEUTICAL FORMULATION COMPRISING  ACTIVE SUBSTANCE, POLYMER AND SURFACTANTBAYER AKTIENGESELLSCHAFT
WO/2021/083616HAIR CARE COMPOSITIONGIVAUDAN SA
WO/2021/069426PEPTIDE BASED COSMETIC OR DERMATOLOGICAL TREATMENT OF THE SKIN  AND ITS APPENDAGESSEDERMA
WO/2021/073961SOLUTION OF CELLULOSE IN A QUATERNARY AMMONIUM COMPOUND AND A  CO-SOLVENTBASF SE
WO/2021/104728BIODEGRADABLE BEADSBASF SE
WO/2021/104729BIODEGRADABLE BEADS WITH DYES AND PIGMENTSBASF SE
WO/2021/069486MEK INHIBITORS FOR THE TREATMENT OF HANTAVIRUS INFECTIONSATRIVA THERAPEUTICS GMBH
WO/2021/069496AN ANHYDROUS PHARMACEUTICAL COMPOSITION FOR MAINTENANCE  TREATMENT OF PSORIASISLEO PHARMA A/S
WO/2021/069497SYSTEMIC ADMINISTRATION OF PEPTIDES FOR THE TREATMENT OF  SPINAL CORD INJURY AND/OR FOR REMYELINATIONAXOLTIS PHARMA
WO/2021/069523CALRETICULIN FOR TREATING OR PREVENTING AN ANGIOGENIC EYE  DISEASEUAB BALTYMAS
WO/2021/069527NON-DEGRADABLE EMBOLISATION MICROSPHEREGUERBET
WO/2021/069528NON DEGRADABLE RADIO-OPAQUE EMBOLISATION MICROSPHEREGUERBET
WO/2021/069533HAIR TREATMENT COMPOSITIONSUNILEVER IP HOLDINGS B.V.
WO/2021/073988ANTIPERSPIRANT EMULSIONUNILEVER IP HOLDINGS B.V.
WO/2021/073989AN ANTIPERSPIRANT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/069542ZAFIRLUKAST DERIVATIVES FOR USE AS CONTRACEPTIVE AGENTSRIGSHOSPITALET
WO/2021/069553USE OF LIVER PROGENITOR OR STEM CELLS, LYSATES THEREOF, AND/OR  CONDITIONED MEDIUM IN DISORDERS CHARACTERIZED BY VASCULAR HYPERPERMEABILITYPROMETHERA BIOSCIENCES S.A./N.V.
WO/2021/069558COMPOSITIONS OF THE OLEA EUROPAEA V. SYLVESTRIS WITH  ANTIMICROBIAL EFFICACYTAPROGGE GMBH
WO/2021/069567NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDESBAYER AKTIENGESELLSCHAFT
WO/2021/069571POLYMORPH OF LORLATINIBSANDOZ AG
WO/2021/069576A PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOIDBLACKHAWK PARTNERS LTD
WO/2021/069578RIBOFLAVIN FOR USE IN CONTROLLING BLOOD PRESSURE DURING  PREGNANCYDSM IP ASSETS B.V.
WO/2021/069590GELATIN CAPSULES WITH GROUND CALCIUM CARBONATECAPSUGEL FRANCE SAS
WO/2021/069615IMPROVED ANTI-HANGOVER COMPOSITION, ITS PREPARATION AND USESZOBRIUS PHARMA AS
WO/2021/074012HAIR TREATMENT METHODUNILEVER IP HOLDINGS B.V.
WO/2021/074025USE OF ESCULENTIN AND ITS DERIVATIVES FOR USE IN THE TREATMENT  OF CYSTIC FIBROSISUNIVERSITà DEGLI STUDI DI ROMA “LA SAPIENZA”
WO/2021/069671HEXAHYDRO-5,8-EPOXYCYCLOHEPTA[c]PYRAZOLE DERIVATIVES USEFUL AS  MODULATORS OF THE CB1 AND/OR CB2 RECEPTORSJANSSEN PHARMACEUTICA NV
WO/2021/069685FLUORESCENT VANCOMYCIN ANALOGUEUNIVERSITE DE STRASBOURG
WO/2021/069686NOVEL THERAPEUTIC COMBINATIONS COMPRISING DERIVATIVES OF  OXAZAPHOSPHORINES FOR THE TREATMENT OF CANCERINSTITUT GUSTAVE ROUSSY
WO/2021/069698HEALING AND CONDUCTIVE COMPOSITION COMPRISING COLLAGENMONDERNA HEALTH & WELLNESS
WO/2021/204409OLEYL PHOSPHOCHOLINE CONTAINING GRANULATESOBLITA THERAPEUTICS BVBA
WO/2021/069705ISOINDOLINONE COMPOUNDSMONTE ROSA THERAPEUTICS
WO/2021/069709ANTI-CHEMOKIN LIKE RECEPTOR 1 HUMANIZED ANTIBODIES AND THEIR  THERAPEUTIC APPLICATIONSOSE IMMUNOTHERAPEUTICS
WO/2021/078553NOVEL PEDIATRIC COMBINATIONCESSATECH A/S
WO/2021/069736NEW CARBAZOLE DERIVATIVES SENSITIZING CELLS TO ANTI-CANCER  AGENTSCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/069740METHOD FOR PREVENTING HUMAN GLANDS FROM RADIATION DAMAGEKCM CONSULTING GMBH
WO/2021/083657COSMETIC PREPARATION COMPRISING ALKALINE EARTH METAL SALTS,  CARBOXYLIC ACIDS AND EMULSIFIERS HAVING BRANCHED HYDROPHOBIC CHAINSBEIERSDORF AG
WO/2021/089278MICROMETRIC SIZE COMPOSITION AND ITS USE AS A PLANT ALKALOID  COADJUVANT AGENTBEIJING ENBIWO BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/074118LIQUID OMEGA-3 FATTY ACID COMPOSITIONS FOR DIRECT ORAL  ADMINISTRATIONHERMES ARZNEIMITTEL GMBH
WO/2021/110306MULTI-TONE HAIR DYEING METHOD IN THREE STEPSHENKEL AG & CO. KGAA
WO/2021/115664HAIR STYLING COMPOSITION I CONTAINING SUGARHENKEL AG & CO. KGAA
WO/2021/074158ORAL CARE COMPOSITIONLACER, S.A.
WO/2021/074159MEMBRANE-BASED TWO COMPONENT THERAPEUTIC GAS RELEASE SYSTEM  FOR ORAL ADMINISTRATIONJULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/074164ORAL CARE COMPOSITIONLACER, S.A.
WO/2021/074197THIENOPYRIMIDONES AS TRPA1 INHIBITORSBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/074198NOVEL TETRAZOLESBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/078611COSMETIC COMPOSITION WITH ENHANCED COLOR STABILITYUNILEVER IP HOLDINGS B.V.
WO/2021/074261B-LYMPHOCYTE SPECIFIC AMATOXIN ANTIBODY CONJUGATESHEIDELBERG PHARMA RESEARCH GMBH
WO/2021/074284USE OF NICOTINAMIDE MONONUCLEOTIDE (NMN) FOR THE PREVENTION  AND/OR TREATMENT OF RHEUMATOID ARTHRITIS, AND CORRESPONDING COMPOSITIONSNUVAMID SA
WO/2021/074314AQUEOUS FORMULATIONS COMPRISING BUFFERED TIOTROPIUM BROMIDE  FOR TOPICAL TREATMENT OF HYPERHIDROSISNOTOXINS IP B.V.
WO/2021/074352NOVEL VACCINE COMPOSITIONSGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/074357THIOPHENE DERIVATIVES FOR USE IN TREATING PORTAL INFLAMMATION  AND FIBROSISENYO PHARMA
WO/2021/121715METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND,  A  HYDROXYCARBOXYLIC ACID ESTER, A COLOURING COMPOUND AND A POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/121716METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, SHELLAC,  A  DYEING COMPOUND AND A POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/121717METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND A  DYEING COMPOUND AND A OLIGOMERESTERHENKEL AG & CO. KGAA
WO/2021/121718METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND  TANNIC ACIDHENKEL AG & CO. KGAA
WO/2021/121719PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED BY USING THE  PIGMENT SUSPENSIONHENKEL AG & CO. KGAA
WO/2021/121720PIGMENT SUSPENSION AND METHOD FOR DYING KERATINOUS MATERIAL  USING THE PIGMENT SUSPENSIONHENKEL AG & CO. KGAA
WO/2021/0893004-[5-[(RAC)-1-[5-(3-CHLOROPHENYL)-3-ISOXAZOLYL]ETHOXY]-4-METHYL-4<i>H</i>-1,2,4-TRIAZOL-3-YL]PYRIDINE  FOR USE IN PREVENTION AND/OR TREATMENT OF SURMENAGE IN A MAMMALTHULIN, Claes
WO/2021/121721METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A DYEING COMPOUND AND A PRE-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/074368IRON(III) COMPLEXES HAVING NEW CONTRAST AGENT PROPERTIES, FOR  MAGNETIC RESONANCE IMAGINGCHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/121722METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A HYDROXYCARBOXYLIC ACID ESTER,  C<sb>1</sb>-C<sb>10</sb> ALCOHOL AND A DYEING  COMPOUNDHENKEL AG & CO. KGAA
WO/2021/121723METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, AN HYDROXYCARBOXYLIC ACID ESTER, A DIOL AND A  DYEING COMPOUNDHENKEL AG & CO. KGAA
WO/2021/121724METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE, A  DYEING COMPOUND AND SHELLACHENKEL AG & CO. KGAA
WO/2021/121725METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND A  COPOLYMER OF (METH)ACRYLIC ACID AND MALEIC ACID (ANHYDRIDE)HENKEL AG & CO. KGAA
WO/2021/121726METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE, A  DYEING COMPOUND AND  GALACTOMANNANHENKEL AG & CO. KGAA
WO/2021/121727METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND A  COPOLYMER OF STYRENE AND MALEIC ACID (ANHYDRIDE)HENKEL AG & CO. KGAA
WO/2021/074389IMMUNOGENIC COMPOUNDS FOR TREATMENT OF ADRENAL CANCERENTEROME S.A.
WO/2021/074398A PROCESS FOR PRODUCING MICROPARTICLES FOR USE AS MICROBEADS  AND MICROPARTICLES PRODUCED ACCORDING TO THE PROCESSSEAGREEN BIO LIMITED
WO/2021/074399CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC  PHYSIOLOGICALLY ACTIVE SUBSTANCESADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/074403CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC  PHYSIOLOGICALLY ACTIVE SUBSTANCESADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/074409COMPOSITION FOR THE TREATMENT OF (PRE)OBESITY AND/OR  ASSOCIATED MORBIDITIES THERETOBASF SE
WO/2021/074414OXAZOLE AND THIOAZOLE-TYPE CULLIN RING UBIQUITIN LIGASE  COMPOUNDS AND USES THEREOFCEMM - FORSCHUNGSZENTRUM FüR MOLEKULARE MEDIZIN GMBH
WO/2021/074418CARBAZOLE-TYPE CULLIN RING UBIQUITIN LIGASE COMPOUNDS AND USES  THEREOFCEMM - FORSCHUNGSZENTRUM FüR MOLEKULARE MEDIZIN GMBH
WO/2021/074423VACCINE PRODUCTJANSSEN VACCINES & PREVENTION B.V.
WO/2021/074431MICROBIAL COMPOSITIONS, STRAINS AND METHODSUNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
WO/2021/110313METHOD FOR COLOURING KERATIN MATERIAL, COMPRISING THE USE OF  AN ORGANIC C1-C6 ALKOXY SILANE AND TWO STRUCTURALLY DIFFERENT CELLULOSE TYPESHENKEL AG & CO. KGAA
WO/2021/089306ANTI-INFLAMMATORY COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/110314METHOD FOR COLOURING KERATIN MATERIAL, COMPRISING THE USE OF  AN ORGANIC C1-C6 ALKOXYSILANE AND FIBRESHENKEL AG & CO. KGAA
WO/2021/078685METHOD OF REDUCING DENTAL HYPERSENSITIVITYUNILEVER IP HOLDINGS B.V.
WO/2021/074452COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYL  PHOSPHONIC ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYL PHOSPHONIC ACID  DERIVATIVES WITH CLINDAMYCIN AND ARTESUNATEDMG DEUTSCHE MALARIA GMBH
WO/2021/078726PHARMACEUTICAL COMPOSITIONS OF GD-BASED CONTRAST AGENTSBRACCO IMAGING SPA
WO/2021/197646AQUEOUS OCTENIDINE-CONTAINING COMPOSITION FOR TREATING AND/OR  PREVENTING AN EXACERBATION OF DISEASES CAUSED BY A CORONAVIRUS INFECTIONSCHüLKE & MAYR GMBH
WO/2021/078761TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL  ADMINISTRATION OF FINGOLIMODLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/121734MODIFIED GRPR ANTAGONIST PEPTIDES FOR IMAGING AND THERAPY OF  CANCERTECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/083766TREATMENT OF PRURITUS IN HORSESEVAX AG
WO/2021/078810SCHIZOPHRENIC DISORDER TREATMENT USING COMBINATION THERAPYCAMBRIDGE COGNITION LTD.
WO/2021/078814USE OF CYCLODEXTRINS AS A RADIOSTABILIZERGE HEALTHCARE LIMITED
WO/2021/078835PHARMACEUTICAL COMPOSITION COMPRISING SELEXIPAGACTELION PHARMACEUTICALS LTD
WO/2021/078864COMPOSITIONS FOR THE TREATMENT OF EPITHELIAL LESIONSGIELLEPI S.P.A.
WO/2021/078889METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE WITH  A FERROPORTIN INHIBITOR (VIT-2763)VIFOR (INTERNATIONAL) AG
WO/2021/078910IMMUNOTHERAPY TARGETING TUMOR NEOANTIGENIC PEPTIDESINSTITUT CURIE
WO/2021/083790DRY SHAMPOO COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/078912TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASENURITAS LIMITED
WO/2021/078920COMPOSITIONS COMPRISING 2'-FUCOSYLLACTOSE TO PREVENT ASTHMAFRIESLANDCAMPINA NEDERLAND B.V.
WO/2021/078925METHODS OF TREATING CANCERASTRAZENECA AB
WO/2021/078937TREATMENT OF STAT3 RELATED DISEASES BY IRON CHELATORSDEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/078939RNA OLIGONUCLEOTIDES FOR PREVENTING AGGREGATION OF PROTEINSUNIVERSITÄT WIEN
WO/2021/078942COMPOUNDS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASEUNIVERSIDAD DEL PAíS VASCO / EUSKAL HERRIKO UNIBERTSITATEA
WO/2021/078952ANALOGUES OF N-ACYL-HOMOSERINE LACTONES AND PHARMACEUTICAL  COMPOSITION COMPRISING SAMESORBONNE UNIVERSITE
WO/2021/078958COMPOUNDS FOR USE (IN PARTICULAR RIPA-56) IN THE PREVENTION  AND/OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASESORBONNE UNIVERSITE
WO/2021/078959AMH-COMPETITIVE ANTAGONIST ANTIBODYGAMAMABS PHARMA
WO/2021/078964ORAL GLIPTIN COMPOSITIONS AND METHOD FOR PREPARATION THEREOFAUTHENDA PHARMACEUTICALS AG
WO/2021/078982PRODUCT FOR COSMETIC SKIN CARES.I.P.R.E.S. S.R.L.
WO/2021/078987COMBINATION TREATMENTS FOR CANCERCELEX ONCOLOGY INNOVATIONS LIMITED
WO/2021/078988RECOMBINANT L-ASPARAGINASEJAZZ PHARMACEUTICALS IRELAND LTD.
WO/2021/078991TREATMENT OF CONDITIONS OF THE NERVOUS SYSTEMKWOK, Jessica
WO/2021/104770ACTIVE SUBSTANCE COMBINATIONS OF UBICHINOL UND GLYCERYL  STEARATE CITRATE AND COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID  ACTIVE SUBSTANCE COMBINATIONSBEIERSDORF AG
WO/2021/104772ACTIVE SUBSTANCE COMBINATIONS OF UBIQUINOL AND CARRAGEENAN AND  COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ACTIVE SUBSTANCE  COMBINATIONSBEIERSDORF AG
WO/2021/104773ACTIVE SUBSTANCE COMBINATIONS OF UBICHINOL UND HYALURONIC ACID  AND COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ACTIVE SUBSTANCE  COMBINATIONSBEIERSDORF AG
WO/2021/104775ACTIVE SUBSTANCE COMBINATIONS OF UBICHINOL AND CREATINE AND  COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ACTIVE SUBSTANCE  COMBINATIONSBEIERSDORF AG
WO/2021/104777ACTIVE SUBSTANCE COMBINATIONS OF UBIQUINOL AND ONE OR MORE  EMULSIFIERS FROM THE GROUP OF PHOSPHATES AND SULFATES, AND COSMETIC OR  DERMATOLOGICAL PREPARATIONS CONTAINING SUCH ACTIVE SUBSTANCE COMBINATIONSBEIERSDORF AG
WO/2021/079010ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS  THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER  NEURODEGENERATIVE CONDITIONSINSTITUT PASTEUR DE MONTEVIDEO
WO/2021/099072HAIR CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/099073HAIR CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/104780ANTIMICROBIAL COMPOSITIONS COMPRISING MODIFIED CLAY AND  COPOLYMERSUNILEVER IP HOLDINGS B.V.
WO/2021/083867PHARMACEUTICAL COMPOSITION INCLUDING A SYNERGISTIC COMBINATION  OF IBUPROFEN AND N-ACETYLCYSTEINEE-PHARMA TRENTO S.P.A.
WO/2021/104781ACTIVE SUBSTANCE COMBINATIONS OF UBIQUINOL AND UBIQUINONE,  COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SUCH ACTIVE SUBSTANCE  COMBINATIONS, AND USE OF UBIQUINOL TO IMPROVE THE EFFICACY OF COSMETIC OR  DERMATOLOGICAL PREPARATIONS WITH AN UBIQUINONE CONTENTBEIERSDORF AG
WO/2021/083879BROMODOMAIN INHIBITORSRHEINISCH-WESTFÄLISCHE TECHNISCHE HOCHSCHULE (RWTH) AACHEN
WO/2021/083899PROCESS FOR PREPARING A DYE COMPOSITION COMPRISING THE MIXING  OF SOLID PARTICLES WITH AN AQUEOUS COMPOSITION CONTAINING ARGININE, AND THE  USE THEREOFL'OREAL
WO/2021/083900METHOD FOR THE TREATMENT OF KERATIN FIBRES BY MEANS OF A  COMPOSITION CONTAINING ARGININE AND OF AN OXIDIZING COMPOSITIONL'OREAL
WO/2021/083901PROCESS FOR PREPARING A DYE COMPOSITION, COMPRISING THE MIXING  OF AT LEAST TWO TYPES OF SOLID PARTICLES WITH AN AQUEOUS COMPOSITION, AND USE  THEREOFL'OREAL
WO/2021/083902ALKALINE COMPOSITION COMPRISING AT LEAST THREE DIFFERENT  ALKALINE AGENTS FOR THE TREATMENT OF KERATIN FIBRES, METHODS AND USESL'OREAL
WO/2021/083903COATED COLOURING SOLID PARTICLES COMPRISING AT LEAST ONE  DIRECT DYE AND/OR ONE OXIDATION DYE PRECURSORL'OREAL
WO/2021/083904PROCESS FOR PREPARING A DYE COMPOSITION BY MIXING SOLID  PARTICLES AND AN OXIDIZING COMPOSITION AND AN ALKALINE COMPOSITIONL'OREAL
WO/2021/083910DRY POWDER FORMULATIONS CONTAINING LEUCINE AND TRILEUCINEASTRAZENECA AB
WO/2021/083912COMBINATION THERAPY HAVING ANTIOXYDANT PROPERTIESGENFIT
WO/2021/083919COMPOSITION CONTAINING PREBIOTIC BACTERIA AND LICOCHALCONE ABEIERSDORF AG
WO/2021/083920COMPOSITION CONTAINING PREBIOTIC BACTERIA AND PROTECTOR  STRAINSBEIERSDORF AG
WO/2021/104782USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL  PREPARATIONS FOR THE CARE OF TATTOOED HUMAN SKIN AND IN PARTICULAR FOR  INCREASING BRILLIANCY  OF TATTOOS ON  DARK HUMAN SKINBEIERSDORF AG
WO/2021/104785A CONDITIONING COMPOSITIONBEIERSDORF AG
WO/2021/104786A CONDITIONING COMPOSITIONBEIERSDORF AG
WO/2021/083958NOVEL PEPTIDES INDUCING SATIETYSPECIALITES PET FOOD
WO/2021/083959METHODS AND COMPOSITIONS FOR TREATING UVEAL MELANOMAINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/083964NEW MEANS AND METHODS FOR THERAPY AND DIAGNOSIS OF DNA VIRUS  INFECTIONSTECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/083970MEDICAL COMPOSITIONS AND THEIR USE IN TREATING INFLAMMATORY  BOWEL DISEASEBIOMILLENIA SAS
WO/2021/083989PROCESS FOR PREPARING NANO- OR MICROPARTICLES COMPRISING A  CARRIER-POLYMER AND ONE OR MORE BIOLOGICALLY ACTIVE INGREDIENTSEVONIK OPERATIONS GMBH
WO/2021/083992DENTAL COMPOSITE MATERIALKULZER GMBH
WO/2021/084007FOAM PRECURSOR LIQUID AND FOAM CLEANSING COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/084013NEW TREATMENT REGIMEN FOR THE TREATMENT OF NEUROLOGICAL  DISEASES OR CONDITIONSBIONURE FARMA, S.L.
WO/2021/084022HYDROPYRAZINO[1,2-D][1,4]DIAZEPINE COMPOUNDS FOR THE TREATMENT  OF AUTOIMMUNE DISEASEF. HOFFMANN-LA ROCHE AG
WO/2021/099088HAIR CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/084030ORAL PHARMACEUTICAL COMPOSITION COMPRISING A MELT-AGGLOMERATED  ACTIVE INGREDIENT COREHERMES ARZNEIMITTEL GMBH
WO/2021/084055BLEACHING POWDER COMPOSITIONKAO GERMANY GMBH
WO/2021/084058COMPOSITION FOR THE PREVENTION AND TREATMENT OF DISEASES OF  THE RESPIRATORY SYSTEMNEILOS S.R.L.
WO/2021/084062ANTI-CD19 THERAPY IN COMBINATION WITH LENALIDOMIDE FOR THE  TREATMENT OF LEUKEMIA OR LYMPHOMAMORPHOSYS AG
WO/2021/089419THERAPEUTIC COMBINATIONS OF ACALABRUTINIB AND CAPIVASERTIB TO  TREAT B-CELL MALIGNANCIESASTRAZENECA AB
WO/2021/084064SEQUENTIAL ANTI-CD19 THERAPYMORPHOSYS AG
WO/2021/099089SUNSCREEN COMPOSITION CONTAINING SILICA FOR PROTECTION FROM  BLUE LIGHTBEIERSDORF AG
WO/2021/084068COMBINATION OF A CXCR7 ANTAGONIST WITH AN S1P1 RECEPTOR  MODULATORIDORSIA PHARMACEUTICALS LTD
WO/2021/099090NOVEL SUNSCREEN COMPOSITION CONTAINING SILICA FOR PROTECTION  AGAINST BLUE LIGHTBEIERSDORF AG
WO/2021/084082COSMETIC COMPOSITION FOR IMPROVED BLEACHING OR DYEING OF  KERATIN FIBERSKAO CORPORATION
WO/2021/084083AQUEOUS OXIDATIVE COMPOSITION COMPRISING XANTHINE DERIVATIVESKAO CORPORATION
WO/2021/084084AQUEOUS OXIDIZING COMPOSITION COMPRISING AMINO ACIDSKAO CORPORATION
WO/2021/084085TWO-PART OXIDATIVE DYEING COMPOSITIONKAO CORPORATION
WO/2021/084087BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE  AGENTSCIS PHARMA AG
WO/2021/089433SOLID DISPERSIONS OF URSOLIC ACID POTASSIUM SALTINDENA S.P.A.
WO/2021/084120LIQUID ORAL FORMULATION OF BUMETANIDENEUROCHLORE
WO/2021/089445ORAL CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/084124COMBINED INHIBITION OF PD-1, TGFβ AND ATM TOGETHER WITH  RADIOTHERAPY FOR THE TREATMENT OF CANCERARES TRADING S.A.
WO/2021/084136COSMETIC COMPOSITION CONTAINING AN EXTRACT FROM OPUNTIA FICUS  INDICAWELEDA AG
WO/2021/089500SUNSCREEN COMPOSITION WITH LOW STICKINESSDSM IP ASSETS B.V.
WO/2021/089501NOVEL METHODDSM IP ASSETS B.V.
WO/2021/089502SUNSCREEN COMPOSITION WITH LOW STICKINESSDSM IP ASSETS B.V.
WO/2021/089513TREATMENT OF CANCER USING A HLA-A2/WT1 X CD3 BISPECIFIC  ANTIBODY AND LENALIDOMIDEF. HOFFMANN-LA ROCHE AG
WO/2021/089554INTRANASAL ADMINISTRATION OF MEROTOCIN FOR IMPROVING LACTATIONFERRING B.V.
WO/2021/089563METHODS OF USING IL-33 ANTAGONISTSMEDIMMUNE LIMITED
WO/2021/089580ORAL FORMULATION OF X842CINCLUS PHARMA AG
WO/2021/089581TOOTH WHITENING COMPOSITIONUNIVERSITAT AUTONOMA DE BARCELONA
WO/2021/110341WATER-RESISTANT COSMETIC SUNSCREENBEIERSDORF AG
WO/2021/089588HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF  CANCERPIERIS PHARMACEUTICALS GMBH
WO/2021/094156A FILM AND A KIT FOR WHITENING TEETHUNILEVER IP HOLDINGS B.V.
WO/2021/104813SIMULTANEOUS IMAGE REPRESENTATION OF TWO DIFFERENT FUNCTIONAL  AREASSIEMENS HEALTHCARE GMBH
WO/2021/099117A COSMETIC COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/089644METAL COMPLEXES BEARING BISSTYRYL-BIPYRIDINE LIGAND AND THEIR  USE AS PHOTOSENSITIZER AGENT IN ONE AND TWO-PHOTON PHOTODYNAMIC THERAPYPARIS SCIENCES ET LETTRES - QUARTIER LATIN
WO/2021/089649ANDROGEN RECEPTOR INHIBITORS FOR THE TREATMENT OF  NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN SUBJECTS WITH SEVERE  HEPATIC IMPAIRMENTJANSSEN PHARMACEUTICA NV
WO/2021/089651DIAGNOSTIC METHODAMAZENTIS SA
WO/2021/089678GLP-1 RECEPTOR AGONISTS IN DEMENTIANOVO NORDISK A/S
WO/2021/089692INHIBITOR OF BINDING BETWEEN PODOCIN AND KERATIN 8 FOR USE IN  THE TREATMENT OF NEPHROTIC SYNDROMETHE UNIVERSITY OF BRISTOL
WO/2021/094192SOLID PARTICLES CONTAINING SOLID PRIMARY PARTICLES THAT  CONSIST ESSENTIALLY OF NATIVE CELLULOSEEVONIK OPERATIONS GMBH
WO/2021/089704COMBINED INHIBITION OF PD-1, TGFB AND TIGIT FOR THE TREATMENT  OF CANCERMERCK PATENT GMBH
WO/2021/089715USE OF COLCHICINE IN THE TREATMENT AND PREVENTION OF LUNG  CANCERMURRAY AND POOLE ENTERPRISES, LTD.
WO/2021/089721TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL INFECTION.HERCULES PHARMACEUTICALS B.V.
WO/2021/089729BIVALENT LECA INHIBITORS TARGETING BIOFILM FORMATION OF  <i>PSEUDOMONAS AERUGINOSA</i>HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/089736COMBINED THERAPY FOR MUSCULAR DISEASESASSOCIATION INSTITUT DE MYOLOGIE
WO/2021/089752SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2  INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACIDNOVO NORDISK A/S
WO/2021/089761SOLID COMPOSITIONS COMPRISING A PCSK9 INHIBITOR AND A SALT OF  N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACIDNOVO NORDISK A/S
WO/2021/094209SUBSTITUTED PYRROLO TRIAZINE CARBOXAMIDE DERIVATIVES AS  PROSTAGLANDIN EP3 RECEPTOR ANTAGONISTSBAYER AKTIENGESELLSCHAFT
WO/2021/094210SUBSTITUTED PYRAZINE CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN  EP3 RECEPTOR ANTAGONISTSBAYER AKTIENGESELLSCHAFT
WO/2021/089768TREATMENT AND PREVENTION OF A NEURODEGENERATIVE DISORDERINFLAZOME LIMITED
WO/2021/089769TREATMENT AND PREVENTION OF NEUROINFLAMMATION OR AN  INFLAMMATORY BRAIN DISORDERINFLAZOME LIMITED
WO/2021/089770PROTEIN PURIFICATIONJANSSEN VACCINES & PREVENTION B.V.
WO/2021/089776TREATMENT AND PREVENTION OF A TRAUMATIC BRAIN DISORDERINFLAZOME LIMITED
WO/2021/089781TREATMENT OR PREVENTION OF PSYCHIATRIC BRAIN DISORDERS USING  THE NLRP3 INHIBITOR N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-1  -ISOPROPYL-1 H-PYRAZOLE-3-SULFONAMIDEINFLAZOME LIMITED
WO/2021/089782TREATMENT OF AUTOINFLAMMATORY DISORDERSINFLAZOME LIMITED
WO/2021/089783TREATMENT OF ARTHRITISINFLAZOME LIMITED
WO/2021/089790MITROCHONDRIA-TARGETING ANTIOXIDANTSGIVAUDAN SA
WO/2021/089791METHODS FOR THE TREATMENT OF CANCERS THAT HAVE ACQUIRED  RESISTANCE TO KINASE INHIBITORSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/089794METHODS OF TREATING CANCER WITH A COMBINATION OF A  PLATINUM-BASED AGENT AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATEGENMAB A/S
WO/2021/089807ANTIVIRAL PREPARATION FROM CHESTNUT SHELLS OF  <i>CASTANEA SATIVA</i> MILLMICRONATURE S.R.L.
WO/2021/0898245-HT2A AGONISTS FOR USE IN TREATMENT OF DEPRESSIONLOPHORA APS
WO/2021/104834COMBINATION THERAPYADC THERAPEUTICS SA
WO/2021/089840FERMENTATION METHOD FOR THE PRODUCTION OF PHYTOESTROGENSMRM HEALTH N.V.
WO/2021/089845CD93 INHIBITORS FOR USE IN THE TREATMENT OF CANCERUNIVERSITÄT BERN
WO/2021/089848USE OF SODIUM OCTENYL-SUCCINATE STARCHES AS A BINDER IN  CONTINUOUS WET GRANULATIONROQUETTE FRERES
WO/2021/094259NPY2 RECEPTOR AGONISTSBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/104844CLEANSING COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/094296USE OF MAST CELL STABILIZER FOR THE TREATMENT OF HEART FAILURE  WITH PRESERVED EJECTION FRACTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/094331INOSITOL PHOSPHATE COMPOUNDS FOR USE IN TREATING, INHIBITING  THE PROGRESSION, OR PREVENTING CARDIOVASCULAR CALCIFICATIONSANIFIT THERAPEUTICS, S.A.
WO/2021/094334CLEANSING COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/094344POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIIICSL BEHRING LENGNAU AG
WO/2021/094378TYPE I INTERFERON INHIBITION IN SYSTEMIC LUPUS ERYTHEMATOSUSASTRAZENECA AB
WO/2021/094379EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS  FOR THE TREATMENT OF CANCERASTRAZENECA AB
WO/2021/094390(S)-2-(1-(5-(CYCLOHEXYLCARBAMOYL)-6-(PROPYLTHIO)PYRIDIN-2-YL)PIPERIDIN-3-YL)  ACETIC ACID FOR USE IN TREATING WOUNDSUNIVERSITY OF LEEDS
WO/2021/094396COMPOSITION FOR ANTIMICROBIAL PHOTODYNAMIC THERAPYCMS DENTAL A/S
WO/2021/094424AN INHIBITOR OF AN IRON-CONTAINING HYDROGENASE OF A  METHANOGENIC ARCHAEON FOR USE IN THE TREATMENT OR PREVENTION OF A  PARKINSONIAN CONDITIONUNIVERSITé DU LUXEMBOURG
WO/2021/094429DEODORANT COMPOSITIONSUNILEVER IP HOLDINGS B.V.
WO/2021/094469ANTI-CLAUDIN-1 MONOCLONAL ANTIBODIES FOR THE PREVENTION AND  TREATMENT OF FIBROTIC DISEASESUNIVERSITé DE STRASBOURG
WO/2021/094561RINSABLE OILY SOLUTION FOR CONTROLLING LICEDERMOWAVE
WO/2021/094562ANTIGENIC PEPTIDES FOR PREVENTION AND TREATMENT OF B-CELL  MALIGNANCYENTEROME S.A.
WO/2021/094563TREATMENT AND PREVENTION OF DENGUE DISEASEJANSSEN PHARMACEUTICALS, INC
WO/2021/129977PLANT EXTRACTS FOR TREATMENT OF INCREASED FACIAL VASCULARITYORIFLAME COSMETICS AG
WO/2021/099241COMPOSITIONS AND METHODS FOR GLUTATHIONE ENHANCEMENT FOR USE  IN BRAIN HEALTHSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/115730HAIR STYLING COMPOSITION CONTAINING DISACCHARIDESHENKEL AG & CO. KGAA
WO/2021/115731MICROPLASTIC-FREE COMPOSITIONHENKEL AG & CO. KGAA
WO/2021/094610CHITOSAN FOR USE IN A METHOD OF PREVENTING OR TREATING A  CARDIOVASCULAR DISEASEBIOMEDICA PHARMA GMBH
WO/2021/094626MEDICAL COMPOSITION FOR TREATING CARDIAC WASTING AND CACHEXIARELAXERA PHARMAZEUTISCHE GMBH & CO. KG
WO/2021/121823TINTING CONDITIONER HAVING IMPROVED DYEING PERFORMANCEHENKEL AG & CO. KGAA
WO/2021/099292AN ANTIPERSPIRANT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/099346PHARMACEUTICAL DELIVERY DEVICEFERRING B.V.
WO/2021/099402PHARMACEUTICAL COMPOSITIONS COMPRISING AN INHIBITOR OF A  HISTON-DEACETYLASE (HDACI) AND AN AGONIST OF TOLL-LIKE-RECEPTOR 7 AND/OR 8  (TLR7 AND/OR TLR8) AND THEIR USE IN THE TREATMENT OF CANCERSTRUMBERG, Dirk
WO/2021/121843COMPOSITION COMPRISING THROMBIN DERIVED PEPTIDES AND USE  THEREOFIN2CURE AB
WO/2021/099444A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUISINTERVET INTERNATIONAL B.V.
WO/2021/099446A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUISINTERVET INTERNATIONAL B.V.
WO/2021/099450INHIBITORS OF HSP70 PROTEININSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/099453AQUEOUS LIQUID EXTRACT OF SPIRULINA FOR PREVENTING AND/OR  TREATING PERIPHERAL CHEMOTHERAPY-INDUCED NEUROPATHIES AND THE SYMPTOMS  THEREOF, AND CORRESPONDING COMPOSITION AND USEALGOSOURCE
WO/2021/099458A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUISINTERVET INTERNATIONAL B.V.
WO/2021/099460CURABLE COMPOSITION FOR DENTAL IMPRESSIONDENTSPLY SIRONA INC.
WO/2021/099462CURABLE COMPOSITION FOR DENTAL IMPRESSIONDENTSPLY SIRONA INC.
WO/2021/099481SOLID COMPOSITION CONTAINING RUFINAMIDEMEDICHEM, S.A.
WO/2021/099515PROCESS FOR TREATING KERATIN FIBERS, COMPRISING A  (POLY)CARBODIIMIDE COMPOUND, AN AQUEOUS DISPERSION OF PARTICLES OF  POLYMER(S)AND A COLORING AGENTL'OREAL
WO/2021/099517COMPOSITION COMPRISING A (POLY)CARBODIIMIDE COMPOUND AND A  COLORING AGENTL'OREAL
WO/2021/099531ZONISAMIDE ORODISPERSIBLE TABLETSBIOHORM, S.L.
WO/2021/121859HAIR TREATMENT PROCESSL'OREAL
WO/2021/121860COSMETIC COMPOSITION COMPRISING A SILICONE RESIN AND A  PARTICULAR AMINO SILICONEL'OREAL
WO/2021/099555COSMETIC PREPARATION CONTAINING ANISIC ACID AND LEVULINIC  ACID, HAVING SELECTIVE ANTIMICRIOBIAL EFFECTBEIERSDORF AG
WO/2021/099572MEDICAL USES OF 4-1BBL ADJUVANTED RECOMBINANT MODIFIED  VACCINIA VIRUS ANKARA (MVA)BAVARIAN NORDIC A/S
WO/2021/099575MESENCHYMAL STEM CELL DERIVED EXTRACELLULAR VESICLES LOADED  WITH AT LEAST ONE PHOTOSENSITIZER AND USES THEREOF FOR THE TREATMENT OF  PERITONEAL CARCINOMATOSISINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/099586RECOMBINANT MVA VIRUSES FOR INTRATUMORAL AND/OR INTRAVENOUS  ADMINISTRATION FOR TREATING CANCERBAVARIAN NORDIC A/S
WO/2021/099608METHODS FOR MANUFACTURING TISSUE INTERFACING COMPONENTSMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/099611INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF  BETA-LACTOGLOBULINARLA FOODS AMBA
WO/2021/099616MASITINIB FOR THE TREATMENT OF SICKLE CELL DISEASEAB SCIENCE
WO/2021/099624COMPOSITIONS COMPRISING A BACTERIAL STRAIN OF THE GENUS  FUSICATENIBACTER4D PHARMA RESEARCH LIMITED
WO/2021/105040MULTIPLE UNIT PELLET SYSTEM TABLET COMPRISING RIBOFLAVINDSM IP ASSETS B.V.
WO/2021/105041MUPS TABLET COMPRISING RIBOFLAVINDSM IP ASSETS B.V.
WO/2021/105051COMPOSITION FOR THE 3D PRINTING OF SEMISOLID DRUGSFUNDACION IDONIAL
WO/2021/099635NEW SOLID STATE FORM OF LURBINECTEDINPHARMA MAR, S.A.
WO/2021/105059UK 114 SALMON PROTEINS FOR USE IN THE TREATMENT, DIAGNOSIS AND  PREVENTION OF MALIGNANT TUMOURSBARTORELLI CUSANI, Alberto
WO/2021/099638COMPOSITION AND FOOD SUPPLEMENT, IN PARTICULAR FOR ORAL AND  DENTAL CARESMILLEAN
WO/2021/105061WHOLE CELL VACCINES AND METHODS OF PRODUCTION THEREOFGOTOVAX AB
WO/2021/105073BENZOCOUMARIN AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS  AND USES THEREOFSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105074DIRECT AMPK ACTIVATOR COMPOUNDS COMBINED WITH INDIRECT AMPK  ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS AND USES THEREOFSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105075DIBENZOPYRAN AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS  AND USES THEREOFSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105076Z-STILBENE AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS AND  USES THEREOFSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105093FREEZE-DRIED POWDER CONTAINING  2-[(3-AMINOPROPYL)AMINO]ETHANETHIOL AND ITS USE FOR PREPARING A THERMOGELCLEVEXEL PHARMA
WO/2021/121882HAIR DYEING PROCESS USING AT LEAST ONE SILICONE COMPRISING AT  LEAST ONE CARBOXYLIC ACID ANHYDRIDE GROUP, AT LEAST ONE AMINO SILICONE AND AT  LEAST ONE PIGMENT AND/OR DIRECT DYEL'OREAL
WO/2021/105137TREM-1 INHIBITORS FOR THE TREATMENT OF VASO-OCCLUSIONS AND  TISSUE INJURIES IN PATIENTS SUFFERING FROM SICKLE CELL DISEASEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/105164PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY  VASCULAR DISEASE AND/OR CARDIAC DYSFUNCTION IN FONTAN-PALLIATED PATIENTSACTELION PHARMACEUTICALS LTD
WO/2021/105167TRIPLE VACCINE AGAINST AVIBACTERIUM PARAGALLINARUM AND AVIAN  ENCEPHALOMYELITIS VIRUS AND FOWL POX VIRUSBOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/105217USE OF RHAMNOSE AND ARABINOSE FOR DENTAL POWDER JET CLEANINGFERTON HOLDING S.A.
WO/2021/105219PARTHANATOS CELL DEATH INHIBITORS FOR USE IN THE TREATMENT OF  PSORIASISUNIVERSIDAD DE MURCIA
WO/2021/105224KDM SUBFAMILY 6 PROTEIN INHIBITOR FOR USE IN THE TREATMENT OF  CANCERFUNDACIó INSTITUT DE RECERCA CONTRA LA LEUCèMIA JOSEP CARRERAS
WO/2021/110544METHOD FOR MANUFACTURING A SOLID ADMINISTRATION FORM AND SOLID  ADMINISTRATION FORMMERCK PATENT GMBH
WO/2021/110545DEPOSITION OF NANOSUSPENSIONS OF ACTIVE PHARMACEUTICAL  INGREDIENTS ON CARRIERSMERCK PATENT GMBH
WO/2021/105331METHODS OF TREATING PULMONARY ARTERIAL HYPERTENSIONACTELION PHARMACEUTICALS LTD
WO/2021/105339SHAMPOO VETERINARY COMPOSITIONSCEVA SANTE ANIMALE
WO/2021/105340NON-RINSED VETERINARY COMPOSITIONSCEVA SANTE ANIMALE
WO/2021/115800TREATMENT OF HEMORRHOIDS WITH ANTICOAGULANT DRUGSDE KEULENAER, Hendrik
WO/2021/105353COMPOSITIONS AND METHODS WITH A PROBIOTIC AND A NUTRIENT  AND/OR MINERAL FOR THE PREVENTION OR TREATMENT OF MASTITISSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105361COMPOSITIONS AND METHODS WITH A PROBIOTIC AND A N-3 FATTY ACID  FOR THE PREVENTION OR TREATMENT OF MASTITISSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105368USE OF NEUROPILIN ANTAGONISTS FOR THE TREATMENT OF  ENDOMETRIOSISINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/105371METHODS FOR STRATIFYING DIABETES PATIENTSIMCYSE SA
WO/2021/105384TARGETING THE NLS REGION OF NUPR1 PROTEIN TO TREAT CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/105391COMBINATION COMPRISING NUPR1 INHIBITORS TO TREAT CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/105392SUSPENSION COMPRISING A PROTEIN PARTICLE SUSPENDED IN A  NON-AQUEOUS VEHICLENOVALIQ GMBH
WO/2021/105393PROCESSES FOR OBTAINING STABLE GLP-1 COMPOSITIONSNOVO NORDISK A/S
WO/2021/105407miRNA-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF FOR  THE PREVENTION AND THE TREATMENT OF TISSUE DISORDERSNOVADIP BIOSCIENCES
WO/2021/105414USE OF 2-PHENYL-6-(1H-IMIDAZOL-1-YL) QUINAZOLINE FOR THE  PREVENTION OF ABUSE AND OF SIDE EFFECTS OF AT LEAST ONE OPIOIDROTTAPHARM BIOTECH S.R.L.
WO/2021/105419(R)-4-(1-(6-(4-(TRIFLUOROMETHYL)BENZYL)-6-AZASPIRO[2.5]OCTANE-5-CARBOXAMIDO)-CYCLOPROPYL)  BENZOIC ACID OR ITS SALT ALSO IN POLYMORPHIC FORM A FOR USE IN THE PREVENTION  OF HETEROTOPIC OSSIFICATIONROTTAPHARM BIOTECH S.R.L.
WO/2021/110561INTERFERON-ASSOCIATED ANTIGEN BINDING PROTEINS FOR USE IN  TREATING HEPATITIS B INFECTIONEVOTEC INTERNATIONAL GMBH
WO/2021/105435PROOXIDATIVE CHAIN-TRANSFER AGENTS FOR USE IN THE TREATMENT OF  MALIGNANT TUMOUR OR INFECTIOUS DISEASESUNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ
WO/2021/110562INTERFERON-ASSOCIATED ANTIGEN BINDING PROTEINS AND USES  THEREOFEVOTEC INTERNATIONAL GMBH
WO/2021/105461USE OF COMPOUNDS FOR THE PREVENTION AND/OR TREATMENT OF  ANKYLOSING SPONDYLITIS, AND CORRESPONDING COMPOSITIONSNUVAMID SA
WO/2021/105474NEW COMPOUNDS FOR TREATMENT OF DISEASES RELATED TO DUX4  EXPRESSIONFACIO INTELLECTUAL PROPERTY B.V.
WO/2021/105481NOVEL COMPOUNDS FOR TREATMENT OF DISEASES RELATED TO DUX4  EXPRESSIONFACIO INTELLECTUAL PROPERTY B.V.
WO/2021/115825COSMETIC COMPOSITION IN THE FORM OF AN OIL-IN-WATER  NANOEMULSION COMPRISING AT LEAST ONE LIQUID FATTY SUBSTANCE, AT LEAST ONE  SOLID FATTY SUBSTANCE AND AT LEAST ONE CATIONIC SURFACTANTL'OREAL
WO/2021/105509CHIMERIC OPSIN GPCR PROTEINSUNIVERSITÄT BERN
WO/2021/110608PEPTIDES AND COMPOSITIONS FOR USE IN COSMETICS AND MEDICINELIPOTRUE, S.L.
WO/2021/110625HAIR TREATMENT PROCESS COMPRISING THE APPLICATION OF A  COMPOSITION COMPRISING CATIONIC POLYMERS AND ORGANOSILANES, FOLLOWED BY A  WASHING STEPL'OREAL
WO/2021/110697SOLID PHARMACEUTICAL FORMULATIONS OF  6-(2-CHLORO-6-METHYLPYRIDIN-4-YL)-5-(-4-FLUOROPHENYL)-1,2,4-TRIAZIN-3-AMINEASTRAZENECA AB
WO/2021/110732METHOD FOR PRODUCING SPRAY-FREEZE-DRIED PARTICLES, AND  PARTICLES PRODUCED ACCORDINGLYRHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
WO/2021/110733A COSMETIC COMPOSITION AND THE USE THEREOF AND A METHOD FOR  IMPROVING SENSORY CHARACTERISTICSBASF SE
WO/2021/110737USE OF MASITINIB FOR THE TREATMENT OF EOSINOPHILIC ASTHMAAB SCIENCE
WO/2021/110748A DAY-AND-NIGHT AND INSIDE-OUTSIDE COLLAGEN-CONTAINING  TREATMENTLABORATORIO GENOVE, S.A.
WO/2021/122005DIALIPHATIC KETONE MIXTURES, COMPOSITIONS COMPRISING SAME AND  USE THEREOFSOLVAY SA
WO/2021/110768COSMETIC CLEANING COMPOSITIONS IN POWDER FORMYODI SAS
WO/2021/115886A HEMOSTATIC AGENT AND USES THEREOFROYAL COLLEGE OF SURGEONS IN IRELAND
WO/2021/115887DOT PRINTING METHOD AND DEVICE FOR ADDITIVE MANUFACTURING OF  DOSAGE FORMS WHICH CONTAIN ACTIVE SUBSTANCESDIHESYS DIGITAL HEALTH SYSTEMS GMBH
WO/2021/110782THE CHOLESTEROL-SYNTHESIS INTERMEDIATES FOR TREATMENT  DEMYELINATING DISORDERSMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/130002FOOD SUPPLEMENT FOR ALZHEIMERFOLIUM BIOSCIENCES EUROPE B.V.
WO/2021/110796INHIBITORS OF SHP2BAYER AKTIENGESELLSCHAFT
WO/2021/110805COMBINATION OF AN AZETIDINE LPA1 RECEPTOR ANTAGONIST WITH  PIRFENIDONE AND/OR NINTEDANIB FOR USE IN THE TREATMENT OF FIBROTIC DISEASESIDORSIA PHARMACEUTICALS LTD
WO/2021/110817POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS  TARGETING TNFA AND OX40LABLYNX NV
WO/2021/110833TOOLS AND METHODS TO DETECT AND ISOLATE COLIBACTIN PRODUCING  BACTERIACONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
WO/2021/115919TOPICAL ORAL COMPOSITIONKONINKLIJKE PHILIPS N.V.
WO/2021/122039COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM  OXIDES, AN A-CYANODIPHENYLACRYLATE DERIVATIVE AND A  4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVEL'OREAL
WO/2021/122041COSMETIC COMPOSITION COMPRISING WATER-SOLUBLE OR  WATER-DISPERSIBLE UV-SCREENING AGENTS, HYDROPHILIC THICKENERS AND HYDROPHILIC  SURFACTANTSL'OREAL
WO/2021/110860REACTIVE CONJUGATESDEBIOPHARM RESEARCH & MANUFACTURING S.A.
WO/2021/110883BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID  MODULATORSALBIREO AB
WO/2021/110884BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID  MODULATORSALBIREO AB
WO/2021/110885BENZOTHIADIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACID  MODULATORSALBIREO AB
WO/2021/110886BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID  MODULATORSALBIREO AB
WO/2021/110887BENZOTHIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACID  MODULATORSALBIREO AB
WO/2021/110915METHOD FOR TRANSFORMING AN ESSENTIAL OILPRANARÔM INTERNATIONAL S.A.
WO/2021/110919TREATMENT OF DISEASES RELATED TO HEPATITIS B VIRUSISA PHARMACEUTICALS
WO/2021/110923PERSONAL DENTAL CARE PRODUCT FOR PREVENTING DEMINERALISATIONCREDENTIS AG
WO/2021/110942PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG  BIS(MONOETHANOLAMINE)SYNTHON B.V.
WO/2021/110959PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG  BIS(MONOETHANOLAMINE)SYNTHON B.V.
WO/2021/110968MACROCYCLES COMPRISING A 4-AMIDO-2,4-PENTADIENOATE MOIETY FOR  THE TREATMENT OF HYPOXIC CANCERSAARHUS UNIVERSITET
WO/2021/110976PEPTIDE COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIESAXOLTIS PHARMA
WO/2021/110978DEEP-LAYER REMINERALIZATION OF HYDROXYLAPATITEDR. KURT WOLFF GMBH & CO. KG
WO/2021/110979LIPID VESICLES AS OXIDATIVE STRESS SENSORSMEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/110983CO-AMORPHOUS FORMS OF BETA-LACTOGLOBULIN AND A DRUG SUBSTANCEZERION APS
WO/2021/110989VACCINE CONJUGATESULTIMOVACS AB
WO/2021/110990ANTI-CLEC-1A ANTIBODIES AND ANTIGEN-BINDING FRAGMENT THEREOFOSE IMMUNOTHERAPEUTICS
WO/2021/110991CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR  STRUCTURES IN THE KIDNEYUNIVERSITÄT ZüRICH
WO/2021/115977LIQUID PHARMACEUTICAL COMPOSITION COMPRISING CYTISINEADAMED PHARMA S.A.
WO/2021/116000INVERSE LATEX FOR A COSMETIC COMPOSITION COMPRISING A SPECIFIC  CHELATING AGENT AND A POLYELECTROLYTE COMBINING A STRONG ACID FUNCTION AND A  NEUTRAL FUNCTIONSOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/116009INVERSE LATEX FOR A COSMETIC COMPOSITION, COMPRISING A  SPECIFIC CHELATING AGENT AND A POLYELECTROLYTE COMBINING A STRONG ACID  FUNCTION AND A WEAK ACID FUNCTIONSOCIéTé D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/111005NOVEL AGENTS AND USES THEREOFFIORETOS, Thoas
WO/2021/111007STABLE COMPOSITIONS OF FC MULTIMERSCSL BEHRING LENGNAU AG
WO/2021/116114AEROSOL HAIR DYEING DEVICE BASED ON A CROTONIC ACID COPOLYMER  AND A FATTY AMINEL'OREAL
WO/2021/116119ANTIBODIES HAVING SPECIFICITY TO HER4 AND USES THEREOFINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/116182POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS  TARGETING IL-13 AND TSLPABLYNX NV
WO/2021/116188COMBINATION PRODUCT CONTRIBUTING TO THE WELL-BEING OF PREGNANT  WOMEN, COMPRISING EPA, DHA, VITAMINS AND MINERALSURGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/122239INHIBITION OF TMEM16A BY BENZBROMARONE OR NICLOSAMIDE FOR  TREATING POLYCYSTIC KIDNEY DISEASE AND/OR POLYCYSTIC LIVER DISEASEUNIVERSITÄT REGENSBURG
WO/2021/116203COMPOSITION OF EXTRACT OF DRIED STIGMAS OF CROCUS SATIVUS  (SAFFRON) AND OF FLAVONOID(S) FOR THE TREATMENT OF SEVERE ALLERGIC ASTHMASTRUNDEN, Christian
WO/2021/130022VIRUS-MIMETIC NANOPARTICLESUNIVERSITÄT REGENSBURG
WO/2021/116244MODULATION OF DRUG RELEASE AND BIOAVAILABILITY OF COMPOSITIONS  CONTAINING DOLUTEGRAVIR SODIUM AND OTHER ANTI HIV DRUGSSANDOZ AG
WO/2021/144080METHOD FOR INCORPORATING ACTIVE SUBSTANCES INTO THE SKINBEIERSDORF AG
WO/2021/116260QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORSCHIESI FARMACEUTICI S.P.A.
WO/2021/122278NON-STICK ANTIBIOTIC GELSAO TECHNOLOGY AG
WO/2021/116275DENTAL RESIN MODIFIED GLASS-IONOMER COMPOSITION AND KIT  COMPRISING SAID COMPOSITIONDENTSPLY SIRONA INC.
WO/2021/116331STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES  COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERYCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/116367CELLULOSE NANOCRYSTAL EFFECT PIGMENTS FOR COSMETIC  APPLICATIONSBASF COLORS & EFFECTS GMBH
WO/2021/116370THICKENING SILICA AS FLUORIDE CARRIER FOR TAILORED DELIVERY  AND SLOW RELEASEGABA INTERNATIONAL HOLDING GMBH
WO/2021/116372INHIBITORS OF KDM5A FOR USE IN TREATMENT OF IDIOPATHIC  INFLAMMATORY MYOPATHIESUNIVERSITEIT ANTWERPEN
WO/2021/116389EPAC1 INHIBITORS FOR THE TREATMENT OF IDIOPATHIC PULMONARY  FIBROSISINSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE  (INSERM)
WO/2021/116420USE OF TLR7 AND/OR TLR8 AGONISTS FOR THE TREATMENT OF  LEPTOSPIROSISINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/122382AQUEOUS COMPOSITION COMPRISING A CATIONIC POLYMER, AN ANIONIC  POLYMER, AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A  FATTY PHASE AND A PIGMENTL'OREAL
WO/2021/122383AQUEOUS COMPOSITION COMPRISING A CATIONIC CELLULOSIC POLYMER,  AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A FATTY  PHASE AND A PIGMENTL'OREAL
WO/2021/116432BIODEGRADABLE MICROCAPSULE SYSTEMSPAPIERFABRIK AUGUST KOEHLER SE
WO/2021/116443COMPOSITION COMPRISING PROPOLIS PARTICLESPOLLENERGIE
WO/2021/116475AMPHOTERICIN B CONJUGATED STABILIZED GOLD NANOPARTICLES AND  USES THEREOFMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/116476AGONISTS OF RNA ADENOSINE N-6 METHYLATION FOR USE IN  SUPPRESSING HIV-1 LATENT PROVIRUS ACTIVATION AND REPLICATIONCHEMESTMED LTD.
WO/2021/116477METHOD OF SUPPRESSING CANCER BY RNA m6A METHYLTRANSFERASE  METTL16 INHIBITORSCHEMESTMED LTD.
WO/2021/228422OXYBUTYNIN FOR INTRAVESICAL USEFARCO-PHARMA GMBH
WO/2021/122412AQUEOUS COMPOSITION FOR TREATING KERATIN FIBRES, COMPRISING A  PLANT OIL, A HYDROCARBON-BASED OIL, A GLYCEROLATED NONIONIC SURFACTANT, A  POLYSACCHARIDE AND A SOLVENTL'OREAL
WO/2021/130038USE OF LOSARTAN FOR THE TREATMENT OF FIBROTIC DISEASES, IN  PARTICULAR EPIDERMOLYSIS BULLOSAALBERT-LUDWIGS-UNIVERSITÄT FREIBURG
WO/2021/116487COMPOUNDS FOR USE IN THE TREATMENT OF NIEMANN-PICK C DISEASESOM INNOVATION BIOTECH, S.A.
WO/2021/122434COMBINATION OF AN AHR-INHIBITOR AND AN PD1-INHIBITOR ANTIBODY  AND ITS USE IN THE TREATMENT OF CANCERBAYER AKTIENGESELLSCHAFT
WO/2021/122481COMPOSITION COMPRISING A NATURAL DYE AND A FATTY AMINEL'OREAL
WO/2021/122482COSMETIC OR DERMATOLOGICAL COMPOSITION ACTING IN PARTICULAR ON  THE EFFECTS OF BLUE LIGHT ON SKIN AND ITS APPENDAGES, AND ASSOCIATED USESSEDERMA
WO/2021/116498ESKETAMINE FORMULATIONS AND METHODS FOR PREPARATION AND  STORAGEJANSSEN PHARMACEUTICA NV
WO/2021/197655SYRINGE AND KIT FOR INTRAVESICAL USEFARCO-PHARMA GMBH
WO/2021/122507INACTIVATED PISCINE ORTHOREOVIRUS VACCINEINTERVET INTERNATIONAL B.V.
WO/2021/122515PARASITE CONTROL IN RUMINANTSINTERVET INTERNATIONAL B.V.
WO/2021/122545USE OF THE GDF-5 MUTANT FOR THE TREATMENT OF PAIN AND  CARTILAGE DESTRUCTIONMERCK PATENT GMBH
WO/2021/122608LOW-MOLECULAR GELLING AGENT AS FRAGRANT SUBSTANCE DISPENSING  SYSTEMHENKEL AG & CO. KGAA
WO/2021/122638DEVICE FOR SPRAYING A TWO-PHASE COMPOSITION COMPRISING AN  AQUEOUS PHASE COMPRISING ONE OR MORE POLYOLS AND AN OILY PHASE COMPRISING  NON-SILICONE OILSL'OREAL
WO/2021/122639TWO-PHASE COMPOSITION COMPRISING AN AQUEOUS PHASE COMPRISING  ONE OR MORE POLYOLS AT A CONTENT RANGING FROM 5% TO 30% BY WEIGHT AND AN OILY  PHASE COMPRISING NON-SILICONE OILSL'OREAL
WO/2021/122647HIGH VISCOSITY ELASTIC GELS AND USES THEREFORWARWICK INTERNATIONAL GROUP LTD.
WO/2021/122717NEW HENNA-BASED EXTRACT FOR USE IN DYEING KERATIN FIBERS, ITS  PREPARATION METHOD AND COMPOSITIONS CONTAINING ITL'OREAL
WO/2021/122733BISPECIFIC ANTI-CCL2 ANTIBODIESF. HOFFMANN-LA ROCHE AG
WO/2021/122741PREBIOTIC AND PROBIOTIC TREATMENT TO REDUCE ORAL DYSBIOSIS AND  PROMOTE EUBIOSISFUNDACIóN PARA EL FOMENTO DE LA INVESTIGACIóN SANITARIA Y  BIOMéDICA DE LA COMUNITAT VALENCIANA
WO/2021/122758COMPOSITIONS COMPRISING CYANIDIN-3-GALACTOSIDE FOR USE AS  VASORELAXANTEVONIK OPERATIONS GMBH
WO/2021/122809COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION  AND/OR TREATMENT OF DYSBIOSIS AND ANTIBACTERIAL ANTIDOTES FOR  MICROBIOME-PROTECTIONEUROPEAN MOLECULAR BIOLOGY LABORATORY
WO/2021/122813ANGIOGENESIS PROMOTING AGENTS FOR PREVENTION OF METASTATIC  CANCERUNIVERSITÄT BASEL
WO/2021/122838NON-ELICITED DEDIFFERENTIATED <i>LAVANDULA  ANGUSTIFOLIA</i> PLANT CELLS, EXTRACTS THEREOF AND COSMETIC USES  THEREOFL'OREAL
WO/2021/122840COSMETIC COMPOSITION COMPRISING A CATIONIC ASSOCIATIVE  POLYMER, A CARBOXYLIC ANIONIC SURFACTANT, OPTIONALLY A NONIONIC SURFACTANT  AND AN AMPHOTERIC OR ZWITTERIONIC SURFACTANTL'OREAL
WO/2021/130088COSMETIC COMPOSITION COMPRISING A POLYMER COMPRISING AT LEAST  ONE CATIONIC (METH)ACRYLAMIDE UNIT, A PARTICULAR SILICONE AND AT LEAST ONE  SURFACTANTL'OREAL
WO/2021/249664ANTI-BLYS ANTIBODY FOR TREATING PROTEINURIC KIDNEY DISEASEGLAXOSMITHKLINE INTELLECTUAL PROPERTY MANAGEMENT LIMITED
WO/2021/122873PROCESS FOR TREATING KERATIN FIBERS USING A COMPOSITION  COMPRISING A CARNITINE SALT OR CARNITINE-BASED SALT COMPRISING A HETEROCYCLIC  ORGANIC ANIONL'OREAL
WO/2021/122874PROCESS FOR TREATING KERATIN FIBERS USING A COMPOSITION  COMPRISING A CARNITINE SALT OR CARNITINE-BASED SALT COMPRISING AN AROMATIC  ORGANIC ANIONL'OREAL
WO/2021/122875ANTIBODIES BINDING TO HLA-A2/MAGE-A4F. HOFFMANN-LA ROCHE AG
WO/2021/122876PROCESS FOR TREATING KERATIN FIBERS USING A COMPOSITION  COMPRISING A CARNITINE SALT OR CARNITINE-BASED SALT COMPRISING AN AROMATIC  ORGANIC ANIONL'OREAL
WO/2021/122896CRYPTOSPORIDIOSIS VACCINEINTERVET INTERNATIONAL B.V.
WO/2021/122923STABILIZATION OF SELENITE IN A NUTRITIONAL SOLUTION BY  DISSOLVED OXYGENBAXTER INTERNATIONAL INC.
WO/2021/122925PARENTERAL NUTRITION SOLUTION COMPRISING A SELENIUM SOURCEBAXTER INTERNATIONAL INC.
WO/2021/122928ORAL RESPIRATORY VACCINEINTERVET INTERNATIONAL B.V.
WO/2021/122935METHOD FOR THE COSMETIC TREATMENT OF KERATIN FIBRES COMPRISING  A STAGE OF APPLICATION OF A RARE EARTH METAL COMPOSITION AND A STAGE OF  APPLICATION OF A COMPOSITION COMPRISING SURFACTANTSL'OREAL
WO/2021/122946METHOD FOR THE COSMETIC TREATMENT OF KERATIN MATERIALS  EMPLOYING A RARE EARTH METAL COMPOSITION AND AN ALKALINE COMPOSITIONL'OREAL
WO/2021/122957DENTAL ROOT CANAL FILLING COMPOSITIONDENTSPLY DETREY GMBH
WO/2021/122996A PHARMACEUTICAL ORAL DOSAGE FORM OF Q203QURIENT CO., LTD.
WO/2021/123003PROCESS FOR THE COSMETIC TREATMENT OF KERATIN FIBRES USING A  DETERGENT COMPOSITION AND A RARE EARTH METAL COMPOSITIONL'OREAL
WO/2021/123011ASSOCIATION OF FAECALIBACTERIUM PRAUSNITZII STRAIN CNCM I-4573  WITH PENTASA<sp>®</sp> FOR THE TREATMENT AND PREVENTION OF  GASTROINTESTINAL INFLAMMATIONEXELIOM BIOSCIENCES
WO/2021/123013SMART DRUG DELIVERY SYSTEM AND PHARMACEUTICAL KIT FOR DUAL  NUCLEAR MEDICAL CYTOTOXIC THERANOSTICSJOHANNES GUTENBERG-UNIVERSITÄT MAINZ
WO/2021/123033NOVEL G-CSF MIMICS AND THEIR APPLICATIONSMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/123047MACROCYCLIC PEPTIDESHERANTIS PHARMA OYJ
WO/2021/164925COLLAGEN HYDROLYSATE AS ACTIVE SUBSTANCE AGAINST PERIODONTITIS  OR GINGIVITISGELITA AG
WO/2021/123061PROCESS FOR PREPARING A COMPOSITION FOR DYEING THE HAIR  STARTING FROM A COMPOSITION IN POWDER FORM AND AN AQUEOUS COMPOSITIONL'OREAL
WO/2021/123084EGFR INHIBITORSF. HOFFMANN-LA ROCHE AG
WO/2021/123087EGFR INHIBITORSF. HOFFMANN-LA ROCHE AG
WO/2021/123088A PHARMACEUTICAL COMPOSITION OF A PYRAZOLE COMPOUND DISPERSED  IN A POLYMER MATRIXINTERVET INTERNATIONAL B.V.
WO/2021/123089ANTIBODIES TO CANINE INTERLEUKIN-4 RECEPTOR  <i>ALPHA</i>INTERVET INTERNATIONAL B.V.
WO/2021/123104MULTIVALENT HVT VECTOR VACCINEINTERVET INTERNATIONAL B.V.
WO/2021/123108A PYRAZOLE PHARMACEUTICAL COMPOSITIONINTERVET INTERNATIONAL B.V.
WO/2021/123110SEMI-SOLID NATURAL PERFUMEEXPRESSIONS PARFUMEES
WO/2021/123117METHOD FOR PRODUCING OIL-IN-WATER EMULSIONSFRESENIUS KABI AUSTRIA GMBH
WO/2021/123119TREATMENT OF ACUTE HEART FAILURELUND, Lars H.
WO/2021/123121LIPID-BASED COMPOSITIONS COMPRISING LIPOPHILIC SALTS AND  ACIDIC PH MODIFIERSCAPSUGEL BELGIUM NV
WO/2021/123131COMPOSITION FOR THE TREATMENT OF HYPERTENSION AND/OR  ASSOCIATED MORBIDITIES THERETOBASF SE
WO/2021/123142COMPOUNDS FOR TREATMENT OF EYE DISEASES ASSOCIATED WITH  EXCESSIVE VASCULARISATIONACTIVE BIOTECH AB
WO/2021/123144PRO-PERFUME COMPOSITIONSFIRMENICH SA
WO/2021/123164OILY SOLID COSMETICL V M H RECHERCHE
WO/2021/123165DOSAGE FORM COMPRISING AMORPHOUS SOLID SOLUTION OF  EMPAGLIFLOZIN WITH POLYMERKRKA, D.D., NOVO MESTO
WO/2021/123170COSMETIC COMPOSITION COMPRISING AT LEAST ONE POLAR OIL, AN  ALIPHATIC MONOALCOHOL, A MIXTURE OF POLYOLS AND AT LEAST ONE HYDROPHILIC  ACTIVE AGENTL'OREAL
WO/2021/123174SIGMA-1 RECEPTOR LIGANDS AND THERAPEUTIC USES THEREOFUNIVERSITE DE STRASBOURG
WO/2021/123192EDOXABAN TABLETSBIOHORM, S.L.
WO/2021/123198LEUKEMIA TREATMENTDEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/123202FORMULATIONS OF ANTI-PD1 ANTIBODIESFORMYCON AG
WO/2021/123228PHARMACEUTICAL COMPOSITION COMPRISING GLP-1 ANALOGUEKRKA, D.D., NOVO MESTO
WO/2021/130126LIQUID COMPOSITION COMPRISING IBUPROFEN AND PHENYLEPHRINENUTRA ESSENTIAL OTC, S.L.
WO/2021/123229SYNTHESIS OF LACTONE DERIVATIVES AND THEIR USE IN THE  MODIFICATION OF PROTEINSGENIE BIOTECH UK LTD.
WO/2021/123232NUCLEIC ACID VACCINATION USING NEO-EPITOPE ENCODING CONSTRUCTSEVAXION BIOTECH APS
WO/2021/123233RETINOL-BASED COMPOSITIONL'OREAL
WO/2021/123243METHODS AND VACCINE COMPOSITIONS TO TREAT CANCERSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/123245NAD-PRECURSORS AND DIETARY RESTRICTION FOR TREATING  AGE-RELATED MEDICAL CONDITIONSLEIBNIZ-INSTITUT FüR ALTERNSFORSCHUNG - FRITZ-LIPMANN-INSTITUT  E.V. (FLI)
WO/2021/123280DIETARY SUPPLEMENT FOR LIPEDEMA PATIENTSPANTEA GMBH
WO/2021/123289SOLUBLE REAR LAYER FOR OTFLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/123291OGA INHIBITOR COMPOUNDSJANSSEN PHARMACEUTICA NV
WO/2021/123297OGA INHIBITOR COMPOUNDSJANSSEN PHARMACEUTICA NV
WO/2021/123300TREATMENT OF HEPATIC AND CARDIOVASCULAR DISORDERSLIFESEARCH
WO/2021/123302COMPOSITION COMPRISING A ROSEWOOD EXTRACTL'OREAL
WO/2021/123306COMPOSITION COMPRISING A CATIONIC CELLULOSE-BASED POLYMER, A  SULFONIC ANIONIC POLYMER AND A FIXING POLYMERL'OREAL
WO/2021/123309COMPOSITION COMPRISING A DISPERSION OF POLYMER PARTICLES IN A  NON-AQUEOUS MEDIUM, A CATIONIC POLYMER AND AN ANIONIC POLYMERL'OREAL
WO/2021/123311COMPOSITION COMPRISING A SOLUBILIZED SOLID FATTY ALCOHOL AND A  MONOALCOHOLL'OREAL
WO/2021/123323LON PROTEASE, ALPHA-HEMOLYSIN, CK1-ALPHA-1; C-MYB INHIBITOR OR  A CEBP-DELTA INHIBITOR AS THERAPEUTICSLINNANE PHARMA AB
WO/2021/123325COMPOSITION COMPRISING A NATURAL DYE, A DISPERSANT, AN OIL AND  A FATTY-PHASE THICKENERL'OREAL
WO/2021/123329HAIR DYEING COMPOSITION COMPRISING A DIRECT DYE, A  SCLEROGLUCAN GUM AND A NON-IONIC ASSOCIATIVE POLYMERL'OREAL
WO/2021/123332LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDSCUREVAC AG
WO/2021/123337RETINOL-BASED COMPOSITIONL'OREAL
WO/2021/123341COMPOSITION COMPRISING DIOSMINKRKA, D.D., NOVO MESTO
WO/2021/123345PROCESS FOR COLOURING KERATIN MATERIALS USING A PARTICULAR  OILY DISPERSION AND AT LEAST TWO AMINE COMPOUNDS THAT ARE DIFFERENT FROM EACH  OTHERL'OREAL
WO/2021/123347PROCESS FOR THE COSMETIC TREATMENT OF KERATIN FIBRES USING A  RARE-EARTH METAL AND A PARTICULAR POLYMERL'OREAL
WO/2021/123352RETINOL-BASED SERUML'OREAL
WO/2021/123355PROBIOTICS FOR REGULATING BLOOD GLUCOSEGENBIOMA APLICACIONES, S.L.
WO/2021/123377COMPOSITION FOR THE TREATMENT OF INFLAMMATION AND/OR  ASSOCIATED MORBIDITIES THERETOBASF SE
WO/2021/123378COMPOSITIONS COMPRISING BACTERIAL STRAINS4D PHARMA RESEARCH LIMITED
WO/2021/123399MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR  VESICLES FOR TARGETED CARGO DELIVERYMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/123419COMPOSITION FOR THE TREATMENT OF AMYLOID-BETA ASSOCIATED  DISEASESBASF SE
WO/2021/130168A PHARMACEUTICAL FORMULATIONWARSZAWSKIE ZAKLADY FARMACEUTYCZNE POLFA SA
WO/2021/123430POLYMERIC NANOPARTICLES AS VACCINE ADJUVANTSTHE PROVOST, FELLOWS, SCHOLARS AND OTHER MEMBERS OF BOARD OF  TRINITY COLLEGE DUBLIN
WO/2021/123432IGG:TGFBETARII FUSION PROTEIN COMPOSITIONARES TRADING S.A.
WO/2021/130170PROCESS FOR THE PREPARATION OF DISPERSIONS COMPRISING  INHALABLE IMMUNOSUPPRESSIVE ACTIVE INGREDIENTSZAMBON S.P.A.
WO/2021/130180TOPICAL COMPOSITIONS COMPRISING PEA PROTEINS AND POLYPHENOLSDEVINTEC SAGL
WO/2021/130181NOVEL FAECAL COMPOSITIONLAURIDSEN, Hengameh, Chloe
WO/2021/130182CAPSULE COMPRISING A FAECAL COMPOSITIONLAURIDSEN, Hengameh, Chloe
WO/2021/130192COMPOSITION COMPRISING ASCORBIC ACIDL'OREAL
WO/2021/130195METHOD OF TREATING VIRUS INFECTION USING A TLR7 AGONISTF. HOFFMANN-LA ROCHE AG
WO/2021/130210PROCESS FOR DESIGNING A RECOMBINANT POXVIRUS FOR A THERAPEUTIC  VACCINETRANSGENE
WO/2021/130215GOLDEN LIPID NANOPARTICLES FOR GENE THERAPYUNIVERSIDAD DEL PAíS VASCO/EUSKAL HERRIKO UNIBERTSITATEA
WO/2021/130219USES OF LIPOTEICHOIC ACID FROM BIFIDOBACTERIABIOPOLIS, S.L.
WO/2021/130223TREATMENT INVOLVING IMMUNE EFFECTOR CELLS GENETICALLY MODIFIED  TO EXPRESS ANTIGEN RECEPTORSBIONTECH CELL & GENE THERAPIES GMBH
WO/2021/130225IN VITRO AND IN VIVO GENE DELIVERY TO IMMUNE EFFECTOR CELLS  USING NANOPARTICLES FUNCTIONALIZED WITH DESIGNED ANKYRIN REPEAT PROTEINS  (DARPINS)BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/130226COMPOSITION FOR THE PREPARATION OF PERINDOPRIL ARGININE  GRANULES, A METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION  COMPRISING THE GRANULESKRKA, D.D., NOVO MESTO
WO/2021/130232BILE ACID DERIVATIVES IN THE MEDICAL INTERVENTION OF ANXIETIES  AND/OR STRESS SYMPTOMSMEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/130237uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL  THERAPYRIGSHOSPITALET
WO/2021/130255DIHYDRO-CYCLOPENTA-ISOQUINOLINE DERIVATIVESUCB BIOPHARMA SRL
WO/2021/130257DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVESUCB BIOPHARMA SRL
WO/2021/130259DIHYDROCYCLOPENTA-ISOQUINOLINE-SULFONAMIDE DERIVATIVES  COMPOUNDSUCB BIOPHARMA SRL
WO/2021/130260TETRAHYDROBENZO-QUINOLINE SULFONAMIDE DERIVATIVES USEFUL AS  IGE MODULATORSUCB BIOPHARMA SRL
WO/2021/130262TETRAHYDROBENZO-QUINOLINE SULFONAMIDES DERIVATIVE COMPOUNDSUCB BIOPHARMA SRL
WO/2021/130264TRANSPARENT COMPOSITION FOR USE IN SKINCARE AND/OR HAIRCARES.P.C.M. SA
WO/2021/130269COMBINATION OF AN ALPHA-PLL WITH A BETA-LACTAM FOR TREATING  ANTIBIOTIC BACTERIAL RESISTANCEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/130270PHARMACEUTICAL COMBINATION OF ANTIVIRAL AGENTS TARGETING HBV  AND/OR AN IMMUNE MODULATOR FOR TREATMENT OF HBVF. HOFFMANN-LA ROCHE AG
WO/2021/170283BIO-FERMENTED SURFACTANTS FOR REDUCING ABRASION OF DENTAL  ENAMELHENKEL AG & CO. KGAA
WO/2021/130291TUMOR-SPECIFIC CLAUDIN 18.2 ANTIBODIESSOTIO A.S.
WO/2021/130305COMPOSITION FOR TREATING OR PREVENTING AN ALLERGY OR ALLERGIC  REACTIONAPOSCIENCE AG
WO/2021/130329RADIOLABELED PEPTIDES FOR NON-INVASIVE DIAGNOSIS AND TREATMENT  OF CXCR4 EXPRESSING TUMORSISTITUTO NAZIONALE TUMORI IRCCS - FONDAZIONE G. PASCALE
WO/2021/130335EMULSIFIED LIP GELL'OREAL
WO/2021/130349COSMETIC COMPOSITIONS COMPRISING MELANOIDINSKAFFE BUENO APS
WO/2021/130377POLYMERIC NANOPARTICLES FOR ENHANCED CANCER TREATMENTTHE QUEEN'S UNIVERSITY OF BELFAST
WO/2021/130381COMBINATION OF A HDAC INHIBITOR AND VX MOLECULES, AND ITS USE  FOR THE TREATMENT OF CYSTIC FIBROSISCENTRE D'ETUDE DES CELLULES SOUCHES (CECS)
WO/2021/130382COMBINATION OF A PROTEASOME INHIBITOR AND A HDAC INHIBITOR AND  ITS USE FOR THE TREATMENT OF GENETIC DISEASES LINKED TO A PROTEIN  CONFORMATIONAL DISORDERCENTRE D'ETUDE DES CELLULES SOUCHES (CECS)
WO/2021/148229COMPOSITION FOR WEIGHT MANAGEMENT OF A SUBJECTMRS-BIOTECH
WO/2021/136763ISOQUINOLINE DERIVATIVES FOR USE IN TREATING GLUT1 DEFICIENCY  SYNDROMEGLIAPHARM SA
WO/2021/136784A COMPOSITION FOR THE TREATMENT OF MALE INFERTILITYLABORATORIO REIG JOFRé, S.A.
WO/2021/136786PREPARATION COMPRISING ELEMENTAL SILVER FOR TREATMENT AND  PREVENTION OF PERIODONTITISGUGGENBICHLER, Joseph Peter
WO/2021/136788PROCESS FOR TREATING KERATIN FIBRES, COMPRISING THE  APPLICATION OF A COMPOSITION COMPRISING A PARTICULAR COMPOUND COMPRISING AT  LEAST TWO TETRAZOLES GROUPSL'OREAL
WO/2021/136808CONJUGATES UNDERGOING INTRAMOLECULAR REARRANGEMENTSASCENDIS PHARMA A/S
WO/2021/136812BACTERIAL DELIVERY VEHICLES FOR IN VIVO DELIVERY OF A DNA  PAYLOADELIGO BIOSCIENCE
WO/2021/136827COMPOUND FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS  SYSTEM DISORDERSABAXYS THERAPEUTICS
WO/2021/136835COMPOSITIONS AND METHODS FOR THE PREVENTION OF S.  <i>AUREUS </i>INFECTIONANTAGONIS
WO/2021/136841PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF  POST-SURGICAL PAINPEPTINOV
WO/2021/151619USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE  INHALATORY TREATMENT OF INFLAMMATORY PULMONARY DISEASESMETRIOPHARM AG
WO/2021/151620USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE  TREATMENT OF RARE CHRONIC INFLAMMATORY PULMONARY DISEASESMETRIOPHARM AG
WO/2021/170290INHIBITORS OF HUMAN DEUBIQUITINASES FOR THE TREATMENT OF  CORONAVIRAL INFECTIONSIMMUNOLOGIK GMBH
WO/2021/1907835-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR TREATMENT OF  ACUTE LUNG INJURYMETRIOPHARM AG
WO/2021/2192446'-METHOXYCINCHONAN-9-OLS FOR THE TREATMENT OF CORONAVIRAL  INFECTIONSIMMUNOLOGIK GMBH
WO/2021/233571TREATMENT AGENT FOR ANTIVIRAL THERAPY, APPLICATOR, AND METHOD  FOR PRODUCING A TREATMENT AGENTNINODERM UG (HAFTUNGSBESCHRÄNKT)
WO/2021/244771METHOD FOR SOLUBILIZING NATURAL, ENDOGENOUS AND SYNTHETIC  CANNABINOIDSATHENION AG
WO/2021/249667COMPOUND FOR THE TREATMENT OF CORONAVIRAL INFECTIONSMETRIOPHARM AG
WO/2021/148241COSMETIC FORMULATION FOR TOPICAL ADMINISTRATION COMPRISING  NOVEL PEPTIDES THAT IMPROVE APPEARANCE AND REGENERATION OF SKINASC REGENITY LTD
WO/2021/160346NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUSINSTITUT PASTEUR
WO/2021/204423USE OF 15-MEMBERED AZALIDES AS ACTIVE AGENTS IN THE TREATMENT  OF VIRAL INFECTIONSUNIVERSITY OF ZAGREB SCHOOL OF MEDICINE
WO/2021/209173NOVEL THERAPEUTIC USE OF PLEUROMUTILINSNABRIVA THERAPEUTICS GMBH
WO/2021/209174THERAPEUTIC USE OF PLEUROMUTILINSNABRIVA THERAPEUTICS GMBH
WO/2021/223914PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC  ADMINISTRATION COMPRISING BRIMONIDINEPHARMATHEN S.A.
WO/2021/228434PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC  ADMINISTRATION CONTAINING CYCLOSPORINEPHARMATHEN S.A.
WO/2021/254662CROSSLINKED STARCH DERIVATIVE-BASED MATRIXROQUETTE FRERES
WO/2021/175497METHOD FOR COLORING KERATIN MATERIAL, COMPRISING THE USE OF  TWO STRUCTURALLY DIFFERENT SILANES AND TWO STRUCTURALLY DIFFERENT POLYMERSHENKEL AG & CO. KGAA
WO/2021/197673AGENTS FOR IMPROVED OXIDATIVE LIGHTENING OF KERATIN FIBRESHENKEL AG & CO. KGAA
WO/2021/180369METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANOSILICON COMPOUND, ALGINIC ACID (SALT),   A DYEING COMPOUND AND A POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/180370METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANOSILICON COMPOUND, A GLYCEROL ESTER, A COLORING COMPOUND AND A  POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/180372PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE  PIGMENT SUSPENSIONHENKEL AG & CO. KGAA
WO/2021/140101PREPARATION AND USE OF CANNABIS NANO-FORMULATIONCANNAXAN GMBH
WO/2021/140103COGNITIVE DISORDER PREVENTION AND THERAPYANIMA
WO/2021/140111HAIR CONDITIONER ALLOWING THE USE OF SOAP AS SHAMPOOLYNELINE SàRL
WO/2021/140113CICLESONIDE FOR AMELIORATING QUALITY OF LIFE (QOL) IN EQUINESBOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/175499PERSONAL CARE COMPOSITION AND METHODSUNILEVER IP HOLDINGS B.V.
WO/2021/140123VACCINES TARGETING NEISSERIA GONORRHOEAEEVAXION BIOTECH APS
WO/2021/140131USE OF TAXODIONE AS AN ANTI-GLYCATION AGENTCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/148249NEW COMPOSITION AS SHAVING PREPARATIONBEIERSDORF AG
WO/2021/140141COSMETIC TREATMENT METHODL'OREAL
WO/2021/140174GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF CHRONIC  KIDNEY DISEASE AND DIABETIC KIDNEY DISEASE IN TYPE 2 DIABETESMEDIMMUNE LIMITED
WO/2021/140183ORAL SOLID CANNABINOID OIL COMPOSITION FOR TREATING  GASTROINTESTINAL DISORDERSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/140194COMPOUNDS FOR PROMOTING FOLLICLE MATURATIONAARHUS UNIVERSITET
WO/2021/136848COMPOSITION FOR USE IN THE TREATMENT OF COGNITIVE DISORDERSBIOSEARCH, S.A.
WO/2021/140228COSMETIC COMPOSITIONCREASEARCH BV
WO/2021/140229COSMETIC COMPOSITIONCREASEARCH BV
WO/2021/144211EDIBLE TOOTHPASTE COMPOSITION TO BE SUCKED OR CHEWED, METHOD  FOR PREPARING SAID TOOTHPASTE COMPOSITIONDANA, Jean Dominique
WO/2021/144231HAIR CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/084139NANO-DRY MELTINGBAYER AKTIENGESELLSCHAFT
WO/2021/144245NATIVE AND POROUS STARCH AS WHITE PIGMENT IN TOOTHPASTEROQUETTE FRERES
WO/2021/144249HYPOPARATHYROIDISM TREATMENTASCENDIS PHARMA BONE DISEASES A/S
WO/2021/144254SALMONELLA-BASED DNA VACCINES IN COMBINATION WITH AN  ANTIBIOTICVAXIMM AG
WO/2021/144267HAIR TREATMENT COMPOSITIONS AND METHODSUNILEVER IP HOLDINGS B.V.
WO/2021/144272HAIR TREATMENT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/144274USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF JOINT PAIN  INDUCED BY PHYSICAL ACTIVITY, AND CORRESPONDING COMPOSITIONSNUVAMID SA
WO/2021/144302BIOMARKERS FOR DETERMINING SUSCEPTIBILITY TO OXOPIPERAZINE  DERIVATIVES AND METHODS OF USING SAMEINTHERA BIOSCIENCE AG
WO/2021/180378METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANOSILICON COMPOUND, HYALURONIC ACID (SALT),  A DYEING COMPOUND AND A POST-TREATMENT  AGENTHENKEL AG & CO. KGAA
WO/2021/180379METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANOSILICON COMPOUND, TWO DYEING COMPOUNDS AND A POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/144313VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIESSYNAFFIX B.V.
WO/2021/144314VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIESSYNAFFIX B.V.
WO/2021/144315CONJUGATES OF ANTIBODIES AN IMMUNE CELL ENGAGERSSYNAFFIX B.V.
WO/2021/144326TOPICAL COMPOSITION COMPRISING HYDROXAMIC ACID AND  ATRACTYLENOLIDEUNILEVER IP HOLDINGS B.V.
WO/2021/144330USE OF FXR AGONISTS FOR TREATING AN INFECTION BY HEPATITIS D  VIRUSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/144333PROBIOTIC COMPOSITION FOR USE AS AN ANTIOXIDANTBIOPOLIS, S.L.
WO/2021/144338METHOD OF TREATMENT OF CANCER OR TUMOURADAPTIMMUNE LIMITED
WO/2021/160366POLYACRYLATE-FREE COSMETIC PREPARATIONBEIERSDORF AG
WO/2021/144360SMALL MOLECULE CSF-1R INHIBITORS IN THERAPEUTIC AND COSMETIC  USESF. HOFFMANN-LA ROCHE AG
WO/2021/144364PARTICLES OF A MIXTURE OF IRON(III)-OXYHYDROXIDE, SUCROSE AND  ONE OR MORE STARCHES, PREFERABLY OF SUCROFERRIC OXYHYDROXIDEVIFOR (INTERNATIONAL) AG
WO/2021/144365PRODUCT AND MANUFACTURING PROCESS FOR A GUMMCNEIL AB
WO/2021/144367LOZENGEMCNEIL AB
WO/2021/144369FIMH MUTANT, COMPOSITIONS THEREWITH AND USE THEREOFJANSSEN PHARMACEUTICALS, INC.
WO/2021/144370PRODUCT AND METHOD OF MANUFACTURING A GUMMCNEIL AB
WO/2021/144381COMPOSITIONS FOR ALLEVIATING THE SYMPTOMS OF LOW ANTERIOR  RESECTION SYNDROME BY TOPICAL ADMINISTRATION TO THE NEORECTUMREPOCEUTICALS A/S
WO/2021/164959METHOD FOR PROVIDING PERSONALIZED CELLS WITH CHIMERIC ANTIGEN  RECEPTORS (CAR) AGAINST TUMOR MICROENVIRONMENT CELLSMILTENYI BIOTEC B.V. & CO. KG
WO/2021/144403DOSAGE FORM WITH SUSTAINED RELEASE MELATONIN PELLETSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/148314ACCELERATED ELIMINATION OF  (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPANE-1,2-DIOLIDORSIA PHARMACEUTICALS LTD
WO/2021/144415IMMUNOGLOBULIN SINGLE DOMAIN ANTIBODIES FOR DELIVERY OF  MUCOSAL VACCINESUNIVERSITEIT GENT
WO/2021/144446PLANT EXTRACT COMPOSITION FOR THE TREATMENT OF LIVER STEATOSISMEDA PHARMA S.P.A.
WO/2021/144447PLANT EXTRACT COMPOSITION FOR THE TREATMENT OF CARDIOVASCULAR  AND METABOLIC DISEASESMEDA PHARMA S.P.A.
WO/2021/144450A COMPOSITION COMPRISING A FLUOROPHORE LABELLED UPAR-TARGETING  PEPTIDE CONJUGATEFLUOGUIDE A/S
WO/2021/144457FORMULATIONS OF CD38 ANTIBODIES AND USES THEREOFGENMAB A/S
WO/2021/144460CONTROLLED RELEASE FORMULATIONSUNIVERSIDAD DE ZARAGOZA
WO/2021/151694SUNSCREEN WITH PIGMENT FILTER SEPARATIONBEIERSDORF AG
WO/2021/156043TESTOSTERONE CONTAINING PHARMACEUTICAL COMPOSITIONDIURNAL LIMITED
WO/2021/148347BILAYER TABLET COMPRISING TELMISARTAN AND AMLODIPINEZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/219255NATURAL MATERIAL PADORGANOID TECHNOLOGIES GMBH
WO/2021/148362DIRECTLY COMPRESSIBLE POLYMER COMBINATIONS FOR MATRIX TABLETS  WITH EXTENDED DRUG RELEASEMERCK PATENT GMBH
WO/2021/148366PLANT-BASED COMPOSITION IN A FORM SUITABLE FOR TOPICAL  ADMINISTRATION AND ASSOCIATED PRODUCTION METHODMENELIK
WO/2021/148396EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS  FOR THE TREATMENT OF CANCERASTRAZENECA AB
WO/2021/148405INHIBITORS OF INTRACELLULAR BACTERIAL GROWTH AND PERSISTENCE  AS ANTIBIOTICSCONSEJO SUPERIOR DE INVESTIGACIONES (CSIC)
WO/2021/148427HYDRATABLE CONCENTRATED SURFACTANT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/148428ISOTROPIC CONCENTRATE AND WASH COMPOSITIONSUNILEVER IP HOLDINGS B.V.
WO/2021/148436SUBSTANCE COMBINATION WITH ISOQUINOLINE ALKALOIDS AND A  COCCIDIOSTAT OR COCCIDIOSIS INOCULANTPHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH
WO/2021/148439METHODS FOR STIMULATING CEREBROVASCULAR FUNCTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/151756BASE EDITOR LACKING HNH AND USE THEREOFETH ZURICH
WO/2021/164974SHAVING AID CONTAINING HYDROXYALKYL CELLULOSESBEIERSDORF AG
WO/2021/148496USE OF TETRAPEPTIDES AND FUNCTIONALISED MICROCAPSULES AS SKIN  PENETRATION CARRIERSINFINITEC ACTIVOS, S.L.
WO/2021/148500COMPOUNDS AND CONJUGATES THEREOFMEDIMMUNE LIMITED
WO/2021/148501COMPOUNDS AND CONJUGATES THEREOFMEDIMMUNE LIMITED
WO/2021/148511LIPID NANOPARTICLESETHERNA IMMUNOTHERAPIES NV
WO/2021/148572COMPOSITION COMPRISING HYALURONIC ACID AND A POLYOL AND/OR  CARBOXYMETHYL CELLULOSELABORATOIRES GENEVRIER SAS
WO/2021/148619TOPICAL COMPOSITIONS COMPRISING A MACROLIDE IMMUNOSUPPRESSANTBAUSCH HEALTH IRELAND LIMITED
WO/2021/148633COMPLEX OF 7-DEACETYFORSKOLINE AND PVPSCIPHARM S.à R.L.
WO/2021/148634TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING THE INGREDIENT  ROTIGOTINE AND AT LEAST ONE NON-AMINE-RESISTANT SILICONE ADHESIVELUYE PHARMA SWITZERLAND AG
WO/2021/148646MICRIBIOTA-DERIVED PROTEINS INDUCING IL-10 RELEASE FROM HUMAN  CELLS AND USES THEREOFENTEROME S.A.
WO/2021/148667AESTHETIC DENTAL FILLING MATERIAL HAVING HIGH CURING DEPTHIVOCLAR VIVADENT AG
WO/2021/151828THE USE OF A POLYLYSINE FOR INCREASING THE GLOSS OF HAIRBASF SE
WO/2021/151857PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED  PHARMACEUTICAL FORMULATIONCHIESI FARMACEUTICI S.P.A.
WO/2021/151865MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAYEVOTEC INTERNATIONAL GMBH
WO/2021/151872ALLERGEN PROTECTION AGAINST URUSHIOLSBEIERSDORF AG
WO/2021/151877TOPICALLY APPLICABLE PREPARATION COMPRISING PEPTIDES FOR  PROTECTING SKIN FROM ALLERGENSBEIERSDORF AG
WO/2021/156104METHOD FOR OBTAINING AN AQUEOUS EXTRACT OF LAVENDER,  COMPOSITIONS COMPRISING SUCH AN EXTRACT AND THEIR COSMETIC USESISP INVESTMENTS LLC.
WO/2021/151879PROTECTING SKIN FROM ALLERGENSBEIERSDORF AG
WO/2021/151889ANTI-αVβ8 INTEGRIN ANTIBODIES FOR USE IN TREATING KIDNEY  DISEASEMEDIMMUNE LIMITED
WO/2021/151905TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR THE TREATMENT OF  RENAL DISEASETRANSITION THERAPEUTICS (IRELAND 2) LIMITED
WO/2021/151918COSMETIC PRODUCT CAKE WITH ECOLOGICAL SUPPORT AND  MANUFACTURING PROCESS THEREOFINTERCOS S.P.A.
WO/2021/165001HUMECTANT-FREE TOOTHPASTE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/151937ECOLOGICAL SUPPORT FOR COSMETIC PRODUCTS AND RELATED FORMATION  PROCESS.INTERCOS S.P.A.
WO/2021/151946COMPOSITIONS COMPRISING BACTERIAL STRAINS4D PHARMA RESEARCH LIMITED
WO/2021/151956COMPOSITION FOR TREATING INTESTINAL OR PULMONARY DISEASESINSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE,  L'ALIMENTATION ET L'ENVIRONNEMENT
WO/2021/151963PHARMACEUTICAL COMPOSITION FOR CONTROLLING PARASITES ON  NON-HUMAN ORGANISMSBAYER ANIMAL HEALTH GMBH
WO/2021/151964USE OF AZOLE COMPOUNDS TO STIMULATE THE IMMUNE SYSTEM AND AS  INHIBITORS FOR S-PLA2GIBDIACCURATE
WO/2021/151974INTERFERING WITH MRNA SPLICING TO ENHANCE RESPONSE TO  CHECKPOINT IMMUNOTHERAPIES.STICHTING HET NEDERLANDS KANKER INSTITUUT - ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/151984TREATMENT OF CANCERINNATE PHARMA
WO/2021/152009GRANULAR PHARMACEUTICAL PRODUCT FOR ORAL ADMINISTRATION FROM A  PRE-FILLED STRAW AND METHOD OF MANUFACTURING SUCH PHARMACEUTICAL PRODUCTALTERNO LABS D.O.O.
WO/2021/156140POLYMORPH OF RUCAPARIB MESYLATESANDOZ AG
WO/2021/152060CONTROLLED RELEASE SELEXIPAG COMPOSITIONACTELION PHARMACEUTICALS LTD
WO/2021/152065APREPITANT FOR USE IN THE TOPICAL TREATMENT OF FACIAL  NEURALGIAASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
WO/2021/156145ADONIRUBIN AND DHA FOR HEART HEALTHDSM IP ASSETS B.V.
WO/2021/152115BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLESMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/152119HUMAN ANTI-INFLAMMATORY PEPTIDES FOR THE INHALATORY TREATMENT  OF INFLAMMATORY PULMONARY DISEASESADVITA LIFESCIENCE GMBH
WO/2021/152129AMORPHOUS SOLID DISPERSION OF  8-CHLORO-N-(4-(TRIFLUOROMETHOXY)PHENYL)QUINOLIN-2-AMINEABIVAX
WO/2021/152136PASTE COMPRISING MAGNETIC ALKOXYSILANE-COATED METAL CONTAINING  NANOPARTICLESMAGFORCE AG
WO/2021/190810IMPROVING THE FASTNESS TO WASHING OF PIGMENT-CONTAINING DYES  BY USING AN OXIDATIVE PRETREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/156172PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB AND A  STABILIZING AGENTBAYER AKTIENGESELLSCHAFT
WO/2021/152172HYPERBRANCHED POLYESTER POLYOL DERIVATIVE AS DRUG SOLUBILIZERFREIE UNIVERSITÄT BERLIN
WO/2021/152175PULMONARY DELIVERY OF ANTIBODIESSANOFI
WO/2021/156213LIPID NANOPARTICLES FOR DELAYED DELIVERY OF FRAGRANCE WITH  ENHANCED WATER SOLUBILITY, THEIR PREPARATION AND USECLARIANT INTERNATIONAL LTD
WO/2021/152184COMPOSITIONS COMPRISING AT LEAST AN AMYLIN RECEPTOR AGONIST  AND A GLP-1 RECEPTOR AGONISTADOCIA
WO/2021/156223NANOFORMULATIONS OF METHYL  {4,6-DIAMINO-2-[5-FLUORO-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL}CARBAMATEADVERIO PHARMA GMBH
WO/2021/156227METHODS OF TREATING AND ASSESSING PULMONARY ARTERIAL  HYPERTENSION WITH SELEXIPAGACTELION PHARMACEUTICALS LTD
WO/2021/156242FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCEFIRMENICH SA
WO/2021/156258TREATMENT INVOLVING ANTIGEN VACCINATION AND BINDING AGENTS  BINDING TO PD-L1 AND CD137BIONTECH SE
WO/2021/156267CORONAVIRUS VACCINECUREVAC AG
WO/2021/156275COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA AND OCULAR  HYPERTENSIONNICOX S.A.
WO/2021/156277IMMUNE CELL EXPRESSING ADAPTER CHIMERIC ANTIGEN RECEPTOR FOR  SENSING SOLUBLE ANTIGENSMILTENYI BIOTEC B.V. & CO. KG
WO/2021/156289COMBINATION CONTAINING A DUOCARMYCIN DERIVATIVE-COMPRISING  ANTIBODY-DRUG CONJUGATE AND THIOSULFATEBYONDIS B.V.
WO/2021/156291CONTROLLED RELEASE SYSTEM OF PHYTOCANNABINOIDS FORMULATIONS  SOLUBLE IN AQUEOUS MEDIA, METHODS AND USES THEREOFI+MED S. COOP.
WO/2021/156310TAFA4 POLYPEPTIDE OR POLYNUCLEOTIDE FOR TREATING INFLAMMATORY  DISEASEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/156326ANTIBODIES FOR USE IN THERAPYGENMAB A/S
WO/2021/156330ORAL CARE COMPOSITION FOR ANIMALSDR. KURT WOLFF GMBH & CO. KG
WO/2021/156340PDAC TREATMENT REGIMENSWEDISH ORPHAN BIOVITRUM AB (PUBL)
WO/2021/156345INJECTABLE COMPOSITION FOR SKIN AND SOFT TISSUE AUGMENTATIONMERZ PHARMA GMBH & CO. KGAA
WO/2021/156360METHODS FOR DISCONTINUING A TREATMENT WITH A TYROSINE KINASE  INHIBITOR (TKI)INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/156369USE OF LOW DOSES OF HYDROXYCHLOROQUINE FOR THE TREATMENT OF  LIPIN-1 DEFICIENCYINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/156381ACTIVE INGREDIENT OF AN ERYTHROCYTES-CONTAINING COMPOSITIONGHASHGHAEINIA, Mehrdad
WO/2021/156385LIPID COMPOSITION COMPRISING OMEGA-3 FATTY ACIDSWELLNESS HOLDING B.V.
WO/2021/160519TREATMENT OF PRIMARY BILIARY CHOLANGITIS WITH ELAFIBRANORGENFIT
WO/2021/156404TREATMENT OF HPV-RELATED DISEASESISA PHARMACEUTICALS
WO/2021/156435MUCOADHESIVE SOLID OR SEMISOLID OCULAR DELIVERY SYSTEMS BASED  ON PREACTIVATED THIOMERSBIOADHESIVE OPHTHALMICS
WO/2021/156437FENFLURAMINE FOR USE IN TREATING PATIENTS WITH LENNOX-GASTAUT  SYNDROMEZOGENIX INTERNATIONAL LIMITED
WO/2021/156439TRIAZOLE COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONISTSASTRAZENECA AB
WO/2021/170374COMPOSITION FOR USE IN PREVENTION OR TREATMENT OF OESOPHAGEAL  DISEASES LINKED TO EPITHELIAL BARRIER DEFECTSTHELIAL B.V.
WO/2021/156451C-X-C MOTIF CHEMOKINE RECEPTOR 4 ANTAGONISTINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/156455LITCHI PRODUCTS AS DERMATOLOGICAL AND COSMETIC AGENTSDR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL
WO/2021/156490CORONA VIRUS BINDERSVIB VZW
WO/2021/170380IMPROVED PREPARATIONBEIERSDORF AG
WO/2021/160543METHOD FOR TREATING VASO OCCLUSIVE CRISES ASSOCIATED WITH  SICKLE CELL DISEASENICOX S.A.
WO/2021/156504TREATMENT OF PANX1 ASSOCIATES DISEASESNURITAS LIMITED
WO/2021/160608PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND  METFORMINZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/160650A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF A CANCERABILITY PHARMACEUTICALS S.L.
WO/2021/160659GAS-FILLED MICROVESICLES FOR THERAPEUTIC USEBRACCO SUISSE SA
WO/2021/170409USE OF A COMBINATION OF A SACCHARIDE AND GLYCEROL FOR  PREBIOTIC BENEFITSUNILEVER IP HOLDINGS B.V.
WO/2021/160700COMPOSITION COMPRISING RAMIPRIL AND INDAPAMIDEADAMED PHARMA S.A.
WO/2021/160708COMBINATION OF REGORAFENIB AND MSLN-TTC FOR TREATING CANCERBAYER AKTIENGESELLSCHAFT
WO/2021/160724PROCESS FOR SITE-SPECIFIC MODIFICATION OF AN ANTIBODYORANO MED
WO/2021/204441METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF A  ORGANOSILICON COMPOUND, A POLYSACCHARIDE, A COLORING COMPOUND AND A  POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/160763FGFR TYROSINE KINASE INHIBITORS AND ANTI-PD1 AGENTS FOR THE  TREATMENT OF UROTHELIAL CARCINOMAJANSSEN PHARMACEUTICA NV
WO/2021/160764FGFR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HIGH-RISK  NON-MUSCLE INVASIVE BLADDER CANCERJANSSEN PHARMACEUTICA NV
WO/2021/160766LIPID COMPOSITION AND USE THEREOF FOR DELIVERY OF A  THERAPEUTICALLY ACTIVE AGENT TO ENDOTHELIUMPANTHERNA THERAPEUTICS GMBH
WO/2021/160768COMPOUNDS USEFUL AS ANTI-VIRAL AGENTSNATURE CRETE PHARMACEUTICALS PC
WO/2021/160769A BACTERIAL COMPOSITION FOR THE TREATMENT OF CANCERUNIVERSITÄT ZüRICH
WO/2021/160850MEASLES-VECTORED COVID-19 IMMUNOGENIC COMPOSITIONS AND  VACCINESINSTITUT PASTEUR
WO/2021/160873NANOPARTICLES ENCAPSULATING SMALL MOLECULESETH ZURICH
WO/2021/165177USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT  OF CARDIAC DISEASES IN FELINESBOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/160881INTRANASAL MRNA VACCINESETHERNA IMMUNOTHERAPIES NV
WO/2021/165204TOPICALLY ADMINISTRABLE LYSATE OF DEDIFFERENTIATED CELLS OF  THE PLANT HELICHRYSUM STOECHAS FOR MOISTURIZING SKINSOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/165205TOPICALLY ADMINISTRABLE LYSATE (LY) OF DEDIFFERENTIATED CELLS  OF THE PLANT HELICHRYSUM STOECHAS FOR ELIMINATING OR REDUCING INFLAMMATION OF  THE SKINSOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/165206TREATMENT OF DRY AMD WITH INTEGRIN ANTAGONISTSOXURION NV
WO/2021/165207TRANSPARENT COLORED COSMETIC INGREDIENT FOR COSMETIC PRODUCTS,  POSSIBLY CAPABLE OF AUTOMATICALLY CHANGING COLOR WHEN IRRADIATED BY  ULTRAVIOLET LIGHT.INTERCOS S.P.A.
WO/2021/165226SUBCUTANEOUS ADMINISTRATION OF FACTOR VIIIBIOTEST AG
WO/2021/165227AMPHIPHILIC POLYMERS AND THEIR USE FOR IMPROVED PRODUCTION OF  NANOPARTICLES FOR THE TARGETED DELIVERY OF ANTIGENSTOPAS THERAPEUTICS GMBH
WO/2021/165240TAFOXIPARIN FOR THE TREATMENT OF PREECLAMPSIADILAFOR AB
WO/2021/175577TRANSPARENT DENTIFRICE COMPRISING ZINCUNILEVER IP HOLDINGS B.V.
WO/2021/175583LIPID NANOPARTICLES COMPRISING A FRAGRANCECLARIANT INTERNATIONAL LTD
WO/2021/165273PRO-MACROBODIES FOR THE ENHANCEMENT OF STRUCTURE RESEARCHLEADXPRO AG
WO/2021/144476PHARMACEUTICAL FORMULATIONSNOVO NORDISK A/S
WO/2021/144477GLP-1 COMPOSITIONS AND USES THEREOFNOVO NORDISK A/S
WO/2021/165285MONO- AND MULTI-TRIAZOLOMINIGASTRINS FOR TARGETING OF  CCK2R-POSITIVE NEOPLASMSPAUL SCHERRER INSTITUT
WO/2021/165306OPTIMIZATION OF PEPTIDE-MELANIN BINDINGASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS
WO/2021/165312VACCINE ADJUVANT COMPRISING AN INVERSE MICROLATEXSOCIéTé D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/165316PHARMACEUTICAL COMPOSITION COMPRISING DAPAGLIFLOZINZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/165348PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED  PHARMACEUTICAL FORMULATIONCHIESI FARMACEUTICI S.P.A.
WO/2021/165369TREATMENT OF CORNEAL VASCULARISATIONVESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/175605OXYGEN/CARBON DIOXIDE COMPOSITIONS FOR MEDICAL USESAVIATION WORKS LIMITED
WO/2021/175606AN EFFECTIVE ANTI-ACNE PERSONAL CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/165402CAPSULE COMPRISING A VITAMIN E ESTER FOR PREVENTING THE ONSET  OF VAGINAL DYSBIOSIS AND RESULTING VAGINAL PATHOLOGIESHULKA S.R.L.
WO/2021/165405A PHARMACEUTICAL COMBINATION OF AN ARTEMISININ COMPOUND,  5-AMINOLEVULINIC ACID OR METHYL-5-AMINOLEVULINIC ACID AND A CHEMOTHERAPEUTIC  AGENTJLP HEALTH GMBH
WO/2021/165420METHOD FOR TREATING CHRONIC GRAFT VERSUS HOST DISEASEMESOBLAST INTERNATIONAL SàRL
WO/2021/170489AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGEUCL BUSINESS PLC
WO/2021/165424AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE 2UCL BUSINESS PLC
WO/2021/165426ANTIMICROBIAL COMPOSITIONSFIRMENICH SA
WO/2021/165429CXCL8 (INTERLEUKIN-8) ACTIVITY INHIBITOR AND CORTICOSTEROID  COMBINATION AND PHARMACEUTICAL COMPOSITION AND USE THEREOFDOMPE' FARMACEUTICI SPA
WO/2021/165452MOLECULES TARGETING MUTANT RAS PROTEINAELIN THERAPEUTICS
WO/2021/165453MOLECULES TARGETING PROTEINSAELIN THERAPEUTICS
WO/2021/165456MOLECULES TARGETING RAS PROTEINAELIN THERAPEUTICS
WO/2021/165463METHOD OF TREATING BACTERIAL INFECTIONS AND PHARMACEUTICAL  COMPOSITION FOR TREATING BACTERIAL INFECTIONSINSTITUT NATIONAL DE RECHERCHE POUR L’AGRICULTURE,  L’ALIMENTATION ET L’ENVIRONNEMENT
WO/2021/165472MASITINIB FOR THE TREATMENT OF A MULTIPLE SCLEROSIS PATIENT  SUBPOPULATIONAB SCIENCE
WO/2021/165477USE OF MICA IN PRESSED POWDERIMERTECH SAS
WO/2021/165484DEPLETION OF EXT1 EXPRESSION AND/OR ACTIVITY IMPROVES CELLULAR  PRODUCTION OF BIOLOGICAL ENTITIESUNIVERSITé DE LIèGE
WO/2021/165499INHIBITORS AND USES THEREOFENTHERA S.R.L.
WO/2021/165510CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE  IN THE TREATMENT OF CANCER-RELATED FATIGUEDOMPE' FARMACEUTICI SPA
WO/2021/170516FORMULATION BASED ON NATURAL INGREDIENTS FOR USE IN TREATING  PROCTOLOGICAL DISORDERSNATHURA S.P.A.
WO/2021/165537A METHOD FOR SEPARATION OR DEPLETION OF EMPTY AAV CAPSIDS FROM  FULL AAV CAPSIDSBIA SEPARATIONS D.O.O.
WO/2021/165538IMPROVED ANTI-SENESCENCE COMPOUNDS AND USES THEREOFCLEARA BIOTECH B.V.
WO/2021/165543PROPIONIBACTERIUM ACNES PROPHYLACTIC AND THERAPEUTIC IMMUNE  TREATMENTORIGIMM BIOTECHNOLOGY GMBH
WO/2021/170548PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF  DYSMENORRHEA AND/OR PREMENSTRUAL SYNDROME (PMS)CORNELLI, Umberto
WO/2021/170566RESHAPING COMPOSITION FOR KERATIN FIBERSKAO GERMANY GMBH
WO/2021/170568RESHAPING COMPOSITION FOR KERATIN FIBERSKAO GERMANY GMBH
WO/2021/175660PREPARATION FOR MAGNETIZING KIDNEY STONES AND KIDNEY STONE  FRAGMENTS AND KIT FOR REMOVING KIDNEY STONES AND KIDNEY STONE FRAGMENTSTECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/165549TREATMENT OF MEDICAL INDICATIONVALLAURIX TRADING SARL MC
WO/2021/170614AEROSOL COMPRISING 5-METHOXY-N.N-DIMETHYLTRYPTAMINEGH RESEARCH LIMITED
WO/2021/170618COMPOSITIONS COMPRISING <i>LUFFA CYLINDRICA</i>  ROOT EXTRACTCLARIANT INTERNATIONAL LTD
WO/2021/170627DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORSUCB BIOPHARMA SRL
WO/2021/175672COSMETIC COMPOSITION FOR FORMING A FILM HAVING ELEVATED  ELASTICITY AND EXTENSIBILITYCOVESTRO DEUTSCHLAND AG
WO/2021/170684KRAS EPITOPES AND ANTIBODIESOBLIQUE THERAPEUTICS AB
WO/2021/170741TREATMENT OF HBVJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/170763ANTI-ADM-ANTIBODIES BINDING TO THE FREE N-TERMINUS FOR  ACCELERATED TRANSITION OF ADM-GLY TO BIO-ADM IN PATIENTS WITH ADM-GLY/  BIO-ADM RATIO ABOVE A THRESHOLD AND COMBINATION WITH VITAMIN CSPHINGOTEC GMBH
WO/2021/170772COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR  OF CD47 MEDIATED SIGNALINGAPREA THERAPEUTICS AB
WO/2021/170784GENE THERAPY FOR MAPLE SYRUP URINE DISEASEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/170793COMBINATION COMPRISING ALPELISIB AND  6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULENE-2-CARBOXYLIC  ACIDSANOFI
WO/2021/170806USES AND COMPOSITIONS BASED ON POLYPHENOLS FOR IMPROVING THE  ORAL BIOAVAILABILITY OF HYDROXYTYROSOLBIOSEARCH, S.A.
WO/2021/170807DAPTOMYCIN FORMULATIONXELLIA PHARMACEUTICALS APS
WO/2021/175716COMPOSITE RNA PARTICLESBIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/170811METHOD OF TREATING EYE DISEASE USING TRPV4 ANTAGONISTSGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
WO/2021/170816USE OF PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR  THERAPEUTIC PURPOSEPAM THERAGNOSTICS GMBH
WO/2021/170817COMPOSITION FOR DISPERSING A LIPOSOLUBLE COMPOUND IN AN  AQUEOUS PHASESENSIENT COSMETIC TECHNOLOGIES
WO/2021/170821METHOD FOR VIRUS PRODUCTIONTECHNISCHE HOCHSCHULE MITTELHESSEN
WO/2021/170828HIGH POLYOL WASH COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/170831ENZYME REPLACEMENT THERAPY FOR TREATING POMPE DISEASEELEVA GMBH
WO/2021/170834COMPOSITION FOR THE PREVENTION AND TREATMENT OF DYSBIOSISMUCOSA INNOVATIONS, S.L.
WO/2021/170841PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE  AND METHODS OF THEIR USEBIOSERGEN AS
WO/2021/170848INTERVENTION STRATEGY FOR PREVENTION OR TREATMENT OF DIABETES  MELLITUS, AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE OR CARDIOVASCULAR DISEASEACADEMISCH MEDISCH CENTRUM
WO/2021/175740FOLATE PREPARATIONS FOR THE TREATMENT OF OCULAR DISEASESAPROFOL AG
WO/2021/175755FORMULATION OF LISINOPRIL AND AMLODIPINEALKALOID AD SKOPJE
WO/2021/175763TOPICAL COMPOSITION COMPRISING CANNABIDIOLEMMAC LIFE SCIENCES LTD.
WO/2021/170869CORONAVIRUS VACCINESKATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/175773DOSAGE FORM PROVIDING PROLONGED RELEASE OF TAPENTADOL  PHOSPHORIC ACID SALTGRüNENTHAL GMBH
WO/2021/175775COSMETIC COMPOSITION WITH OPTIMIZED STARCH AND COSMETIC  APPLICATIONS THEREOFINTERCOS S.P.A.
WO/2021/170874A METHOD OF PRODUCING A CRYSTALLINE FORM OF SODIUM  2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLIN-4-YL]ACETATE  TRIHYDRATEAIC246 GMBH & CO. KG
WO/2021/170875PHARMACEUTICAL COMPOSITIONS COMPRISING  2-[(4<i>S</i>)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4<i>H</i>-QUINAZOLIN-4-YL]ACETATE  AND SODIUM IONSAIC246 GMBH & CO. KG
WO/2021/170878SODIUM  2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLIN-4-YL]ACETATE  AND PHARMACEUTICAL COMPOSITIONS THEREOFAIC246 GMBH & CO. KG
WO/2021/170879SODIUM  2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLIN-4-YL]ACETATE  MONOHYDRATE, ITS PREPARATION AND USEAIC246 GMBH & CO. KG
WO/2021/170882POTASSIUM SALT OF  2-[(4<i>S</i>)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4<i>H</i>-QUINAZOLIN-4-YL]ACETIC  ACIDAIC246 GMBH & CO. KG
WO/2021/175816COMPOUNDS FOR USE IN A METHOD OF TREATING, PREVENTING AND/OR  REDUCING THE SYMPTOMS OF PAINTHE BECKLEY FOUNDATION
WO/2021/175823PLD FOR USE IN COMBINATION IN THE TREATMENT OF CORONAVIRUSPHARMA MAR, S.A.
WO/2021/175824METHOD FOR ADMINISTRATION OF AN ANTI CANCER AGENTBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/175826COMPOUNDS FOR USE IN THE TREATMENT OF CORONAVIRUS INFECTIONPHARMA MAR, S.A.
WO/2021/175829COMPOUNDS FOR USE IN AUTOIMMUNE CONDITIONSPHARMA MAR, S.A.
WO/2021/175831COMPOUNDS FOR USE IN VIRAL INFECTIONSPHARMA MAR, S.A.
WO/2021/175857COMPOUNDS FOR USE IN INFLAMMATORY CONDITIONSPHARMA MAR, S.A.
WO/2021/175877COMPOSITION FOR USE IN A TREATMENT OF CERVICAL CELL  ABNORMALITIES COMPRISING SELENITE COMPOUND AND ACIDSELO MEDICAL GMBH
WO/2021/175914CONDITIONING REGIMEN FOR TRANSPLANTHANSA BIOPHARMA AB
WO/2021/175924TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR  USE IN COMBINATION THERAPYACTIVE BIOTECH AB
WO/2021/175926COMPOSITION FOR POLYAMINE BIOSYNTHESISBM HEALTH GMBH
WO/2021/175960FULLY SYNTHETIC, LONG-CHAIN NUCLEIC ACID FOR VACCINE  PRODUCTION TO PROTECT AGAINST CORONAVIRUSESROCKETVAX AG
WO/2021/175971HETEROCYCLIC DERIVATIVES AS TRMP8 ANTAGONISTSGIVAUDAN SA
WO/2021/175998COPROCOCCUS BACTERIA FOR USE IN THE TREATMENT OF METABOLIC  SYNDROME AND INFLAMMATORY BOWEL DISEASESINSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE,  L'ALIMENTATION ET L'ENVIRONNEMENT
WO/2021/176000PROCESS FOR PRODUCING A HYDROLYSATE OF SCUTELLARIA ROOT, WHICH  IS ENRICHED AND STANDARDIZED WITH FLAVONOIDS OF INTEREST, THE HYDROLYSATE  OBTAINED BY SUCH A PROCESS, AND COSMETIC AND DERMOCOSMETIC APPLICATIONS OF  SUCH A HYDROLYSATEEXSYMOL
WO/2021/176001METHOD FOR TREATING INFLAMMATORY LUNG DISEASES USING  MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLSMESOBLAST INTERNATIONAL SàRL
WO/2021/176010ANTIVIRAL TREATMENTECOSYNTH NV
WO/2021/176017TREATMENT OF VIRAL INFECTIONPNEUMAGEN LTD
WO/2021/176026COSMETIC COMPOSITIONGIVAUDAN SA
WO/2021/176035BLOOD PREPARATION USEFUL FOR WOUND HEALING AND TISSUE  REGENERATIONNOVYSTEM S.P.A.
WO/2021/176038SYNERGISTIC AND TARGETING COMPOSITIONS FOR TREATMENT OF  ARTERIAL AND VENOUS THROMBOSISASTRAZENECA AB
WO/2021/176044LOW DOSE HUMAN INTERLEUKIN-2 FOR THE TREATMENT OF AMYOTROPHIC  LATERAL SCLEROSISCENTRE HOSPITALIER UNIVERSITAIRE DE NIMES
WO/2021/176045IMIDAZOTRIAZINES ACTING ON CANCER VIA INHIBITION OF CDK12BAYER AKTIENGESELLSCHAFT
WO/2021/254667COBICISTAT FOR PREVENTION AND/OR TREATMENT OF CORONAVIRUS  INFECTIONSUNIVERSITÄT HEIDELBERG
WO/2021/176070METHODS OF SLOWING BRAIN VOLUME LOSSACTELION PHARMACEUTICALS LTD
WO/2021/176074COMPOSITION COMPRISING AN AVENANTHRAMIDE WITH IMPROVED SKIN  PENETRATIONSYMRISE AG
WO/2021/176082VIRAL MULTIMERIC PEPTIDE CONSTRUCTS FOR TARGETING PDZ DOMAINSUNIVERSITY OF COPENHAGEN
WO/2021/176083PHARMACEUTICAL COMPOSITIONS COMPRISING DASATINIB ANHYDROUS AND  USES THEREOFZENTIVA K.S.
WO/2021/176085STEROIDAL NITRONE F2 FOR USE IN THE PREVENTION AND/OR  TREATMENT OF PERMANENT CEREBRAL ISCHAEMIAISQUAEMIA BIOTECH, S.L.
WO/2021/176088COMPOUNDS FOR THE TREATMENT OF COVID-19DOMPE' FARMACEUTICI SPA
WO/2021/176093NICOTINAMIDE MONONUCLEOTIDE AND BIS-NICOTINAMIDE DINUCLEOTIDE  DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIANUVAMID SA
WO/2021/176094LIPID CONJUGATED PEPTIDE INHIBITORS OF PICK1UNIVERSITY OF COPENHAGEN
WO/2021/180602SARS-COV-2 (SARS2, COVID-19) ANTIBODIESHARBOUR ANTIBODIES BV
WO/2021/180603SOFT CHEWABLE FORMED BODY FOR THE ADMINISTRATION TO ANIMALSBAYER ANIMAL HEALTH GMBH
WO/2021/176096PHARMACEUTICAL COMPOSITION COMPRISING SGLT2 INHIBITORKRKA, D.D., NOVO MESTO
WO/2021/180604SARS-COV-2 (SARS2, COVID-19) ANTIBODIESHARBOUR ANTIBODIES BV
WO/2021/176098MODULATORS OF ARALAR FOR TREATING NEUROLOGICAL DISORDERSUNIVERSITé DE LAUSANNE
WO/2021/180612MIXTURE COMPOSITION COMPRISING GLYCOLIPIDS AND TRIETHYL  CITRATEEVONIK OPERATIONS GMBH
WO/2021/176100IONTOPHORETIC COMPOSITION FOR ADMINISTERING S-KETAMINELTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/180643HSD11B1 INHIBITORS FOR USE IN IMMUNOTHERAPY AND USES THEREOFUNIVERSITE DE GENEVE
WO/2021/180727THERAPEUTIC AGENT TARGETING HER2HOBER BIOTECH AB
WO/2021/180731COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES AND  CONDITIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180732COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180739COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180740COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF LUNG DISEASES AND CONDITIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180741COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF PANCREATIC DISEASES AND CONDITIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180742METHYL-CYCLODEXTRIN FOR USE IN TREATING ENVELOPED VIRUS  INFECTIONS SUCH AS COV-2GARNIER, Patrice
WO/2021/180774MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAYEVOTEC INTERNATIONAL GMBH
WO/2021/180780TREATMENT AND/OR DIAGNOSIS OF A CANCER TYPE CHARACTERIZED BY  EXPRESSING ZINC TRANSPORTER ZIP4UNIVERSITAT POMPEU FABRA
WO/2021/180787PROTEOLYSIS TARGETING CHIMERA (PROTAC) FOR DEGRADATION OF  AURORA A-KINASEJULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/180821COMPOSITIONS OF IL-6/IL-6R ANTIBODIES AND METHODS OF USE  THEREOFTIZIANA LIFE SCIENCES PLC
WO/2021/180832HYBRID CAR AND HYBRID TCR CELLS TO TREAT INFECTIOUS DISEASESUNIVERSITEIT GENT
WO/2021/180839ANTI-AGING CARE COMPOSITION COMPRISING PERFUMESBASF SE
WO/2021/180848SUNFLOWER PHOSPHOLIPID COMPOSITION CONTAINING  PHOSPHATIDYLCHOLINELIPOID GMBH
WO/2021/180850METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE IMESOBLAST INTERNATIONAL SàRL
WO/2021/180851METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE IIMESOBLAST INTERNATIONAL SàRL
WO/2021/180857COMBINATIONS OF BETA-LACTAM COMPOUNDS, PROBENECID, AND  VALPROIC ACID AND USES THEREOFITERUM THERAPEUTICS INTERNATIONAL LIMITED
WO/2021/180862PHARMACEUTICAL COMPOSITIONS COMPRISING ELAGOLIX SODIUMSYNTHON B.V.
WO/2021/180867A NANOPARTICLE FOR USE IN THE TREATMENT OF AN OCULAR DISEASEUNIVERSITÄT REGENSBURG
WO/2021/180884FETUIN A FOR TREATMENT OF RENAL DISORDERSUNIVERSITAET BERN
WO/2021/180885TREATMENT OF STEM CELL DEFICIENCYOSPEDALE SAN RAFFAELE S.R.L.
WO/2021/185675PERSONAL CARE COMPOSITION, METHOD FOR USING SUCH COMPOSITIONS  AND ITS IMPROVEMENT OF DEPOSITION EFFECTBASF SE
WO/2021/180890CD22 TARGETING-MOIETY FOR THE TREATMENT OF B-CELL ACUTE  LYMPHOBLASTIC LEUKEMIA (B-ALL)FUNDACIó INSTITUT DE RECERCA CONTRA LA LEUCèMIA JOSEP CARRERAS
WO/2021/180896TOPICAL PREPARATIONSEPITHEAL LIMITED
WO/2021/197802TOPICAL COMPOSITION BASED ON POROUS PARTICLES AND A  CROSSPOLYMER COMPRISING ADIPIC ACID AND NEOPENTYLGLYCOLUNILEVER IP HOLDINGS B.V.
WO/2021/185680A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS SEROTYPE  9, SEQUENCE TYPE 16INTERVET INTERNATIONAL B.V.
WO/2021/180908THERAPEUTIC SYSTEM FOR THE TOPIC, TRANSDERMAL AND  TRANSCUTANEOUS APPLICATION OF CARBON MONOXIDEJULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/180913NEW USE AND METHOD OF TREATMENTREDWOOD PHARMA AB
WO/2021/180915USE OF A NICOTINAMIDE MONONUCLEOTIDE OR SOME OF ITS  DERIVATIVES FOR PREVENTING AND/OR TREATING DORSAL PAIN, AND CORRESPONDING  COMPOSITIONSNUVAMID SA
WO/2021/180916USE OF A NICOTINAMIDE MONONUCLEOTIDE OR SOME OF ITS  DERIVATIVES FOR THE PREVENTION AND/OR TREATMENT OF MUSCLE, LIGAMENT OR TENDON  PAIN INDUCED BY PHYSICAL ACTIVITY, AND CORRESPONDING COMPOSITIONSNUVAMID SA
WO/2021/180919METHOD FOR THE TREATMENT OF A RESPIRATORY DISEASE, DISORDER,  OR CONDITION RESULTING FROM A VIRAL INFECTIONSOFTHALE NV
WO/2021/180943COMPOSITIONS IMPROVING POXVIRUS STABILITYBAVARIAN NORDIC A/S
WO/2021/180963A PROTEASE INHIBITOR REGIMEN FOR TREATING SUBJECTS INFECTED  WITH HIVJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/180969CYCLIC PEPTIDES AND THEIR CONJUGATES FOR ADDRESSING  ALPHA-V-BETA-6 INTEGRIN IN VIVOTECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/180972DETOXIFIED LIPOPOLYSACCHARIDES (LPS), NATURALLY NON-TOXIC LPS,  AND USES THEREOFHEPHAISTOS-PHARMA
WO/2021/180973BIFIDOBACTERIUM LONGUMPRECISIONBIOTICS GROUP LIMITED
WO/2021/185719RGD-CONTAINING PEPTIDE AND USE THEREOF FOR CANCER TREATMENTAC BIOSCIENCE SA
WO/2021/185723THERAPEUTIC TREATMENT OF CHROMATINOPATHIESUNIVERSITA' DEGLI STUDI DI TRENTO
WO/2021/185728BIOCOMPOSITES COMPRISING PROBIOTICS, COLLAGEN AND BACTERIAL  EXTRACELLULAR POLYSACCHARIDE AND USES THEREOFBIOSEARCH, S.A.
WO/2021/185736CONSUMER PRODUCT COMPRISING A PLURALITY OF MICROCAPSULES  DEFINED BY THE MEAN TOTAL SURFACE AREAGIVAUDAN SA
WO/2021/185746COMPOUNDS FOR USE IN TREATMENT OF RESPIRATORY DISEASEAARHUS UNIVERSITET
WO/2021/180981STABILIZATION OF PHARMACEUTICAL COMPOSITIONS COMPRISING  POLYSORBATELEK PHARMACEUTICALS D.D.
WO/2021/185773GOLD-CONTAINING AGENTS FOR THE TREATMENT OF LUNG INFECTIONSPRODUKEM MOLEKULARES DESIGN GMBH
WO/2021/185775ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPESBIONTECH CELL & GENE THERAPIES GMBH
WO/2021/190979WHITENING ORAL CARE COMPOSITIONSRHODIA OPERATIONS
WO/2021/185783COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/185791TREATMENT OF EPILEPSYKATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/185798POLYPEPTIDE FOR THE THERAPY OF GLOMERULAR KIDNEY DISEASE AND  ANALYSIS OF THE COURSE AND PROGNOSIS OF DEPENDENT SYNDROMESPHARIS BIOTEC GMBH
WO/2021/185802COMPOSITION FOR ENHANCING UROLITHIN PRODUCTION IN A HUMAN  SUBJECTMIGALIS APS
WO/2021/185804SCORED TABLETGRüNENTHAL GMBH
WO/2021/185807A TARGETING MODULE COMPRISING PD-L1 AND/OR PD-L2 FOR USE IN A  METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR MEDIATED IMMUNE RESPONSE  IN A MAMMALGEMOAB GMBH
WO/2021/190993COMPOSITIONS CONTAINING RHAMNOLIPIDE, ALKYL POLYGLYCOSIDE AND  ACYL LACTYLATEEVONIK OPERATIONS GMBH
WO/2021/185821LIQUID FORMULATIONS OF GLUCAGON ANALOGUESZEALAND PHARMA A/S
WO/2021/185832NEW THERAPEUTIC TREATMENTSWEDISH ORPHAN BIOVITRUM AG
WO/2021/185838NEW THERAPEUTIC USE OF ANAKINRA FOR COVID-19SWEDISH ORPHAN BIOVITRUM AB (PUBL)
WO/2021/185842USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND  MEDICAL TREATMENTS OR USES THEREOFPVAC MEDICAL TECHNOLOGIES LTD
WO/2021/185844USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND  MEDICAL TREATMENTS OR USES THEREOFPVAC MEDICAL TECHNOLOGIES LTD
WO/2021/185851VACCINE COMPOSITIONS FOR HIV PREVENTION AND TREATMENTINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/185874USE OF LACTOFERRINMEAD JOHNSON NUTRITION COMPANY
WO/2021/185876USE OF LACTOFERRINMEAD JOHNSON NUTRITION COMPANY
WO/2021/185887REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCH FOR TREATING  INITIAL NON-RESPONDERSGRüNENTHAL GMBH
WO/2021/185890GINSENOSIDE COMPOSITIONSGIVAUDAN SA
WO/2021/185897GINSENOSIDE COMPOSITIONSGIVAUDAN SA
WO/2021/185912METHOD FOR THE TREATMENT NLRP3-ASSOCIATED DISEASESSOFTHALE NV
WO/2021/185920PROCESS FOR BLEACHING KERATIN FIBERS USING AN OXIDIZING  COMPOSITION AND UV-VISIBLE RADIATIONL'OREAL
WO/2021/185921LIQUID FORMULATION OF GM-CSF FOR INHALATIONDRUGRECURE APS
WO/2021/185948A STABILIZED PROTEIN OF INTERESTMICREOS HUMAN HEALTH B.V.
WO/2021/185953COSMETIC COMPOSITION AND TREATMENT FOR TREATING SKIN SAGGINGSEDERMA
WO/2021/185959ESTROGEN-RELATED RECEPTOR ALPHA AGONISTS FOR THE TREATMENT AND  THE PROGNOSIS OF BONE METASTASESINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/185969VARIANTS OF HLYA AND USES THEREOFNUMAFERM GMBH
WO/2021/186000IMPROVED LIQUID COMPOSITION FOR CLEANING, SANITIZING AND/OR  DISINFECTINGCORTICALIS AS
WO/2021/186001DOSE TREATMENTS OF TAUOPATHIESAC IMMUNE SA
WO/2021/186024NEW ANTI-VEGFC ANTIBODIES AND USES THEREOFCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
WO/2021/204517COMPOSITION FOR USE IN PREVENTING ATHEROSCLEROSIS DEVELOPPMENTALGOSOURCE
WO/2021/186035CYCLOTIDES IN COMBINATION WITH KAPPA OPIOID RECEPTOR LIGANDS  FOR MS THERAPYMEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/186041JOSAMYCIN FOR USE IN PREVENTION AND TREATMENT OF FIBROSISUNIVERSITÄT ROSTOCK
WO/2021/186042PLASMID COMPRISING ALOPECIA ANTIGENNOVO NORDISK A/S
WO/2021/186053COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION  & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE  INFECTIONABIVAX
WO/2021/186054SORTILIN ANTAGONISTS FOR USE IN THE TREATMENT OF DIABETIC  RETINOPATHYINSUSENSE APS
WO/2021/186060RADIOLABELED GASTRIN ANALOGUE FOR USE IN A METHOD OF TREATING  AND/OR IMAGING CCKB RECEPTOR POSITIVE DISEASES, IN PARTICULAR PULMONARY AND  EXTRAPULMONARY SMALL-CELL CARCINOMADEBIOPHARM INTERNATIONAL S.A.
WO/2021/186061IDEBENONE FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS  SYNDROME (ARDS) IN PATIENTS DIAGNOSED WITH A CORONAVIRUS INFECTIONBEMIDO SA
WO/2021/204520COMPOSITION COMPRISING RESVERATROLGALENUS G.H. AG
WO/2021/186074COMPOSITIONS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDERSTALICLA SA
WO/2021/191094ERBB-TARGETED THERAPIES FOR NEUROPATHIC PAINUNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
WO/2021/191108TREATMENT OR PREVENTION OF ACUTE ORGAN DAMAGE INDUCED BY VIRAL  INFECTION WITH A NK1 INHIBITOR AND/OR A GABAPENTINOIDPLUS VITECH, S.L.
WO/2021/191131PROTEIN DISULFIDE ISOMERASE INHIBITORS FOR USE IN THE  TREATMENT OF ALPHA 1-ANTITRYPSIN DEFICIENCYUNIVERSITE DE BORDEAUX
WO/2021/191136DMEH ENHANCERLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/186078METHOD FOR PRODUCING POLYMERSOMESHEIDELBERG UNIVERSITY
WO/2021/186079COLLOIDAL CARRIER SYSTEMS FOR TRANSFER OF AGENTS TO A DESIRED  SITE OF ACTIONHEIDELBERG UNIVERSITY
WO/2021/186080HEAT-TREATED PLATELET-DERIVED GROWTH FACTOR EXTRACT FOR USE IN  A METHOD OF PREVENTING OR TREATING A TISSUE DEFECTPANGERŠIČ, Rok
WO/2021/213749COLOR-STABLE SUNSCREENBEIERSDORF AG
WO/2021/197906CLEANSING COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/197908METHOD OF TREATING THE SCALPUNILEVER IP HOLDINGS B.V.
WO/2021/1911691,2,4-TRIOXANE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME  FOR USE IN THE TREATMENT OF COVID-19ARTEMIFLOW GMBH
WO/2021/213752TRANSPARENT COSMETIC GELBEIERSDORF AG
WO/2021/213753ENVIRONMENTALLY FRIENDLY COSMETIC SUNSCREENBEIERSDORF AG
WO/2021/213760ENVIRONMENTALLY FRIENDLY SUNSCREENBEIERSDORF AG
WO/2021/191185COMPOSITIONS COMPRISING NATURALLY DERIVED PRESERVATIVESUNILEVER IP HOLDINGS B.V.
WO/2021/191197COMBINATION THERAPY COMPRISING AN AXL INHIBITORBERGENBIO ASA
WO/2021/191226MOUTHWASH, IN PARTICULAR FOR TREATING THE HUMAN ORAL AND  PHARYNGEAL CAVITYSANIXTREME GMBH & CO. KG
WO/2021/191236NUCLEOTIDE ANALOGUES FOR THE TREATMENT OF CORONAVIRUSESR.G.C.C. HOLDINGS AG
WO/2021/191240COMBINATION THERAPYANTABIO SAS
WO/2021/191243PIGMENT COMPRISING RAPHANUS SATIVUS EXTRACT AND  MONTMORILLONITEGIVAUDAN SA
WO/2021/191251COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF  LacNAc-LacFRIESLANDCAMPINA NEDERLAND B.V.
WO/2021/191253METHODS FOR PRODUCING HEME PEROXIDASESTECHNISCHE UNIVERSITÄT WIEN
WO/2021/191265RNA PARTICLES COMPRISING POLYSARCOSINEBIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/191266AEROSOLIZATION OF HDL FOR THE TREATMENT OF LUNG INFECTIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/191268A MODIFIED RELEASE MULTIPLE UNIT ORAL DOSAGE FORM OF  DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE AND A PROCESS FOR ITS  PREPARATIONINIBSA GINECOLOGíA, S.A.
WO/2021/191273COMPOSITIONS FOR USE IN TREATING MEIBOMIAN GLAND DYSFUNCTIONHOVIONE SCIENTIA LIMITED
WO/2021/191274NEW STRATEGY TO TREAT AND PREVENT DISEASES CAUSED BY  ENTEROBACTERIAEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/191278DIMALEATE FORM OF  1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREALEK PHARMACEUTICALS D.D.
WO/2021/239292TREATMENT OF CANCERIMMUTEP S.A.S.
WO/2021/191297VIRUCIDAL HAND CREAM FORMULATIONUNIVERSITÄT BASEL
WO/2021/191305CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF COVID-19DOMPE' FARMACEUTICI SPA
WO/2021/191312METHODS OF TREATING COVID-19 WITH RIFAXIMINBAUSCH HEALTH IRELAND LIMITED
WO/2021/191318SOLID DISPERSIONS OF RIFAXIMIN FOR THE TREATMENT OF OVERT  HEPATIC ENCEPHALOPATHYBAUSCH HEALTH IRELAND LIMITED
WO/2021/191320OPHTHALMIC FORMULATION COMPRISING  N-[5-(AMINOSULFONYL)-4-METHYL-1,3-  THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)PHENYL]ACETAMIDE HEMIHYDRATEAICURIS GMBH & CO. KG
WO/2021/191336A COMBINATION OF FLAVONOIDS AND SPHINGOSINE 1 PHOSPHATE LYASE  INHIBITORS FOR THE TREATMENT OF LUNG INFLAMMATIONAC BIOSCIENCE SA
WO/2021/191342VIRUSTATIC AGENTREINMüLLER, Johannes
WO/2021/191353METHODS FOR PROVIDING A VACCINEWüRFEL, Wolfgang
WO/2021/198041A PHARMACEUTICAL COMPOSITION COMPRISING HYDROXYCHLOROQUINE,  CHLOROQUINE, OR METABOLITE THEREOFBLACKHAWK PARTNERS LIMITED
WO/2021/198051BIO-BASED POLYURETHANE DISPERSIONS FOR DECORATIVE COSMETIC  APPLICATIONSCOVESTRO DEUTSCHLAND AG
WO/2021/191412CATHEPSIN SUBSTRATES & CATHEPSIN INHIBITORS AND USES  THEREOFECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/191413DISINFECTANT COMPOSITIONSARCH UK BIOCIDES LTD
WO/2021/191416DRY POWDER FORMULATION FOR PULMONARY DELIVERY AND METHODS OF  USEASTRAZENECA AB
WO/2021/191417COMPOUNDS FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIESSOM INNOVATION BIOTECH, S.A.
WO/2021/191422NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR THE TREATMENT OF  BACTERIAL INFECTIONSNUVAMID SA
WO/2021/191431A CONSUMABLE PRODUCT COMPRISING MALTED CEREALS FOR PROMOTING  RECOVERY AT PHYSICAL ACTIVITYLANTMÄNNEN FUNCTIONAL FOODS AB
WO/2021/191432TARGETING QUORUM-SENSING PEPTIDES FOR DIAGNOSIS, TREATMENT  AND/OR PREVENTION OF COLORECTAL CANCER METASTASISUNIVERSITEIT GENT
WO/2021/191435USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF  ADRENOLEUKODYSTROPHY OR ADRENOMYELONEUROPATHYPOXEL
WO/2021/191436METHODS FOR TREATMENT OF VIRUSAPEIRON BIOLOGICS AG
WO/2021/198099USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF  DIABETIC NEPHROPATHYPOXEL
WO/2021/204568A TOPICAL COMPOSITION FOR TREATMENT OF PRURITUSUNIVERSITÄT BASEL
WO/2021/191455NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND  ANTI-INTERFERON EFFECTUNIVERSITE DE PARIS
WO/2021/191456COMPOSITIONS FOR THE TREATMENT OF A RESPIRATORY CONDITIONVECTURA LIMITED
WO/2021/198115TREATMENTUNION THERAPEUTICS A/S
WO/2021/198116FORMULATIONUNION THERAPEUTICS A/S
WO/2021/191460NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND  ANTI-INTERFERON EFFECTUNIVERSITE DE PARIS
WO/2021/191461AN INSULIN SENSITIZER FOR USE IN THE PREVENTION AND/OR  TREATMENT OF THE DAMAGES CAUSED BY RETINAL DETACHMENTSORBONNE UNIVERSITE
WO/2021/191462COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USESSHARED VISION TECHNOLOGY LTD.
WO/2021/204572BEADS COMPRISING A BUFFER SYSTEMCHEMISCHE FABRIK BUDENHEIM KG
WO/2021/198135METHOD OF TREATING VIRAL INFECTIONSIMMUPHARMA FRANCE SA
WO/2021/198139VIRUCIDAL COMPOSITIONS AND USE THEREOFECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/228465METHOD FOR TREATING HUMAN HAIR WITH AGENTS CONTAINING MIXTURES  OF ORGANIC C1-C6 ALKOXY SILOXANESHENKEL AG & CO. KGAA
WO/2021/191464USE OF CONJUGATES COMPRISING TUMOUR-SELECTIVE LIGANDS AND  GROUPS CAPABLE OF RELEASING CARBON MONOXIDE (CO), FOR EXERTING  IMMUNOMODULATORY EFFECTS IN CANCER TREATMENTINSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES
WO/2021/198176POLYPEPTIDE FOR THE PROPHYLAXIS AND TREATMENT OF VIRAL  INFECTIONSPHARIS BIOTEC GMBH
WO/2021/198177BIOMATERIAL COMPRISING A POROUS RESORBABLE MATRIX AND  ASSOCIATED MANUFACTURING METHODUNIVERSITE GRENOBLE ALPES
WO/2021/198191QUINAZOLINONE DERIVATIVES AND USES THEREOF FOR TREATING A  CANCERENYO PHARMA
WO/2021/191469COMPOSITION FOR THE TREATMENT OF GASTRO-INTESTINAL DYSFUNCTION  AND/OR ASSOCIATED MORBIDITIES THERETOBASF SE
WO/2021/191470COMPOSITION COMPRISING GLYCERIDES FOR THE TREATMENT OF  GASTRO-INTESTINAL DYSFUNCTION AND/OR ASSOCIATED MORBIDITIES THERETOBASF SE
WO/2021/198195AGONIST COMBINATIONZEALAND PHARMA A/S
WO/2021/198196GLP-1/GLP-2 DUAL AGONISTSZEALAND PHARMA A/S
WO/2021/198198OIL-IN-WATER EMULSION COMPRISING A SOLID LIPID MATERIALFIRMENICH SA
WO/2021/191474ACTIVITY-DEPENDENT GENE THERAPY FOR NEUROLOGICAL DISORDERSUCL BUSINESS LTD.
WO/2021/198212OPHTHALMIC FORMULATION AND ITS USEOY FINNSUSP AB
WO/2021/198216NEW METHOD TO TREAT THE HEPATOTOXICITY INDUCED BY AMANITINSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/198220TREATMENT AND PREVENTION OF SECONDARY INFLAMMATION IN PATIENTS  SUFFERING FROM A VIRAL INFECTIONALLERO THERAPEUTICS B.V.
WO/2021/198223TREATMENT OF SYMPTOMATIC VIRAL DISEASESSYNACT PHARMA APS
WO/2021/198229SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY  FOR IMAGING AND THERAPY PURPOSESANTAROS MEDICAL AB
WO/2021/198253USE OF BIOMARKERS IN THE TREATMENT OF FIBROTIC CONDITIONSBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/198254BIOCHANIN A DERIVATIVES FOR TREATMENT OF BEST1 -RELATED  RETINOPATHIESUNIVERSITÄT REGENSBURG
WO/2021/198255AN NK-1 RECEPTOR ANTAGONIST FOR TREATING A DISEASE SELECTING  FROM SEPSIS, SEPTIC SHOCK,, ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) OR  MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS)NERRE THERAPEUTICS LIMITED
WO/2021/198256COMPOSITION HAVING IMPROVED VOLUNTARY ACCEPTANCEBAYER ANIMAL HEALTH GMBH
WO/2021/198258TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN  VACCINATIONBIONTECH SE
WO/2021/198284USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF  CARDIOVASCULAR DISEASESPOXEL
WO/2021/198285HOMOGENEOUS LIQUID COMPOSITION COMPRISING 1,2-OCTANEDIOL AND  USE THEREOFMINASOLVE SAS
WO/2021/198288METHODS AND COMPOSITIONSALLIGATOR BIOSCIENCE AB
WO/2021/198312VIRAL INFECTIONS- TREATMENT WITH CONVALESCENT PLASMA/SERUMREGEN LAB SA
WO/2021/198316COMPOUNDS, COMPOSITIONS AND DEVICES FOR USE IN THE PREVENTION  OR TREATMENT OF CORONA-VIRUS INFECTIONSVOSSENSTEYN
WO/2021/198327LIQUID PHARMACEUTICAL FORMULATIONS POLYETHYLENE GLYCOL-BASED  PRODRUGS OF ADRENOMEDULLIN AND USEBAYER AKTIENGESELLSCHAFT
WO/2021/198328PHARMACEUTICAL FORMULATIONS POLYETHYLENE GLYCOL-BASED PRODRUGS  OF ADRENOMEDULLIN AND USEBAYER AKTIENGESELLSCHAFT
WO/2021/198332CONDENSATION PRODUCT FOR USE IN A METHOD FOR THE TREATMENT OF  COVID-19BASF SE
WO/2021/198333BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAPF. HOFFMANN-LA ROCHE AG
WO/2021/198336USE OF HAEMOGLOBIN FROM ANNELIDS FOR TREATING ACUTE  RESPIRATORY DISTRESS SYNDROMEHEMARINA
WO/2021/198346EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING COVID-19DR. NESSELHUT BESITZGESELLSCHAFT MBH
WO/2021/198353A FLEXIBLE FOIL FOR THE DELIVERY OF THERAPEUTIC CARGOSDANMARKS TEKNISKE UNIVERSITET
WO/2021/198369AGENTS FOR USE IN THE THERAPEUTIC OR PROPHYLACTIC TREATMENT OF  RETINAL PIGMENT EPITHELIUM ASSOCIATED DISEASESPANDA-JONAS, Songhomitra
WO/2021/198376NOVEL SALMONELLA-BASED CORONAVIRUS VACCINEVAXIMM AG
WO/2021/204634TOPICAL PHARMACEUTICAL COMPOSITION IN THE FORM OF AN AQUEOUS  GEL COMPRISING AT LEAST AMITRIPTYLINEALGOTHERAPEUTIX
WO/2021/198395SURFACTANT PROTEIN D FOR USE IN TREATING CORONAVIRUS  INFECTIONSTRIMUNOCOR LIMITED
WO/2021/198399COMPOSITIONS AND METHODS CONTAINING N-ACETYLCYSTEIN AND  NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF NEUROLOGICAL DISEASES  AND CONDITIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/204649GM-CSF ANTAGONISTS FOR USE IN THE TREATMENT OF SEVERE  PULMONARY COVID-19, CYTOKINE RELEASE SYNDROME AND/OR ACUTE RESPIRATORY  DISTRESS SYNDROMEGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/204655MODIFIED VECTORS FOR PRODUCTION OF RETROVIRUSGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/198410AMYLOSE/CAROTENOIDS COMPLEXATION PROCESSECLYPSE INK BIOTECHNOLOGY
WO/2021/198413STABILIZED VACCINE COMPOSITIONSJANSSEN VACCINES & PREVENTION B.V.
WO/2021/198415METHODS OF TREATMENT USING NICLOSAMIDESOFTHALE NV
WO/2021/198439REDUCED CALORIC INTAKE AND IMMUNOTHERAPY FOR THE TREATMENT OF  CANCERIFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE
WO/2021/198440COMPOSITIONS FOR CORONAVIRUS INFECTION TREATMENT AND/OR  PREVENTIONFRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E.V.
WO/2021/198442ISOQUINOLINE DERIVATIVES FOR USE IN THERAPYVESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/198449TUMOR ANTIGENS FOR LIVER CANCER IMMUNOTHERAPYISTITUTO NAZIONALE TUMORI IRCCS - FONDAZIONE G. PASCALE
WO/2021/198454METHOD FOR TREATING HYPERINFLAMMATION USING MESENCHYMAL  LINEAGE PRECURSOR OR STEM CELLSMESOBLAST INTERNATIONAL SàRL
WO/2021/198464WOUND CARE COMPOSITIONS AND METHODS OF PREPARATION THEREOFT.J.SMITH AND NEPHEW,LIMITED
WO/2021/204705CARBOXYLATE LIGAND MODIFIED FERRIC IRON HYDROXIDE COMPOSITIONS  FOR USE IN THE TREATMENT OR PREVENTION OF IRON DEFICIENCY ASSOCIATED WITH  LIVER DISEASESNEMYSIS LTD.
WO/2021/204713AXL INHIBITORS FOR ANTIVIRAL THERAPYBERGENBIO ASA
WO/2021/198500NOVEL IMMUNOMODULATORVIROKINE THERAPEUTICS LTD
WO/2021/209274HYDRATABLE COSMETIC COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/204717AMINOQUINOLINES FOR TREATING CORONAVIRUS INFECTIONSOXANDIA LTD
WO/2021/198504ACTIVE SUBSTANCES FOR MEDICAL USEINFLAMED PHARMA GMBH
WO/2021/198506USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF  AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)POXEL
WO/2021/198511METHODS AND COMPOSITIONS FOR TREATMENT OF SARS-COV-2 INFECTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/198516COMPOSITIONINOCELLS B.V.
WO/2021/198517COMPOSITIONINOCELLS B.V.
WO/2021/198524REGIMEN FOR REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCHGRüNENTHAL GMBH
WO/2021/204751PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF LIVER DISEASESPOXEL
WO/2021/204755PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF LIVER DISEASESPOXEL
WO/2021/204756METHODS FOR THE TREATMENT OF HEADACHE DISORDERSBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/204757TREATMENT OF ARDS AND OTHER PARAMETERS RELATED TO COVID-19STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
WO/2021/204762CRYSTALLINE FORMS OF A TYK2 INHIBITORSAREUM LIMITED
WO/2021/204781ARTC1 LIGANDS FOR CANCER TREATMENTUNIVERSITÄT ZüRICH
WO/2021/204800DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORSUCB BIOPHARMA SRL
WO/2021/204801DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORSUCB BIOPHARMA SRL
WO/2021/204802LABELLED SUBSTANCE AND METHODS OF DETECTION OF INFLAMMATION  AND INFECTION USING SAID SUBSTANCEPVAC MEDICAL TECHNOLOGIES LTD
WO/2021/20481225-HYDROXYVITAMIN D2 AND/OR D3 FOR USE IN OBESITYCARBOGEN AMCIS B.V.
WO/2021/204814NACHR, SUCH AS NICOTINE, FOR USE IN THE PREVENTION AND THE  TREATMENT OF COVID-19 DISEASEASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
WO/2021/198534PLASMA KALLIKREIN INHIBITORS FOR USE IN THE TREATMENT OF  CORONAVIRAL DISEASEOXURION NV
WO/2021/204825INACTIVATED SARS-CoV-2 VIRUS VACCINEVALNEVA AUSTRIA GMBH
WO/2021/198535USE OF AN ARSENIC COMPOUND FOR TREATING A SHORT OR LONG  CYTOKINE STORM IN VARIOUS AUTOIMMUNE/INFLAMMATORY DISEASES IN HUMANS OR  ANIMALSMEDSENIC
WO/2021/204843TOPICAL USE OF ERLOTINIB FOR TREATING KERATODERMAS IN CHILDRENLABORATOIRES C.T.R.S.
WO/2021/204861COMPOSITIONS FOR USE IN THE INHIBITION OF CORONAVIRUS  REPLICATIONNORDIC PHARMA LAB APS
WO/2021/204873IMMUNOGENIC COMPOSITION COMPRISING AN ANTIGENIC MOIETY AND A  LIPOSOMAL FORMULATION, METHOD OF PRODUCING THE COMPOSITION, THE COMPOSITION  FOR USE AS A MEDICAMENT, IN PARTICULAR FOR USE AS A VACCINEINNOMEDICA HOLDING AG
WO/2021/239307NOVEL TRANSDUCTION ENHANCERS AND USES THEREOFUNIVERSITÄT ZüRICH
WO/2021/204883PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY BOWEL  DISEASESCVASTHERA
WO/2021/204889METHOD FOR PRODUCING A POROUS ACTIVE INGREDIENT CARRIER BY  MEANS OF HOT-MELT EXTRUSIONRESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH
WO/2021/204923PIPERAZINE DERIVATIVES AS ANTIVIRAL AGENTS FOR USE IN THE  TREATMENT OF A CORONAVIRUS INFECTIONVIRONOVA MEDICAL AB
WO/2021/204924COMPOUNDS FOR USE IN THE TREATMENT OF HYPERCYTOKINEMIAVIRONOVA MEDICAL AB
WO/2021/204935MEMBRANES FOR MEDICAL DEVICESDEFYMED
WO/2021/204955COMPOUNDS FOR TREATING PNEUMONIA, SEPSIS, AND CORONAVIRUS  INFECTIONHEIDELBERG IMMUNOTHERAPEUTICS GMBH
WO/2021/204969PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY  AGAINST AN INFECTION BY SARS-COV-2 (COVID-19)EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/204985USE OF VIDOFLUDIMUS FOR THE TREATMENT OF CORONAVIRUS  INFECTIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/204991IMMUNOSTIMULATORY COMPOSITIONSBAYER ANIMAL HEALTH GMBH
WO/2021/204994OFATUMUMAB FOR TREATING MS WHILE MAINTAINING SERUM IGGNOVARTIS AG
WO/2021/204998NATURAL ANTIBODIES IN PROPHYLAXIS AND THERAPYHEIDELBERG IMMUNOTHERAPEUTICS GMBH
WO/2021/205010NUCLEIC ACIDS ENCODING HUMAN FUS PROTEIN AND USE IN THE  TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)INSERM - INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE
WO/2021/205017IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USEVALNEVA AUSTRIA GMBH
WO/2021/205025COMBINATORY TREATMENT FOR LYMPHOMAUNIVERSITE DE PARIS
WO/2021/205026PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ENVELOPED DNA OR  RNA VIRUS INDUCED INFECTIONS AND DISORDERSLOGICK ENERGETICS B.V.
WO/2021/205027INDIVIDUALIZED THERAPEUTIC ANTICANCER VACCINEVACCIBODY AS
WO/2021/205029USE OF MASITINIB FOR THE TREATMENT OF CORONAVIRUS DISEASE 2019  (COVID-19)AB SCIENCE
WO/2021/213822COMPOSITIONS COMPRISING CYS-PEPTIDESEVONIK OPERATIONS GMBH
WO/2021/209402IMMUNOCONJUGATESF. HOFFMANN-LA ROCHE AG
WO/2021/209405MULTI-PHASE COSMETIC COMPOSITION COMPRISING AT LEAST TWO  IMMISCIBLE OILY PHASESCHANEL PARFUMS BEAUTE
WO/2021/219360COMPRESSED TABLET COMPRISING L-THEANINEDSM IP ASSETS B.V.
WO/2021/209419BI- AND MONOCYCLIC NUCLEOSIDE ANALOGS FOR TREATMENT OF  HEPATITIS EJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/209425ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS EJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/209427SPIROCYCLIC NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF  HEPATITIS EJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/209437NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS  PREVENTION AND TREATMENT WITHOUT PRESERVATIVESFRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E. V.
WO/2021/209441USE OF A POLAR EXTRACT OF <i>SKELETONEMA</i> IN  PHOTODYNAMIC THERAPYIFREMER
WO/2021/209442NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS  PREVENTION AND TREATMENTFRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E. V.
WO/2021/209450RESINIFERATOXIN COMPOSITIONSMESTEX AG
WO/2021/209452DOSAGE UNITS AND REGIMEN, USES, METHODS OR FORMULATIONS OF  COMPOSITIONS COMPRISING A RECOMBINANT PROTEIN COMPRISING INTERLEUKIN-12 AND  AN ANTIBODY BINDING THE EXTRA-DOMAIN B OF FIBRONECTINPHILOGEN S.P.A.
WO/2021/209455COMPOSITION FOR IMPROVING COGNITIVE FUNCTIONACTIV'INSIDE
WO/2021/209458COMBINATION TREATMENT OF CANCERARES TRADING S.A.
WO/2021/209459METHODS OF USING SOLID DISPERSIONS OF RIFAXIMIN FOR THE  TREATMENT OF SICKLE CELL DISEASEBAUSCH HEALTH IRELAND LIMITED
WO/2021/223966ADENOMYOSIS ASSOCIATED INFERTILITY AND HDAC INHIBITORSNADEZHDA REPRODUCTIVE SCIENCE OOD
WO/2021/209465PEPTIDE FOR THE TREATMENT OF NET-ASSOCIATED DISEASESUNIVERSITEIT MAASTRICHT
WO/2021/209471ULIPRISTAL ACETATE OTFLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/209472ORAL THIN FILM WITH SMOOTH FUSED FILMLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/209493MEANS AND METHODS OF PREVENTING AND TREATING INFECTIONSSOLYPLUS GMBH
WO/2021/219376PERSONAL CARE COMPOSITIONS WITH ENHANCED SOLUBILITY ACTIVESUNILEVER IP HOLDINGS B.V.
WO/2021/219378STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINEUNILEVER IP HOLDINGS B.V.
WO/2021/209510INHIBITORS OF TRPC6 FOR TREATING RESPIRATORY CONDITIONSBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/209520MOLECULES FOR USE IN THE TREATMENT OF VIRAL INFECTIONSISTITUTO EUROPEO DI ONCOLOGIA S.R.L.
WO/2021/209521VECTORS FOR THE TREATMENT OF ACID CERAMIDASE DEFICIENCYGENETHON
WO/2021/209539PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF  THE NLRP3 INFLAMMASOME PATHWAYJANSSEN PHARMACEUTICA NV
WO/2021/209541TAXIFOLIN FORMULATION COMPRISING THIAMINEEVANIUM HEALTHCARE GMBH
WO/2021/209545COMPOSITION COMPRISING TRABECTEDIN AND AN AMINO ACIDEVER VALINJECT GMBH
WO/2021/209548COMPOSITIONS AND METHODS FOR TREATING HAIR FOLLICLE-LINKED  CONDITIONSHENLEZ APS
WO/2021/209552PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS  OF THE NLRP3 INFLAMMASOME PATHWAYJANSSEN PHARMACEUTICA NV
WO/2021/209562LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF  PATHOGENIC INFECTIONSTATENS SERUM INSTITUT
WO/2021/209563COMPOUNDS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS BY  RESPIRATORY SYNDROME-RELATED CORONAVIRUSSOM INNOVATION BIOTECH, S.A.
WO/2021/213891USE OF A MULTIFUNCTIONAL LIGAND FOR TREATING DRY EYES,  MEIBOMIAN GLAND DYSFUNCTIONS AND LACRIMAL GLAND DYSFUNCTIONSH4 ORPHAN PHARMA
WO/2021/209566O/W EMULSION CONTAINING ETHANOLDR. KURT WOLFF GMBH & CO. KG
WO/2021/213898A CHIMERIC ENDOLYSIN POLYPEPTIDE.MICREOS HUMAN HEALTH B.V.
WO/2021/209589PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR TREATING VIRAL  AND BACTERIAL PNEUMONIA AND SEPSISANDREAS HETTICH GMBH & CO. KG
WO/2021/209590IMPROVED PROBIOTIC STRAINS AND USES THEREOFAMUCIN OY LTD
WO/2021/233614COMPOSITIONS AND METHODS FOR PROVIDING SCALP CARE BENEFITSUNILEVER IP HOLDINGS B.V.
WO/2021/209591CONTRACEPTIVE COMPOSITIONS WITH REDUCED ADVERSE EFFECTSESTETRA SRL
WO/2021/209593ACTIVE PRINCIPLE COMPRISING A PEEL EXTRACT OF IMMATURE PUNICA  GRANATUM FRUIT AND USES FOR PREVENTING AND/OR COMBATTING ACNESOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
WO/2021/209594BROMODOMAIN INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF  CORONAVIRUS INFECTIONS AND DISEASES CAUSED THEREBYEBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/209596THERAPEUTIC USE OF PLEUROMUTILINSNABRIVA THERAPEUTICS GMBH
WO/2021/209607SCD83 FOR WOUND HEALING, HAIR GROWTH, AND SKIN AND HAIR CAREFRIEDRICH-ALEXANDER-UNIVERSITÄT ERLANGEN-NüRNBERG
WO/2021/209608MEDICAL METHODS AND MEDICAL USESJOSEPH, Bertrand Marie René
WO/2021/213923MEDICAL USE OF DARIDOREXANTIDORSIA PHARMACEUTICALS LTD
WO/2021/213924CORONAVIRUS VACCINEBIONTECH SE
WO/2021/213931NOVEL NON-PROTEINIC FURIN INHIBITOREPHYLA
WO/2021/209620CYSTEINE PROTEASE INHIBITORS FOR USE IN THE PREVENTION AND/OR  TREATMENT OF CORONAVIRUSALBERT-LUDWIGS-UNIVERSITÄT FREIBURG
WO/2021/209623COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID  AND METHOD FOR MANUFACTURING SAMEELEONOR SPRL
WO/2021/209625HIGH POTENCY NATURAL KILLER CELLSONK THERAPEUTICS LIMITED
WO/2021/228492PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND  OIL PHASEUNILEVER IP HOLDINGS B.V.
WO/2021/209627MODULATION OF T CELL CYTOTOXICITY AND RELATED THERAPYCANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/209631FMT PERFORMANCE PREDICTION TEST TO GUIDE AND OPTIMIZE  THERAPEUTIC MANAGEMENT OF GVHD PATIENTSMAAT PHARMA
WO/2021/209633METHODS AND FORMULATIONS FOR ADMINISTRATION OF THIOCARBAMATE  DERIVATIVES A2A INHIBITORSITEOS BELGIUM SA
WO/2021/213946PROPHYLAXIS AND TREATMENT OF CORONAVIRUS INFECTIONENGLMEIER, Ludwig
WO/2021/213948A VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAEINTERVET INTERNATIONAL B.V.
WO/2021/213949A COMBINATION OF VACCINES TO PROPHYLACTICALLY TREAT A PIGINTERVET INTERNATIONAL B.V.
WO/2021/209644USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED  ACUTE RESPIRATORY DISTRESSPHARMING INTELLECTUAL PROPERTY B.V.
WO/2021/209645COMPOSITION FOR TREATING KERATIN TISSUEPVAC MEDICAL TECHNOLOGIES LTD
WO/2021/213992METHOD OF GENERATING A DRIED DRUG FORMULATIONHOFFMANN-LA ROCHE INC.
WO/2021/228502PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND  OIL PHASEUNILEVER IP HOLDINGS B.V.
WO/2021/228503PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND  OIL PHASEUNILEVER IP HOLDINGS B.V.
WO/2021/214018TREATMENT REGIMEN WITH MINOXIDIL AND CAFFEINEDR. KURT WOLFF GMBH & CO. KG
WO/2021/214023COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE  TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASESBAYER AKTIENGESELLSCHAFT
WO/2021/219428METHOD FOR DELIPIDATING PLANT EXTRACTSMAX ZELLER SOEHNE AG
WO/2021/214033VIDOFLUDIMUS FOR USE IN THE TREATMENT OR PREVENTION OF VIRAL  DISEASESIMMUNIC AG
WO/2021/214043IMMUNIZATION SCHEME FOR VARIANT SURFACE GLYCOPROTEIN CARRIERSDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN  RECHTS
WO/2021/214045HPMC CAPSULE WITH REDUCED POWDER RETENTIONCAPSUGEL FRANCE SAS
WO/2021/214053PROCESS FOR DENSIFYING KERATIN FIBERS, BASED ON SILICONE, AN  ALKOXYSILANE AND A COLORING AGENTL'OREAL
WO/2021/214055COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE OF FORMULA  (I), AT LEAST ONE NON AMINO SILICONE OF FORMULA (II) AND AT LEAST ONE  COLORING AGENTL'OREAL
WO/2021/214056PROCESS FOR THE TREATMENT OF KERATIN FIBERS EMPLOYING A  COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE OF FORMULA (I), AT LEAST ONE  NON AMINO SILICONE OF FORMULA (II) HAVING A WEIGHT-AVERAGE MOLECULAR WEIGHT  OF LESS THAN OR EQUAL TO 1500 G/MOL AND AT LEAST ONE COLORING AGENTL'OREAL
WO/2021/214081SARS-COV-2 VACCINESNEC ONCOIMMUNITY AS
WO/2021/233630ORAL CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/228519PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND  OIL PHASEUNILEVER IP HOLDINGS B.V.
WO/2021/214119THERAPEUTIC COMBINATION FOR THE TREATMENT OF BREAST CANCERIFOM - FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE
WO/2021/214126DRUG ANTIBODY CONJUGATESPHARMA MAR, S.A.
WO/2021/214129ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF  CANCERUNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/219458GRANULES COMPRISING SURFACE-REACTED CALCIUM CARBONATE AS  EXCIPIENTOMYA INTERNATIONAL AG
WO/2021/214139COMPOSITION FOR USE IN THE TREATMENT OF GROUP-B STREPTOCOCCUS  (GBS) INFECTIONSGIELLEPI S.P.A.
WO/2021/214158CO-CRYSTAL OF GABAPENTIN, KETOPROFEN AND LYSINE,  PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USEDOMPE' FARMACEUTICI SPA
WO/2021/214163SYNERGISTIC ADMIXTURES OF GABAPENTIN AND KETOPROFEN,  PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USEDOMPE' FARMACEUTICI SPA
WO/2021/214170ORALLY ADMINISTERED HYDROGEL COMPOSITION, KIT AND USEKIFIK
WO/2021/214175ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE PREVENTION AND/OR  THE TREATMENT OF SPLEEN DISORDERSUNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/214179SYNTHETIC <i>STREPTOCOCCUS PNEUMONIAE</i>  SACCHARIDE CONJUGATES TO CONSERVED MEMBRANE PROTEINMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/214200ROCK INHIBITORS FOR USE IN TREATING OR PREVENTING PULMONARY  EDEMAATRIVA THERAPEUTICS GMBH
WO/2021/214205PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCTFIRMENICH SA
WO/2021/214209PRODUCT AND PROCESS FOR THE DECONTAMINATION OF NANOPARTICLES  FROM THE SKINLEIBNIZ-INSTITUT FüR POLYMERFORSCHUNG DRESDEN E.V.
WO/2021/214220GLUCAGON ANALOGUES AS LONG-ACTING GLP-1/GLUCAGON RECEPTOR  AGONISTS IN THE TREATMENT OF FATTY LIVER DISEASE AND STEATOHEPATITISBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/214221ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY  CONJUGATES AND FOLFIRISANOFI
WO/2021/214222ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY  CONJUGATES, TRIFLURIDINE AND TIPIRACILSANOFI
WO/2021/214223ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY  CONJUGATES AND FOLFOXSANOFI
WO/2021/214227ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY  CONJUGATES AND CETUXIMABSANOFI
WO/2021/214233TREATMENT OF HYPOTHALAMIC OBESITYSANIONA A/S
WO/2021/214234SYNERGISTIC PRESERVATIVE/PERSONAL CARE COMPOSITION CONTAINING  AN ALKYLENE GLYCOL ESTERARCH UK BIOCIDES LTD
WO/2021/214245NOVEL PHARMACOLOGICAL CHAPERONE COMPOUNDS OF HUMAN ACID  ALPHA-GLUCOSIDASE AND THE THERAPEUTIC USE THEREOFUNIVERSITé GRENOBLE ALPES
WO/2021/214253DOSAGE REGIMEN FOR THE TREATMENT OF CANCERASTRAZENECA AB
WO/2021/214254PHARMACEUTICAL FORMULATIONSASTRAZENECA AB
WO/2021/219495METHODS FOR TREATING OR PREVENTING A VIRAL INFECTION OR  INHIBITING VIRAL REPLICATIONDALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH
WO/2021/214270COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC  ANTIGEN RECEPTORSASTRAZENECA AB
WO/2021/214279REPLICATION-COMPETENT CONTROLLED HERPESVIRUSES EXPRESSING A  SARS COV-2 ANTIGENHSF PHARMACEUTICALS
WO/2021/214282METHODS FOR PREVENTING INDUCTION OF IMMUNE RESPONSES TO THE  TRANSDUCED CELLS EXPRESSING A TRANSGENE PRODUCT AFTER OCULAR GENE THERAPYINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/214292COMPOSITION COMPRISING FIBRE AND MULBERRYSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/214293COMPOSITION COMPRISING A DNA-DEGRADING ENZYME FOR USE IN A  METHOD FOR THE TREATMENT OF IMMUNOSUPPRESSION AFTER ACUTE TISSUE INJURYKLINIKUM DER UNIVERSITÄT MüNCHEN (KUM)
WO/2021/214296TREATMENT OF CORONA VIRUS INFECTIONSJOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/239346METHODS OF TREATMENT OF VIRAL DISEASESSOFTHALE NV
WO/2021/214297IMMUNIZATION AGAINST SARS-COV-RELATED DISEASESISA PHARMACEUTICALS B.V.
WO/2021/214300COMPOSITION COMPRISING A FIBROUS MATERIALWEIDMANN HOLDING AG
WO/2021/214303PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF  MYELOPROLIFERATIVE NEOPLASMSUNIVERSITÄTSKLINIKUM JENA
WO/2021/214320PLASMINOGEN FOR USE IN TREATING AND PREVENTING LUNG  DYSFUNCTIONPREVIPHARMA CONSULTING GMBH
WO/2021/214321NOVEL COMBINATION FOR THE TREATMENT OF AIDS21C BIO
WO/2021/214326USE OF MULBERRY EXTRACT FOR CONTROLLING POSTPRANDIAL GLUCOSE  RESPONSESOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/214328PH-DEPENDENT RELEASE NANOPARTICLES FOR INCORPORATION OF ACTIVE  SUBSTANCES, PREPARATION METHOD AND THERAPEUTIC USES OF SAMECENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/116503THERAPEUTIC COMPOSITIONS COMPRISING DEUTERATED OR PARTIALLY  DEUTERATED N,N-DIMETHYLTRYPTAMINE COMPOUNDSSMALL PHARMA LTD
WO/2021/214337SYSTEMIC FORMULATION OF A PYRIDINONE DERIVATE FOR COELIAC  DISEASEDR. FALK PHARMA GMBH
WO/2021/214338SYSTEMIC FORMULATION OF A PYRIDINONE DERIVATE FOR TG2-RELATED  DISEASESDR. FALK PHARMA GMBH
WO/2021/214339VACCINE AGAINST HUMAN-PATHOGENIC CORONAVIRUSESACM BIOLABS PTE LTD
WO/2021/214341SRC KINASE ACTIVATORS AND/OR ENG FUNCTION INHIBITORS AS  ENHANCERS OF SKIN HOMEOSTASIS/REGENERATION AND HAIR GROWTHDERMA INNOVATE S.L.
WO/2021/219543SEMAGLUTIDE FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITISNOVO NORDISK A/S
WO/2021/219545COMPOSITION FOR TREATING AND/OR PREVENTING VESTIBULODYNIAPEPTONIC MEDICAL AB
WO/2021/219547ANHYDROUS COSMETIC COMPOSITION COMPRISING POLYOLS,  MONOALCOHOLS, FATTY AMINES AND AT LEAST 0.1% OF CARBOXYLIC ACIDSL'OREAL
WO/2021/219576MULTIPARTICULATE DOSAGE FORM CONTAINING EVA COPOLYMER AND  ADDITIONAL EXCIPIENTGRüNENTHAL GMBH
WO/2021/219577DOSAGE FORM COMPRISING HOT-MELT EXTRUDED PELLETS CONTAINING  EVA COPOLYMER AND GLIDING AGENTGRüNENTHAL GMBH
WO/2021/219581SYSTEM AND METHOD FOR PROVIDING FERTILITY ENHANCING DIETARY  RECOMMENDATIONS IN INDIVIDUALS WITH PROSTATE CONDITIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/239360PEG-FREE SOAP GEL PREPARATIONBEIERSDORF AG
WO/2021/224058COMPOSITION COMPRISING ALBUMIN FOR USE IN THE TREATMENT OF  AMYOTROPHIC LATERAL SCLEROSIS (ALS) BY PLASMA EXCHANGEGRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/219619METHODS TO GENERATE VACCINE COMPOSITIONS THAT PRIME HUMAN  LEUKOCYTE ANTIGEN CLASS I RESTRICTED CD8 T-CELL RESPONSES AGAINST VIRAL  NON-VIRION-INTEGRAL DERIVED EPITOPESGENOVIE AB
WO/2021/219622HAND SANITISER COMPOSITIONDSM IP ASSETS B.V.
WO/2021/219624A NICOTINE ORAL DELIVERY PRODUCTJT INTERNATIONAL SA
WO/2021/219634METHOD FOR PRODUCING MILK LIKE PRODUCTSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/219635METHOD FOR PRODUCING MILK LIKE PRODUCTSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/219639PHARMACEUTICAL COMPOSITION AND METHOD FOR INDUCING AN IMMUNE  RESPONSER.G.C.C. HOLDINGS AG
WO/2021/224068PEPTIDES CONTAINING A PCNA INTERACTING MOTIF FOR USE IN THE  TREATMENT OF SOLID CANCERTHERAPIM PTY LTD
WO/2021/219671TREATMENT OF PULMONARY COMPLICATIONS OF CORONAVIRUS INFECTIONSNOORIK BIOPHARMACEUTICALS AG
WO/2021/219691DAPAGLIFLOZIN AND AMBRISENTAN FOR THE PREVENTION AND TREATMENT  OF COVID-19ASTRAZENECA AB
WO/2021/219710SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND HISTIDINENOVO NORDISK A/S
WO/2021/219719METHODS FOR RADIOLABELLING PSMA BINDING LIGANDS AND THEIR KITSADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/219720METHODS FOR RADIOLABELING PSMA BINDING LIGANDS AND THEIR KITSADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/219722AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING AT LEAST  ONE SILICONE ACRYLIC COPOLYMER AND AT LEAST ONE PROPELLANTL'OREAL
WO/2021/219750ANTI-CANCER VACCINES AND RELATED THERAPYTHE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/219762USE OF A SYNTHETIC AAV CAPSID FOR GENE THERAPY OF MUSCLE AND  CENTRAL NERVOUS SYSTEM DISORDERSGENETHON
WO/2021/219763IONIC LIQUID AS AN ANTIPERSPIRANTNOVIGO GMBH & CO. KG
WO/2021/228570USE OF SULCONAZOLE COMPOUNDS FOR THE TREATMENT OF CORONAVIRUS  INFECTIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/219808SOLID AND LIQUISOLID FORMULATIONS OF CORALLOPYRONIN ARHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
WO/2021/224114ANTIBACTERIAL COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/228574SUNSCREEN HAVING LOW TACKINESS AND HIGH UV PROTECTIONBEIERSDORF AG
WO/2021/219817LIQUISOLID PHARMACEUTICAL FORMULATION AND PROCESS FOR  MANUFACTURINGRHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
WO/2021/224118PERSONAL CARE COMPOSITIONS COMPRISING A METAL PIROCTONE  COMPLEXUNILEVER IP HOLDINGS B.V.
WO/2021/219846STIMULATION OF THE GROWTH OF GUT BIFIDOBACTERIAADARE PHARMACEUTICALS SAS
WO/2021/239384MINERAL-OIL-FREE W/O EMULSION WITH A VARIABLE CONSISTENCYBEIERSDORF AG
WO/2021/239385SUNSCREEN WITH A COMBINATION OF CARNAUBA WAX AND HYDROGENATED  RAPESEED OILBEIERSDORF AG
WO/2021/224133AN ANTIPERSPIRANT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/219857HELP APHERESIS FOR THE TREATMENT OF SERIOUSLY ILL COVID-19  PATIENTSSEIDEL, Dietrich
WO/2021/224138METHODS OF REDUCING MORTALITY RISK IN SUBJECTS SUFFERING FROM  AN UNDERLYING DISEASE OR CONDITION BY ADMINISTRATION OF METHYLNALTREXONEBAUSCH HEALTH IRELAND LIMITED
WO/2021/219879TREATMENTS OF INFLAMMATORY BOWEL DISEASEAQILION AB
WO/2021/2198815-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-QUINOLINE-3-CARBOXAMIDE  POTASSIUM SALT FOR TREATING INFLAMMATORY BOWEL DISEASESAQILION AB
WO/2021/224144METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF  COVID-19WISTA LABORATORIES LTD.
WO/2021/224145METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF  COVID-19WISTA LABORATORIES LTD.
WO/2021/224146METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF  HYPOXEMIAWISTA LABORATORIES LTD.
WO/2021/224153COMBINATION OF MICRONUTRIENTS TO STIMULATE THE ENDOGENOUS  PRODUCTION OF HYDROGEN SULFIDE (H<sb>2</sb>S)PARTHENOGEN SAGL
WO/2021/224167AN ANTIPERSPIRANT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/254685SUBSTANCE FOR DYEING KERATIN FIBERS, CONTAINING SPECIFIC  NONIONIC EMULSIFIERS, PIGMENTS AND AMINOSILICONESHENKEL AG & CO. KGAA
WO/2021/224169HYDROGEL IRRADIATIONASCENDIS PHARMA A/S
WO/2021/259538PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE  PIGMENT SUSPENSIONHENKEL AG & CO. KGAA
WO/2021/259539METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF A  POLYETHYLENE GLYCOL ETHER OF A PROPYLENE GLYCOL FATTY ACID ESTERHENKEL AG & CO. KGAA
WO/2021/219896TREATMENT AND/OR PREVENTION OF A DISEASE OR A SYNDROME RELATED  TO A VIRUS INFECTIONATLAS BIOTECHNOLOGY S.A.
WO/2021/224198Mifepristone oral form for its use in cervix ripening and  labour inductionDISPHAR INTERNATIONAL BV
WO/2021/224203THE USE OF HYPERBRANCHED COPOLYMERS FOR BALANCING MICROBIAL  GROWTHDSM IP ASSETS B.V.
WO/2021/233672METHOD FOR OBTAINING AN EXTRACT OF SANDALWOOD, COMPOSITIONS  COMPRISING SAME AND COSMETIC USES THEREOFISP INVESTMENTS LLC.
WO/2021/224234ANTIVIRAL USE OF CILENGITIDEHELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/224235USE OF DOPAMINE D3 PARTIAL AGONISTS FOR TREATING CENTRAL  NERVOUS SYSTEM DISORDERSBIOPROJET PHARMA
WO/2021/224259METHOD FOR COSMETIC TREATMENT BY COMBINED ILLUMINATION AND  APPLICATION OF A COMPOSITION COMPRISING NIACINAMIDE, AND ASSOCIATED DEVICELIGHTINDERM
WO/2021/224260EXOSOME-ANCHORING FUSION PROTEINS AND VACCINESBIOVELOCITA S.R.L
WO/2021/224261SOLUBLE TORS AND FUSIONS TO ANTI-CD3 RECOGNISING KRAS G12D FOR  THE TREATMENT OF CANCERIMMUNOCORE LIMITED
WO/2021/224264ANTIPATHOGEN VESICLEEK BIOSCIENCES GMBH
WO/2021/224270METHOD TO TREAT VIRAL INFECTION INDUCED BY A CORONAVIRUSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/224301PEPTIDES FOR PREVENTING OR TREATING VIRAL INFECTIONSSORBONNE UNIVERSITE
WO/2021/224313NOVEL AMORPHOUS ACTIVE PHARMACEUTICAL INGREDIENTSDISRUPTIVE MATERIALS PHARMA AB
WO/2021/233681DRUG DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES  FUNCTIONALIZED WITH BIOACTIVE COMPOUNDS FROM EUPHORBIA EXTRACT AND THE USES  THEREOFCELLBITEC, S.L.
WO/2021/224334COMBINATION CONTAINING TWO NICOTINE-CONTAINING DRUGS FOR THE  TREATMENT OF COVID-19LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/224338TREATMENT OF HYPERURICEMIAFREDERIKSBERG HOSPITAL
WO/2021/224354PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A  INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEMQUANTUM GENOMICS
WO/2021/224356NEW COMPOSITIONS AND METHODS OF TREATING COVID-19 DISEASE4LIVING BIOTECH
WO/2021/144478COMBINATION TREATMENT FOR FUMARATE-RELATED DISEASESIMCYSE SA
WO/2021/224381COMBINATION THERAPY FOR TREATING CANCERASTRAZENECA AB
WO/2021/224382COMPOUNDS FOR THE TREATMENT OF COVID-19DOMPE' FARMACEUTICI SPA
WO/2021/254687PIGMENT SUSPENSION AND COSMETIC PRODUCT PREPARED USING THE  PIGMENT SUSPENSIONHENKEL AG & CO. KGAA
WO/2021/224397IMMUNOGENIC PEPTIDES WITH EXTENDED OXIDOREDUCTASE MOTIFSIMCYSE SA
WO/2021/254688METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, AN ALKYL(POLY)GLYCOSIDE, A DYEING COMPOUND AND A  POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/259543METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A DERIVATIVE OF ALKYLATED SILANOL, A COLORING  COMPOUND AND A POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/259544PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE  PIGMENT SUSPENSIONHENKEL AG & CO. KGAA
WO/2021/224403IMMUNOGENIC PEPTIDES WITH NEW OXIDOREDUCTASE MOTIFSIMCYSE SA
WO/2021/224416METHODS TO GENETICALLY MODIFY CELLS FOR DELIVERY OF  THERAPEUTIC PROTEINSCELLECTIS S.A.
WO/2021/224419PHOTOOXIDATIVE INACTIVATION OF PATHOGENS INCLUDING SARS-CoV-2SCHIKORA, Detlef
WO/2021/224429EXOSOME-ANCHORING CORONAVIRUS FUSION PROTEINS AND VACCINESBIOVELOCITA S.R.L
WO/2021/224432IL-18 BINDING PROTEIN (IL-18BP) IN RESPIRATORY DISEASESAB2 BIO SA
WO/2021/224439CLICK OMVsDE STAAT DER NEDERLANDEN, VERT. DOOR DE MINISTER VAN VWS,  MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT
WO/2021/224444PROCESS FOR PRODUCING AN ORAL THIN FILM COMPRISING  MICROPARTICLESLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/224449STEM CELLS FOR TREATMENT OF RESPIRATORY DISORDERSXINTELA AB
WO/2021/224455COMPOSITION TO BE USED FOR STRENGTHENING THE IMMUNE SYSTEM IN  HUMAN AND ANIMAL TO ACQUIRE PAN-IMMUNITYLEGACY HEALTHCARE (SWITZERLAND) SA
WO/2021/228714ANTIVIRAL COMPOSITION COMPRISING EEYARESTATIN IUNIVERSIDAD DE CASTILLA LA MANCHA
WO/2021/224463COSMETIC COMPOSITION COMPRISING CELLODEXTRINSPFEIFER & LANGEN GMBH & CO. KG
WO/2021/224467TREATMENT OF PROSTATE CANCER WITH A COMBINATION OF ABIRATERONE  ACETATE AND NIRAPARIBJANSSEN PHARMACEUTICA NV
WO/2021/224469TREATMENTS OF PROSTATE CANCER WITH COMBINATIONS OF ABIRATERONE  ACETATE AND NIRAPARIBJANSSEN PHARMACEUTICA NV
WO/2021/224471PHARMACEUTICAL FORMULATIONS OF ABIRATERONE ACETATE AND  NIRAPARIBJANSSEN PHARMACEUTICA NV
WO/2021/224494NEW TREATMENTS OF VIRAL INFECTIONSKANCERA AB
WO/2021/224499BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20GENMAB A/S
WO/2021/228731FELINE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 VACCINEINTERVET INTERNATIONAL B.V.
WO/2021/224503PARAPOXVIRUS FOR CONDITIONING FOR AND TREATMENT OF CORONAVIRUS  INFECTIONSAICURIS GMBH & CO. KG
WO/2021/228746A NOVEL ANTIBODY BINDING SPECIFICALLY TO HUMAN CEACAM1/3/5 AND  USE THEREOFLEUKOCOM GMBH
WO/2021/228750COMPATIBLE SOLUTES FOR PREVENTING OR TREATING SARS-COV-2  INFECTIONSBITOP AG
WO/2021/228758ATR INHIBITORS FOR THE TREATMENT OF CANCERASTRAZENECA AB
WO/2021/228760FORMULATIONS OF ANTI-IL-33 ANTIBODIESMEDIMMUNE LIMITED
WO/2021/228762USE OF TMPRSS2 INHIBITORS FOR THE TREATMENT OF LUNG VIRAL  INFECTIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/228768PREVENTION OF INFECTIOUS DISEASES BY MODULATING THE IMMUNE  SYSTEMVAKZINE PROJEKT MANAGEMENT GMBH
WO/2021/224505MODULATION OF MIXED LINEAGE KINASE DOMAIN-LIKE PROTEIN  SIGNALINGEBERHARD KARLS UNIVERSITÄT TüBINGEN
WO/2021/228783METHODS FOR TREATING MULTIPLE MYELOMAJANSSEN PHARMACEUTICA NV
WO/2021/228788COMPOSITION COMPRISING METHYLFOLATEALFASIGMA S.P.A.
WO/2021/228800SLOW RELEASE PLASMINOGEN ACTIVATOR FORMULATION FOR USE IN THE  TREATMENT OF THROMBOTIC OR HAEMORRHAGIC DISEASEOP2LYSIS
WO/2021/228805METHODS AND COMPOSITIONS USING SERPIN PRODUCING BACTERIASOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/228816ADMINISTRATION OF HOMOLOGOUS ADENOVIRAL VECTORSJANSSEN VACCINES & PREVENTION B.V.
WO/2021/228817EMID2 PROTEIN AS ANTI-CANCER TREATMENTINTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY  - ICGEB
WO/2021/228824COSMETIC COMPOSITION BASED ON BIOSOURCED ISODODECANE AND  PREPARATION METHOD THEREOFGLOBAL BIOENERGIES
WO/2021/228832RED CELL EXTRACELLULAR VESICLES (RCEVS) CONTAINING CARGOES AND  METHODS OF USE AND PRODUCTION THEREOFERYTECH PHARMA
WO/2021/228846COMPOUND FOR PREVENTING OR TREATING A VIRAL INFECTIONINSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE  (INSERM)
WO/2021/228849USE OF DI- AND TRICARBOXYLIC FATTY ACIDS IN THE PREVENTION OF  BIOFILM FORMATIONKATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/228852SOLID SOLUTION MADE FROM GUM ARABIC AND AT LEAST ONE  LIPOSOLUBLE ACTIVE SUBSTANCEMETABOLIC TUNING AG
WO/2021/233735PHARMACEUTICAL PREPARATION FOR USE IN THE TREATMENT OF  SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)CYTOPHARMA GMBH
WO/2021/228853VACCINE AGAINST SARS-COV VIRUSOSE IMMUNOTHERAPEUTICS
WO/2021/228863USES AND FORMULATIONS OF CANNABINOIDSADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228865USES AND FORMULATIONS OF CANNABINOIDSADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228866AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE  PREVENTION AND/OR TREAETMENT OF THROMBOCYTOPENIAAPLAGON OY
WO/2021/228867METHODS FOR IMAGE-GUIDED RADIOTHERAPYUNIVERSITE CLAUDE BERNARD LYON 1
WO/2021/228875TREATMENT OF RESPIRATORY VIRAL INFECTIONSKYON BIOTECH AG
WO/2021/239463CROSSLINKABLE PREPOLYMERS FOR CHEMICALLY STABLE POLYMER GELSLUMENDO AG
WO/2021/228917PREVENTION OF VISIBLE PARTICLE FORMATION IN PARENTERAL PROTEIN  SOLUTIONSF. HOFFMANN-LA ROCHE AG
WO/2021/228921INHALABLE LACTOSE CONTAINING COMPOSITIONMEGGLE GMBH & CO. KG
WO/2021/228937UROGENITAL CLEANSING COMPOSITIONPEPTONIC MEDICAL AB
WO/2021/228942PROTEASE FORMULATION FOR TREATMENT OF MICROBIAL INFECTIONSZYMIQ TECHNOLOGY AB
WO/2021/254697METAMIZOLE DERIVATIVES FOR THE PREVENTION AND TREATMENT OF  PULMONARY HYPERTENSIONCHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/228956NEW METHOD TO TREAT CUTANEOUS T-CELL LYMPHOMAS AND TFH DERIVED  LYMPHOMASINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/228983A PHARMACEUTICAL COMPOSITION COMPRISING AN ARSENIC COMPOUND,  AN INDUCTOR OF TYPE-1 IFN AND A PROTEIN KINASE INHIBITOR FOR TREATING CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/239471CANCER TREATMENT STRATEGIES USING ARENAVIRUS VECTORSHOOKIPA BIOTECH GMBH
WO/2021/229002TREATMENT OF COMPLICATIONS CAUSED BY INFECTIONS OF SEVERE  ACUTE RESPIRATORY SYNDROME CORONAVIRUSJOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/229013PEPTIDIC SCAFFOLDS, PROCESSES FOR MANUFACTURING THE SAME, AND  USES THEREOF AS SOLUBLE SUPPORTSSYNHELIX
WO/2021/229014COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED  IMMUNOGENIC FRAGMENTSLIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG
WO/2021/229015COMPOSITION OF NANOPARTICLESLIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG
WO/2021/229020NANOPARTICLES AS CARRIER-SYSTEM FOR ADJUVANTS/ANTIGENSLIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG
WO/2021/229035UBIQUITIN-LIGASE INHIBITORS FOR THE TREATMENT OF CANCERFUNDACIóN PROFESOR NOVOA SANTOS
WO/2021/244831THERAPEUTIC SOLID DOSAGE FORMSSMALL PHARMA LTD
WO/2021/239478SUNSCREEN WITH A COMBINATION OF WAXES, CETYL PALMITATE AND  HYDROGENATED RAPESEED OILBEIERSDORF AG
WO/2021/229065NEW IMMUNOGENIC COMPOSITIONS AND USE THEREOF FOR PREPARING  HEPATITIS C AND HEPATITIS B VACCINESUNIVERSITE DE TOURS
WO/2021/229086COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF MARINE  MOLLUSC VIRAL INFECTIONIFREMER
WO/2021/233796MCT FORMULATIONS FOR IMPROVING COGNITIVE FUNCTIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/259554BIODEGRADABLE ADHESIVE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/229100BRADYKININ B2 RECEPTOR ANTAGONIST FOR TREATMENT OF  SARS-COV2-INFECTIONHELMHOLTZ ZENTRUM MüNCHEN DEUTSCHES FORSCHUNGSZENTRUM FüR  GESUNDHEIT UND UMWELT (GMBH)
WO/2021/229101STEM CELLS FOR TREATING SKIN LESIONSRIGSHOSPITALET
WO/2021/229102MEANS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL  AGGREGATIONVIB VZW
WO/2021/233834SARS-COV-2 ANTIBODIES AND METHODS OF SELECTING AND USING THE  SAMEASTRAZENECA UK LIMITED
WO/2021/229104ANTI-CD38 SINGLE-DOMAIN ANTIBODIES IN DISEASE MONITORING AND  TREATMENTUNIVERSITé DE LIèGE
WO/2021/233851NEW MALONITRILE DERIVATIVESF. HOFFMANN-LA ROCHE AG
WO/2021/233853THE USE OF CHELATORS FOR THE PREVENTION OF VISIBLE PARTICLE  FORMATION IN PARENTERAL PROTEIN SOLUTIONSF. HOFFMANN-LA ROCHE AG
WO/2021/233874ELAFIBRANOR FOR THE TREATMENT OF PRIMARY SCLEROSING  CHOLANGITISGENFIT
WO/2021/233885MIMOTOPE PEPTIDES OF THE SPIKE PROTEIN FROM THE SARS-COV-2  VIRUSSYNTHETIC VACCINES LTD
WO/2021/233899USE OF PSYCHOTROPIC DRUGS FOR THE TREATMENT OF CORONAVIRUS  INFECTIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/233901PROBIOTIC BACTERIA FOR TREATING ALZHEIMER'S DISEASERRW B.V.
WO/2021/233902PLANT COMPOUNDS FOR TREATING ALZHEIMER'S DISEASERRW B.V.
WO/2021/259557COSMETIC PREPARATION COMPRISING ANTIPERSPIRANT INORGANIC  SALTS, CARBOXYLIC ACIDS AND 1,3-PROPANEDIOLBEIERSDORF AG
WO/2021/233923IMPROVEMENT OF INSOLUBLE FIBRE FERMENTABILITY AND SHORT CHAIN  FATTY ACID PRODUCTION BY BIFIDOBACTERIUM LONGUMSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/233924METHODS FOR ENHANCING ADOPTIVE CELL TRANSFER IMMUNOTHERAPIESHANSA BIOPHARMA AB
WO/2021/233927ANTIBODY THAT BINDS SPECIFICALLY TO THE SARS COV 2 SPIKE  PROTEIN, AND METHODS FOR ITS MANUFACTUREIGNOVA GMBH
WO/2021/233944PARA-AMINO-BENZYL LINKERS, PROCESS FOR THEIR PREPARATION AND  THEIR USE IN CONJUGATESLES LABORATOIRES SERVIER
WO/2021/233948METHOD TO TREAT A PATHOGEN LUNG INFECTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/233950COMPOUNDS FOR USE IN THE REACTIVATION OF HIV IN LATENT  HIV-INFECTED CELLSCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/233956EZETIMIBE FOR TREATING ENVELOPED VIRUS INFECTIONSMELETIOS THERAPEUTICS
WO/2021/233960USE OF HUMAN MILK OLIGOSACCHARIDES IN NUTRITIONAL COMPOSITIONS  FOR ENHANCING BONE DEVELOPMENT AND/OR BONE STRENGTHSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/233962METHODS FOR THE DIAGNOSIS AND TREATMENT OF CYTOKINE RELEASE  SYNDROMEINSTITUT CURIE
WO/2021/233966METHODS FOR THE TREATMENT OF CORONAVIRUS INFECTIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/233967INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOFINTERVET INTERNATIONAL B.V.
WO/2021/233971BBETA-15-42 FOR THE TREATMENT OF VIRAL ENDOTHELITISJOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/233973COMPOSITIONS FOR REDUCING SALTY TASTE AND USES THEREOFFIRMENICH SA
WO/2021/233988COMPOSITION COMBINING JONZAC THERMAL SPRING WATER AND A  CENTELLA ASIATICA EXTRACT AND THE REPAIRING/HEALING EFFECT THEREOFLABORATOIRES LéA
WO/2021/233989VIRAL VACCINE VECTOR FOR IMMUNIZATION AGAINST A  BETACORONAVIRUSHENNRICH, Alexandru Adrian
WO/2021/234005A PERSONAL CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/234006COMPOSITIONS AND METHODS FOR TREATING CANCER EXPRESSING CD90  AND CD326MILTENYI BIOTEC B.V. & CO. KG
WO/2021/244852THERAPEUTIC ANTIBODIES WITH NEUTRALIZING ACTIVITY AGAINST  SARS-COV-2 GLYCOPROTEIN SCORAT THERAPEUTICS GMBH
WO/2021/234007PROPOFOL FOR DIAGNOSIS OF PRIMARY HEADACHETESA LABTEC GMBH
WO/2021/234008ORAL FILM FOR SAFE ADMINISTRATION OF APITESA LABTEC GMBH
WO/2021/234009ANTI-AGING COSMETIC COMPOSITIONS COMPRISING NMNNUVAMID SA
WO/2021/239544OPHTHALMIC COMPOSITION BASED ON HYALURONIC ACID TO PROTECT  FROM DAMAGES CAUSED BY ENVIRONMENTAL POLLUTIONCOLOMBO, Stefano
WO/2021/234014ANTI-ACNE COMPOSITIONSL'OREAL
WO/2021/244854USE OF SAA, RSAA, OR INHIBITORS OF SAA IN THE TREATMENT OF  DYSREGULATED INFLAMMATIONLIKA ANTISEPSIS GBR
WO/2021/239546USE OF A MINERAL BLEND AS COSMETIC AGENT FOR WET COSMETIC  COMPOSITIONSOMYA INTERNATIONAL AG
WO/2021/234031A PARTICLE ENCAPSULATING HYDROPHILIC OR AMPHIPHILIC BIOLOGICAL  COMPOUNDSSPHERA ENCAPSULATION S.R.L.
WO/2021/259560CO-GROUND ACTIVE(S) COMPRISING PRODUCT COMPRISING  SURFACE-REACTED CALCIUM CARBONATEOMYA INTERNATIONAL AG
WO/2021/234055COMPOSITIONS AND METHODS FOR PROVIDING SKIN CARE BENEFITSUNILEVER IP HOLDINGS B.V.
WO/2021/234057PEPTIDE FOR USE IN THE PREVENTION AND/OR TREATMENT OF A  DISEASE CAUSED BY A VIRUS AFFECTING THE RESPIRATORY TRACTFUNDACIóN PARA EL FOMENTO DE LA INVESTIGACIóN SANITARIA Y  BIOMéDICA DE LA COMUNITAT VALENCIANA (FISABIO)
WO/2021/234074COMPOSITION COMPRISING DIFFERENT SPECIFIC COLLAGENS AND USES  ON THE SKINMONDERNA HEALTH & WELLNESS
WO/2021/234084MAXI-K POTASSIUM CHANNEL OPENERS FOR THE TREATMENT OF FRAGILE  X ASSOCIATED DISORDERSKAERUS BIOSCIENCE LIMITED
WO/2021/234094CEFTRIAXONE COMPOSITIONS WITH MAGNESIUM COMPONENTXELLIA PHARMACEUTICALS APS
WO/2021/234097MEK-INHIBITORS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS  INFECTIONS AND/OR COVID-19 CYTOKINE STORMATRIVA THERAPEUTICS GMBH
WO/2021/254721AGENT FOR DYEING KERATINOUS FIBRES, CONTAINING PIGMENTS AND  C<sb>2</sb>-C<sb>30</sb> ALKYL METHICONESHENKEL AG & CO. KGAA
WO/2021/239578EMULSIONS FOR CONTROLLED DRUG RELEASEAVIGNON UNIVERSITE
WO/2021/234111COMPOSITION COMPRISING SAFRANAL AND PROBIOTICSACTIV' INSIDE
WO/2021/234127NUCLEOSIDE ANALOGUE TO INHIBIT THE MAIN PROTEASE OF SARS-CoV-2  VIRUSINSTITUT DE RECHERCHE EN SEMIOCHIMIE ET ETHOLOGIE APPLIQUEE
WO/2021/234128NUCLEOSIDE ANALOGUES TO INHIBIT THE MAIN PROTEASE OF A  CORONAVIRUSINSTITUT DE RECHERCHE EN SEMIOCHIMIE ET ETHOLOGIE APPLIQUEE
WO/2021/254723A PERSONAL CARE COMPOSITION BASED ON TITANIUM OXIDE AND A  CROSSPOLYMER OF ADIPIC ACID AND NEOPENTYL GLYCOLUNILEVER IP HOLDINGS B.V.
WO/2021/234134BARK-FREE, STABLE DOUBLE EMULSIONCAPSUM
WO/2021/234135BARK-FREE, STABLE DISPERSIONCAPSUM
WO/2021/239622BRANCHED AMINO-ACID-BASED POLYMERS FOR HAIR STRENGTHENINGBASF SE
WO/2021/234159MORINGA PEREGRINA SEED EXTRACT RICH IN 2,5-DIFORMYLFURAN,  PROCESS FOR OBTAINING SAME AND USE THEREOF IN COSMETIC COMPOSITIONSAGENCE FRANCAISE POUR LE DEVELOPPEMENT D'AL ULA
WO/2021/234165PROTEIN HYDROLYSATE OF <i>MORINGA PEREGRINA</i>  SEED CAKE FOR ITS APPLICATION AS A MEDICAMENT, PROCESS FOR OBTAINING SAME AND  PHARMACEUTICAL AND DERMATOLOGICAL COMPOSITIONSAGENCE FRANCAISE POUR LE DEVELOPPEMENT D'AL ULA
WO/2021/234166EXTRACT OF MORINGA PEREGRINA SEED CAKE, METHOD FOR OBTAINING  SAME AND USE THEREOF IN COSMETIC OR NUTRICOSMETIC COMPOSITIONSAGENCE FRANCAISE POUR LE DEVELOPPEMENT D'AL ULA
WO/2021/249751COSMETIC PRODUCT WITH HIGH DEGREE OF EMPTYING OF THE  PREPARATION FROM THE PACKAGINGBEIERSDORF AG
WO/2021/254729AVERMECTINS FOR USE IN TREATING CORONAVIRIDAE INFECTIONHUVEPHARMA EOOD
WO/2021/239643BENZYLAMINE DERIVATIVES AS DDRS INHIBITORSCHIESI FARMACEUTICI S.P.A.
WO/2021/239662PI3K GAMMA INHIBITOR PEPTIDE FOR TREATMENT OF  FIBROPROLIFERATIVE VASCULAR DISEASESKITHER BIOTECH S.R.L.
WO/2021/234178TNFα IMMUNOCONJUGATE THERAPY FOR THE TREATMENT OF BRAIN TUMORSPHILOGEN S.P.A
WO/2021/239666THERAPEUTIC METHODSDIACCURATE
WO/2021/239667NEW THERAPY FOR THE TREATMENT OF TUMORSUNIVERSITà DEGLI STUDI DI TRENTO
WO/2021/239687TCDTA-DERIVED FE(III) COMPLEXES FOR USE IN MAGNET RESONANCE  IMAGING WITH LIVER AND KIDNEY EXCRETIONCHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/249760A COSMETIC COMPOSITION COMPRISING 6-METHYL-PICOLINAMIDEUNILEVER IP HOLDINGS B.V.
WO/2021/239709METHOD FOR PRODUCING A LIPOSOME DISPERSIONLEON-NANODRUGS GMBH
WO/2021/239720COSMETIC COMPOSITION COMPRISING AT LEAST 30% BY WEIGHT OF  BRANCHED ALKANE AND A COMBINATION OF PARTICULAR SILICONESL'OREAL
WO/2021/239730NANOPARTICLES, IONIZING RADIATION AND INNOVATIVE THERAPEUTIC  COMBINATIONS THEREOFNANOBIOTIX
WO/2021/234181USE OF FAP INHIBITOR IN A METHOD OF DIAGNOSISUNIVERSITÄT HEIDELBERG
WO/2021/259580HIGHLY VISCOUS COSMETIC NANOEMULSIONBEIERSDORF AG
WO/2021/239742ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES  AND PROCESS FOR ITS PREPARATIONGIVAUDAN SA
WO/2021/239786EGFR TKIS FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG  CANCERASTRAZENECA AB
WO/2021/244910HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR  PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A  DONORGRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/239790METHOD FOR THE TREATMENT OF VIRUS INFECTION WITH IVIG AND  CONVALESCENT PLASMAGRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/239796METHOD FOR THE TREATMENT OF A VIRAL INFECTION WITH HUMAN  ALPHA-1 ANTITRYPSINGRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/239798SOLID SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (S-SNEDDS)EVONIK OPERATIONS GMBH
WO/2021/239809TREATMENT OF COVID-19 PATIENTSASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS
WO/2021/239812POLYPEPTIDE USEFUL IN ADOPTIVE CELL THERAPYQUELL THERAPEUTICS LIMITED
WO/2021/239815FIBROBLAST GROWTH FACTOR 21 (FGF21) GENE THERAPY FOR CENTRAL  NERVOUS SYSTEM DISORDERSUNIVERSITAT AUTòNOMA DE BARCELONA
WO/2021/239817THERAPEUTIC COMBINATIONS COMPRISING AGONISTS OF FERROPTOSIS  FOR TREATING PROLIFERATIVE DISORDERSCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG-SPEYER-HAUS
WO/2021/254750USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGINGUNILEVER IP HOLDINGS B.V.
WO/2021/254751USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGINGUNILEVER IP HOLDINGS B.V.
WO/2021/254752USE OF DIINDOLYLMETHANE COMPOUNDS FOR TREATING SIGNS OF SKIN  AGINGUNILEVER IP HOLDINGS B.V.
WO/2021/254753USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGINGUNILEVER IP HOLDINGS B.V.
WO/2021/254754USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGINGUNILEVER IP HOLDINGS B.V.
WO/2021/239838SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)  POLYPEPTIDES AND USES THEREOF FOR VACCINE PURPOSESINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/239844SGLT-2 INHIBITORS OR IL-1R ANTAGONISTS FOR REDUCTION OF  HYPOGLYCAEMIA IN PREDIABETESUNIVERSITÄTSSPITAL BASEL
WO/2021/239850USE OF NMN TO REDUCE IMMUNODEPRESSION AND IMMUNOSENESCENCENUVAMID SA
WO/2021/239878TREATMENT OF INFECTIONSACT THERAPEUTICS LTD
WO/2021/239880NUCLEIC ACID BASED COMBINATION VACCINESCUREVAC AG
WO/2021/239890BIFIDOBACTERIA FOR PREVENTING, REDUCING OR TREATING SKIN AGINGDUPONT NUTRITION BIOSCIENCES APS
WO/2021/239892MONO- AND BIS-NITROSYLATED PROPANEDIOLS FOR THERAPEUTIC USEATTGENO AB
WO/2021/239893AMORPHOUS SOLID DISPERSION OF ACALABRUTINIBBEND RESEARCH, INC.
WO/2021/239905COMPOUNDS FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF  THROMBIINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/239906MONO- AND BIS-NITROSYLATED ALKYL POLYOLS FOR THERAPEUTIC USEATTGENO AB
WO/2021/239915FOXO INHIBITORS FOR USE IN THE TREATMENT OF DISEASES CAUSED BY  ABNORMAL PROCESSING OF TDP-43 AND/OR FUS PROTEINSADMINISTRACIóN GENERAL DE LA COMUNIDAD AUTóNOMA DE EUSKADI
WO/2021/239917COMBINATION SOLID ORAL DOSAGE FORMS OF GONADOTROPIN-RELEASING  HORMONE ANTAGONISTSMYOVANT SCIENCES GMBH
WO/2021/244964COMPOSITIONS AND METHODS FOR TREATING INFECTIONS AND NETOPATHYBLACK CAT BIO LIMITED
WO/2021/239935NEUTRALIZING ANTIBODIES AGAINST SARS-RELATED CORONAVIRUSUNIVERSITÄT ZU KÖLN
WO/2021/239938COSMETIC COMPOSITION WITH ENHANCED COLOR STABILITY FOR  RETINOIC ACID PRECURSORUNILEVER IP HOLDINGS B.V.
WO/2021/239943AZELASTINE AS ANTIVIRAL TREATMENTCEBINA GMBH
WO/2021/239961A COMPOSITION COMPRISING HP-HMG FOR USE IN TREATING  INFERTILITYFERRING B.V.
WO/2021/239965CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR P95HER2 AND USES  THEREOFFUNDACIó PRIVADA INSTITUT D'INVESTIGACIó ONCOLòGICA DE VALL  HEBRON
WO/2021/239968CD40 BINDING PROTEINSTRIKE PHARMA AB
WO/2021/239976TRIARYLPYRIDINE COMPOUNDS AND USE THEREOF FOR TREATING CANCERINSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE  (INSERM)
WO/2021/244983COOLING PERSONAL CARE COMPOSITION COMPRISING A POLYOL AND A  POLYOXYEHTYLENE-POLYOXYPROPYLENE BLOCK COPOLYMERUNILEVER IP HOLDINGS B.V.
WO/2021/239980A PEPTIDE COCKTAILHUBRO THERAPEUTICS AS
WO/2021/239987MULTISPECIFIC ANTIBODYNUMAB THERAPEUTICS AG
WO/2021/239992ANTIFUNGAL PRODRUGSCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/239996IMMUNOMODULATORY COMPLEX AND USES THEREOF FOR THERAPYCOMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/240004PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE  AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A  GLUCAGON SUPPRESSOR WITH PRANDIAL ACTIONADOCIA
WO/2021/240006PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE  AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A  GLUCAGON SUPPRESSOR WITH PRANDIAL ACTIONADOCIA
WO/2021/244996SYNTHETIC OLIGOSACCHARIDE VACCINES AGAINST STREPTOCOCCUS  PNEUMONIAE WITH MICROPARTICLE ADJUVANT FORMULATIONSMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/245001MICROEMULSION FOR THE TREATMENT OF DRY EYE SYNDROMEAZAD PHARMA AG
WO/2021/240013VACCINE FORMULATIONSIMNATE SARL
WO/2021/245018A HIGH SPF SKIN CLEANSING COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/245032NUTRACEUTIC COMPOSITION CONTAINING LIMONENE AND A DRY EXTRACT  OF COCOA FIBRE FOR THE TREATMENT OF OBESITYTARGETING GUT DISEASE SRL
WO/2021/254773A TOPICAL ANTIMICROBIAL COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/245081COMPOSITION COMPRISING AT LEAST THREE TYPES OF  POLYSACCHARIDES, AT LEAST ONE PASTY COMPOUND OF PLANT ORIGIN AND WATERL'OREAL
WO/2021/245082A HIGH UV PROTECTION CLEANSING COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/245095METHOD TO IMPROVE IMMUNOTHERAPIESINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/245107MODULATORS OF PURINERGIC RECEPTORS AND RELATED IMMUNE  CHECKPOINT FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROMINSTITUT GUSTAVE ROUSSY
WO/2021/245111RECOMBINANT RHABDOVIRUS ENCODING FOR A CD80 EXTRACELLULAR  DOMAIN FC-FUSION PROTEINBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/245140DIAGNOSIS, PREVENTION AND TREATMENT OF CORONAVIRUS INFECTIONEMERGEX VACCINES HOLDING LIMITED
WO/2021/245159NATURALLY DERIVED SURFACTANT SYSTEM AND COMPOSITION COMPRISING  THE SAMEUNILEVER IP HOLDINGS B.V.
WO/2021/245160NATURALLY DERIVED SURFACTANT SYSTEM WITH POLYGLYCEROL ESTERS  AND COMPOSITIONS COMPRISING THE SAMEUNILEVER IP HOLDINGS B.V.
WO/2021/245172STABILIZATION OF 1,2,4-TRIOXANE COMPOUNDS BY CHLOROGENIC ACIDSARTEMIFLOW GMBH
WO/2021/245179LIQUID OPHTHALMIC COMPOSITION COMPRISING A SPIRULINA PLATENSIS  FULL EXTRACTWELIFEPHARMA SAGL
WO/2021/245184HUMAN ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME  CORONAVIRUS-2 (SARS-CoV-2)NEURIMMUNE AG
WO/2021/245199GLP1R AGONIST NMDAR ANTAGONIST CONJUGATESKØBENHAVNS UNIVERSITET
WO/2021/254790AN ANTIMICROBIAL COMPOSITION FOR TACKLING MALODOURUNILEVER IP HOLDINGS B.V.
WO/2021/245204STABLE FORMULATION OF EFINACONAZOLETHE MATERIA COMPANY LIMITED
WO/2021/245206TOPICAL SOLUTION OF EFINACONAZOLE WITH HIGH SUBUNGUAL  PENETRATIONTHE MATERIA COMPANY LIMITED
WO/2021/245207USE OF E. COLI STRAINS EXPRESSING HIGH LEVEL OF ALPHA-GAL TO  MODULATE IMMUNITY AND PROVIDE PROTECTION AGAINST INFECTIOUS DISEASES IN  ANIMALSINSTITUT NATIONAL DE RECHERCHE POUR L' AGRICULTURE, L'  ALIMENTATION ET L' ENVIRONNEMENT
WO/2021/245223HIGH DOSE AND LOW VOLUME BOTULINUM TOXIN TREATMENT OF FACIAL  WRINKLESMERZ PHARMA GMBH & CO. KGAA
WO/2021/245224METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING OCULAR  DISEASESINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/245233IMPROVING ANTIBODY TOLERABILTY ASSOCIATED WITH INTRAVENOUS  ADMINISTRATIONBIOINVENT INTERNATIONAL AB
WO/2021/249886AQUEOUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN  MATERIALS COMPRISING A FATTY ACID MONOESTER, A FATTY ACID SALT, A PULLULAN  AND A POLYOLL'OREAL
WO/2021/245237MODEL FOR PREDICTION OF TOLERABILITY ISSUES IN CONNECTION WITH  INTRAVENOUS ADMINISTRATION OF THERAPEUTIC ANTIBODIESBIOINVENT INTERNATIONAL AB
WO/2021/245238IMPROVING ANTIBODY TOLERABILITY ASSOCIATED WITH INTRAVENOUS  ADMINISTRATIONBIOINVENT INTERNATIONAL AB
WO/2021/245249TREATMENT OF CD30-POSITIVE CANCERTESSA THERAPEUTICS LTD.
WO/2021/245254USE OF MULTIFUNCTIONAL LIGANDS FOR TREATING THE RESPIRATORY  DISTRESS AND CYTOKINE STORM SYNDROMES ASSOCIATED WITH CORONAVIRUS VIRAL  INFECTIONSH4 ORPHAN PHARMA
WO/2021/245260THERAPEUTIC NANOCARRIER SYSTEM AND METHODS OF USEGREGORIOU, Yiota
WO/2021/245263PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER  RADIOTHERAPY AND IMAGINGRIGSHOSPITALET
WO/2021/245280USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF  TOURETTE SYNDROMENOEMA PHARMA AG
WO/2021/245281METHODS OF TREATMENT OF TUBEROUS SCLEROSIS COMPLEXNOEMA PHARMA AG
WO/2021/249921NANOPARTICLES AS BIORESORBABLE AND RADIOPAQUE  ACTIVE-INGREDIENT CARRIERS FOR THE THERAPY OF CANCERS OF THE PANCREASFRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E.V.
WO/2021/254803THICKENED ALKALYZATION COMPONENT FOR OXIDATIVE HAIR LIGHTENING  PRODUCTHENKEL AG & CO. KGAA
WO/2021/254804AGENT FOR DYEING KERATINOUS MATERIAL, IN PARTICULAR HUMAN  HAIR, CONTAINING AMINOSILICONES, PIGMENTS AND ALKYLPOLYGLYCOSIDESHENKEL AG & CO. KGAA
WO/2021/249951METHODS AND COMPOSITIONS FOR TREATMENT OF BRAIN VIRAL  INFECTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/245291TREM-1 INHIBITOR FOR USE IN THE TREATMENT OF A SUBJECT  SUFFERING FROM A CORONAVIRUS INFECTIONINOTREM
WO/2021/249960COMPOSITIONS COMPRISING NARCISSUS SPP. PLANT EXTRACT AND USE  THEREOFCLARIANT INTERNATIONAL LTD
WO/2021/249969COMBINATION PRODUCT FOR THE TREATMENT OF CANCER DISEASESMERCK PATENT GMBH
WO/2021/249974FUCOIDAN-FUNCTIONALIZED POLYSACCHARIDE PARTICLES WITH T-PA FOR  TARGETED THROMBOLYTIC THERAPYINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/249982ANTIVIRAL COMPOUNDSIBYLLA BIOTECH S.R.L.
WO/2021/249990ANTI-HBV ANTIBODIES AND METHODS OF USEHOFFMANN-LA ROCHE INC.
WO/2021/249996COMPOSITIONS COMPRISING 2X-121 AND METHODS FOR TREATING  CORONAVIRUS INFECTIONONCOLOGY VENTURE APS
WO/2021/250001RETINOL-BASED COMPOSITIONL'OREAL
WO/2021/250008RETINOL-BASED COMPOSITIONL'OREAL
WO/2021/250010ATP-HYDROLYZING ENZYME USEFUL FOR TREATING DYSBIOSISMV BIOTHERAPEUTICS SA
WO/2021/254835A TOPICAL ANTIMICROBIAL COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/250019COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF URINARY TRACT  INFECTIONS AND FOR USE IN COSMETICSG. POHL-BOSKAMP GMBH & CO. KG
WO/2021/250025SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION AND  THEIR USE IN MEDICINE, IN THE PREVENTION AND TREATMENT OF CANCERUNIVERSITÄT ZüRICH
WO/2021/250029SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTIONUNIVERSITÄT ZüRICH
WO/2021/250038COMPOUND AND METHOD FOR THE TREATMENT OF CORONAVIRUSESAPTEEUS
WO/2021/250043ASSAY FOR THE DETECTION OF THE CYS-LIKE PROTEASE (MPRO) OF  SARS-COV-2CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/250061PROTEIN OR PEPTIDE, ESPECIALLY FOR PROPHYLAXIS AND/OR  TREATMENT OF AN INFECTION AND/OR INFECTIOUS DISEASE AND/OR A SEQUELA THEREOFPROF. DR. MED. CHRISTOPH KARLE PRAXIS FüR DIAGNOSTIK HOHENLOHE
WO/2021/250081NRF2 ACTIVATOR FOR USE IN TREATING DILATED CARDIOMYOPATHIESGENETHON
WO/2021/250082TREATMENT OF DILATED CARDIOMYOPATHIESGENETHON
WO/2021/254851PROCYANIDINS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION  TRIGGERED BY COVID-19HORPHAG RESEARCH IP (PYC) LTD.
WO/2021/250110PROCESS FOR THE PREPARATION OF AN EXTRACT OF EPILOBIUM SPP.  WITH HIGH OENOTHEIN B CONTENTISTITUTO FARMOCHIMICO FITOTERAPICO EPO S.R.L. ED IN FORMA  ABBREVIATA: EPO S.R.L.
WO/2021/250130PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELLFIRMENICH SA
WO/2021/250178NOVEL LACTOCOCCUS LACTIS STRAIN FOR THE PRODUCTION OF  BIOACTIVE COMPOUNDS HAVING ANTIMICROBIAL EFFECTINNOVACIóN EN GESTIóN Y CONSERVACIóN DE UNGULADOS S.L.  (INGULADOS)
WO/2021/250193METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF  CHRONIC KIDNEY DISEASEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/250194SMALL MOLECULE MODULATORS OF IL-17LEO PHARMA A/S
WO/2021/250196NEW USE OF RABEXIMODCYXONE AB
WO/2021/250198METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF  FGFR3-RELATED COGNITIVE DEFICITINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/250199RABEXIMOD IN THE TREATMENT OF RHEUMATOID ARTHRITISCYXONE AB
WO/2021/250200CANCER THERAPYPROKARIUM LIMITED
WO/2021/250204ORAL FORMULATION COMPRISING A CRYSTALLINE FORM OF RABEXIMODCYXONE AB
WO/2021/259663COSMETIC COMPOSITION FOR IMPROVING APPEARANCE OF SKINUNILEVER IP HOLDINGS B.V.
WO/2021/250205IMPROVED ADHESIVE DRUG CARRIERUMC UTRECHT HOLDING B.V.
WO/2021/250207BROMELAIN PROTEASE, BROMELAIN, JACALIN-LIKE LECTIN, EXTRACT  FROM THE STEM AND/OR THE FRUIT OF A PINEAPPLE PLANT, COMBINATION PREPARATION,  BROMELAIN PROTEASE INHIBITOR, PROTEIN/PROTEASE MIX, AND GLYCATED BROMELAIN  PROTEIN FORMED BY EXOGENOUS NON-ENZYMATIC GLYCATION, FOR USE IN THE TREATMENT  OR PROPHYLAXIS OF VIRUS INFECTIONS CAUSED BY CORONAVIRUSES IN A HUMAN OR  ANIMALURSAPHARM ARZNEIMITTEL GMBH
WO/2021/250212PEPTIDES FOR TREATMENT OF SEPSIS AND CANCERNORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NTNU)
WO/2021/250219A RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) VACCINE  AGAINST CORONAVIRUS DISEASEBAVARIAN NORDIC A/S
WO/2021/259668USE OF A BORON CLUSTER AS TRANSMEMBRANE CARRIERJACOBS UNIVERSITY BREMEN GGMBH
WO/2021/250231THIENOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF  CORONAVIRUS INFECTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/259669NANOPARTICULATE COMPOSITIONALGIAX PHARMACEUTICALS GMBH
WO/2021/250236COMPOSITION COMPRISING NANOPARTICLES, METHOD FOR THE  PREPARATION OF A COMPOSITION COMPRISING NANOPARTICLES AND USES OF THE  COMPOSITION FOR DENTAL TREATMENTUNIVERSITAT INTERNACIONAL DE CATALUNYA, FUNDACIó PRIVADA
WO/2021/250239A HYDROALCOHOLIC GEL AND A METHOD OF MANUFACTURING SAID GELVIRAMAL LIMITED
WO/2021/250240DIAZA-18-CROWN-6 DERIVATIVE USEFUL FOR CHELATING RADIUM,  CONJUGATE AND RADIUM CHELATE COMPRISING THE SAME, AND USES THEREOFORANO
WO/2021/259673HYDROXYCHLOROQUINE LIQUID COMPOSITIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/254909THICKENED ALKALYZATION COMPONENT FOR OXIDATIVE HAIR DYEING  PRODUCTHENKEL AG & CO. KGAA
WO/2021/250260MODULATORS OF TIGHT JUNCTION PERMEABILITYTHE UNIVERSITY OF BATH
WO/2021/250263LIPID NANOPARTICLESETHERNA IMMUNOTHERAPIES NV
WO/2021/254919SELECTIVE TMPRSS2 INHIBITORS AND MEDICAL USE THEREOFMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/254928METHYLENE BLUE AND RIBOFLAVIN FOR PROPHYLACTIC AND THERAPEUTIC  ANTI-VIRAL THERAPYCERNY, Erich, H.
WO/2021/254937FECAL MATTER FOR TREATMENT OF CACHEXIAACADEMISCH MEDISCH CENTRUM
WO/2021/250275ANTIBODY FORMULATION DILUENTICHNOS SCIENCES SA
WO/2021/254978COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONSMERCK PATENT GMBH
WO/2021/254982COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONSMERCK PATENT GMBH
WO/2021/254998BIODEGRADABLE UV ABSORBERSBASF SE
WO/2021/255003IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDSGIVAUDAN SA
WO/2021/255025IMPROVEMENTS IN ULTRASOUND-MEDIATED THERAPYBRACCO SUISSE SA
WO/2021/255046HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/255047HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/255048HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/255049HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/255050HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/255051HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/255129NOVEL USE OF A MODULATOR OF GLUCOSYLCERAMIDE DEGRADATION FOR  VIRAL INFECTIONSSPEDDING RESEARCH SOLUTIONS, SAS
WO/2021/259742MODIFIED EXOTOXIN A PROTEINSGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/259743KLEBSIELLA PNEUMONIAE O-ANTIGEN VACCINEGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/255156NOVEL DIPEPTIDE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF  AND A NOVEL THERAPEUTIC USE OF DIPEPTIDE COMPOUNDSUNIVERSITE PARIS-SACLAY
WO/2021/259748COMPOSITIONS COMPRISING ZINC AND ANTIMICROBIAL AGENTUNILEVER IP HOLDINGS B.V.
WO/2021/255159FORMULATION COMPRISING DAPRODUSTATGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
WO/2021/255160METHOD FOR PRODUCING PERSONALIZED COSMETICSBASF SE
WO/2021/255172MARC1 INHIBITORS FOR TREATMENT OF LIPID METABOLISM DISORDERSCLEMENT, Bernd
WO/2021/255177METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATIONBASF SE
WO/2021/255179PLASMA-TREATED HYDROGEL COMPOSITIONS AND USES THEREOFUNIVERSITAT POLITèCNICA DE CATALUNYA
WO/2021/255182TREATMENT AND PREVENTION OF DISEASE CAUSED BY TYPE IV COLLAGEN  DYSFUNCTIONSINGAPORE HEALTH SERVICES PTE. LTD.
WO/2021/255194COMPOSITION COMPRISING A SHORT-CHAIN FATTY ACID SALT AND AT  LEAST ONE LONG-CHAIN FATTY ACIDL'OREAL
WO/2021/255200GELLED COMPOSITION COMPRISING A SHORT-CHAIN FATTY ACID SALTL'OREAL
WO/2021/255204NEW STRATEGY FOR TREATING PANCREATIC CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/255217AMATOXIN AND AMATOXIN CONJUGATES FOR USE IN INHIBITION OF RNA  VIRUS REPLICATIONHEIDELBERG PHARMA RESEARCH GMBH
WO/2021/255218A PHARMACEUTICAL COMBINATION COMPRISING AN ANTI-VIRAL  PROTONOPHORE AND A SERINE PROTEASE INHIBITORCHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/255219SWINE INFLUENZA A VIRUS VACCINE COMPRISING A NUCLEIC ACID  CONSTRUCT HAVING A SPECIFIC ORDER OF GENESINTERVET INTERNATIONAL B.V.
WO/2021/255222SWINE INFLUENZA A VIRUS VACCINE COMPRISING TWO DISTINCT RNA  REPLICON PARTICLESINTERVET INTERNATIONAL B.V.
WO/2021/259772PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN THE  PROPHYLAXIS AND/OR TREATMENT OF VIRAL INFECTIONS CAUSED BY CORONAVIRIDAEEVONIK OPERATIONS GMBH
WO/2021/255226ANTIVIRAL USE OF CALIXARENESCEBINA GMBH
WO/2021/259783POLYMER-CARGO-COMPLEXES COMPRISING CROSS-LINKED COPOLYMERS AND  CARGO MOLECULESHELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/255239OXOPIPERAZINE DERIVATIVES FOR THE TREATMENT OF CANCERINTHERA BIOSCIENCE AG
WO/2021/255245GENE THERAPY EXPRESSION SYSTEM ALLOWING AN ADEQUATE EXPRESSION  IN THE MUSCLES AND IN THE HEART OF SGCGGENETHON
WO/2021/255246ACALABRUTINIB MALEATE DOSAGE FORMSACERTA PHARMA B.V.
WO/2021/255251PULMONARY FORMULATION COMPRISING CANNABINOIDSCANNOVEX BV
WO/2021/255252FORMULATION COMPRISING CANNABINOIDSCANNOVEX BV
WO/2021/255255COMPOSITION COMPRISING A POLYOL, A POLYGLYCEROL ESTER, A  HYALURONIC ACID SALT AND A SPECIFIC HYDROPHILIC POLYMERL'OREAL
WO/2021/255260COMPOSITION COMPRISING A POLYOL AND AT LEAST ONE POLYGLYCERYL  ESTERL'OREAL
WO/2021/255264BIODEGRADABLE COMPOSITIONS AND IMPLANTSRE-VANA THERAPEUTICS LTD
WO/2021/255270SELF-AMPLIFYING SARS-COV-2 RNA VACCINEZIPHIUS VACCINES
WO/2021/259809PROCESS FOR DYEING KERATIN FIBERS USING A DIRECT DYE AND A  SACCHARINATE SALT AND COMPOSITION COMPRISING THEML'OREAL
WO/2021/259810COMPOSITION FOR SIMULTANEOUS BLEACHING AND DYEING OF KERATIN  FIBERS, COMPRISING A PARTICULAR HETEROCYCLIC SALT, AND PROCESS USING THIS  COMPOSITIONL'OREAL
WO/2021/255282CONJUGATED AND LABELLED APELIN, PREPARATION AND USES THEREOFUNIVERSITE D'AIX MARSEILLE
WO/2021/255295SWELLABLE GELATIN COMPOSITIONSUNIVERSITEIT GENT
WO/2021/259866DIMETHYL SULFONE FOR TREATMENT OF CHRONICALLY HEAT STRESSED  POULTRYEVONIK OPERATIONS GMBH
WO/2021/259869OXINE-CONTAINING CELL RADIOLABELLING AGENTSKING'S COLLEGE LONDON
WO/2021/259925CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY,  PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOFSAPREME TECHNOLOGIES B.V.
WO/2021/259927ANTI-CD2 ANTIBODIESZELARION MALTA LIMITED
WO/2021/259928COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND  A SAPONIN OR A LIGAND-SAPONIN CONJUGATESAPREME TECHNOLOGIES B.V.
WO/2021/259943HAIR CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/259944CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN  EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME,  THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITIONSAPREME TECHNOLOGIES B.V.
WO/2021/259962COMPOSITIONS AND KITS OF PARTS COMPRISING  N,N-DIMETHYLTRYPTAMINE AND HARMINE AND THEIR USE IN THERAPYUNIVERSITY OF ZüRICH
WO/2021/259963IMMUNIZATION AGAINST WNT4 FOR TREATMENT AND PROPHYLAXIS OF  BREAST CANCERPANDORA ENDOCRINE INNOVATION B.V.
WO/2021/259972ANTICANCER COMBINATION THERAPY COMPRISING A SOS1 INHIBITOR AND  A KRAS G12C INHIBITORBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/259973COMPOSITION COMPRISING A PARTICULAR SILICONE EMULSION, A  PARTICULAR (METH)ACRYLAMIDE POLYMER, SURFACTANTS AND A CATIONIC  POLYSACCHARIDEL'OREAL
WO/2021/259974COMPOSITION COMPRISING A POLYMER COMPRISING AT LEAST ONE  CATIONIC (METH)ACRYLAMIDE UNIT, A PARTICULAR SILICONE AND A CHEMICAL  OXIDIZING AGENT AND/OR AN OXIDATION DYEL'OREAL
WO/2021/260048COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE  COPOLYMER COMPRISING AT LEAST TWO DIFFERENT POLYMER UNITS BEARING A(N)  (UN)SATURATED HYDROCARBON-BASED CHAIN IN A FATTY MEDIUML'OREAL
WO/2021/260054SAPONIN DERIVATIVES FOR USE IN MEDICINESAPREME TECHNOLOGIES B.V.
WO/2021/260061SAPONIN DERIVATIVES FOR USE IN MEDICINESAPREME TECHNOLOGIES B.V.
WO/2021/260062PROCESS FOR TREATING KERATIN FIBRES, COMPRISING THE  APPLICATION OF A MAKEUP-REMOVING COMPOSITION, THE KERATIN FIBRES HAVING BEEN  DYED BEFOREHANDL'OREAL
WO/2021/260065MVA-BASED VACCINE AGAINST COVID-19 EXPRESSING SARS-COV-2  ANTIGENSCONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/260068VASOPRESSIN-2 RECEPTOR ANTAGONIST PEPTIDES AND USES THEREOFCOMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/260078COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE  COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A SURFACTANTL'OREAL
WO/2021/260079COSMETIC COMPOSITION COMPRISING A GRAFTED POLYHYDROXYALKANOATE  COPOLYMER IN A FATTY MEDIUML'OREAL
WO/2021/260093SOFT GELATIN CAPSULESITF RESEARCH PHARMA, S.L.U
WO/2021/260109A COMBINATION OF A CBP/p300 BROMODOMAIN INHIBITOR AND AN EGFR  INHIBITOR FOR USE IN TREATING EGFR-MUTANT NSCLCTOLREMO THERAPEUTICS AG
WO/2021/260110HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND  THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF FIBROTIC DISEASETOLREMO THERAPEUTICS AG
WO/2021/260111COMBINATION OF A CBP/P300 BROMODOMAIN INHIBITOR AND A KRAS  INHIBITOR FOR THE TREATMENT OF CANCERTOLREMO THERAPEUTICS AG
WO/2021/260120ARIMOCLOMOL FOR TREATING GAUCHER DISEASEORPHAZYME A/S
WO/2021/260129HUMANIZED ANTIGEN BINDING UNITS FOR TARGETING OSTEOSARCOMA  CELLSOSLO UNIVERSITETSSYKEHUS HF
WO/2021/260131VIRUS-LIKE PARTICLES OF CMV MODIFIED BY FUSIONSAIBA AG
WO/2021/260139METHODS OF TREATMENT AND DIAGNOSTIC OF PATHOLOGICAL CONDITIONS  ASSOCIATED WITH INTENSE STRESSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/260141COMPOSITIONINEOS SERVICES BELGIUM SA
WO/2021/260145METHOD FOR INCORPORATING ORGANIC COMPOUNDS IN SOLUTION WITHIN  A HYDROGELLABORATOIRES VIVACY
WO/2021/260152INHIBITORS OF ACID SPHINGOMYELINASE FOR PREVENTING AND  TREATING THE COVID-19 DISEASEASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
WO/2021/260164THROMBIN C-TERMINAL PEPTIDES TO TREAT CORONAVIRAL INFECTIONSIN2CURE AB
WO/2021/260168USE OF COMPOUNDS AS SELF-TANNING SUBSTANCES AND TANNING  COMPOSITIONS THEREOFCHEMCOM S.A.
WO/2021/260176SYNTHETIC EPITOPES OF BETACORONAVIRUSESVIROMETIX AG
WO/2021/260186ENGINEERED T CELLS CONDITIONALLY EXPRESSING A RECOMBINANT  RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODSJUNO THERAPEUTICS GMBH
WO/2021/260193PREVENTION OF AXONAL DAMAGE USING ANTIBODY BINDING TO AMYLOID  BETA 1-42MEDIMMUNE LIMITED
WO/2021/260197ENHANCED OLIGONUCLEOTIDES FOR MODULATING FUBP1 EXPRESSIONF. HOFFMANN-LA ROCHE AG
WO/2021/260198AGARICUS BLAZEI FERMENTED GRAINS AGAINST LAWSONIA  INTRACELLULARIS INFECTIONNUTRECO IP ASSETS B.V.
WO/2021/260202METHODS AND PREBIOTIC COMPOUNDS FOR IMPROVING ORAL HYGIENE AND  RELATED ORAL CARE COMPOSITIONSS&C CONSULTANCY
WO/2021/260208SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATIONBAYER AKTIENGESELLSCHAFT
WO/2021/260209CCR8 ANTIBODIES AND USES THEREOFBAYER AKTIENGESELLSCHAFT
WO/2021/260210ANTI CCR8 ANTIBODY THERAPY: BIOMARKERS & COMBINATION  THERAPIESBAYER AKTIENGESELLSCHAFT
WO/2021/260211TARGETED RELEASE RIFAXIMIN COMPOSITIONSBAUSCH HEALTH IRELAND LIMITED
WO/2021/105524PHARMACEUTICAL COMPOSITION OF IBUPROFEN SALT WITH LYSINE IN  THE FORM OF AN ORAL SOLUTIONMMC INTERNATIONAL HEALTH HOLDING, S.L.
WO/2021/219903CANNABINOIDS FOR USE IN SUPRESSING CANCER STEM CELLSEMERALD HEALTH BIOTECHNOLOGY ESPAÑA S.L.
WO/2021/250289PROBIOTIC FOR THE TREATMENT OF INFERTILITY AND RECURRENT  PREGNANCY LOSSBIOSEARCH, S.A.
WO/2021/019116PHARMACEUTICAL COMPOSITION FOR USE IN THE PROPHYLACTIC AND/OR  THERAPEUTIC TREATMENT OF L-DOPA-INDUCED DYSKINESIAUNIVERSIDADE DE SANTIAGO DE COMPOSTELA
WO/2021/023903HYPOLEPTINEMIC COMPOSITION AND USE THEREOFUNIVERSITAT ROVIRA I VIRGILI
WO/2021/023908FOOD PRODUCT DERIVED FROM THE OLIVE PLANT, PRODUCTION METHOD  AND ASSOCIATED USESROQUE INICIATIVAS SL
WO/2021/044073RECOMBINANT NANNOCHLOROPSIS GADITANA PROTEINUNIVERSIDAD DE CáDIZ
WO/2021/058847COMBINED USE OF BIOTIN AND THIAMINE IN THE TREATMENT OF  HUNTINGTON'S DISEASECONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/099662THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND  IMAGING AGENTS TO CANCER CELLSUNIVERSITAT POLITèCNICA DE VALèNCIA
WO/2021/099665PLACENTAL DECIDUA PARIETALIS STEM CELLS FOR USE IN CHRONIC  STRESS URINARY INCONTINENCEFUNDACIóN PARA LA INVESTIGACIóN BIOMéDICA DEL HOSPITAL 12 DE  OCTUBRE
WO/2021/136862LIQUID GALENIC COMPOSITION FOR ORAL USE COMPRISING MELATONIN  AND A ZINC SALT AND CORRESPONDING METHOD AND USELABORATORIOS VIÑAS S.A.
WO/2021/152192LOW AND VERY LOW MOLECULAR WEIGHT HEPARINS FOR THE TREATMENT  OF DEEP VEIN THROMBOSISLABORATORIOS FARMACéUTICOS ROVI, S.A.
WO/2021/165558BREAKABLE GALENIC CAPSULEFINGERCLIK, S.L.
WO/2021/198545USE OF BREASTMILK EXOSOMES AS RADIOISOTOPE VEHICLE FOR THE  DIAGNOSIS AND TREATMENT OF NEOPLASMSINSTITUTO DE SALUD CARLOS III (ISCIII)
WO/2021/205049COMPOUNDS FOR THE PROPHYLAXIS AND/OR TREATMENT OF ACUTE  RESPIRATORY DISTRESS SYNDROMESERVICIO ANDALUZ DE SALUD